0000081362-24-000058.txt : 20240502 0000081362-24-000058.hdr.sgml : 20240502 20240502164314 ACCESSION NUMBER: 0000081362-24-000058 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 94 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240502 DATE AS OF CHANGE: 20240502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUAKER CHEMICAL CORP CENTRAL INDEX KEY: 0000081362 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRODUCTS OF PETROLEUM & COAL [2990] ORGANIZATION NAME: 01 Energy & Transportation IRS NUMBER: 230993790 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12019 FILM NUMBER: 24909231 BUSINESS ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR STREET CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 BUSINESS PHONE: 6108324000 MAIL ADDRESS: STREET 1: ONE QUAKER PARK STREET 2: 901 HECTOR ST CITY: CONSHOHOCKEN STATE: PA ZIP: 19428 10-Q 1 kwr-20240331.htm 10-Q kwr-20240331
000008136212/312024Q1falseP1YP1Y00000813622024-01-012024-03-3100000813622024-04-30xbrli:sharesiso4217:USD00000813622023-01-012023-03-31iso4217:USDxbrli:shares00000813622024-03-3100000813622023-12-3100000813622022-12-3100000813622023-03-310000081362us-gaap:CommonStockMember2022-12-310000081362us-gaap:AdditionalPaidInCapitalMember2022-12-310000081362us-gaap:RetainedEarningsMember2022-12-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000081362us-gaap:NoncontrollingInterestMember2022-12-310000081362us-gaap:RetainedEarningsMember2022-07-012022-09-300000081362us-gaap:NoncontrollingInterestMember2022-07-012022-09-3000000813622022-07-012022-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300000081362us-gaap:CommonStockMember2022-07-012022-09-300000081362us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300000081362us-gaap:CommonStockMember2022-09-300000081362us-gaap:AdditionalPaidInCapitalMember2022-09-300000081362us-gaap:RetainedEarningsMember2022-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300000081362us-gaap:NoncontrollingInterestMember2022-09-3000000813622022-09-300000081362us-gaap:CommonStockMember2023-12-310000081362us-gaap:AdditionalPaidInCapitalMember2023-12-310000081362us-gaap:RetainedEarningsMember2023-12-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000081362us-gaap:NoncontrollingInterestMember2023-12-310000081362us-gaap:RetainedEarningsMember2023-07-012023-09-300000081362us-gaap:NoncontrollingInterestMember2023-07-012023-09-3000000813622023-07-012023-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300000081362us-gaap:CommonStockMember2023-07-012023-09-300000081362us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300000081362us-gaap:CommonStockMember2023-09-300000081362us-gaap:AdditionalPaidInCapitalMember2023-09-300000081362us-gaap:RetainedEarningsMember2023-09-300000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300000081362us-gaap:NoncontrollingInterestMember2023-09-3000000813622023-09-30kwr:countrykwr:segment0000081362kwr:ArgentineAndTurkishSubsidiariesMemberus-gaap:GeographicConcentrationRiskMembersrt:SubsidiariesMemberus-gaap:AssetsTotalMember2024-01-012024-03-31xbrli:pure0000081362us-gaap:SalesRevenueNetMemberkwr:ArgentineAndTurkishSubsidiariesMemberus-gaap:GeographicConcentrationRiskMembersrt:SubsidiariesMember2024-01-012024-03-310000081362kwr:ArgentineAndTurkishSubsidiariesMembersrt:SubsidiariesMember2024-01-012024-03-310000081362country:ARsrt:SubsidiariesMember2023-01-012023-03-310000081362kwr:I.K.V.TribologieIKVTMember2024-02-012024-02-29iso4217:EUR0000081362kwr:I.K.V.TribologieIKVTMember2024-02-290000081362us-gaap:CustomerRelationshipsMemberkwr:I.K.V.TribologieIKVTMember2024-02-290000081362us-gaap:CustomerRelationshipsMemberkwr:I.K.V.TribologieIKVTMember2024-02-012024-02-290000081362kwr:I.K.V.TribologieIKVTMemberus-gaap:TechnologyBasedIntangibleAssetsMember2024-02-290000081362kwr:I.K.V.TribologieIKVTMemberus-gaap:TechnologyBasedIntangibleAssetsMember2024-02-012024-02-290000081362us-gaap:TrademarksMemberkwr:I.K.V.TribologieIKVTMember2024-02-290000081362us-gaap:TrademarksMemberkwr:I.K.V.TribologieIKVTMember2024-02-012024-02-290000081362srt:AmericasMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362srt:AmericasMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362us-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362us-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362srt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362srt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362us-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362us-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362us-gaap:IntersegmentEliminationMembersrt:AmericasMember2024-01-012024-03-310000081362us-gaap:IntersegmentEliminationMembersrt:AmericasMember2023-01-012023-03-310000081362us-gaap:IntersegmentEliminationMemberus-gaap:EMEAMember2024-01-012024-03-310000081362us-gaap:IntersegmentEliminationMemberus-gaap:EMEAMember2023-01-012023-03-310000081362us-gaap:IntersegmentEliminationMembersrt:AsiaPacificMember2024-01-012024-03-310000081362us-gaap:IntersegmentEliminationMembersrt:AsiaPacificMember2023-01-012023-03-310000081362us-gaap:SalesRevenueNetMemberkwr:TopFiveMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-06-300000081362us-gaap:SalesRevenueNetMemberkwr:LargestCustomerMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-06-300000081362srt:AmericasMemberus-gaap:OperatingSegmentsMemberkwr:MetalsMember2024-01-012024-03-310000081362us-gaap:EMEAMemberus-gaap:OperatingSegmentsMemberkwr:MetalsMember2024-01-012024-03-310000081362srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberkwr:MetalsMember2024-01-012024-03-310000081362us-gaap:OperatingSegmentsMemberkwr:MetalsMember2024-01-012024-03-310000081362srt:AmericasMemberkwr:MetalworkingAndOtherMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362kwr:MetalworkingAndOtherMemberus-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362kwr:MetalworkingAndOtherMembersrt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362kwr:MetalworkingAndOtherMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310000081362srt:AmericasMemberus-gaap:OperatingSegmentsMemberkwr:MetalsMember2023-01-012023-03-310000081362us-gaap:EMEAMemberus-gaap:OperatingSegmentsMemberkwr:MetalsMember2023-01-012023-03-310000081362srt:AsiaPacificMemberus-gaap:OperatingSegmentsMemberkwr:MetalsMember2023-01-012023-03-310000081362us-gaap:OperatingSegmentsMemberkwr:MetalsMember2023-01-012023-03-310000081362srt:AmericasMemberkwr:MetalworkingAndOtherMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362kwr:MetalworkingAndOtherMemberus-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362kwr:MetalworkingAndOtherMembersrt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362kwr:MetalworkingAndOtherMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000081362kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember2024-03-310000081362us-gaap:LandMember2024-03-31kwr:position0000081362us-gaap:RestructuringChargesMember2023-12-310000081362us-gaap:RestructuringChargesMember2024-01-012024-03-310000081362us-gaap:RestructuringChargesMember2024-03-310000081362kwr:StockOptionsCompensationExpenseMember2024-01-012024-03-310000081362kwr:StockOptionsCompensationExpenseMember2023-01-012023-03-310000081362kwr:NonvestedStockAwardsCompensationExpenseMember2024-01-012024-03-310000081362kwr:NonvestedStockAwardsCompensationExpenseMember2023-01-012023-03-310000081362kwr:DirectorsStockOwnershipPlanCompensationExpenseMember2024-01-012024-03-310000081362kwr:DirectorsStockOwnershipPlanCompensationExpenseMember2023-01-012023-03-310000081362us-gaap:PerformanceSharesMember2024-01-012024-03-310000081362us-gaap:PerformanceSharesMember2023-01-012023-03-310000081362us-gaap:EmployeeStockOptionMember2024-03-310000081362us-gaap:EmployeeStockOptionMember2024-01-012024-03-310000081362us-gaap:RestrictedStockMember2024-01-012024-03-310000081362srt:MinimumMemberus-gaap:RestrictedStockMember2024-01-012024-03-310000081362srt:MaximumMemberus-gaap:RestrictedStockMember2024-01-012024-03-310000081362us-gaap:RestrictedStockMember2024-03-310000081362us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310000081362us-gaap:RestrictedStockUnitsRSUMember2024-03-310000081362srt:MaximumMemberus-gaap:PerformanceSharesMember2024-01-012024-03-310000081362kwr:PerformanceStockUnitsROICMember2024-01-012024-03-310000081362kwr:PerformanceStockUnitsROICMember2024-03-310000081362us-gaap:PerformanceSharesMember2024-03-310000081362us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310000081362us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-310000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310000081362us-gaap:PensionPlansDefinedBenefitMember2024-03-310000081362us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-03-310000081362srt:AmericasMembersrt:ScenarioPreviouslyReportedMemberus-gaap:OperatingSegmentsMember2023-12-310000081362srt:ScenarioPreviouslyReportedMemberus-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2023-12-310000081362srt:ScenarioPreviouslyReportedMembersrt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2023-12-310000081362srt:ScenarioPreviouslyReportedMember2023-12-310000081362srt:AmericasMemberus-gaap:OperatingSegmentsMember2024-03-310000081362us-gaap:EMEAMemberus-gaap:OperatingSegmentsMember2024-03-310000081362srt:AsiaPacificMemberus-gaap:OperatingSegmentsMember2024-03-310000081362us-gaap:CustomerListsMember2024-03-310000081362us-gaap:CustomerListsMember2023-12-310000081362kwr:TrademarksFormulationsandproducttechnologymemberMember2024-03-310000081362kwr:TrademarksFormulationsandproducttechnologymemberMember2023-12-310000081362us-gaap:OtherIntangibleAssetsMember2024-03-310000081362us-gaap:OtherIntangibleAssetsMember2023-12-310000081362kwr:HoughtonCombinationMember2023-12-310000081362kwr:AmendedRevolverMember2024-03-310000081362kwr:AmendedRevolverMember2023-12-310000081362kwr:AmendedUsTermLoanMember2024-03-310000081362kwr:AmendedUsTermLoanMember2023-12-310000081362kwr:AmendedEuroTermLoanMember2024-03-310000081362kwr:AmendedEuroTermLoanMember2023-12-310000081362kwr:IndustrialDevelopmentBondsMember2024-03-310000081362kwr:IndustrialDevelopmentBondsMember2023-12-310000081362kwr:BankLinesOfCreditAndOtherDebtObligationsMember2024-03-310000081362kwr:BankLinesOfCreditAndOtherDebtObligationsMember2023-12-310000081362kwr:AmendedEuroTermLoanMember2022-12-310000081362kwr:AmendedUsTermLoanMember2022-12-310000081362kwr:AmendedRevolverMember2022-12-310000081362kwr:AmendedCreditFacilityMember2022-12-310000081362kwr:OriginalCreditFacilityAndTheAmendedCreditFacilityMember2024-01-012024-03-310000081362kwr:OldCreditFacilityMember2024-03-310000081362srt:MinimumMemberkwr:AmendedCreditFacilityMember2024-01-012024-03-310000081362srt:MaximumMemberkwr:AmendedCreditFacilityMember2024-01-012024-03-310000081362us-gaap:RevolvingCreditFacilityMemberus-gaap:LetterOfCreditMember2024-03-310000081362us-gaap:LetterOfCreditMemberkwr:AmendedRevolverMember2024-03-310000081362us-gaap:InterestRateSwapMember2023-09-300000081362us-gaap:InterestRateSwapMember2023-07-012023-09-300000081362us-gaap:InterestRateSwapMember2024-03-310000081362kwr:AmendedRevolverMemberus-gaap:OtherAssetsMember2022-12-310000081362us-gaap:OtherAssetsMember2024-03-310000081362us-gaap:OtherAssetsMember2023-12-310000081362us-gaap:CorporateBondSecuritiesMember2024-03-310000081362us-gaap:CorporateBondSecuritiesMember2023-12-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-12-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-03-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-01-012024-03-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-03-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-03-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-03-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-03-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-03-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-012023-03-310000081362us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000081362us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-03-310000081362us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-03-310000081362us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000081362us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100000813622023-06-012023-06-300000081362currency:MXN2024-03-310000081362currency:JPY2024-03-310000081362currency:CNY2024-03-310000081362us-gaap:ForeignExchangeForwardMember2024-01-012024-03-310000081362us-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2024-01-012024-03-310000081362us-gaap:OtherNoncurrentAssetsMemberus-gaap:InterestRateSwapMember2023-01-012023-06-300000081362us-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2023-01-012023-09-300000081362us-gaap:AccruedLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2024-01-012024-03-310000081362us-gaap:InterestRateSwapMember2024-01-012024-03-310000081362us-gaap:InterestRateSwapMember2023-01-012023-06-300000081362us-gaap:InterestExpenseMember2024-01-012024-03-310000081362us-gaap:InterestExpenseMember2023-01-012023-03-310000081362us-gaap:NonoperatingIncomeExpenseMember2024-01-012024-03-310000081362us-gaap:NonoperatingIncomeExpenseMember2023-01-012023-03-310000081362kwr:HoughtonEnvironmentalMattersMember2023-12-310000081362kwr:HoughtonEnvironmentalMattersMember2024-03-310000081362srt:MinimumMemberkwr:CoralChemicalCompanyMember2024-03-310000081362srt:MaximumMemberkwr:CoralChemicalCompanyMember2024-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 10-Q
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2024
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission file number 001-12019
QUAKER CHEMICAL CORPORATION
(Exact name of registrant as specified in its charter)
Pennsylvania23-0993790
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
901 E. Hector Street,
Conshohocken, Pennsylvania
19428 – 2380
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: 610-832-4000
Not Applicable
Former name, former address and former fiscal year, if changed since last report.
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $1 par valueKWR
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes    x     No    o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   x     No    o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerxAccelerated filero
Non-accelerated fileroSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  o   No  x
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Number of Shares of Common Stock Outstanding on April 30, 2024
17,989,892

Quaker Chemical Corporation
Table of Contents
Page
Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023
Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2024 and March 31, 2023
Item 5.
1
PART I
FINANCIAL INFORMATION
Item 1.    Financial Statements (Unaudited).
Quaker Chemical Corporation
Condensed Consolidated Statements of Operations
(Unaudited; Dollars in thousands, except per share data)
Three Months Ended
March 31,
20242023
Net sales$469,759 $500,148 
Cost of goods sold (excluding amortization expense - See Note 13)288,196 326,698 
Gross profit181,563 173,450 
Selling, general and administrative expenses124,180 119,549 
Restructuring and related charges, net1,857 3,972 
Operating income55,526 49,929 
Other income (expense), net1,080 (2,239)
Interest expense, net(10,824)(13,242)
Income before taxes and equity in net income of associated companies45,782 34,448 
Taxes on income before equity in net income of associated companies12,508 9,533 
Income before equity in net income of associated companies33,274 24,915 
Equity in net income of associated companies1,984 4,626 
Net income35,258 29,541 
Less: Net income attributable to noncontrolling interest31 7 
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Per share data:
Net income attributable to Quaker Chemical Corporation common shareholders – basic$1.96 $1.64 
Net income attributable to Quaker Chemical Corporation common shareholders – diluted$1.95 $1.64 
Dividends declared$0.455 $0.435 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2
Quaker Chemical Corporation
Condensed Consolidated Statements of Comprehensive Income
(Unaudited; Dollars in thousands)
Three Months Ended
March 31,
20242023
Net income$35,258 $29,541 
Other comprehensive (loss) income, net of tax
Currency translation adjustments(25,389)14,468 
Defined benefit retirement plans354 (126)
Current period change in fair value of derivatives2,345 390 
Unrealized gain on available-for-sale securities45 334 
Other comprehensive (loss) income(22,645)15,066 
Comprehensive income12,613 44,607 
Less: Comprehensive loss (income) attributable to noncontrolling interest42 (10)
Comprehensive income attributable to Quaker Chemical Corporation$12,655 $44,597 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
Quaker Chemical Corporation
Condensed Consolidated Balance Sheets
(Unaudited; Dollars in thousands, except par value)
March 31,
2024		December 31,
2023
ASSETS
Current assets
Cash and cash equivalents$195,750$194,527
Accounts receivable, net440,018444,950
Inventories
  Raw materials and supplies116,411119,047
  Work-in-process and finished goods124,055114,810
Prepaid expenses and other current assets56,79554,555
Total current assets933,029927,889
Property, plant and equipment, at cost445,118453,419
  Less: Accumulated depreciation(242,888)(245,608)
    Property, plant and equipment, net202,230207,811
Right of use lease assets38,19538,614
Goodwill522,575512,518
Other intangible assets, net886,146896,721
Investments in associated companies99,850101,151
Deferred tax assets10,11710,737
Other non-current assets22,22818,770
Total assets$2,714,370$2,714,211
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current portion of long-term debt$27,790$23,444
Accounts payable191,161184,813
Dividends payable8,1858,186
Accrued compensation28,02455,194
Accrued restructuring1,5163,350
Accrued pension and postretirement benefits2,2102,208
Other accrued liabilities91,34190,315
Total current liabilities350,227367,510
Long-term debt740,408730,623
Long-term lease liabilities22,81922,937
Deferred tax liabilities150,618146,957
Non-current accrued pension and postretirement benefits28,93129,457
Other non-current liabilities29,57531,805
Total liabilities1,322,5781,329,289
Commitments and contingencies (Note 18)
Equity
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding
March 31, 2024 – 17,989,801 shares; December 31, 2023 – 17,991,988 shares
17,99017,992
Capital in excess of par value942,546940,101
Retained earnings577,682550,641
Accumulated other comprehensive loss(146,987)(124,415)
Total Quaker shareholders’ equity1,391,2311,384,319
Noncontrolling interest561603
Total equity1,391,7921,384,922
Total liabilities and equity$2,714,370$2,714,211
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
Quaker Chemical Corporation
Condensed Consolidated Statements of Cash Flows
(Unaudited; Dollars in thousands)
Three Months Ended
March 31,
20242023
Cash flows from operating activities
Net income$35,258 $29,541 
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of debt issuance costs353 353 
Depreciation and amortization20,802 20,246 
Equity in undistributed earnings of associated companies, net of dividends(1,675)(4,401)
Deferred compensation, deferred taxes and other, net568 (2,231)
Share-based compensation3,884 3,527 
Restructuring and related charges, net1,857 3,972 
Pension and other postretirement benefits(551)(415)
Decrease in cash from changes in current assets and current liabilities, net of acquisitions:
Accounts receivable1,431 (3,974)
Inventories(6,576)(5,792)
Prepaid expenses and other current assets(1,054)(6,765)
Change in restructuring liabilities(3,666)(2,747)
Accounts payable and accrued liabilities(23,400)6,468 
Net cash provided by operating activities27,231 37,782 
Cash flows from investing activities
Investments in property, plant and equipment(4,460)(6,161)
Payments related to acquisitions, net of cash acquired(24,899)— 
Proceeds from disposition of assets58 — 
Net cash used in investing activities(29,301)(6,161)
Cash flows from financing activities
Payments of long-term debt(4,711)(4,703)
Borrowings (payments) on revolving credit facilities, net20,902 (9,776)
Payments on other debt, net— (469)
Dividends paid(8,186)(7,809)
Other stock related activity(1,442)(2,109)
Net cash provided by (used in) financing activities6,563 (24,866)
Effect of foreign exchange rate changes on cash(3,270)2,154 
Net increase in cash and cash equivalents1,223 8,909 
Cash and cash equivalents at the beginning of the period194,527 180,963 
Cash and cash equivalents at the end of the period$195,750 $189,872 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
Quaker Chemical Corporation
Condensed Consolidated Statements of Changes in Equity
(Unaudited; Dollars in thousands, except per share amounts)
Common
Stock		Capital in
Excess of
Par Value		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Noncontrolling
Interest		Total
Balance as of December 31, 2022$17,950 $928,288 $469,920 $(138,240)$667 $1,278,585 
Net income— — 29,534 — 7 29,541 
Amounts reported in other comprehensive income— — — 15,063 3 15,066 
Dividends ($0.435 per share)
— — (7,822)— — (7,822)
Share issuance and equity-based compensation plans32 1,386 — — — 1,418 
Balance as of March 31, 2023$17,982 $929,674 $491,632 $(123,177)$677 $1,316,788 
Balance as of December 31, 2023$17,992 $940,101 $550,641 $(124,415)$603 $1,384,922 
Net income— — 35,227 — 31 35,258 
Amounts reported in other comprehensive loss— — — (22,572)(73)(22,645)
Dividends ($0.455 per share)
— — (8,186)— — (8,186)
Share issuance and equity-based compensation plans(2)2,445 — — — 2,443 
Balance as of March 31, 2024$17,990 $942,546 $577,682 $(146,987)$561 $1,391,792 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 1 – Basis of Presentation and Description of Business
As used in these Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Report”), the terms “Quaker Houghton,” the “Company,” “we,” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires.
Basis of Presentation
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting of normal recurring adjustments which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2023 (as amended, the “2023 Form 10-K”).
Description of Business
The Company was organized in 1918 and incorporated as a Pennsylvania business corporation in 1930. Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, the Company’s customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Quaker Houghton develops, produces, and markets a broad range of formulated chemical specialty products and offers chemical management services, which the Company refers to as FluidcareTM, for various heavy industrial and manufacturing applications sold in its three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific.
Hyper-inflationary economies
Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three months ended March 31, 2024, the Company's Argentine and Turkish subsidiaries together represented 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three months ended March 31, 2024 and 2023, the Company recorded $0.9 million of remeasurement gains and $0.5 million of remeasurement losses associated with the applicable currency conversions, respectively. These gains and losses were recorded within Other income (expense), net, in the Company’s Condensed Consolidated Statements of Operations.
Note 2 – Business Acquisitions
During February 2024, the Company acquired I.K.V. Tribologie IKVT and its subsidiaries (“IKV”) for 32.2 million EUR, or $34.6 million, including an initial cash payment of 27.6 million EUR, or $29.7 million, subject to routine and customary post-closing adjustments related to working capital and net indebtedness levels as well as earn-out provisions related to the finalization of 2023 earnings currently estimated at 4.6 million EUR, or $4.9 million, that is payable during 2024. Assets acquired included approximately $4.8 million of cash and cash equivalents. IKV, which will be part of the Company’s EMEA segment, specializes in high-performance lubricants and greases, including original equipment manufacturer first-fill greases that are primarily used in the automotive, aerospace, electronics, and other industrial markets. The acquisition of IKV strengthens the Company’s position in first-fill greases. The Company preliminarily allocated $15.0 million of the purchase price to intangible assets, comprised of approximately $11.1 million of customer relationships to be amortized over 16 years; $3.2 million of product technologies to be amortized over 14 years; and $0.7 million of trademarks to be amortized over 5 years. In addition, the Company recognized $16.0 million of goodwill in the EMEA segment, none of which is deductible for tax purposes. The goodwill recognized on the transaction is primarily attributable to expected cost and growth synergies. As of March 31, 2024, the allocation of the purchase price has not been finalized.
The results of operations of IKV subsequent to the acquisition date are included in the unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2024.
7
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 3 – Recently Issued Accounting Standards
Recently Issued Accounting Standards Not Yet Adopted
The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures in November 2023. This ASU expands on reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The disclosure specifies that significant segment expenses are expenses that are regularly provided to the chief operating decision maker and are used to evaluate performance by segment to make decisions about resource allocations. ASU 2023-07 is effective for annual reports for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the disclosure requirements of this standard and the impact on its Consolidated Financial Statements and related disclosures.
The FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures in December 2023. This ASU requires public business entities to disclose additional information in specified categories with respect to the reconciliation of the effective tax rate to the statutory rate (the “rate reconciliation”) for federal, state, and foreign income taxes. It also requires greater detail about individual reconciling items in the rate reconciliation to the extent the impact of those items exceeds a specified threshold. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the disclosure requirements of this standard and the impact on its Consolidated Financial Statements.
Note 4 – Business Segments
The Company’s operating segments, which are consistent with its reportable segments, reflect the structure of the Company’s internal organization, the method by which the Company’s resources are allocated and the manner by which the chief operating decision maker assesses the Company’s performance. The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific. The three segments are composed of the net sales and operations in each respective region.
Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related Cost of goods sold (“COGS”), and Selling, general and administrative expenses (“SG&A”). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs and Restructuring and related charges, net, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense, net and Other income (expense), net.
The following table presents information about the performance of the Company’s reportable segments for the three months ended March 31, 2024 and 2023:
Net sales20242023
Americas$229,754 $251,413 
EMEA138,422 152,449 
Asia/Pacific101,583 96,286 
Total net sales$469,759 $500,148 
Segment operating earnings
Americas$66,770 $66,125 
EMEA29,571 27,571 
Asia/Pacific30,377 27,652 
Total segment operating earnings126,718 121,348 
Restructuring and related charges, net(1,857)(3,972)
Non-operating and administrative expenses(54,177)(51,771)
Depreciation of corporate assets and amortization(15,158)(15,676)
Operating income55,526 49,929 
Other income (expense), net1,080 (2,239)
Interest expense, net(10,824)(13,242)
Income before taxes and equity in net income of associated companies$45,782 $34,448 
8
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables. The following table summarizes inter-segment revenues for the three months ended March 31, 2024 and 2023:
Inter-segment revenues20242023
Americas$2,513 $2,827 
EMEA7,060 6,093 
Asia/Pacific1,131 59 
Note 5 – Net Sales and Revenue Recognition
Arrangements Resulting in Net Reporting
As part of the Company’s FluidcareTM business, certain third-party product sales to customers are managed by the Company. The Company transferred third-party products under arrangements recognized on a net reporting basis of $19.8 million and $20.7 million for the three months ended March 31, 2024 and 2023, respectively.
Customer Concentration
A significant portion of the Company’s revenues are realized from the sale of process fluids and services to manufacturers of steel, aluminum, automobiles, aerospace, industrial and agricultural equipment, and durable goods. As previously disclosed in the Company’s 2023 Form 10-K, the Company’s five largest customers combined (each composed of multiple subsidiaries or divisions with semiautonomous purchasing authority) accounted for approximately 12% of consolidated net sales for 2023, with its largest customer accounting for approximately 3% of consolidated net sales.
Contract Assets and Liabilities
The Company had no material contract assets recorded on its Condensed Consolidated Balance Sheets as of March 31, 2024 or December 31, 2023.
The Company had approximately $4.0 million and $4.5 million of deferred revenue as of March 31, 2024 and December 31, 2023, respectively. For the three months ended March 31, 2024, the Company satisfied materially all of the associated performance obligations and recognized into revenue materially all advance payments received and recorded as of December 31, 2023.
Disaggregated Revenue
The Company sells its various industrial process fluids, its specialty chemicals and its technical expertise as a global product portfolio. The Company generally manages and evaluates its performance by reportable segment first, and then by customer industries. Net sales of each of the Company’s major product lines are generally spread throughout all three of the Company’s geographic regions, and in most cases, are approximately proportionate to the level of total sales in each region.
The following tables disaggregate the Company’s net sales by segment and customer industry.
Three Months Ended March 31, 2024
Customer IndustriesAmericasEMEAAsia/PacificConsolidated
Total
Metals$66,026 $32,820 $50,911 $149,757 
Metalworking and other163,728 105,602 50,672 320,002 
$229,754 $138,422 $101,583 $469,759 
Three Months Ended March 31, 2023
Customer IndustriesAmericasEMEAAsia/PacificConsolidated
Total
Metals$68,134 $39,103 $46,660 $153,897 
Metalworking and other183,279 113,346 49,626 346,251 
$251,413 $152,449 $96,286 $500,148 
9
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 6 - Leases
The Company has operating leases for certain facilities, vehicles, and machinery and equipment with remaining lease terms up to 11 years. Operating lease expense is recognized on a straight-line basis over the lease term. In addition, the Company has certain land use leases with remaining lease terms up to 91 years.
The Company had no material variable lease costs, sublease income, or finance leases for the three months ended March 31, 2024 and 2023. The components of the Company’s lease expense are as follows:
20242023
Operating lease expense$3,743 $3,936 
Short-term lease expense199 211 
Supplemental cash flow information related to the Company’s leases for the three months ended March 31, 2024 and 2023 is as follows:
20242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$3,661 $3,857 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities3,234 2,833 
Supplemental balance sheet information related to the Company’s leases is as follows:
March 31,
2024		December 31,
2023
Right of use lease assets$38,195 $38,614 
Other current liabilities11,818 11,965 
Long-term lease liabilities22,819 22,937 
Total operating lease liabilities$34,637 $34,902 
Weighted average remaining lease term (years)5.05.1
Weighted average discount rate5.21 %4.91 %
Maturities of operating lease liabilities as of March 31, 2024 were as follows:
For the remainder of 2024$10,341 
For the year ended December 31, 20259,864 
For the year ended December 31, 20267,552 
For the year ended December 31, 20274,165 
For the year ended December 31, 20282,402 
For the year ended December 31, 2029 and beyond5,262 
  Total lease payments39,586 
    Less: imputed interest(4,949)
Present value of lease liabilities$34,637 
Note 7 – Restructuring and Related Activities
In 2022, the Company initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. As of March 31, 2024, the program included restructuring and associated severance costs to reduce headcount by approximately 120 positions globally. These headcount reductions began in the fourth quarter of 2022 and are expected to be completed in 2024.
10
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Employee separation benefits vary depending on local regulations within certain foreign countries and include severance and other benefits. The exact timing to complete, and final costs associated with, all actions will depend on a number of factors and are subject to change. Restructuring costs incurred during the three months ended March 31, 2024 and 2023 include employee severance and facility closure costs that are recorded in Restructuring and related charges, net in the Company’s Condensed Consolidated Statements of Operations.
Changes in the Company’s accruals for its restructuring program are as follows:
Accrued restructuring as of December 31, 2023$3,350
Restructuring and related charges, net1,857 
Cash payments(3,666)
Currency translation adjustments(25)
Accrued restructuring as of March 31, 2024$1,516
In connection with the plans for closure of certain manufacturing and non-manufacturing facilities, the Company has made available for sale certain facilities and property. As of March 31, 2024, the Company classified certain properties with aggregate book value of approximately $3.7 million as held-for-sale. These assets are recorded in Prepaid expenses and other current assets on the Company’s Condensed Consolidated Balance Sheets. The Company expects to complete the sale of these properties over the next 12 months.
Note 8 – Share-Based Compensation
The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:
20242023
Stock options$175$431
Non-vested stock awards and restricted stock units2,5352,171
Director stock ownership plan3010
Performance stock units1,144915
  Total share-based compensation expense$3,884$3,527
Stock Options
As of March 31, 2024, unrecognized compensation expense related to unvested stock options was $0.1 million, to be recognized over a weighted average remaining period of 1.0 year.
Restricted Stock Awards
During the three months ended March 31, 2024, the Company granted 872 non-vested restricted share awards under its long-term incentive plan (“LTIP”), which are subject to time-based vesting, generally over one to three years. As of March 31, 2024, unrecognized compensation expense related to the non-vested restricted shares was $4.3 million, to be recognized over a weighted average remaining period of 1.3 years.
Restricted Stock Units
During the three months ended March 31, 2024, the Company granted 41,093 restricted stock units under its LTIP, which are subject to time-based vesting, generally over one to three years. The fair value of these grants is based on the closing price of the Company’s common stock on the date of grant. As of March 31, 2024, unrecognized compensation expense related to non-vested restricted stock units was $8.8 million, to be recognized over a weighted average remaining period of 1.9 years.
Performance Stock Units
As a component of its LTIP, the Company grants performance-based stock unit awards (“PSUs”). The number of shares that may ultimately be issued as settlement for each award may range from 0% up to 200% of the target award, subject to the achievement of the Company’s market-based total shareholder return (“TSR”) metric relative to the performance of a selected peer group, and separately the achievement of a performance-based return on invested capital (“ROIC”) measure. The service vesting period required for the PSUs is generally three years and the measurement period of the market-based and performance objectives is generally from January 1 of the year of grant through December 31 of the year prior to issuance of the shares.
11
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
As mentioned above, a portion of the Company’s PSU valuation is subject to the achievement of the Company’s TSR relative to the performance of a selected peer group. For PSUs granted prior to 2024, the Company’s peer group was the S&P Midcap 400 Materials group. For the 2024 annual LTIP grants, the Company made an election to change peer groups to the S&P 1500 Chemical group to measure the Company’s relative TSR.
Compensation expense for PSUs is measured based on the grant date fair value and is recognized on a straight-line vesting method basis over the applicable vesting period. In the first quarter of 2024, the Company granted 17,970 PSUs with a ROIC condition at a grant date fair value of $200.16 per unit, which was based on the closing trading price of the Company’s common stock on the date of grant. PSUs granted with a relative TSR condition are valued using a Monte Carlo simulation on the date of grant. The grant-date fair value of the PSUs valued using a Monte Carlo simulation was $234.19 per unit, which incorporated the assumptions set forth in the table below:
2024
Grants
Number of PSUs granted17,850
Risk-free interest rate4.55%
Dividend yield0.91%
Expected term (years)3.0
As of March 31, 2024, there was approximately $13.4 million of total unrecognized compensation cost related to PSUs, which the Company expects to recognize over a weighted-average period of 2.5 years.
Note 9 – Pension and Other Postretirement Benefits
The components of net periodic benefit cost (income) are as follows for the three months ended March 31, 2024 and 2023:
Pension BenefitsOther Postretirement Benefits
2024202320242023
Service cost$109$104$—$— 
Interest cost2,3752,4551519 
Expected return on plan assets(2,030)(1,997)——
Actuarial loss (gain) amortization127101(29)(30)
Prior service cost (income) amortization78— (4)
Net periodic benefit cost (income)$588 $671$(14)$(15)
Employer Contributions
As of March 31, 2024, $0.9 million and less than $0.1 million of contributions have been made to the Company’s U.S. and foreign pension plans and its other postretirement benefit plans, respectively. Taking into consideration current minimum cash contribution requirements, the Company currently expects to make full year cash contributions of approximately $5.7 million to its U.S. and foreign pension plans and approximately $0.2 million to its other postretirement benefit plans in 2024.
12
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 10 – Other income (expense), net
The components of Other income (expense), net are as follows for the three months ended March 31, 2024 and 2023:
20242023
Non-income tax refunds and other related credits$2,155$360
Income from third party license fees225325
Gain (loss) on disposals of property, plant, equipment and other assets, net407(19)
Foreign exchange losses, net(448)(3,326)
Pension and postretirement benefit costs, non-service components(465)(552)
Facility remediation recoveries, net— 827
Product liability claim(896)—
Other non-operating income, net102146
  Total other income (expense), net$1,080$(2,239)
During 2021, two of the Company’s locations suffered property damages as a result of flooding and electrical fire, respectively. Facility remediation recoveries, net, during the three months ended March 31, 2023, reflect recoveries recorded on the payments received from insurers related to previously incurred costs from the remediation and restoration of property damage. See Note 18 of Notes to the Condensed Consolidated Financial Statements.
Product liability claim costs includes recorded expense related to the payment of a product liability dispute with one of the Company’s customers during the three months ended March 31, 2024.
Note 11 – Income Taxes
The Company’s effective tax rates for the three months ended March 31, 2024 and 2023 were 27.3% and 27.7%, respectively. The Company’s effective tax rate for the three months ended March 31, 2024 was largely driven by a mix of earnings and withholding taxes, offset by changes in uncertain tax positions. Comparatively, the effective tax rate for the first three months of 2023 was largely impacted by foreign tax inclusions, withholding taxes, and foreign tax credits, partially offset with changes in uncertain tax positions and favorable return to provision adjustments.
Note 12 – Earnings Per Share
The following table summarizes earnings per share calculations for the three months ended March 31, 2024 and 2023:
20242023
Basic earnings per common share
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Less: income allocated to participating securities(159)(145)
Net income available to common shareholders$35,068 $29,389 
Basic weighted average common shares outstanding17,908,81417,866,670
Basic earnings per common share$1.96 $1.64 
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Less: income allocated to participating securities(158)(145)
Net income available to common shareholders$35,069 $29,389 
Basic weighted average common shares outstanding17,908,81417,866,670
Effect of dilutive securities30,04832,076
Diluted weighted average common shares outstanding17,938,86217,898,746
Diluted earnings per common share$1.95 $1.64 
Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included were 39,066 and 15,327 for the three months ended March 31, 2024 and 2023, respectively.
13
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 13 – Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the three months ended March 31, 2024 were as follows:
AmericasEMEAAsia/PacificTotal
Balance as of December 31, 2023$283,103$65,940$163,475$512,518
Goodwill additions— 16,011 — 16,011
Currency translation adjustments(115)(663)(5,176)(5,954)
Balance as of March 31, 2024$282,988$81,288$158,299$522,575
Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:
Gross Carrying
Amount		Accumulated
Amortization		Net Book Value
March 31, 2024December 31, 2023March 31, 2024December 31, 2023March 31, 2024December 31, 2023
Customer lists and rights to sell$843,295$841,562$253,464$243,872$589,831$597,690
Trademarks, formulations and product technology163,391161,61357,41155,879105,980105,734
Other5,8645,8925,7535,776111116
Total definite-lived intangible assets$1,012,550$1,009,067$316,628$305,527$695,922$703,540
The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded amortization expense for the three months ended March 31, 2024 and 2023 as follows:
20242023
Amortization expense$14,472 $14,513 
Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:
For the remainder of 2024$43,248
For the year ended December 31, 202557,158
For the year ended December 31, 202656,470
For the year ended December 31, 202756,175
For the year ended December 31, 202855,835
For the year ended December 31, 202955,373
As of March 31, 2024 and December 31, 2023, the Company had indefinite-lived intangible assets for trademarks and tradenames totaling $190.2 million and $193.2 million, respectively.
14
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 14 – Debt
The following table sets forth the components of the Company’s debt:
As of March 31, 2024As of December 31, 2023
Interest
Rate		Outstanding
Balance		Interest
Rate		Outstanding
Balance
Credit Facilities:
Revolver5.00%$51,806 5.13%$30,904 
U.S. Term Loan6.54%557,500 6.71%561,250 
Euro Term Loan5.00%148,032 5.13%152,366 
Industrial development bonds5.26%10,000 5.26%10,000 
Bank lines of credit and other debt obligationsVarious2,294 Various1,092 
Total debt$769,632 $755,612 
Less: debt issuance costs(1,434)(1,545)
Less: short-term and current portion of long-term debts(27,790)(23,444)
Total long-term debt$740,408 $730,623 
Credit facilities
During June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase.
As of March 31, 2024, the Company was in compliance with all of the Credit Facility covenants. See Note 19 of Notes to Consolidated Financial Statements in the Company’s 2023 Form 10-K.
The weighted average variable interest rate incurred on the outstanding borrowings under the Credit Facility during the three months ended March 31, 2024 was approximately 6.4%. As of March 31, 2024, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.1%. As part of the Credit Facility, in addition to paying interest on outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $445 million, which is net of bank letters of credit of approximately $3 million, as of March 31, 2024.
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings to an average fixed rate of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of March 31, 2024, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements.
In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized an aggregate of $2.2 million of certain third-party and creditor debt issuance costs. Approximately $0.7 million of the capitalized costs were attributed to the Euro Term Loan and U.S. Term Loan. These costs were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Approximately $1.5 million of the capitalized costs were attributed to the Revolver and recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs will collectively be amortized into Interest expense over the five year term of the Credit Facility. As of March 31, 2024, the Company had $1.4 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.1 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2023, the Company had $1.5 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheets.
15
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Industrial development bonds
As of March 31, 2024 and December 31, 2023, the Company had fixed rate, industrial development authority bonds totaling $10.0 million in principal amount due in 2028. These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting facilities in certain foreign subsidiaries, which are not collateralized. The Company’s other debt obligations primarily consist of certain domestic and foreign low interest rate or interest-free municipality-related loans, local credit facilities of certain foreign subsidiaries, and capital lease obligations. Total unused capacity under these arrangements as of March 31, 2024 was approximately $34 million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of March 31, 2024 were approximately $5 million.
Interest expense, net
The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:
20242023
Interest expense$11,282 $13,876 
Amortization of debt issuance costs353 353 
  Total$11,635 $14,229 
Based on the variable interest rates associated with the Credit Facility, as of March 31, 2024 and as of December 31, 2023, the amounts at which the Company’s total debt were recorded are not materially different from their fair market value.
Note 15 – Accumulated Other Comprehensive Income
The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance as of December 31, 2023$(115,417)$(10,738)$333 $1,407 $(124,415)
Other comprehensive (loss) income before Reclassifications(25,316)320 63 3,045 (21,888)
Amounts reclassified from AOCI— 150 (7)— 143 
Related tax amounts— (116)(11)(700)(827)
Balance as of March 31, 2024$(140,733)$(10,384)$378 $3,752 $(146,987)
Balance as of December 31, 2022$(132,161)$(4,595)$(1,484)$— $(138,240)
Other comprehensive income (loss) before Reclassifications14,465 (243)462 506 15,190 
Amounts reclassified from AOCI— 76 (40)— 36 
Related tax amounts— 41 (88)(116)(163)
Balance as of March 31, 2023$(117,696)$(4,721)$(1,150)$390 $(123,177)
16
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
Note 16 – Fair Value Measurements
The Company values its company-owned life insurance policies at fair value. During June 2023, the Company surrendered and liquidated $1.9 million of these life insurance policies. As a result, the Company owns an immaterial amount of company-owned life insurance policies as of March 31, 2024 and December 31, 2023.
Additionally, see Note 17 for a description of the Company’s derivative instruments.
Note 17 – Hedging Activities
The Company’s ongoing business operations expose it to various risks, including fluctuating foreign exchange rates and interest rate risk. To manage these risks, the Company periodically enters into derivative financial instruments, such as foreign exchange forward contracts and interest rate swap agreements. The Company does not hold or enter into financial instruments for trading or speculative purposes.
Foreign Exchange Forward Contracts
The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. These forward contracts are marked-to-market at each reporting date. Changes in the fair value of the underlying instrument and settlements are recognized in earnings in Other income (expense), net. The fair value of the forward contract is determined from sources independent of the Company, including the financial institutions which are party to the derivative instruments.
Open foreign exchange forward contracts as of March 31, 2024 were entered into as hedges in Japanese yen and Mexican peso against the U.S. dollar and Chinese yuan against the Euro. As of March 31, 2024, the Company had open foreign exchange forward contracts with notional U.S. dollar values of the following:
CurrencyMarch 31,
2024
Mexican Peso$41,000 
Japanese Yen7,200 
  Chinese Yuan7,800 
$56,000 
Open foreign exchange forward contracts as of March 31, 2024 had maturities occurring over a period of one month.
Interest Rate Swaps
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as the Secured Overnight Financing Rate (“SOFR”), in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings into a fixed rate obligation. See Note 14 of Notes to Condensed Consolidated Financial Statements. These interest rate swaps are designated as cash flow hedges and, as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective and reclassified to interest expense in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur.
The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:
Derivatives instrumentsCondensed Consolidated Balance Sheets LocationMarch 31,
2024		December 31,
2023
Interest rate swaps:Other non-current assets$4,873 $1,828 
Foreign currency forward contracts:Other accrued liabilities— 159 
Prepaid expenses and other current assets687 — 
17
Quaker Chemical Corporation
Notes to Condensed Consolidated Financial Statements - Continued
(Unaudited; Dollars in thousands, except per share amounts, unless otherwise stated)
The following table presents the net unrealized loss deferred to AOCI:
Derivatives designated as cash flow hedgesMarch 31,
2024		December 31,
2023
Interest rate swapsAOCI$3,752 $1,407 
The following table presents the location and the amount of net gain recognized in the Company’s Condensed Consolidated Statements of Operations related to derivative instruments for the three months ended March 31, 2024 and 2023:
Derivative instrumentsCondensed Consolidated Statements of Operations Location20242023
Interest rate swapsInterest expense, net$1,286 $— 
Foreign exchange forward contractsOther income, net943 293 
   Total$2,229 $293 
Note 18 – Commitments and Contingencies
As previously disclosed in its 2023 Form 10-K, the Company is party to certain environmental matters and other litigation. See Note 25 of Notes to Consolidated Financial Statements in the Company’s 2023 Form 10-K. During the three months ended March 31, 2024, there have been no significant changes to the facts or circumstances of any of the previously disclosed matters. Although there can be no assurance regarding the outcome of any of the ongoing environmental matters or litigation, the Company believes that it has made adequate accruals for costs and liabilities associated with these matters. The Company has accrued approximately $5 million as of both March 31, 2024 and December 31, 2023, respectively, for these ongoing matters.
The Company previously disclosed in its 2023 Form 10-K that one of its locations suffered property damage as a result of an electrical fire. The Company and its insurance carrier continue to review the impact of the electrical fire on the production facility’s operations as it relates to a potential business interruption insurance claim; however, as of the date of this Report, the Company cannot reasonably estimate any probable amount of business interruption insurance claim recoverable. Therefore, the Company has not recorded a gain contingency for a possible business interruption insurance claim as of March 31, 2024.
In December 2021, the Company completed its acquisition of Coral Chemical Company (“Coral”), a privately held, U.S.-based provider of metal finishing fluid solutions. Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have worked to finalize certain post-closing adjustments. During the second quarter of 2022, after failing to reach resolution, the Sellers filed suit asserting certain amounts owed related to tax attributes of the acquisition. Since the second quarter of 2022, there have been no material changes to the facts and circumstances of the claim asserted by the Sellers, and the Company continues to believe the potential range of exposure for this claim is $0 to $1.5 million.
In addition, during the three months ended March 31, 2024, there are no new environmental matters or litigation that the Company believes will have a material adverse effect on the Company’s results of operations, cash flows, or financial condition.

18
Quaker Chemical Corporation
Management’s Discussion and Analysis
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
As used in this Report, the terms “Quaker Houghton,” the “Company,” “we” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires.
Executive Summary
Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, our customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge, and customized services. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the U.S.
Quaker Houghton delivered strong results in the first quarter of 2024. Net sales in the first quarter of 2024 were $469.8 million, a decrease of 6% compared to $500.1 million in the first quarter of 2023. This was primarily driven by a decrease in selling price and product mix of approximately 5% and a 1% decrease in sales volumes. The decrease in selling price and product mix was primarily attributable to our index-based customer contracts. The decline in sales volumes was a result of soft end market conditions compared to the prior year, primarily in the Americas and EMEA segments, partially offset by a broad improvement in end market activity in the Asia/Pacific segment as well as new business wins across all segments.
The Company generated net income in the first quarter of 2024 of $35.2 million, or $1.95 per diluted share, compared to net income of $29.5 million, or $1.64 per diluted share in the first quarter of 2023. Excluding non-recurring and non-core items in each period, the Company’s first quarter 2024 non-GAAP earnings per diluted share was $2.09 compared to $1.89 in the prior year quarter and the Company’s current quarter adjusted EBITDA was $83.3 million compared to $78.8 million in the first quarter of 2023. The increase in current quarter earnings was primarily driven by an improvement in gross margins related to a reduction in raw material costs compared to the prior year quarter, partially offset by lower net sales and higher selling, general and administrative expenses (“SG&A”) as a result of year-over-year inflationary pressures and higher labor-related costs. See the Non-GAAP Measures section of this Item below, as well as other items discussed in the Company’s Consolidated Operations Review in the Operations section of this Item, below.
The Company’s first quarter 2024 operating performance in each of its three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific, reflects similar drivers to that of its consolidated performance. Operating earnings for all segments increased compared to the prior year quarter, driven by an improvement in margins in all three segments. Additional details of each segment’s operating performance are further discussed in the Company’s Reportable Segments Review, in the Operations section of this Item, below.
Net cash flows provided by operating activities were $27.2 million in the first three months of 2024 compared to $37.8 million in the first three months of 2023. The lower operating cash flow year-over-year reflects an increase in the net cash outflows from working capital in the first three months of 2024 partially offset by higher operating performance in the first three months of 2024 compared to 2023. The key drivers of the Company’s operating cash flow and working capital are further discussed in the Company’s Liquidity and Capital Resources section of this Item, below.
Overall, the Company delivered strong results in the first quarter of 2024 highlighted by margin improvement and earnings growth, notwithstanding the macroeconomic and geopolitical challenges, continued soft end market conditions and other factors that have impacted the Company’s customers and end markets. Looking at the remainder of 2024, the Company remains focused on executing on items within its control as it manages through a dynamic end market environment. The Company is encouraged by its continued execution on its financial and operational priorities.
Critical Accounting Policies and Estimates
Our significant accounting policies are described in “Management’s Discussion and Analysis” and “Note 1 – Significant Accounting Policies” to the Consolidated Financial Statements in our 2023 Form 10-K. There have been no material changes to the critical accounting policies and estimates previously disclosed in its 2023 Form 10-K remain materially consistent.
Recently Issued Accounting Standards
See Note 3 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report for a discussion regarding recently issued accounting standards.
19
Quaker Chemical Corporation
Management’s Discussion and Analysis
Liquidity and Capital Resources
As of March 31, 2024, we had cash and cash equivalents of $195.8 million. Total cash and cash equivalents were $194.5 million as of December 31, 2023. The approximately $1.2 million increase in cash and cash equivalents was the net result of $27.2 million of cash provided by operating activities and $6.6 million of cash provided financing activities, offset by $29.3 million of cash used in investing activities and an unfavorable impact due to the effect of foreign currency translation of approximately $3.3 million.
Net cash flows provided by operating activities were $27.2 million in the first three months of 2024 compared to $37.8 million in the first three months of 2023. The decrease in net operating cash flow year-over-year reflects higher cash outflows from working capital in 2024, driven by higher Accounts payable and accrued liabilities outflows due primarily to higher incentive compensation payments in the current year due to our improved 2023 results and a lower inflow from accounts payable due to timing of spend and payments. The decrease in net operating cash flows was partially offset by higher operating performance in 2024 compared to 2023.
Net cash flows used in investing activities were $29.3 million in the first three months of 2024 compared to $6.2 million in the first three months of 2023. The increase in cash used in investing activities year-over-year is the result of increased payments in the current year related to the IKV acquisition. See Note 2 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report for further information about business acquisitions.
Net cash flows provided by financing activities were $6.6 million in the first three months of 2024 compared to net cash flows used in financing activities of $24.9 million in the first three months of 2023. The increase in cash inflows was primarily related to net borrowings on the Company’s revolving credit facility in the first three months of 2024, primarily under the Company’s Credit Facility as described further below, as compared to net repayments in the first three months of 2023. In addition, the Company paid $8.2 million of cash dividends during the first three months of 2024, a $0.4 million, or 5% increase compared to the prior year quarter.
During June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase. The Credit Facility contains affirmative and negative covenants, financial covenants and events of default. Financial covenants contained in the Credit Facility include a consolidated interest coverage ratio test and a consolidated net leverage ratio test. As of March 31, 2024, the Company was in compliance with all of the Credit Facility covenants. Refer to the description of the Company’s primary Credit Facility in Note 19 of Notes to Consolidated Financial Statements in its 2023 Form 10-K and in Note 14 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report for more information about the covenants and events of default.
As of March 31, 2024, the Company had Credit Facility borrowings outstanding of $757.3 million. As of December 31, 2023, the Company had Credit Facility borrowings outstanding of $744.5 million. The Company’s other debt obligations are primarily industrial development bonds, bank lines of credit and municipality-related loans, which totaled $12.3 million as of March 31, 2024 and $11.1 million as of December 31, 2023. Total unused capacity under these arrangements as of March 31, 2024 was approximately $34 million. The Company’s total net debt as of March 31, 2024, which consists of total borrowings of $769.6 million less cash and cash equivalents of $195.8 million, was approximately $573.8 million.
The weighted average variable interest rate incurred on the outstanding borrowings under the Credit Facility during the three months ended March 31, 2024 was approximately 6.4%. As of March 31, 2024, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.1%. As part of the Credit Facility, in addition to paying interest on the outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $445 million, which is net of bank letters of credit of approximately $3 million, as of March 31, 2024.
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as SOFR, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three-year interest rate swaps to convert a portion of the Company’s variable rate borrowings into an average fixed rate obligation of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of March 31, 2024, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report for further information.
20
Quaker Chemical Corporation
Management’s Discussion and Analysis
In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized certain third-party and creditor debt issuance costs. Costs attributed to the Euro Term Loan and U.S. Term Loan were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Costs attributed to the Revolver were recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs are collectively being amortized into Interest expense over the five-year term of the Credit Facility. As of March 31, 2024, the Company had $1.4 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.1 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2023, the Company had $1.5 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet in Item 1 of this Report.
The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. During the first three months of 2024, the Company entered into and settled forward contracts resulting in other income of $0.9 million as compared to $0.3 million during first three months of 2023. See Note 17 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report for further information.
In the fourth quarter of 2022, the Company’s management initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. The exact timing to complete all actions and final associated costs will depend on a number of factors and are subject to change. The Company is continuing to evaluate and expects to implement further actions under this program, and as a result, additional headcount reductions and restructuring costs may be incurred in the future. The Company expects to generate full run-rate cost savings from the global cost and optimization program of approximately $20 million by the end of 2024. The Company expects total cash costs of this program to be approximately 1 to 1.5 times annualized savings. The Company recognized Restructuring and related charges of $1.9 million and $4.0 million for the three months ended March 31, 2024, and 2023, respectively, under this program. The Company made cash payments related to the settlement of restructuring liabilities under the restructuring program during the first three months of 2024 of approximately $3.7 million compared to $2.7 million in the first three months of 2023. The Company has remaining restructuring accruals, as of March 31, 2024, for this program of $1.5 million, which the Company expects to settle over the next twelve months. See Note 7 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report for further information.
As of March 31, 2024, the Company’s gross liability for uncertain tax positions, including interest and penalties, was $18.4 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability. However, should the entire liability be paid, the amount of the payment may be reduced by up to $5.7 million as a result of offsetting benefits in other tax jurisdictions.
As previously disclosed in the Company’s 2023 Form 10-K, on February 28, 2024, the Board of Directors of the Company approved a new share repurchase program (“2024 Share Repurchase Program”), authorizing the Company to repurchase up to an aggregate of $150 million of the Company’s outstanding common stock and replacing the prior share repurchase program. The 2024 Share Repurchase Program is effective immediately and has no expiration date. There were no shares repurchased during the first three months of 2024.
The Company previously disclosed in its 2023 Form 10-K that one of its locations suffered property damage as a result of an electrical fire. The Company and its insurance carrier continue to review the impact of the electrical fire on the production facility’s operations as it relates to a potential business interruption insurance claim; however, as of the date of this Report, the Company cannot reasonably estimate the probable amount of business interruption insurance claim recoverable, if any. Therefore, the Company has not recorded a gain contingency for a possible business interruption insurance claim as of March 31, 2024.
21
Quaker Chemical Corporation
Management’s Discussion and Analysis
The Company believes that its existing cash, anticipated cash flows from operations and available liquidity will be sufficient to support its operating requirements and fund its business objectives for at least the next twelve months, including but not limited to, payments of dividends to shareholders, capital expenditures, other growth opportunities (including potential acquisitions), pension plan contributions, implementing actions to achieve the Company’s sustainability goals and other potential known or anticipated contingencies. The Company also believes it has sufficient additional liquidity to support its operating requirements and to fund its business obligations for the period beyond the next twelve months, including the aforementioned items which are expected to recur annually, as well as future principal and interest payments on the Company’s Credit Facility, tax obligations and other long-term liabilities. The Company’s liquidity is affected by many factors, some based on normal operations of our business and others related to the impact of the pandemic and other global events on our business and on global economic conditions as well as industry uncertainties, which we cannot predict. We also cannot predict economic conditions and industry downturns or the timing, strength or duration of recoveries. We may seek, as we believe appropriate, additional debt or equity financing that would provide capital for corporate purposes, working capital funding, additional liquidity needs or to fund future growth opportunities, including possible acquisitions and organic investments. The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including the actual and projected demand for our products, specialty chemical industry conditions, competitive factors, and the condition of financial markets, among others.
Non-GAAP Measures
The information in this Form 10-Q includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader’s understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not considered indicative of future operating performance or not considered core to the Company’s operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP. In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share, as discussed and reconciled below to the most comparable respective GAAP measures, may not be comparable to similarly named measures reported by other companies.
The Company presents EBITDA, which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies. The Company also presents adjusted EBITDA, which is calculated as EBITDA plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company’s operations. In addition, the Company presents non-GAAP operating income, which is calculated as operating income plus or minus certain items that are not considered indicative of future operating performance or not considered core to the Company’s operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the “two-class share method.” The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
22
Quaker Chemical Corporation
Management’s Discussion and Analysis
Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company’s non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Non-GAAP Operating Income and Margin ReconciliationsThree Months Ended
March 31,
20242023
Operating income$55,526 $49,929 
Restructuring and related charges, net (a)1,857 3,972 
Strategic planning (credits) expenses (b)(109)2,087 
Customer insolvency costs (g)1,522 — 
Other charges (d)446 305 
Non-GAAP operating income$59,242 $56,293 
Non-GAAP operating margin (%) (l)12.6 %11.3 %
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income ReconciliationsThree Months Ended
March 31,
20242023
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Depreciation and amortization (j)21,056 20,510 
Interest expense, net10,824 13,242 
Taxes on income before equity in net income of associated companies (k)12,508 9,533 
EBITDA79,615 72,819 
Equity income in a captive insurance company (e)(506)(422)
Restructuring and related charges, net (a)1,857 3,972 
Strategic planning (credits) expenses (b)(109)2,087 
Customer insolvency costs (g)1,522 — 
Facility remediation recoveries (c)— (827)
Product liability claim costs (h)896 — 
Currency conversion impacts of hyper-inflationary economies (f)(904)456 
Other charges (d)911 706 
Adjusted EBITDA$83,282 $78,791 
Adjusted EBITDA margin (%) (l)17.7 %15.8 %
Adjusted EBITDA$83,282 $78,791 
Less: Depreciation and amortization (j)21,056 20,510 
Less: Interest expense, net10,824 13,242 
Less: Taxes on income before equity in net income of associated companies - adjusted (k)13,729 11,047 
Non-GAAP net income$37,673 $33,992 
23
Quaker Chemical Corporation
Management’s Discussion and Analysis
Non-GAAP Earnings per Diluted Share ReconciliationsThree Months Ended
March 31,
20242023
GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders$1.95 $1.64 
Equity income in a captive insurance company per diluted share (e)(0.03)(0.02)
Restructuring and related charges, net per diluted share (a)0.08 0.17 
Strategic planning (credits) expenses per diluted share (b)— 0.10 
Customer insolvency costs per diluted share (g)0.06 — 
Facility remediation recoveries per diluted share (c)— (0.04)
Product liability claim costs per diluted share (h)0.04 — 
Currency conversion impacts of hyper-inflationary economies per diluted share (f)(0.05)0.03
Other charges per diluted share (d)0.04 0.02 
Impact of certain discrete tax items per diluted share (i)— (0.01)
Non-GAAP earnings per diluted share (m)$2.09 $1.89 
(a)Restructuring and related charges, net represent the costs incurred by the Company associated with the Company’s restructuring program. These costs are not indicative of the future operating performance of the Company. See Note 7 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
(b)Strategic planning (credits) expenses include certain consultant and advisory expenses and credits for the Company’s long-term strategic planning, as well as process optimization and the next phase of the Company’s long-term integration to further optimize its footprint, processes and other functions. These credits and costs are not indicative of the future operating performance of the Company.
(c)Facility remediation recoveries represent the net gain associated with the insurance receipts from remediation, cleaning and subsequent restoration of property damage to certain of the Company’s facilities. These are non-recurring and are not indicative of the future operating performance of the Company. There were no such gains recognized for the three months ended March 31, 2024. See Note 10 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
(d)Other charges include executive transition costs incurred during 2023, charges incurred by an inactive subsidiary of the Company as a result of the termination of restrictions on insurance settlement reserves, non-service components of the Company’s pension and postretirement net periodic benefit income and expense, and certain legal, financial, and other advisory and consultant costs incurred in connection with the Company's recent acquisitions. See Notes 2, 9, and 10 of Notes to Condensed Consolidated Financial Statements, which appear in Item 1 of this Report.
(e)Equity income in a captive insurance company represents the after-tax income attributable to the Company’s interest in Primex, Ltd. (“Primex”), a captive insurance company. The Company holds a 32% investment in and has significant influence over Primex, and therefore accounts for this interest under the equity method of accounting. The income attributable to Primex is not indicative of the future operating performance of the Company and is not considered core to the Company’s operations.
(f)Currency conversion impacts of hyper-inflationary economies represents the foreign currency remeasurement impacts associated with the Company’s affiliates in Argentina and Türkiye whose local economies are designated as hyper-inflationary under U.S. GAAP. These pre-tax foreign currency remeasurement impacts are not deductible for tax purposes for both the three months ended March 31, 2024 and 2023. The (credits) charges incurred relate to the immediate recognition of foreign currency remeasurement in the Condensed Consolidated Statements of Operations and are not indicative of the future operating performance of the Company. See Note 1 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
(g)Customer insolvency costs represent charges associated with a specific reserve for trade accounts receivable within the Company’s EMEA reportable segment related to a specific customer who filed for bankruptcy protection. These expenses are not indicative of the future operating performance of the Company.
(h)Product liability claim costs includes recorded expense related to the payment of a product liability dispute with one of the Company’s customers during the three months ended March 31, 2024. See Note 10 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
24
Quaker Chemical Corporation
Management’s Discussion and Analysis
(i)The impacts of certain discrete tax items include certain impacts of tax law changes, valuation allowance adjustments, uncertain tax positions and prior year true-ups, and the impact on certain intercompany asset transfers. The Company does not believe these items are core or indicative of future performance of the Company. See Note 11 of Notes to Condensed Consolidated Financial Statements, which appears in Item 1 of this Report.
(j)Depreciation and amortization for both the three months ended March 31, 2024 and 2023 includes approximately $0.3 million of amortization expense recorded within equity in net income of associated companies in the Company’s Condensed Consolidated Statements of Operations, which is attributable to the amortization of the fair value step up for the Company’s 50% interest in a joint venture in Korea as a result of required purchase accounting adjustments.
(k)Taxes on income before equity in net income of associated companies – adjusted presents the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of net income attributable to Quaker Chemical Corporation to adjusted EBITDA and was determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility.
(l)The Company calculates adjusted EBITDA margin and non-GAAP operating margin as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales.
(m)The Company calculates non-GAAP earnings per diluted share as non-GAAP net income attributable to the Company divided by the weighted average number of diluted shares outstanding using the “two-class share method.”
Off-Balance Sheet Arrangements
The Company had no material off-balance sheet commitments or obligations as of March 31, 2024. The Company’s off-balance sheet items outstanding as of March 31, 2024 includes approximately $5 million of total bank letters of credit and guarantees. The bank letters of credit and guarantees are not significant to the Company’s liquidity or capital resources. See Note 14 of Notes to Condensed Consolidated Financial Statements in Item 1 of this Report.
Operations
Consolidated Operations Review – Comparison of the First Quarter of 2024 with the First Quarter of 2023
Net sales were $469.8 million in the first quarter of 2024 compared to $500.1 million in the first quarter of 2023. The net sales decrease of $30.3 million, or 6%, year-over-year reflects a decrease in selling price and product mix of approximately 5%, and a decline in sales volumes of approximately 1%. The decrease in selling price and product mix was primarily attributable to our index-based customer contracts. The decline in sales volumes was primarily attributable to a continuation of soft end market conditions across the Company’s EMEA and Americas segments, partially offset by an increase in sales volumes in the Asia/Pacific segment and a positive contribution from new business wins in all segments.
COGS was $288.2 million in the first quarter of 2024 compared to $326.7 million in the first quarter of 2023, a decrease of $38.5 million or 12%. The decrease in COGS reflects lower spend on the decline in current year sales volumes and a decline in the Company’s global raw material costs.
Gross profit was $181.6 million in the first quarter of 2024 compared to $173.5 million in the first quarter of 2023, an increase of approximately $8.1 million or 5%. The Company’s reported gross margin in the first quarter of 2024 was 38.7% compared to 34.7% in the first quarter of 2023 primarily driven by a reduction in raw material costs.
SG&A was $124.2 million in the first quarter of 2024 compared to $119.5 million in the first quarter of 2023, an increase of approximately $4.7 million or 4%, driven by higher labor-related costs and higher incentive compensation due to improved Company performance and a charge related to a customer insolvency.
The Company incurred Restructuring and related charges of $1.9 million and $4.0 million during the first quarters of 2024 and 2023, respectively, related to reductions in headcount and site closures under the Company’s restructuring program. See the Non-GAAP Measures section of this Item, above.
Operating income in the first quarter of 2024 was $55.5 million compared to $49.9 million in the first quarter of 2023. Excluding non-recurring and non-core expenses that are not indicative of the future operating performance of the Company described in the Non-GAAP Measures section of this Item, above, the Company’s non-GAAP operating income increased to $59.2 million in the first quarter of 2024 as compared to $56.3 million in the first quarter of 2023 primarily due to higher gross profit partially offset by higher SG&A, as described above.
25
Quaker Chemical Corporation
Management’s Discussion and Analysis
The Company had Other income, net of $1.1 million in the first quarter of 2024 as compared to Other expense of $2.2 million in the first quarter of 2023. Both the first quarter of 2024 and 2023 included foreign exchange transaction losses, which were higher in the prior year. The first quarter of 2023 also included facility remediation recoveries, net of $0.8 million. The Company had no such facility remediation recoveries during the first quarter of 2024. Additionally, the Company had Other income from non-income tax credits, partially offset by a non-recurring product liability claim expense in the first quarter of 2024. See the Non-GAAP Measures section of this Item, above.
Interest expense, net, was $10.8 million in the first quarter of 2024 compared to $13.2 million in the first quarter of 2023, a decrease of $2.4 million as a result of lower borrowings outstanding in 2024 as compared to 2023.
The Company’s effective tax rates for the first quarters of 2024 and 2023 were 27.3% and 27.7%, respectively. The Company’s effective tax rate for the first quarter of 2024 was largely driven by a mix of earnings and withholding taxes, offset by changes in uncertain tax positions. Comparatively, the effective tax rate for the first quarter of 2023 was largely driven by foreign tax inclusions, withholding taxes, foreign tax credits, and net tax expense related to share-based compensation, partially offset by changes in uncertain tax positions and favorable return to provision adjustments. Excluding the impact of non-core items in each quarter, described in the Non-GAAP Measures section of this Item above, the Company estimates that its effective tax rate for both the first quarters of 2024 and 2023 was approximately 27%. The Company may experience continued volatility in its effective tax rates due to several factors, including the timing of tax audits, the expiration of applicable statutes of limitations as they relate to uncertain tax positions, the unpredictability of timing and amount of certain incentives in various tax jurisdictions, and the timing and amount of certain share-based compensation-related tax benefits, among other factors. In addition, the foreign tax credit valuation allowance, or absence thereof, is based on a number of variables, including forecasted mix of earnings, which may vary.
Equity in net income of associated companies was $2.0 million in the first quarter of 2024 compared to $4.6 million in the first quarter of 2023, a decrease of $2.6 million, primarily due to lower current year income from the Company’s 50% interest in a joint venture in Korea.
Net income attributable to noncontrolling interest was less than $0.1 million in both the first quarter of 2024 and 2023.
Foreign exchange negatively impacted the Company’s first quarter of 2024 results by approximately 1% compared to the first quarter of 2023 driven by the impact from foreign currency translation on earnings as well as higher foreign exchange transaction losses in the current quarter as compared to the prior year first quarter.
Reportable Segments Review - Comparison of the First Quarter of 2024 with the First Quarter of 2023
The Company’s reportable segments reflect the structure of the Company’s internal organization, the method by which the Company’s resources are allocated and the manner by which the chief operating decision maker of the Company assesses performance. The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific.
Segment operating earnings for the Company’s reportable segments are comprised of net sales less COGS and SG&A directly related to the respective segment’s product sales. Operating expenses not directly attributable to the segments, such as certain corporate and administrative costs and Restructuring and related charges, net, are excluded from segment results. Other items not specifically identified with the Company’s reportable segments include Interest expense, net, and Other income (expense), net.
Americas
Americas represented approximately 49% of the Company’s consolidated net sales in the first quarter of 2024. The segment’s net sales were $229.8 million, a decrease of $21.7 million or 9%, compared to the first quarter of 2023. This was driven by a decrease in sales volumes of approximately 5% and lower selling price and product mix of approximately 5%, partially offset by a favorable impact from foreign currency translation of 1%. The current quarter decline in sales volumes compared to the prior year was primarily driven by softer market conditions and customer order patterns, partially offset by new business wins. The decrease in selling price and product mix was primarily attributable to our index-based customer contracts. The favorable foreign exchange impact was primarily due to the weakening of the U.S. dollar against the Mexican peso in the first quarter of 2024 compared to the first quarter of 2023. This segment’s operating earnings were $66.8 million, an increase of $0.6 million or 1% compared to the first quarter of 2023, primarily driven by improvement in the segment’s operating margins for the reasons described in our consolidated results.
26
Quaker Chemical Corporation
Management’s Discussion and Analysis
EMEA
EMEA represented approximately 29% of the Company’s consolidated net sales in the first quarter of 2024. The segment’s net sales were $138.4 million, a decrease of $14.0 million or 9%, compared to the first quarter of 2023. This was driven by lower selling price and product mix of approximately 6% and a decrease in sales volumes of 4%, partially offset by a favorable impact from foreign currency translation of 1%. The decrease in selling price and product mix was primarily attributable to our index-based customer contracts. The decline in sales volumes was primarily driven by softer market conditions and customer order patterns, partially offset by new business wins. The favorable foreign currency translation impact was primarily due to the weakening of the U.S. dollar against the euro in the first quarter of 2024 compared to the first quarter of 2023. This segment’s operating earnings were $29.6 million, an increase of $2.0 million or 7%, compared to the first quarter of 2023 primarily driven by an improvement in operating margins for the reasons described in our consolidated results.
Asia/Pacific
Asia/Pacific represented approximately 22% of the Company’s consolidated net sales in the first quarter of 2024. The segment’s net sales were $101.6 million, an increase of $5.3 million or 6%, compared to the first quarter of 2023. This was driven by higher sales volumes of 15%, partially offset by a decrease in selling price and product mix of 5% and an unfavorable impact from foreign currency translation of 4%. The increase in sales volumes was primarily driven by an increase in end market activity compared to the prior year period and new business wins. The decrease in selling price and product mix was primarily attributable to our index-based customer contracts. The unfavorable foreign exchange impact was primarily due to the strengthening of the U.S. dollar against the Chinese renminbi in the first quarter of 2024 compared to the first quarter of 2023. This segment’s operating earnings were $30.4 million, an increase of $2.7 million or 10% compared to the first quarter of 2023 primarily driven by an increase in net sales and an improvement in operating margins for the reasons described in our consolidated results.
Factors That May Affect Our Future Results
Certain information included in this Report and other materials filed or to be filed by us with the SEC, as well as information included in oral statements or other written statements made or to be made by us, contain or may contain forward-looking statements that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts and can generally be identified by words such as “may,” “could,” “should,” “would,” “believe,” “expect,” “anticipate,” “estimate,” “intend,” “outlook,” “target,” “possible,” “potential,” “plan” or similar expressions, but these terms are not the exclusive means of identifying such statements. We have based these forward-looking statements on assumptions, projections and expectations about future events that we believe are reasonable based on currently available information, including statements regarding the potential effects of the conflicts in Ukraine and the Middle East, inflation, and global supply chain constraints on the Company’s business, results of operations, and financial condition; our expectation that we will maintain sufficient liquidity and remain in compliance with the terms of the Company’s credit facility; expectations about future demand and raw material costs; and statements regarding the impact of increased raw material costs and pricing initiatives.
These forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, intentions, financial condition, results of operations, future performance, and business, which may differ materially from expectations, estimates and projections of many factors, including, but not limited to:
•the timing and extent of the projected impacts on our business of acts of war or terrorism, including the conflicts in Ukraine and the Middle East, and actions taken by various governments and governmental organizations in response;
•inflationary pressures, cost increases and the impacts of constraints and disruptions in the global supply chain;
•the potential timing, impacts, benefits and other uncertainties of acquisitions and divestitures, including our ability to realize synergies, integrate acquisitions or separate divested assets and businesses;
•the potential for changes in global and regional economic conditions and for a variety of macroeconomic events, including the possibility of global or regional slowdowns or recessions, a global pandemic, interest rate changes, inflation, deflation or stagflation and its impact on our business, raw materials purchases and/or profitability of our business impact the value of our assets; and
•our future results and plans including our sustainability goals and enterprise strategy
Such statements include information relating to current and future business activities, operational matters, capital spending, and financing sources. From time to time, forward-looking statements are also included in the Company’s other periodic reports on Forms 10-K, 10-Q and 8-K, press releases, and other materials released to, or statements made to, the public.
27
Quaker Chemical Corporation
Management’s Discussion and Analysis
Any or all of the forward-looking statements in this Report, in the Company’s 2023 Form 10-K and in any other public statements we make may turn out to be wrong. This can occur as a result of inaccurate assumptions or as a consequence of known or unknown risks and uncertainties. Many factors discussed in this Report will be important in determining our future performance. Consequently, actual results may differ materially from those that might be anticipated from our forward-looking statements.
We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. However, any further disclosures made on related subjects in the Company’s subsequent reports on Forms 10-K, 10-Q, 8-K and other related filings should be consulted. A major risk is that demand for the Company’s products and services is largely derived from the demand for our customers’ products, which subjects the Company to uncertainties related to downturns in a customer’s business and unanticipated customer production slowdowns and shutdowns.
Other major risks and uncertainties include, but are not limited to, inflationary pressures, including the potential for continued significant increases in raw material costs; supply chain disruptions; customer financial instability; rising interest rates and the possibility of economic recession; economic and political disruptions including the impacts of the military conflicts between Russia and Ukraine and between Israel and Hamas; tariffs, trade restrictions and the economic and other sanctions imposed by other nations on Russia and/or other government organizations; suspensions of activities in Russia by many multinational companies and the potential expansion of military activity; foreign currency fluctuations; significant changes in applicable tax rates and regulations; future terrorist attacks and other acts of violence; the impacts of consolidation in our industry, including loss or consolidation of a major customer; and the potential occurrence of cyber-security breaches, cyber-security attacks and other security incidents.
Furthermore, the Company is subject to the same business cycles as those experienced by our customers in the steel, automobile, aircraft, industrial equipment, aluminum, and durable goods industries. Other factors could also adversely affect us, including those related to acquisitions and the integration of acquired businesses.
Therefore, we caution you not to place undue reliance on our forward-looking statements. For more information regarding these risks and uncertainties as well as certain additional risks that we face, refer to the Risk Factors section, which appears in Item 1A in our 2023 Form 10-K and in our quarterly and other reports filed from time to time with the SEC. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.
Quaker Houghton on the Internet
Financial results, news and other information about Quaker Houghton can be accessed from the Company’s website at https://www.quakerhoughton.com. This site includes important information on the Company’s locations, products and services, financial reports, news releases and career opportunities. The Company’s periodic and current reports on Forms 10-K, 10-Q, 8-K, and other filings, including exhibits and supplemental schedules filed therewith, and amendments to those reports, filed with the SEC are available on the Company’s website, free of charge, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Information contained on, or that may be accessed through, the Company’s website is not incorporated by reference in this Report and, accordingly, you should not consider that information part of this Report.
28
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We have evaluated the information required under this Item that was disclosed in Part II, Item 7A, of our Annual Report on Form 10-K for the year ended December 31, 2023, and we believe there has been no material change to that information.
Item 4. Controls and Procedures.
Evaluation of disclosure controls and procedures. As required by Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), our management, including our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Report. Based on that evaluation, our principal executive officer and our principal financial officer have concluded that, as of March 31, 2024, the end of the period covered by this Report, our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) were effective.
Changes in internal control over financial reporting. As required by Rule 13a-15(d) under the Exchange Act, our management, including our principal executive officer and principal financial officer, has evaluated our internal control over financial reporting to determine whether any changes to our internal control over financial reporting occurred during the quarter ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, there were no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter ended March 31, 2024.
29
PART II.
OTHER INFORMATION
Items 3 and 4 of Part II are inapplicable and have been omitted.
Item 1. Legal Proceedings.
Incorporated by reference is the information in Note 18 of Notes to the Condensed Consolidated Financial Statements in Part I, Item 1, of this Report.
Item 1A. Risk Factors.
The Company’s business, financial condition, results of operations and cash flows are subject to various risks that could cause actual results to vary materially from recent results or from anticipated future results. In addition to the other information set forth in this Report, you should carefully consider the risk factors previously disclosed in Part I, Item 1A of the Company’s 2023 Form 10-K. There have been no material changes to the risk factors described therein.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities.
The following table sets forth information concerning shares of the Company’s common stock acquired by the Company during the period covered by this Report:
Period(a)
Total Number
of Shares
Purchased (1)		(b)
Average
Price Paid
Per Share (2)		(c)
Total Number of
Shares Purchased as part of Publicly Announced Plans or Programs		(d)
Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (3)
January 1 - January 31281$206.14 —$150,000,000 
February 1 - February 29357$197.96 —$150,000,000 
March 1 - March 316,479$200.16 —$150,000,000 
Total7,117$200.29 —$150,000,000 
(1)All of these shares were acquired from employees related to the surrender of Quaker Chemical Corporation shares in payment of the exercise price of employee stock options exercised or for the payment of taxes upon exercise of employee stock options or the vesting of restricted stock awards or units.
(2)The price paid for shares acquired from employees pursuant to employee benefit and share-based compensation plans is based on the closing price of the Company’s common stock on the date of exercise or vesting as specified by the plan pursuant to which the applicable option, restricted stock award, or restricted stock unit was granted.
(3)On February 28, 2024, the Board of Directors of the Company approved, and the Company announced, a share repurchase program, pursuant to which the Company is authorized to repurchase up to $150,000,000 of Quaker Chemical Corporation common stock (the “2024 Share Repurchase Program”), and it has no expiration date. There were no shares acquired by the Company pursuant to the 2024 Share Repurchase Program during the quarter ended March 31, 2024.
Limitation on the Payment of Dividends
The Credit Facility has certain limitations on the payment of dividends and other so-called restricted payment covenants. See Note 14 of Notes to Condensed Consolidated Financial Statements, in Part I, Item 1, of this Report.
Item 5. Other Information.
Insider Trading Arrangements and Policies
No director or officer (as defined in Rule 16a-1(f) promulgated under the Exchange Act) of the Company adopted or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the period covered by this Report.
30
Item 6. Exhibits.
(a) Exhibits
3.1
–
3.2
–
31.1
–
31.2
–
32.1
–
32.2
–
101.INS
–Inline XBRL Instance Document*
101.SCH
–Inline XBRL Taxonomy Schema Document*
101.CAL
–Inline XBRL Taxonomy Calculation Linkbase Document*
101.DEF
–Inline XBRL Taxonomy Definition Linkbase Document*
101.LAB
–Inline XBRL Taxonomy Label Linkbase Document*
101.PRE
–Inline XBRL Taxonomy Presentation Linkbase Document*
104
–Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS)*
* Filed herewith.
** Furnished herewith.
*********
31
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
QUAKER CHEMICAL CORPORATION
(Registrant)
/s/ Shane W. Hostetter
Date: May 2, 2024
Shane W. Hostetter, Executive Vice President, Chief Financial Officer (officer duly authorized on behalf of, and principal financial officer of, the Registrant)
32
 EX-31.1 2 kwr2024q1-exx311.htm EX-31.1 Document

EXHIBIT 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE COMPANY PURSUANT TO RULE 13a 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
I, Andrew E. Tometich, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 2, 2024

/s/ Andrew E. Tometich
Andrew E. Tometich
Chief Executive Officer
1
 EX-31.2 3 kwr2024q1-exx312.htm EX-31.2 Document

EXHIBIT 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER OF THE COMPANY PURSUANT TO RULE 13a-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
I, Shane W. Hostetter, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Quaker Chemical Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: May 2, 2024

/s/ Shane W. Hostetter
Shane W. Hostetter
Chief Financial Officer
1
 EX-32.1 4 kwr2024q1-exx321.htm EX-32.1 Document

EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended March 31, 2024 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 2, 2024

/s/ Andrew E. Tometich
Andrew E. Tometich
Chief Executive Officer of Quaker Chemical Corporation
1
 EX-32.2 5 kwr2024q1-exx322.htm EX-32.2 Document

EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
The undersigned hereby certifies that the Form 10-Q Quarterly Report of Quaker Chemical Corporation (the “Company”) for the quarterly period ended March 31, 2024 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: May 2, 2024

/s/ Shane W. Hostetter
Shane W. Hostetter
Chief Financial Officer of Quaker Chemical Corporation
1
 EX-101.SCH 6 kwr-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Condensed Consolidated Statements of Changes in Equity link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals) link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Basis of Presentation and Description of Business link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Business Acquisitions link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Recently Issued Accounting Standards link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Net Sales and Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Restructuring and Related Activities link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Pension and Other Postretirement Benefits link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Other (expense) income, net link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Income Taxes and Uncertain Income Tax Positions link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Accumulated Other Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Hedging Activities link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Basis of Presentation and Description of Business (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Net Sales and Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Restructuring and Related Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Share Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Other (expense) income, net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Accumulated Other Comprehensive Income (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Hedging Activities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Basis of Presentation and Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Business Acquisitions - (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Business Segments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Business Segments - Performance of Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Leases - Supplemental Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Restructuring and Related Activities (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Share-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Other (expense) income, net (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Income Taxes and Uncertain Income Tax Positions - (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Earnings Per Share - Basic (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Earnings Per Share - Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Earnings Per Share - Antidilutive Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Debt - Debt Related Expenses Included within Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Hedging Activities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 kwr-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 kwr-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 kwr-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Consolidated Entities [Axis] Consolidated Entities [Axis] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Less: Net income attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Statistical Measurement [Domain] Statistical Measurement [Domain] Derivative liability, notional amount Derivative Liability, Notional Amount Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Decrease in cash from changes in current assets and current liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Cash acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Remaining lease terms (in years) Lessee, Operating Lease, Remaining Lease Term Debt Debt Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Cash payments to acquire businesses Payments to Acquire Businesses, Gross Houghton Combination Houghton Combination [Member] Hougton, a business combination. Number of countries in which entity operates Number of Countries in which Entity Operates Revolving Credit Facility Revolving Credit Facility [Member] Service cost Defined Benefit Plan, Service Cost, Net Defined Benefit Plan, Service Cost, Net Deferred tax liabilities Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Performance stock units Performance Stock Units Performance Shares [Member] Accounts payable Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Other income (expense), net Total other income (expense), net Nonoperating Income (Expense) Commitments and contingencies (Note 18) Commitments and Contingencies Previously Reported Previously Reported [Member] Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Currency translation adjustments Restructuring Reserve, Foreign Currency Translation Gain (Loss) Other stock related activity Proceeds from Issuance or Sale of Equity Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Accumulated Other Comprehensive Income Equity [Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Geographical [Axis] Geographical [Axis] Option award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Income Taxes and Uncertain Income Tax Positions Income Tax Disclosure [Text Block] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Concentration Risk [Line Items] Concentration Risk [Line Items] Customer [Axis] Customer [Axis] Current liabilities Liabilities, Current [Abstract] Intersegment Sales Elimination Intersegment Eliminations [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Inventories Inventory, Net [Abstract] Dividends paid Payments of Ordinary Dividends, Common Stock Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) Diluted earnings per common share (in dollars per share) Earnings Per Share, Diluted Trademarks, formulations and product technology Trademarks Formulations And Product Technology [Member] Trademarks Formulations And Product Technology [Member] PEO Total Compensation Amount PEO Total Compensation Amount Vesting shares target upper (as a percent) Vesting Shares Target Upper Percent Vesting Shares Target Upper Percent Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Goodwill [Roll Forward] Goodwill [Roll Forward] Schedule Of Monte Carlo Option Pricing Model And The Assumptions Schedule of Monte Carlo option pricing model and the assumptions [Table Text Block] Schedule of Monte Carlo option pricing model and the assumptions Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Total Interest and Debt Expense Schedule of Net Benefit Costs Schedule of Net Benefit Costs [Table Text Block] Other comprehensive (loss) income before Reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Trading Symbol Trading Symbol Letters of credit outstanding amount Letters of Credit Outstanding, Amount Restructuring Plan [Domain] Restructuring Plan [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Net income attributable to Quaker Chemical Corporation Net income attributable to Quaker Chemical Corporation Net Income (Loss) Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Schedule of Notional Amounts of Outstanding Derivative Positions Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Leases Lessee, Operating Leases [Text Block] Corporate Bond Securities Corporate Bond Securities [Member] All Currencies [Domain] All Currencies [Domain] Outstanding Balance Debt and Lease Obligation LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Fair Value Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Other Other Intangible Assets [Member] Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of goods sold (excluding amortization expense - See Note 13) Cost of Goods and Services Sold Change in restructuring liabilities Increase (Decrease) in Restructuring Reserve Executive Category: Executive Category [Axis] Intangible assets, amortization period Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life Effect of foreign exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Credit faclity as percentage of consolidated EBITDA (as a percent) Credit facility as percentage of consolidated EBITDA Credit facility as percentage of consolidated EBITDA Name Measure Name Name Forgone Recovery, Individual Name Goodwill Beginning balance Ending balance Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Number of PSUs granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business For the year ended December 31, 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Letter of Credit Letter of Credit [Member] Argentina Subsidiaries [Member] Notional amount Derivative, Notional Amount Dividends declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Unrealized gain on available-for-sale securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Long-term lease liabilities Operating Lease, Liability, Noncurrent Foreign exchange losses, net Realized Gain (Loss), Foreign Currency Transaction, before Tax Retirement Plan Type [Domain] Retirement Plan Type [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Other accrued liabilities Accrued Liabilities [Member] Trademarks Trademarks [Member] Amounts reclassified from AOCI Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Income Statement Location [Axis] Income Statement Location [Axis] Non-current accrued pension and postretirement benefits Liability, Defined Benefit Plan, Noncurrent Schedule of Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Foreign currency forward contracts: Foreign Exchange Forward [Member] Product and Service [Domain] Product and Service [Domain] Other Performance Measure, Amount Other Performance Measure, Amount Interest expense Interest Expense, Debt Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Schedule of Lease, Cost Lease, Cost [Table Text Block] Inventories Increase (Decrease) in Inventories Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Accrued restructuring, beginning balance Accrued restructuring, ending balance Restructuring Reserve Antidilutive shares (in share) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Nonvested stock awards granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Borrowings (payments) on revolving credit facilities, net Proceeds from (Repayments of) Long-Term Debt Proceeds from (Repayments of) Long-Term Debt Document Quarterly Report Document Quarterly Report Unrecognized share-based compensation expense, nonvested stock award Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Dividends declared Dividends, Common Stock Goodwill [Line Items] Goodwill [Line Items] Property, plant and equipment, at cost Property, Plant and Equipment, Gross Leased assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability For the remainder of 2024 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Trading Arrangement: Trading Arrangement [Axis] Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Schedule of Interest Income and Interest Expense Disclosure Interest Income and Interest Expense Disclosure [Table Text Block] Employer contributions Defined Benefit Plan, Plan Assets, Contributions by Employer PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Other current liabilities Operating Lease, Liability, Current Derivative term (in years) Derivative, Term of Contract Unrealized (Loss) Gain in Available-for- Sale Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Revolver Amended Revolver [Member] Amended Revolver Surrendered and liquidated life insurance policies Life Insurance, Corporate or Bank Owned, Change in Value Amortization expense Amortization of Intangible Assets ARGENTINA ARGENTINA Entity Shell Company Entity Shell Company For the year ended December 31, 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Net Book Value Finite-Lived Intangible Assets, Net Restatement Determination Date Restatement Determination Date Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash and cash equivalents at the beginning of the period Cash and cash equivalents at the end of the period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization For the year ended December 31, 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Less: income allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Variable lease cost Variable Lease, Cost Operating lease expense Operating Lease, Cost Common stock, shares issued (in shares) Common Stock, Shares, Issued Purchase price Business Combination, Consideration Transferred Gross profit Gross Profit Commitment fee percentage (as a percent) Line of Credit Facility, Commitment Fee Percentage Security Exchange Name Security Exchange Name Original Credit Facility Previous Credit Facility [Member] Syndicated multicurrency, unsecured revolving credit facility with a group of lenders. Selling, general and administrative expenses Selling, General and Administrative Expense Accumulated other comprehensive loss Beginning Balance Ending Balance Accumulated Other Comprehensive Income (Loss), Net of Tax Currency Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Share-Based Payment Arrangement, Option Employee Stock Option [Member] Hedging Activities Derivative Instruments and Hedging Activities Disclosure [Text Block] Schedule of Finite-lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Weighted average remaining life, nonvested stock awards (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Comprehensive income attributable to Quaker Chemical Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Document Type Document Type Work-in-process and finished goods Inventory, Finished Goods and Work in Process, Gross Goodwill additions Goodwill, Acquired During Period Long-term debt interest rate (as a percent) Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate Geographic Concentration Risk Geographic Concentration Risk [Member] Tabular List, Table Tabular List [Table Text Block] Short-term lease expense Short-Term Lease, Cost EMEA EMEA [Member] Segment Reporting, Measurement Disclosures [Abstract] Entity Address, Address Line One Entity Address, Address Line One Retirement Benefits, Description [Abstract] Pension and other postretirement benefits Pension and Other Postretirement Benefits Cost (Reversal of Cost) Share-Based Compensation Share-Based Payment Arrangement [Text Block] For the year ended December 31, 2029 and beyond Lessee, Operating Lease, Liability, to be Paid, after Year Four Lessee, Operating Lease, Liability, to be Paid, after Year Four Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Coral Chemical Company (Coral) Coral Chemical Company (Coral) [Member] Business acquisition of Coral, a privately held, U.S.-based provider of metal finishing fluid solutions. Business Acquisition [Axis] Business Acquisition [Axis] Currency conversion impacts of hyper-inflationary accounting Amount Recognized in Income Due to Inflationary Accounting Derivative [Table] Derivative [Table] Customer Concentration Risk Customer Concentration Risk [Member] Restructuring Charges Restructuring Charges [Member] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other accrued liabilities Other Liabilities, Current Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Statement [Abstract] Income from third party license fees Revenue from Contract with Customer, Including Assessed Tax Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Supplemental cash flow information related to leases Supplemental cash flow information related to leases Supplemental cash flow information related to leases Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Sublease income Sublease Income Business Acquisitions Business Combination Disclosure [Text Block] Industrial development revenue bond Industrial Development Revenue Bond This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility. Indefinite lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Other income (expense), net Nonoperating Income (Expense) [Member] Operating Segments Operating Segments [Member] Grant date per value (in dollars per unit) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Dividends payable Dividends Payable, Current Income Tax Disclosure [Abstract] Derivative, fixed interest rate (as a percent) Derivative, Fixed Interest Rate Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Currency translation adjustments Goodwill, Foreign Currency Translation Gain (Loss) Facility remediation recoveries, net Gain On Insurance Recoveries Gain On Insurance Recoveries Investments in associated companies Equity Method Investments Statistical Measurement [Axis] Statistical Measurement [Axis] Land Land [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Facilities Vehicles and Machinery and Equipment Facilities Vehicles and Machinery and Equipment [Member] Operating leases for certain facilities, vehicles and machinery and equipment. Other comprehensive (loss) income, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract] Entity Interactive Data Current Entity Interactive Data Current Top Five Customers Customer Concentration Risk Top Five [Member] Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer. Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Japanese Yen Japan, Yen Other Assets Other Assets [Member] Schedule of Other Nonoperating (Expense) Income Schedule of Other Nonoperating Income (Expense) [Table Text Block] Consolidation Items [Domain] Consolidation Items [Domain] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Mexican Peso Mexico, Pesos Current assets Assets, Current [Abstract] Leases [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Debt issuance costs Debt Issuance Costs, Current, Net For the year ended December 31, 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Operating cash flows from operating leases Operating Lease, Payments Schedule of Share-Based Payment Arrangement, Cost by Plan Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Interest cost Defined Benefit Plan, Interest Cost Other Income and Expenses [Abstract] PEO PEO [Member] Loss contingency, estimate of possible loss Loss Contingency, Estimate of Possible Loss Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Pension and Other Postretirement Benefits Retirement Benefits [Text Block] Customer lists and rights to sell Customer Lists [Member] Non-income tax refunds and other related credits Proceeds From Non Income Tax Refunds The amount of cash received during the period as refunds for the overpayment of non-income taxes. Deferred compensation, deferred taxes and other, net Increase Decrease In Deferred Compensation And Other Net The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items. Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Customer [Domain] Customer [Domain] Net gain (loss) reclassified from AOCI to earnings Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Net income available to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Interest rate swaps: Interest Rate Swap [Member] Expected future employer contributions, remainder of fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Total operating lease liabilities Present value of lease liabilities Operating Lease, Liability Total liabilities Liabilities Basis of Presentation and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Income before equity in net income of associated companies Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments Income Loss From Continuing Operations Before Noncontrolling Interests and Income Loss From Equity Method Investments All Executive Categories All Executive Categories [Member] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Defined Benefit Pension Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Non-vested stock awards and restricted stock units Nonvested Stock Awards Compensation Expense [Member] The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards. Debt Disclosure [Abstract] Assets and Liabilities, Lessee [Abstract] Assets and Liabilities, Lessee [Abstract] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Number of reportable segments Number of Reportable Segments Per share data: Earnings Per Share [Abstract] Hyper-inflationary economies Hyper-inflationary economies [Policy Text Block] Hyper-inflationary economies policy. Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding March 31, 2024 – 17,989,801 shares; December 31, 2023 – 17,991,988 shares Common Stock, Value, Issued Related tax amounts Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Organization, Consolidation and Presentation of Financial Statements [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Net periodic benefit cost (income) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Earnouts Business Combination, Contingent Consideration, Liability Revenue from Contract with Customer [Abstract] All Individuals All Individuals [Member] Performance Stock Units, ROIC Performance Stock Units, ROIC [Member] Performance Stock Units, ROIC Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Statement [Table] Statement [Table] Current fiscal year end date Current Fiscal Year End Date Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Recently Issued Accounting Standards Accounting Standards Update and Change in Accounting Principle [Text Block] Indefinite-lived trademarks Indefinite-Lived Trademarks Number of positions eliminated Restructuring and Related Cost, Number of Positions Eliminated PEO Name PEO Name Segment operating earnings Operating Income Loss Segment Reporting The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges. Concentration risk (as a percent) Concentration Risk, Percentage Schedule of Product Information [Table] Schedule of Product Information [Table] Asia/Pacific Asia Pacific [Member] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Finite-Lived Intangible Asset, Expected Amortization, Year Five Finite-Lived Intangible Asset, Expected Amortization, Year Five Schedule of Goodwill Schedule of Goodwill [Table Text Block] Net unrealized loss deferred to AOCI Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net Other Postretirement Benefits Other Postretirement Benefits Plan [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Prior service cost (income) amortization Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Accrued compensation Accrued Salaries, Current Other non-operating income, net Other Operating Income (Expense), Net Interest Rate Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Statement of Financial Position [Abstract] Business Combination and Asset Acquisition [Abstract] Total Quaker shareholders’ equity Equity, Attributable to Parent Consolidation Items [Axis] Consolidation Items [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Restricted Stock Restricted Stock [Member] Houghton Environmental Matters Houghton Environmental Matters [Member] Houghton environmental matters. Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Derivative Instruments Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Revision of Prior Period [Domain] Revision of Prior Period [Domain] Other (expense) income, net Other Income and Other Expense Disclosure [Text Block] Restructuring and Related Activities Restructuring and Related Activities Disclosure [Text Block] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Accounting Standards Update and Change in Accounting Principle [Abstract] Accrued pension and postretirement benefits Liability, Defined Benefit Plan, Current 2024 Grants Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Less: debt issuance costs Debt Issuance Costs, Net Other intangible assets, net Intangible Assets, Net (Excluding Goodwill) Other non-current assets Other Noncurrent Assets [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Acquired intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Document Period Focus Document Fiscal Period Focus For the year ended December 31, 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] For the year ended December 31, 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Title Trading Arrangement, Individual Title Share-based compensation Share-Based Payment Arrangement, Noncash Expense Common Stock Common Stock [Member] Defined benefit retirement plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Earnings Per Share Earnings Per Share [Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Product Liability Accrual, Period Expense Product Liability Accrual, Period Expense Minimum Minimum [Member] Property, plant and equipment, net Property, Plant and Equipment, Net Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Depreciation and amortization Results of Operations, Depreciation, Depletion, Amortization and Accretion Other comprehensive (loss) income Amounts reported in other comprehensive income Other Comprehensive Income (Loss), Net of Tax Statement of Cash Flows [Abstract] ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Net income Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Deferred tax assets Deferred Income Tax Assets, Net Retirement Plan Type [Axis] Retirement Plan Type [Axis] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Less: income allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Retained Earnings Retained Earnings [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and equity Liabilities and Equity Other non-current assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Industrial development bonds Industrial development bonds [Member] Industrial development bonds. Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Right of use lease assets Operating Lease, Right-of-Use Asset Current period change in fair value of derivatives Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) Basic earnings per common share (in dollars per share) Earnings Per Share, Basic Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Unrecognized compensation expense, options Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Argentine and Turkish Subsidiaries Argentine and Turkish Subsidiaries [Member] Argentine and Turkish Subsidiaries Bank lines of credit and other debt obligations Bank lines of credit and other debt obligations [Member] Bank lines of credit and other debt obligations. Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Currency [Axis] Currency [Axis] For the remainder of 2024 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Net income available to common shareholders Net Income (Loss) Available to Common Stockholders, Diluted Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Amended Credit Facility Amended Credit Facility [Member] Amended Credit Facility Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Restructuring and related charges, net Restructuring and related charges, net Restructuring and related charges, net Restructuring and related charges, net Restructuring Charges China, Yuan Renminbi China, Yuan Renminbi Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Interest expense, net Interest Expense [Member] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Equity in undistributed earnings of associated companies, net of dividends Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Product technologies Technology-Based Intangible Assets [Member] Termination Date Trading Arrangement Termination Date Common stock, shares authorized (in shares) Common Stock, Shares Authorized Depreciation of corporate assets and amortization Other Depreciation and Amortization Americas Americas [Member] Vesting shares target lower (as a percent) Vesting Shares Target Lower Percent Vesting Shares Target Lower Percent Less: short-term and current portion of long-term debts Short-Term Debt Non-operating and administrative expenses Nonoperating Charges The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment. Schedule of Balance Sheet Classification and Fair Values of Derivative Instruments Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Derivative Instrument [Axis] Derivative Instrument [Axis] Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Maximum increase in borrowing capacity Maximum increase in borrowing capacity Maximum increase in borrowing capacity Metals Metals [Member] Metals product line. All Adjustments to Compensation All Adjustments to Compensation [Member] Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Award Timing Disclosures [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Less: Comprehensive loss (income) attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Unused borrowing capacity Debt Instrument, Unused Borrowing Capacity, Amount Restructuring Plan [Axis] Restructuring Plan [Axis] Statement of Comprehensive Income [Abstract] Gain (loss) on disposals of property, plant, equipment and other assets, net Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Short-term borrowings and current portion of long-term debt Debt, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current For the year ended December 31, 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Payments on other debt, net Proceeds from (Repayments of) Other Debt Insider Trading Arrangements [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Deferred revenue Deferred Revenue Accrued restructuring Restructuring Reserve, Current Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Effect of dilutive securities (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements U.S. Term Loan Amended U.S. Term Loan [Member] Amended U.S. Term Loan Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] For the year ended December 31, 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Adjustment to Compensation, Amount Adjustment to Compensation Amount Proceeds from disposition of assets Proceeds from Sale of Property, Plant, and Equipment Noncontrolling interest Equity, Attributable to Noncontrolling Interest Cash payments Payments for Restructuring Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Less: Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Debt related expenses included within Interest expense: Interest and Debt Expense [Abstract] Payments of long-term debt Repayments of Long-Term Debt Entity central index key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total share-based compensation expense Share-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Taxes on income before equity in net income of associated companies Income Tax Expense (Benefit) Fair Value Measurements Fair Value Disclosures [Text Block] Sales Revenue Net Revenue Benchmark [Member] Name Trading Arrangement, Individual Name Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Real estate, held-for-sale Real Estate, Held-for-Sale Weighted average remaining lease term (years) Operating Lease, Weighted Average Remaining Lease Term Net sales Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Euro Term Loan Amended EURO Term Loan [Member] Amended EURO Term Loan Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment flag Amendment Flag Actuarial loss (gain) amortization Defined Benefit Plan, Amortization of Gain (Loss) Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Payments related to acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Interest expense, net Interest Income (Expense), Net Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Director stock ownership plan Directors Stock Ownership Plan Compensation Expense [Member] The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan. Long-term debt term (in years) Long-Term Debt, Term Long-term debt Long-Term Debt, Excluding Current Maturities Revenue recognized under net reporting arrangements Net Reporting Amount Amount recognized as revenue under net reporting arrangements Diluted weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Assets Total Assets, Total [Member] IKV I.K.V. Tribologie IKVT [Member] I.K.V. Tribologie IKVT Pension and postretirement benefit costs, non-service components Pension And Postretirement Benefit Income, Non-Service Components Other income related to non-service pension cost components Share issuance and equity-based compensation plans Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture Net Sales and Revenue Recognition Revenue from Contract with Customer [Text Block] Investments in property, plant and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Capital in excess of par value Additional Paid in Capital, Common Stock Capital in Excess of Par Value Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Lease, Cost [Abstract] Lease, Cost [Abstract] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Equity in net income of associated companies Income (Loss) from Equity Method Investments Loss Contingencies [Line Items] Loss Contingencies [Line Items] Revision of Prior Period [Axis] Revision of Prior Period [Axis] Cover [Abstract] Amortization of debt issuance costs Amortization of Debt Issuance Costs Restructuring and Related Activities [Abstract] Other non-current liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Total lease payments Lessee, Operating Lease, Liability, to be Paid Raw materials and supplies Inventory, Raw Materials and Supplies, Gross Long-term debt, weighted average interest rate, over time (as a percent) Long-Term Debt, Weighted Average Interest Rate, over Time Pension Benefits Pension Plan [Member] Business Segments Segment Reporting Disclosure [Text Block] Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Derivative variable interest rate (as a percent) Derivative, Variable Interest Rate Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Income before taxes and equity in net income of associated companies Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Stock options Stock Options Compensation Expense [Member] The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan. Largest Customers Largest customer [Member] Reflects the percentage that revenues in the period from the entity's largest customer is to net revenues. Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Basic weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Concentration Risk Type [Domain] Concentration Risk Type [Domain] Operating income Operating Income (Loss) Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Revenues [Abstract] Consolidated Entities [Domain] Consolidated Entities [Domain] Original Credit Facility and the Amended Credit Facility Original Credit Facility and the Amended Credit Facility [Member] Original Credit Facility and the Amended Credit Facility Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Product Information [Line Items] Product Information [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Statement [Line Items] Statement [Line Items] Concentration Risk [Table] Concentration Risk [Table] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Schedule of Debt Schedule of Debt [Table Text Block] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer Relationships Customer Relationships [Member] Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Supplemental balance sheet information Supplemental balance sheet information Supplemental balance sheet information Metalworking and other Metalworking and Other [Member] Metals product line. Noncontrolling Interest Noncontrolling Interest [Member] EX-101.PRE 10 kwr-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover - shares
 3 Months Ended
Mar. 31, 2024
Apr. 30, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-12019  
Entity Registrant Name QUAKER CHEMICAL CORPORATION  
Entity Incorporation, State or Country Code PA  
Entity Tax Identification Number 23-0993790  
Entity Address, Address Line One 901 E. Hector Street  
Entity Address, City or Town Conshohocken  
Entity Address, State or Province PA  
Entity Address, Postal Zip Code 19428 – 2380  
City Area Code 610  
Local Phone Number 832-4000  
Title of 12(b) Security Common Stock, $1 par value  
Trading Symbol KWR  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   17,989,892
Entity central index key 0000081362  
Current fiscal year end date --12-31  
Document Fiscal Year Focus 2024  
Document Period Focus Q1  
Amendment flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 469,759 $ 500,148
Cost of goods sold (excluding amortization expense - See Note 13) 288,196 326,698
Gross profit 181,563 173,450
Selling, general and administrative expenses 124,180 119,549
Restructuring and related charges, net 1,857 3,972
Operating income 55,526 49,929
Other income (expense), net 1,080 (2,239)
Interest expense, net (10,824) (13,242)
Income before taxes and equity in net income of associated companies 45,782 34,448
Taxes on income before equity in net income of associated companies 12,508 9,533
Income before equity in net income of associated companies 33,274 24,915
Equity in net income of associated companies 1,984 4,626
Net income 35,258 29,541
Less: Net income attributable to noncontrolling interest 31 7
Net income attributable to Quaker Chemical Corporation $ 35,227 $ 29,534
Per share data:    
Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) $ 1.96 $ 1.64
Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) 1.95 1.64
Dividends declared (in dollars per share) $ 0.455 $ 0.435
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of Comprehensive Income [Abstract]    
Net income $ 35,258 $ 29,541
Other comprehensive (loss) income, net of tax    
Currency translation adjustments (25,389) 14,468
Defined benefit retirement plans 354 (126)
Current period change in fair value of derivatives 2,345 390
Unrealized gain on available-for-sale securities 45 334
Other comprehensive (loss) income (22,645) 15,066
Comprehensive income 12,613 44,607
Less: Comprehensive loss (income) attributable to noncontrolling interest 42 (10)
Comprehensive income attributable to Quaker Chemical Corporation $ 12,655 $ 44,597
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 195,750 $ 194,527
Accounts receivable, net 440,018 444,950
Inventories    
Raw materials and supplies 116,411 119,047
Work-in-process and finished goods 124,055 114,810
Prepaid expenses and other current assets 56,795 54,555
Total current assets 933,029 927,889
Property, plant and equipment, at cost 445,118 453,419
Less: Accumulated depreciation (242,888) (245,608)
Property, plant and equipment, net 202,230 207,811
Right of use lease assets 38,195 38,614
Goodwill 522,575 512,518
Other intangible assets, net 886,146 896,721
Investments in associated companies 99,850 101,151
Deferred tax assets 10,117 10,737
Other non-current assets 22,228 18,770
Total assets 2,714,370 2,714,211
Current liabilities    
Short-term borrowings and current portion of long-term debt 27,790 23,444
Accounts payable 191,161 184,813
Dividends payable 8,185 8,186
Accrued compensation 28,024 55,194
Accrued restructuring 1,516 3,350
Accrued pension and postretirement benefits 2,210 2,208
Other accrued liabilities 91,341 90,315
Total current liabilities 350,227 367,510
Long-term debt 740,408 730,623
Long-term lease liabilities 22,819 22,937
Deferred tax liabilities 150,618 146,957
Non-current accrued pension and postretirement benefits 28,931 29,457
Other non-current liabilities 29,575 31,805
Total liabilities 1,322,578 1,329,289
Commitments and contingencies (Note 18)
Equity    
Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding March 31, 2024 – 17,989,801 shares; December 31, 2023 – 17,991,988 shares 17,990 17,992
Capital in excess of par value 942,546 940,101
Retained earnings 577,682 550,641
Accumulated other comprehensive loss (146,987) (124,415)
Total Quaker shareholders’ equity 1,391,231 1,384,319
Noncontrolling interest 561 603
Total equity 1,391,792 1,384,922
Total liabilities and equity $ 2,714,370 $ 2,714,211
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 1 $ 1
Common stock, shares authorized (in shares) 30,000,000 30,000,000
Common stock, shares issued (in shares) 17,989,801 17,991,988
Common stock, shares outstanding (in shares) 17,989,801 17,991,988
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Net income $ 35,258 $ 29,541
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of debt issuance costs 353 353
Depreciation and amortization 20,802 20,246
Equity in undistributed earnings of associated companies, net of dividends (1,675) (4,401)
Deferred compensation, deferred taxes and other, net 568 (2,231)
Share-based compensation 3,884 3,527
Restructuring and related charges, net 1,857 3,972
Pension and other postretirement benefits (551) (415)
Decrease in cash from changes in current assets and current liabilities, net of acquisitions:    
Accounts receivable 1,431 (3,974)
Inventories (6,576) (5,792)
Prepaid expenses and other current assets (1,054) (6,765)
Change in restructuring liabilities (3,666) (2,747)
Accounts payable and accrued liabilities (23,400) 6,468
Net cash provided by operating activities 27,231 37,782
Cash flows from investing activities    
Investments in property, plant and equipment (4,460) (6,161)
Payments related to acquisitions, net of cash acquired (24,899) 0
Proceeds from disposition of assets 58 0
Net cash used in investing activities (29,301) (6,161)
Cash flows from financing activities    
Payments of long-term debt (4,711) (4,703)
Borrowings (payments) on revolving credit facilities, net 20,902 (9,776)
Payments on other debt, net 0 (469)
Dividends paid (8,186) (7,809)
Other stock related activity (1,442) (2,109)
Net cash provided by (used in) financing activities 6,563 (24,866)
Effect of foreign exchange rate changes on cash (3,270) 2,154
Net increase in cash and cash equivalents 1,223 8,909
Cash and cash equivalents at the beginning of the period 194,527 180,963
Cash and cash equivalents at the end of the period $ 195,750 $ 189,872
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Equity - 3 months ended Mar. 31, 2024 - USD ($)
$ in Thousands
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance at Dec. 31, 2023 $ 1,384,922 $ 17,992 $ 940,101 $ 550,641 $ (124,415) $ 603
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 35,258          
Amounts reported in other comprehensive income (22,645)          
Ending balance at Mar. 31, 2024 $ 1,391,792          
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Equity (Parentheticals) - $ / shares
 3 Months Ended
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Statement of Stockholders' Equity [Abstract]        
Dividends declared (in dollars per share) $ 0.455 $ 0.455 $ 0.435 $ 0.435
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation and Description of Business
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Description of Business Basis of Presentation and Description of Business
As used in these Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Report”), the terms “Quaker Houghton,” the “Company,” “we,” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires.
Basis of Presentation
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting of normal recurring adjustments which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2023 (as amended, the “2023 Form 10-K”).
Description of Business
The Company was organized in 1918 and incorporated as a Pennsylvania business corporation in 1930. Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, the Company’s customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Quaker Houghton develops, produces, and markets a broad range of formulated chemical specialty products and offers chemical management services, which the Company refers to as FluidcareTM, for various heavy industrial and manufacturing applications sold in its three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific.
Hyper-inflationary economies
Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three months ended March 31, 2024, the Company's Argentine and Turkish subsidiaries together represented 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three months ended March 31, 2024 and 2023, the Company recorded $0.9 million of remeasurement gains and $0.5 million of remeasurement losses associated with the applicable currency conversions, respectively. These gains and losses were recorded within Other income (expense), net, in the Company’s Condensed Consolidated Statements of Operations.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Acquisitions
 3 Months Ended
Mar. 31, 2024
Business Combination and Asset Acquisition [Abstract]  
Business Acquisitions Business Acquisitions
During February 2024, the Company acquired I.K.V. Tribologie IKVT and its subsidiaries (“IKV”) for 32.2 million EUR, or $34.6 million, including an initial cash payment of 27.6 million EUR, or $29.7 million, subject to routine and customary post-closing adjustments related to working capital and net indebtedness levels as well as earn-out provisions related to the finalization of 2023 earnings currently estimated at 4.6 million EUR, or $4.9 million, that is payable during 2024. Assets acquired included approximately $4.8 million of cash and cash equivalents. IKV, which will be part of the Company’s EMEA segment, specializes in high-performance lubricants and greases, including original equipment manufacturer first-fill greases that are primarily used in the automotive, aerospace, electronics, and other industrial markets. The acquisition of IKV strengthens the Company’s position in first-fill greases. The Company preliminarily allocated $15.0 million of the purchase price to intangible assets, comprised of approximately $11.1 million of customer relationships to be amortized over 16 years; $3.2 million of product technologies to be amortized over 14 years; and $0.7 million of trademarks to be amortized over 5 years. In addition, the Company recognized $16.0 million of goodwill in the EMEA segment, none of which is deductible for tax purposes. The goodwill recognized on the transaction is primarily attributable to expected cost and growth synergies. As of March 31, 2024, the allocation of the purchase price has not been finalized.
The results of operations of IKV subsequent to the acquisition date are included in the unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2024.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Recently Issued Accounting Standards
 3 Months Ended
Mar. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]  
Recently Issued Accounting Standards Recently Issued Accounting Standards
Recently Issued Accounting Standards Not Yet Adopted
The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures in November 2023. This ASU expands on reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The disclosure specifies that significant segment expenses are expenses that are regularly provided to the chief operating decision maker and are used to evaluate performance by segment to make decisions about resource allocations. ASU 2023-07 is effective for annual reports for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the disclosure requirements of this standard and the impact on its Consolidated Financial Statements and related disclosures.
The FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures in December 2023. This ASU requires public business entities to disclose additional information in specified categories with respect to the reconciliation of the effective tax rate to the statutory rate (the “rate reconciliation”) for federal, state, and foreign income taxes. It also requires greater detail about individual reconciling items in the rate reconciliation to the extent the impact of those items exceeds a specified threshold. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the disclosure requirements of this standard and the impact on its Consolidated Financial Statements.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Segments
 3 Months Ended
Mar. 31, 2024
Segment Reporting, Measurement Disclosures [Abstract]  
Business Segments Business Segments
The Company’s operating segments, which are consistent with its reportable segments, reflect the structure of the Company’s internal organization, the method by which the Company’s resources are allocated and the manner by which the chief operating decision maker assesses the Company’s performance. The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific. The three segments are composed of the net sales and operations in each respective region.
Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related Cost of goods sold (“COGS”), and Selling, general and administrative expenses (“SG&A”). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs and Restructuring and related charges, net, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense, net and Other income (expense), net.
The following table presents information about the performance of the Company’s reportable segments for the three months ended March 31, 2024 and 2023:
Net sales20242023
Americas$229,754 $251,413 
EMEA138,422 152,449 
Asia/Pacific101,583 96,286 
Total net sales$469,759 $500,148 
Segment operating earnings
Americas$66,770 $66,125 
EMEA29,571 27,571 
Asia/Pacific30,377 27,652 
Total segment operating earnings126,718 121,348 
Restructuring and related charges, net(1,857)(3,972)
Non-operating and administrative expenses(54,177)(51,771)
Depreciation of corporate assets and amortization(15,158)(15,676)
Operating income55,526 49,929 
Other income (expense), net1,080 (2,239)
Interest expense, net(10,824)(13,242)
Income before taxes and equity in net income of associated companies$45,782 $34,448 
All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables. The following table summarizes inter-segment revenues for the three months ended March 31, 2024 and 2023:
Inter-segment revenues20242023
Americas$2,513 $2,827 
EMEA7,060 6,093 
Asia/Pacific1,131 59 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Sales and Revenue Recognition
 3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Net Sales and Revenue Recognition Net Sales and Revenue Recognition
Arrangements Resulting in Net Reporting
As part of the Company’s FluidcareTM business, certain third-party product sales to customers are managed by the Company. The Company transferred third-party products under arrangements recognized on a net reporting basis of $19.8 million and $20.7 million for the three months ended March 31, 2024 and 2023, respectively.
Customer Concentration
A significant portion of the Company’s revenues are realized from the sale of process fluids and services to manufacturers of steel, aluminum, automobiles, aerospace, industrial and agricultural equipment, and durable goods. As previously disclosed in the Company’s 2023 Form 10-K, the Company’s five largest customers combined (each composed of multiple subsidiaries or divisions with semiautonomous purchasing authority) accounted for approximately 12% of consolidated net sales for 2023, with its largest customer accounting for approximately 3% of consolidated net sales.
Contract Assets and Liabilities
The Company had no material contract assets recorded on its Condensed Consolidated Balance Sheets as of March 31, 2024 or December 31, 2023.
The Company had approximately $4.0 million and $4.5 million of deferred revenue as of March 31, 2024 and December 31, 2023, respectively. For the three months ended March 31, 2024, the Company satisfied materially all of the associated performance obligations and recognized into revenue materially all advance payments received and recorded as of December 31, 2023.
Disaggregated Revenue
The Company sells its various industrial process fluids, its specialty chemicals and its technical expertise as a global product portfolio. The Company generally manages and evaluates its performance by reportable segment first, and then by customer industries. Net sales of each of the Company’s major product lines are generally spread throughout all three of the Company’s geographic regions, and in most cases, are approximately proportionate to the level of total sales in each region.
The following tables disaggregate the Company’s net sales by segment and customer industry.
Three Months Ended March 31, 2024
Customer IndustriesAmericasEMEAAsia/PacificConsolidated
Total
Metals$66,026 $32,820 $50,911 $149,757 
Metalworking and other163,728 105,602 50,672 320,002 
$229,754 $138,422 $101,583 $469,759 
Three Months Ended March 31, 2023
Customer IndustriesAmericasEMEAAsia/PacificConsolidated
Total
Metals$68,134 $39,103 $46,660 $153,897 
Metalworking and other183,279 113,346 49,626 346,251 
$251,413 $152,449 $96,286 $500,148 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases
 3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Leases Leases
The Company has operating leases for certain facilities, vehicles, and machinery and equipment with remaining lease terms up to 11 years. Operating lease expense is recognized on a straight-line basis over the lease term. In addition, the Company has certain land use leases with remaining lease terms up to 91 years.
The Company had no material variable lease costs, sublease income, or finance leases for the three months ended March 31, 2024 and 2023. The components of the Company’s lease expense are as follows:
20242023
Operating lease expense$3,743 $3,936 
Short-term lease expense199 211 
Supplemental cash flow information related to the Company’s leases for the three months ended March 31, 2024 and 2023 is as follows:
20242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$3,661 $3,857 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities3,234 2,833 
Supplemental balance sheet information related to the Company’s leases is as follows:
March 31,
2024		December 31,
2023
Right of use lease assets$38,195 $38,614 
Other current liabilities11,818 11,965 
Long-term lease liabilities22,819 22,937 
Total operating lease liabilities$34,637 $34,902 
Weighted average remaining lease term (years)5.05.1
Weighted average discount rate5.21 %4.91 %
Maturities of operating lease liabilities as of March 31, 2024 were as follows:
For the remainder of 2024$10,341 
For the year ended December 31, 20259,864 
For the year ended December 31, 20267,552 
For the year ended December 31, 20274,165 
For the year ended December 31, 20282,402 
For the year ended December 31, 2029 and beyond5,262 
  Total lease payments39,586 
    Less: imputed interest(4,949)
Present value of lease liabilities$34,637 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring and Related Activities
 3 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Restructuring and Related Activities
In 2022, the Company initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. As of March 31, 2024, the program included restructuring and associated severance costs to reduce headcount by approximately 120 positions globally. These headcount reductions began in the fourth quarter of 2022 and are expected to be completed in 2024.
Employee separation benefits vary depending on local regulations within certain foreign countries and include severance and other benefits. The exact timing to complete, and final costs associated with, all actions will depend on a number of factors and are subject to change. Restructuring costs incurred during the three months ended March 31, 2024 and 2023 include employee severance and facility closure costs that are recorded in Restructuring and related charges, net in the Company’s Condensed Consolidated Statements of Operations.
Changes in the Company’s accruals for its restructuring program are as follows:
Accrued restructuring as of December 31, 2023$3,350
Restructuring and related charges, net1,857 
Cash payments(3,666)
Currency translation adjustments(25)
Accrued restructuring as of March 31, 2024$1,516
In connection with the plans for closure of certain manufacturing and non-manufacturing facilities, the Company has made available for sale certain facilities and property. As of March 31, 2024, the Company classified certain properties with aggregate book value of approximately $3.7 million as held-for-sale. These assets are recorded in Prepaid expenses and other current assets on the Company’s Condensed Consolidated Balance Sheets. The Company expects to complete the sale of these properties over the next 12 months.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:
20242023
Stock options$175$431
Non-vested stock awards and restricted stock units2,5352,171
Director stock ownership plan3010
Performance stock units1,144915
  Total share-based compensation expense$3,884$3,527
Stock Options
As of March 31, 2024, unrecognized compensation expense related to unvested stock options was $0.1 million, to be recognized over a weighted average remaining period of 1.0 year.
Restricted Stock Awards
During the three months ended March 31, 2024, the Company granted 872 non-vested restricted share awards under its long-term incentive plan (“LTIP”), which are subject to time-based vesting, generally over one to three years. As of March 31, 2024, unrecognized compensation expense related to the non-vested restricted shares was $4.3 million, to be recognized over a weighted average remaining period of 1.3 years.
Restricted Stock Units
During the three months ended March 31, 2024, the Company granted 41,093 restricted stock units under its LTIP, which are subject to time-based vesting, generally over one to three years. The fair value of these grants is based on the closing price of the Company’s common stock on the date of grant. As of March 31, 2024, unrecognized compensation expense related to non-vested restricted stock units was $8.8 million, to be recognized over a weighted average remaining period of 1.9 years.
Performance Stock Units
As a component of its LTIP, the Company grants performance-based stock unit awards (“PSUs”). The number of shares that may ultimately be issued as settlement for each award may range from 0% up to 200% of the target award, subject to the achievement of the Company’s market-based total shareholder return (“TSR”) metric relative to the performance of a selected peer group, and separately the achievement of a performance-based return on invested capital (“ROIC”) measure. The service vesting period required for the PSUs is generally three years and the measurement period of the market-based and performance objectives is generally from January 1 of the year of grant through December 31 of the year prior to issuance of the shares.
As mentioned above, a portion of the Company’s PSU valuation is subject to the achievement of the Company’s TSR relative to the performance of a selected peer group. For PSUs granted prior to 2024, the Company’s peer group was the S&P Midcap 400 Materials group. For the 2024 annual LTIP grants, the Company made an election to change peer groups to the S&P 1500 Chemical group to measure the Company’s relative TSR.
Compensation expense for PSUs is measured based on the grant date fair value and is recognized on a straight-line vesting method basis over the applicable vesting period. In the first quarter of 2024, the Company granted 17,970 PSUs with a ROIC condition at a grant date fair value of $200.16 per unit, which was based on the closing trading price of the Company’s common stock on the date of grant. PSUs granted with a relative TSR condition are valued using a Monte Carlo simulation on the date of grant. The grant-date fair value of the PSUs valued using a Monte Carlo simulation was $234.19 per unit, which incorporated the assumptions set forth in the table below:
2024
Grants
Number of PSUs granted17,850
Risk-free interest rate4.55%
Dividend yield0.91%
Expected term (years)3.0
As of March 31, 2024, there was approximately $13.4 million of total unrecognized compensation cost related to PSUs, which the Company expects to recognize over a weighted-average period of 2.5 years.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits
 3 Months Ended
Mar. 31, 2024
Retirement Benefits, Description [Abstract]  
Pension and Other Postretirement Benefits Pension and Other Postretirement Benefits
The components of net periodic benefit cost (income) are as follows for the three months ended March 31, 2024 and 2023:
Pension BenefitsOther Postretirement Benefits
2024202320242023
Service cost$109$104$—$— 
Interest cost2,3752,4551519 
Expected return on plan assets(2,030)(1,997)——
Actuarial loss (gain) amortization127101(29)(30)
Prior service cost (income) amortization78— (4)
Net periodic benefit cost (income)$588 $671$(14)$(15)
Employer Contributions
As of March 31, 2024, $0.9 million and less than $0.1 million of contributions have been made to the Company’s U.S. and foreign pension plans and its other postretirement benefit plans, respectively. Taking into consideration current minimum cash contribution requirements, the Company currently expects to make full year cash contributions of approximately $5.7 million to its U.S. and foreign pension plans and approximately $0.2 million to its other postretirement benefit plans in 2024.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other (expense) income, net
 3 Months Ended
Mar. 31, 2024
Other Income and Expenses [Abstract]  
Other (expense) income, net Other income (expense), net
The components of Other income (expense), net are as follows for the three months ended March 31, 2024 and 2023:
20242023
Non-income tax refunds and other related credits$2,155$360
Income from third party license fees225325
Gain (loss) on disposals of property, plant, equipment and other assets, net407(19)
Foreign exchange losses, net(448)(3,326)
Pension and postretirement benefit costs, non-service components(465)(552)
Facility remediation recoveries, net— 827
Product liability claim(896)—
Other non-operating income, net102146
  Total other income (expense), net$1,080$(2,239)
During 2021, two of the Company’s locations suffered property damages as a result of flooding and electrical fire, respectively. Facility remediation recoveries, net, during the three months ended March 31, 2023, reflect recoveries recorded on the payments received from insurers related to previously incurred costs from the remediation and restoration of property damage. See Note 18 of Notes to the Condensed Consolidated Financial Statements.
Product liability claim costs includes recorded expense related to the payment of a product liability dispute with one of the Company’s customers during the three months ended March 31, 2024.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes and Uncertain Income Tax Positions
 3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes and Uncertain Income Tax Positions Income Taxes
The Company’s effective tax rates for the three months ended March 31, 2024 and 2023 were 27.3% and 27.7%, respectively. The Company’s effective tax rate for the three months ended March 31, 2024 was largely driven by a mix of earnings and withholding taxes, offset by changes in uncertain tax positions. Comparatively, the effective tax rate for the first three months of 2023 was largely impacted by foreign tax inclusions, withholding taxes, and foreign tax credits, partially offset with changes in uncertain tax positions and favorable return to provision adjustments.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table summarizes earnings per share calculations for the three months ended March 31, 2024 and 2023:
20242023
Basic earnings per common share
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Less: income allocated to participating securities(159)(145)
Net income available to common shareholders$35,068 $29,389 
Basic weighted average common shares outstanding17,908,81417,866,670
Basic earnings per common share$1.96 $1.64 
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Less: income allocated to participating securities(158)(145)
Net income available to common shareholders$35,069 $29,389 
Basic weighted average common shares outstanding17,908,81417,866,670
Effect of dilutive securities30,04832,076
Diluted weighted average common shares outstanding17,938,86217,898,746
Diluted earnings per common share$1.95 $1.64 
Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included were 39,066 and 15,327 for the three months ended March 31, 2024 and 2023, respectively
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Other Intangible Assets
 3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
Changes in the carrying amount of goodwill for the three months ended March 31, 2024 were as follows:
AmericasEMEAAsia/PacificTotal
Balance as of December 31, 2023$283,103$65,940$163,475$512,518
Goodwill additions— 16,011 — 16,011
Currency translation adjustments(115)(663)(5,176)(5,954)
Balance as of March 31, 2024$282,988$81,288$158,299$522,575
Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:
Gross Carrying
Amount		Accumulated
Amortization		Net Book Value
March 31, 2024December 31, 2023March 31, 2024December 31, 2023March 31, 2024December 31, 2023
Customer lists and rights to sell$843,295$841,562$253,464$243,872$589,831$597,690
Trademarks, formulations and product technology163,391161,61357,41155,879105,980105,734
Other5,8645,8925,7535,776111116
Total definite-lived intangible assets$1,012,550$1,009,067$316,628$305,527$695,922$703,540
The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded amortization expense for the three months ended March 31, 2024 and 2023 as follows:
20242023
Amortization expense$14,472 $14,513 
Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:
For the remainder of 2024$43,248
For the year ended December 31, 202557,158
For the year ended December 31, 202656,470
For the year ended December 31, 202756,175
For the year ended December 31, 202855,835
For the year ended December 31, 202955,373
As of March 31, 2024 and December 31, 2023, the Company had indefinite-lived intangible assets for trademarks and tradenames totaling $190.2 million and $193.2 million, respectively.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt Debt
The following table sets forth the components of the Company’s debt:
As of March 31, 2024As of December 31, 2023
Interest
Rate		Outstanding
Balance		Interest
Rate		Outstanding
Balance
Credit Facilities:
Revolver5.00%$51,806 5.13%$30,904 
U.S. Term Loan6.54%557,500 6.71%561,250 
Euro Term Loan5.00%148,032 5.13%152,366 
Industrial development bonds5.26%10,000 5.26%10,000 
Bank lines of credit and other debt obligationsVarious2,294 Various1,092 
Total debt$769,632 $755,612 
Less: debt issuance costs(1,434)(1,545)
Less: short-term and current portion of long-term debts(27,790)(23,444)
Total long-term debt$740,408 $730,623 
Credit facilities
During June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase.
As of March 31, 2024, the Company was in compliance with all of the Credit Facility covenants. See Note 19 of Notes to Consolidated Financial Statements in the Company’s 2023 Form 10-K.
The weighted average variable interest rate incurred on the outstanding borrowings under the Credit Facility during the three months ended March 31, 2024 was approximately 6.4%. As of March 31, 2024, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.1%. As part of the Credit Facility, in addition to paying interest on outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $445 million, which is net of bank letters of credit of approximately $3 million, as of March 31, 2024.
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings to an average fixed rate of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of March 31, 2024, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements.
In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized an aggregate of $2.2 million of certain third-party and creditor debt issuance costs. Approximately $0.7 million of the capitalized costs were attributed to the Euro Term Loan and U.S. Term Loan. These costs were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Approximately $1.5 million of the capitalized costs were attributed to the Revolver and recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs will collectively be amortized into Interest expense over the five year term of the Credit Facility. As of March 31, 2024, the Company had $1.4 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.1 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2023, the Company had $1.5 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheets.
Industrial development bonds
As of March 31, 2024 and December 31, 2023, the Company had fixed rate, industrial development authority bonds totaling $10.0 million in principal amount due in 2028. These bonds have similar covenants to the Credit Facility noted above.
Bank lines of credit and other debt obligations
The Company has certain unsecured bank lines of credit and discounting facilities in certain foreign subsidiaries, which are not collateralized. The Company’s other debt obligations primarily consist of certain domestic and foreign low interest rate or interest-free municipality-related loans, local credit facilities of certain foreign subsidiaries, and capital lease obligations. Total unused capacity under these arrangements as of March 31, 2024 was approximately $34 million.
In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of March 31, 2024 were approximately $5 million.
Interest expense, net
The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:
20242023
Interest expense$11,282 $13,876 
Amortization of debt issuance costs353 353 
  Total$11,635 $14,229 
Based on the variable interest rates associated with the Credit Facility, as of March 31, 2024 and as of December 31, 2023, the amounts at which the Company’s total debt were recorded are not materially different from their fair market value.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income
 3 Months Ended
Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Income Accumulated Other Comprehensive Income
The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance as of December 31, 2023$(115,417)$(10,738)$333 $1,407 $(124,415)
Other comprehensive (loss) income before Reclassifications(25,316)320 63 3,045 (21,888)
Amounts reclassified from AOCI— 150 (7)— 143 
Related tax amounts— (116)(11)(700)(827)
Balance as of March 31, 2024$(140,733)$(10,384)$378 $3,752 $(146,987)
Balance as of December 31, 2022$(132,161)$(4,595)$(1,484)$— $(138,240)
Other comprehensive income (loss) before Reclassifications14,465 (243)462 506 15,190 
Amounts reclassified from AOCI— 76 (40)— 36 
Related tax amounts— 41 (88)(116)(163)
Balance as of March 31, 2023$(117,696)$(4,721)$(1,150)$390 $(123,177)
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company values its company-owned life insurance policies at fair value. During June 2023, the Company surrendered and liquidated $1.9 million of these life insurance policies. As a result, the Company owns an immaterial amount of company-owned life insurance policies as of March 31, 2024 and December 31, 2023.
Additionally, see Note 17 for a description of the Company’s derivative instruments.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Hedging Activities
 3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Hedging Activities Hedging Activities
The Company’s ongoing business operations expose it to various risks, including fluctuating foreign exchange rates and interest rate risk. To manage these risks, the Company periodically enters into derivative financial instruments, such as foreign exchange forward contracts and interest rate swap agreements. The Company does not hold or enter into financial instruments for trading or speculative purposes.
Foreign Exchange Forward Contracts
The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. These forward contracts are marked-to-market at each reporting date. Changes in the fair value of the underlying instrument and settlements are recognized in earnings in Other income (expense), net. The fair value of the forward contract is determined from sources independent of the Company, including the financial institutions which are party to the derivative instruments.
Open foreign exchange forward contracts as of March 31, 2024 were entered into as hedges in Japanese yen and Mexican peso against the U.S. dollar and Chinese yuan against the Euro. As of March 31, 2024, the Company had open foreign exchange forward contracts with notional U.S. dollar values of the following:
CurrencyMarch 31,
2024
Mexican Peso$41,000 
Japanese Yen7,200 
  Chinese Yuan7,800 
$56,000 
Open foreign exchange forward contracts as of March 31, 2024 had maturities occurring over a period of one month.
Interest Rate Swaps
In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as the Secured Overnight Financing Rate (“SOFR”), in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings into a fixed rate obligation. See Note 14 of Notes to Condensed Consolidated Financial Statements. These interest rate swaps are designated as cash flow hedges and, as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective and reclassified to interest expense in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur.
The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:
Derivatives instrumentsCondensed Consolidated Balance Sheets LocationMarch 31,
2024		December 31,
2023
Interest rate swaps:Other non-current assets$4,873 $1,828 
Foreign currency forward contracts:Other accrued liabilities— 159 
Prepaid expenses and other current assets687 — 
The following table presents the net unrealized loss deferred to AOCI:
Derivatives designated as cash flow hedgesMarch 31,
2024		December 31,
2023
Interest rate swapsAOCI$3,752 $1,407 
The following table presents the location and the amount of net gain recognized in the Company’s Condensed Consolidated Statements of Operations related to derivative instruments for the three months ended March 31, 2024 and 2023:
Derivative instrumentsCondensed Consolidated Statements of Operations Location20242023
Interest rate swapsInterest expense, net$1,286 $— 
Foreign exchange forward contractsOther income, net943 293 
   Total$2,229 $293 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
As previously disclosed in its 2023 Form 10-K, the Company is party to certain environmental matters and other litigation. See Note 25 of Notes to Consolidated Financial Statements in the Company’s 2023 Form 10-K. During the three months ended March 31, 2024, there have been no significant changes to the facts or circumstances of any of the previously disclosed matters. Although there can be no assurance regarding the outcome of any of the ongoing environmental matters or litigation, the Company believes that it has made adequate accruals for costs and liabilities associated with these matters. The Company has accrued approximately $5 million as of both March 31, 2024 and December 31, 2023, respectively, for these ongoing matters.
The Company previously disclosed in its 2023 Form 10-K that one of its locations suffered property damage as a result of an electrical fire. The Company and its insurance carrier continue to review the impact of the electrical fire on the production facility’s operations as it relates to a potential business interruption insurance claim; however, as of the date of this Report, the Company cannot reasonably estimate any probable amount of business interruption insurance claim recoverable. Therefore, the Company has not recorded a gain contingency for a possible business interruption insurance claim as of March 31, 2024.
In December 2021, the Company completed its acquisition of Coral Chemical Company (“Coral”), a privately held, U.S.-based provider of metal finishing fluid solutions. Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have worked to finalize certain post-closing adjustments. During the second quarter of 2022, after failing to reach resolution, the Sellers filed suit asserting certain amounts owed related to tax attributes of the acquisition. Since the second quarter of 2022, there have been no material changes to the facts and circumstances of the claim asserted by the Sellers, and the Company continues to believe the potential range of exposure for this claim is $0 to $1.5 million.
In addition, during the three months ended March 31, 2024, there are no new environmental matters or litigation that the Company believes will have a material adverse effect on the Company’s results of operations, cash flows, or financial condition.
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net income attributable to Quaker Chemical Corporation $ 35,227 $ 29,534
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation and Description of Business (Policies)
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation
The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting of normal recurring adjustments which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2023 (as amended, the “2023 Form 10-K”).
Hyper-inflationary economies
Hyper-inflationary economies
Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three months ended March 31, 2024, the Company's Argentine and Turkish subsidiaries together represented 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three months ended March 31, 2024 and 2023, the Company recorded $0.9 million of remeasurement gains and $0.5 million of remeasurement losses associated with the applicable currency conversions, respectively. These gains and losses were recorded within Other income (expense), net, in the Company’s Condensed Consolidated Statements of Operations.
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Segments (Tables)
 3 Months Ended
Mar. 31, 2024
Segment Reporting, Measurement Disclosures [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents information about the performance of the Company’s reportable segments for the three months ended March 31, 2024 and 2023:
Net sales20242023
Americas$229,754 $251,413 
EMEA138,422 152,449 
Asia/Pacific101,583 96,286 
Total net sales$469,759 $500,148 
Segment operating earnings
Americas$66,770 $66,125 
EMEA29,571 27,571 
Asia/Pacific30,377 27,652 
Total segment operating earnings126,718 121,348 
Restructuring and related charges, net(1,857)(3,972)
Non-operating and administrative expenses(54,177)(51,771)
Depreciation of corporate assets and amortization(15,158)(15,676)
Operating income55,526 49,929 
Other income (expense), net1,080 (2,239)
Interest expense, net(10,824)(13,242)
Income before taxes and equity in net income of associated companies$45,782 $34,448 
All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables. The following table summarizes inter-segment revenues for the three months ended March 31, 2024 and 2023:
Inter-segment revenues20242023
Americas$2,513 $2,827 
EMEA7,060 6,093 
Asia/Pacific1,131 59 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Sales and Revenue Recognition (Tables)
 3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following tables disaggregate the Company’s net sales by segment and customer industry.
Three Months Ended March 31, 2024
Customer IndustriesAmericasEMEAAsia/PacificConsolidated
Total
Metals$66,026 $32,820 $50,911 $149,757 
Metalworking and other163,728 105,602 50,672 320,002 
$229,754 $138,422 $101,583 $469,759 
Three Months Ended March 31, 2023
Customer IndustriesAmericasEMEAAsia/PacificConsolidated
Total
Metals$68,134 $39,103 $46,660 $153,897 
Metalworking and other183,279 113,346 49,626 346,251 
$251,413 $152,449 $96,286 $500,148 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases (Tables)
 3 Months Ended
Mar. 31, 2024
Leases [Abstract]  
Schedule of Lease, Cost The components of the Company’s lease expense are as follows:
20242023
Operating lease expense$3,743 $3,936 
Short-term lease expense199 211 
Supplemental cash flow information related to the Company’s leases for the three months ended March 31, 2024 and 2023 is as follows:
20242023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$3,661 $3,857 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities3,234 2,833 
Supplemental balance sheet information related to the Company’s leases is as follows:
March 31,
2024		December 31,
2023
Right of use lease assets$38,195 $38,614 
Other current liabilities11,818 11,965 
Long-term lease liabilities22,819 22,937 
Total operating lease liabilities$34,637 $34,902 
Weighted average remaining lease term (years)5.05.1
Weighted average discount rate5.21 %4.91 %
Schedule of Lessee, Operating Lease, Liability, Maturity
Maturities of operating lease liabilities as of March 31, 2024 were as follows:
For the remainder of 2024$10,341 
For the year ended December 31, 20259,864 
For the year ended December 31, 20267,552 
For the year ended December 31, 20274,165 
For the year ended December 31, 20282,402 
For the year ended December 31, 2029 and beyond5,262 
  Total lease payments39,586 
    Less: imputed interest(4,949)
Present value of lease liabilities$34,637 
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring and Related Activities (Tables)
 3 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Related Costs
Changes in the Company’s accruals for its restructuring program are as follows:
Accrued restructuring as of December 31, 2023$3,350
Restructuring and related charges, net1,857 
Cash payments(3,666)
Currency translation adjustments(25)
Accrued restructuring as of March 31, 2024$1,516
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Arrangement, Cost by Plan
The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:
20242023
Stock options$175$431
Non-vested stock awards and restricted stock units2,5352,171
Director stock ownership plan3010
Performance stock units1,144915
  Total share-based compensation expense$3,884$3,527
Schedule Of Monte Carlo Option Pricing Model And The Assumptions The grant-date fair value of the PSUs valued using a Monte Carlo simulation was $234.19 per unit, which incorporated the assumptions set forth in the table below:
2024
Grants
Number of PSUs granted17,850
Risk-free interest rate4.55%
Dividend yield0.91%
Expected term (years)3.0
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits (Tables)
 3 Months Ended
Mar. 31, 2024
Retirement Benefits, Description [Abstract]  
Schedule of Net Benefit Costs
The components of net periodic benefit cost (income) are as follows for the three months ended March 31, 2024 and 2023:
Pension BenefitsOther Postretirement Benefits
2024202320242023
Service cost$109$104$—$— 
Interest cost2,3752,4551519 
Expected return on plan assets(2,030)(1,997)——
Actuarial loss (gain) amortization127101(29)(30)
Prior service cost (income) amortization78— (4)
Net periodic benefit cost (income)$588 $671$(14)$(15)
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other (expense) income, net (Tables)
 3 Months Ended
Mar. 31, 2024
Other Income and Expenses [Abstract]  
Schedule of Other Nonoperating (Expense) Income
The components of Other income (expense), net are as follows for the three months ended March 31, 2024 and 2023:
20242023
Non-income tax refunds and other related credits$2,155$360
Income from third party license fees225325
Gain (loss) on disposals of property, plant, equipment and other assets, net407(19)
Foreign exchange losses, net(448)(3,326)
Pension and postretirement benefit costs, non-service components(465)(552)
Facility remediation recoveries, net— 827
Product liability claim(896)—
Other non-operating income, net102146
  Total other income (expense), net$1,080$(2,239)
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table summarizes earnings per share calculations for the three months ended March 31, 2024 and 2023:
20242023
Basic earnings per common share
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Less: income allocated to participating securities(159)(145)
Net income available to common shareholders$35,068 $29,389 
Basic weighted average common shares outstanding17,908,81417,866,670
Basic earnings per common share$1.96 $1.64 
Diluted earnings per common share
Net income attributable to Quaker Chemical Corporation$35,227 $29,534 
Less: income allocated to participating securities(158)(145)
Net income available to common shareholders$35,069 $29,389 
Basic weighted average common shares outstanding17,908,81417,866,670
Effect of dilutive securities30,04832,076
Diluted weighted average common shares outstanding17,938,86217,898,746
Diluted earnings per common share$1.95 $1.64 
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Changes in the carrying amount of goodwill for the three months ended March 31, 2024 were as follows:
AmericasEMEAAsia/PacificTotal
Balance as of December 31, 2023$283,103$65,940$163,475$512,518
Goodwill additions— 16,011 — 16,011
Currency translation adjustments(115)(663)(5,176)(5,954)
Balance as of March 31, 2024$282,988$81,288$158,299$522,575
Schedule of Finite-Lived Intangible Assets
Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:
Gross Carrying
Amount		Accumulated
Amortization		Net Book Value
March 31, 2024December 31, 2023March 31, 2024December 31, 2023March 31, 2024December 31, 2023
Customer lists and rights to sell$843,295$841,562$253,464$243,872$589,831$597,690
Trademarks, formulations and product technology163,391161,61357,41155,879105,980105,734
Other5,8645,8925,7535,776111116
Total definite-lived intangible assets$1,012,550$1,009,067$316,628$305,527$695,922$703,540
Schedule of Finite-lived Intangible Assets Amortization Expense The Company recorded amortization expense for the three months ended March 31, 2024 and 2023 as follows:
20242023
Amortization expense$14,472 $14,513 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:
For the remainder of 2024$43,248
For the year ended December 31, 202557,158
For the year ended December 31, 202656,470
For the year ended December 31, 202756,175
For the year ended December 31, 202855,835
For the year ended December 31, 202955,373
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt (Tables)
 3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
The following table sets forth the components of the Company’s debt:
As of March 31, 2024As of December 31, 2023
Interest
Rate		Outstanding
Balance		Interest
Rate		Outstanding
Balance
Credit Facilities:
Revolver5.00%$51,806 5.13%$30,904 
U.S. Term Loan6.54%557,500 6.71%561,250 
Euro Term Loan5.00%148,032 5.13%152,366 
Industrial development bonds5.26%10,000 5.26%10,000 
Bank lines of credit and other debt obligationsVarious2,294 Various1,092 
Total debt$769,632 $755,612 
Less: debt issuance costs(1,434)(1,545)
Less: short-term and current portion of long-term debts(27,790)(23,444)
Total long-term debt$740,408 $730,623 
Schedule of Interest Income and Interest Expense Disclosure
The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:
20242023
Interest expense$11,282 $13,876 
Amortization of debt issuance costs353 353 
  Total$11,635 $14,229 
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income (Tables)
 3 Months Ended
Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):
Currency
Translation
Adjustments		Defined
Benefit
Pension
Plans		Unrealized
(Loss) Gain in
Available-for-
Sale Securities		Derivative
Instruments		Total
Balance as of December 31, 2023$(115,417)$(10,738)$333 $1,407 $(124,415)
Other comprehensive (loss) income before Reclassifications(25,316)320 63 3,045 (21,888)
Amounts reclassified from AOCI— 150 (7)— 143 
Related tax amounts— (116)(11)(700)(827)
Balance as of March 31, 2024$(140,733)$(10,384)$378 $3,752 $(146,987)
Balance as of December 31, 2022$(132,161)$(4,595)$(1,484)$— $(138,240)
Other comprehensive income (loss) before Reclassifications14,465 (243)462 506 15,190 
Amounts reclassified from AOCI— 76 (40)— 36 
Related tax amounts— 41 (88)(116)(163)
Balance as of March 31, 2023$(117,696)$(4,721)$(1,150)$390 $(123,177)
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Hedging Activities (Tables)
 3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Amounts of Outstanding Derivative Positions As of March 31, 2024, the Company had open foreign exchange forward contracts with notional U.S. dollar values of the following:
CurrencyMarch 31,
2024
Mexican Peso$41,000 
Japanese Yen7,200 
  Chinese Yuan7,800 
$56,000 
Schedule of Balance Sheet Classification and Fair Values of Derivative Instruments
The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:
Derivatives instrumentsCondensed Consolidated Balance Sheets LocationMarch 31,
2024		December 31,
2023
Interest rate swaps:Other non-current assets$4,873 $1,828 
Foreign currency forward contracts:Other accrued liabilities— 159 
Prepaid expenses and other current assets687 — 
The following table presents the net unrealized loss deferred to AOCI:
Derivatives designated as cash flow hedgesMarch 31,
2024		December 31,
2023
Interest rate swapsAOCI$3,752 $1,407 
The following table presents the location and the amount of net gain recognized in the Company’s Condensed Consolidated Statements of Operations related to derivative instruments for the three months ended March 31, 2024 and 2023:
Derivative instrumentsCondensed Consolidated Statements of Operations Location20242023
Interest rate swapsInterest expense, net$1,286 $— 
Foreign exchange forward contractsOther income, net943 293 
   Total$2,229 $293 
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of Presentation and Description of Business (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
segment
country
Mar. 31, 2023
USD ($)
Number of reportable segments | segment 3  
Number of countries in which entity operates | country 25  
Argentina | Argentine and Turkish Subsidiaries    
Currency conversion impacts of hyper-inflationary accounting $ (0.9)  
Argentina | Argentine and Turkish Subsidiaries | Assets Total | Geographic Concentration Risk    
Concentration risk (as a percent) 1.00%  
Argentina | Argentine and Turkish Subsidiaries | Sales Revenue Net | Geographic Concentration Risk    
Concentration risk (as a percent) 2.00%  
Argentina | ARGENTINA    
Currency conversion impacts of hyper-inflationary accounting   $ 0.5
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Acquisitions - (Details)
$ in Thousands, € in Millions
 1 Months Ended
Feb. 29, 2024
USD ($)
Feb. 29, 2024
EUR (€)
Mar. 31, 2024
USD ($)
Feb. 29, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Business Acquisition [Line Items]          
Goodwill     $ 522,575   $ 512,518
IKV          
Business Acquisition [Line Items]          
Purchase price $ 34,600 € 32.2      
Acquired intangible assets 15,000        
Goodwill 16,000        
Cash payments to acquire businesses 29,700 € 27.6      
Earnouts 4,900     € 4.6  
Cash acquired 4,800        
IKV | Customer Relationships          
Business Acquisition [Line Items]          
Acquired intangible assets $ 11,100        
Intangible assets, amortization period 16 years 16 years      
IKV | Product technologies          
Business Acquisition [Line Items]          
Acquired intangible assets $ 3,200        
Intangible assets, amortization period 14 years 14 years      
IKV | Trademarks          
Business Acquisition [Line Items]          
Acquired intangible assets $ 700        
Intangible assets, amortization period 5 years 5 years      
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Segments - Narrative (Details)
 3 Months Ended
Mar. 31, 2024
segment
Segment Reporting, Measurement Disclosures [Abstract]  
Number of reportable segments 3
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Business Segments - Performance of Reportable Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Segment Reporting Information [Line Items]    
Net sales $ 469,759 $ 500,148
Restructuring and related charges, net (1,857) (3,972)
Non-operating and administrative expenses (54,177) (51,771)
Depreciation of corporate assets and amortization (15,158) (15,676)
Operating income 55,526 49,929
Other income (expense), net 1,080 (2,239)
Interest expense, net (10,824) (13,242)
Income before taxes and equity in net income of associated companies 45,782 34,448
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 469,759 500,148
Segment operating earnings 126,718 121,348
Operating Segments | Americas    
Segment Reporting Information [Line Items]    
Net sales 229,754 251,413
Segment operating earnings 66,770 66,125
Operating Segments | EMEA    
Segment Reporting Information [Line Items]    
Net sales 138,422 152,449
Segment operating earnings 29,571 27,571
Operating Segments | Asia/Pacific    
Segment Reporting Information [Line Items]    
Net sales 101,583 96,286
Segment operating earnings 30,377 27,652
Intersegment Sales Elimination | Americas    
Segment Reporting Information [Line Items]    
Net sales 2,513 2,827
Intersegment Sales Elimination | EMEA    
Segment Reporting Information [Line Items]    
Net sales 7,060 6,093
Intersegment Sales Elimination | Asia/Pacific    
Segment Reporting Information [Line Items]    
Net sales $ 1,131 $ 59
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Sales and Revenue Recognition - Narrative (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Mar. 31, 2024
USD ($)
segment
Mar. 31, 2023
USD ($)
Jun. 30, 2023
Dec. 31, 2023
USD ($)
Concentration Risk [Line Items]        
Revenue recognized under net reporting arrangements $ 19.8 $ 20.7    
Deferred revenue $ 4.0     $ 4.5
Number of reportable segments | segment 3      
Top Five Customers | Sales Revenue Net | Customer Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk (as a percent)     12.00%  
Largest Customers | Sales Revenue Net | Customer Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk (as a percent)     3.00%  
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net Sales and Revenue Recognition - Disaggregated Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Product Information [Line Items]    
Net sales $ 469,759 $ 500,148
Operating Segments    
Product Information [Line Items]    
Net sales 469,759 500,148
Operating Segments | Americas    
Product Information [Line Items]    
Net sales 229,754 251,413
Operating Segments | EMEA    
Product Information [Line Items]    
Net sales 138,422 152,449
Operating Segments | Asia/Pacific    
Product Information [Line Items]    
Net sales 101,583 96,286
Operating Segments | Metals    
Product Information [Line Items]    
Net sales 149,757 153,897
Operating Segments | Metals | Americas    
Product Information [Line Items]    
Net sales 66,026 68,134
Operating Segments | Metals | EMEA    
Product Information [Line Items]    
Net sales 32,820 39,103
Operating Segments | Metals | Asia/Pacific    
Product Information [Line Items]    
Net sales 50,911 46,660
Operating Segments | Metalworking and other    
Product Information [Line Items]    
Net sales 320,002 346,251
Operating Segments | Metalworking and other | Americas    
Product Information [Line Items]    
Net sales 163,728 183,279
Operating Segments | Metalworking and other | EMEA    
Product Information [Line Items]    
Net sales 105,602 113,346
Operating Segments | Metalworking and other | Asia/Pacific    
Product Information [Line Items]    
Net sales $ 50,672 $ 49,626
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases - Narrative (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Lessee, Lease, Description [Line Items]    
Variable lease cost $ 0 $ 0
Sublease income $ 0 $ 0
Facilities Vehicles and Machinery and Equipment    
Lessee, Lease, Description [Line Items]    
Remaining lease terms (in years) 11 years  
Land    
Lessee, Lease, Description [Line Items]    
Remaining lease terms (in years) 91 years  
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases - Supplemental Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Lease, Cost [Abstract]      
Operating lease expense $ 3,743 $ 3,936  
Short-term lease expense 199 211  
Supplemental cash flow information related to leases      
Operating cash flows from operating leases 3,661 3,857  
Leased assets obtained in exchange for new operating lease liabilities 3,234 $ 2,833  
Supplemental balance sheet information      
Right of use lease assets 38,195   $ 38,614
Other current liabilities 11,818   11,965
Long-term lease liabilities 22,819   22,937
Total operating lease liabilities $ 34,637   $ 34,902
Weighted average remaining lease term (years) 5 years   5 years 1 month 6 days
Weighted average discount rate 5.21%   4.91%
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Lessee, Operating Lease, Liability, Payment, Due [Abstract]    
For the remainder of 2024 $ 10,341  
For the year ended December 31, 2025 9,864  
For the year ended December 31, 2026 7,552  
For the year ended December 31, 2027 4,165  
For the year ended December 31, 2028 2,402  
For the year ended December 31, 2029 and beyond 5,262  
Total lease payments 39,586  
Less: imputed interest (4,949)  
Present value of lease liabilities $ 34,637 $ 34,902
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Restructuring and Related Activities (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
position
Mar. 31, 2023
USD ($)
Restructuring Cost and Reserve [Line Items]    
Number of positions eliminated | position 120  
Real estate, held-for-sale $ 3,700  
Restructuring Reserve [Roll Forward]    
Restructuring and related charges, net 1,857 $ 3,972
Restructuring Charges    
Restructuring Reserve [Roll Forward]    
Accrued restructuring, beginning balance 3,350  
Restructuring and related charges, net 1,857  
Cash payments (3,666)  
Currency translation adjustments (25)  
Accrued restructuring, ending balance $ 1,516  
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total share-based compensation expense $ 3,884 $ 3,527
Stock options    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total share-based compensation expense 175 431
Non-vested stock awards and restricted stock units    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total share-based compensation expense 2,535 2,171
Director stock ownership plan    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total share-based compensation expense 30 10
Performance stock units    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total share-based compensation expense $ 1,144 $ 915
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based compensation expense $ 3,884 $ 3,527
Share-Based Payment Arrangement, Option    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Unrecognized compensation expense, options $ 100  
Weighted average remaining life, nonvested stock awards (in years) 1 year  
Restricted Stock    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Weighted average remaining life, nonvested stock awards (in years) 1 year 3 months 18 days  
Nonvested stock awards granted (in shares) 872  
Unrecognized share-based compensation expense, nonvested stock award $ 4,300  
Restricted Stock | Minimum    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Option award vesting period (in years) 1 year  
Restricted Stock | Maximum    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Option award vesting period (in years) 3 years  
Restricted Stock Units (RSUs)    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Weighted average remaining life, nonvested stock awards (in years) 1 year 10 months 24 days  
Nonvested stock awards granted (in shares) 41,093  
Unrecognized share-based compensation expense, nonvested stock award $ 8,800  
Performance Stock Units    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based compensation expense 1,144 $ 915
Unrecognized compensation expense, options $ 13,400  
Weighted average remaining life, nonvested stock awards (in years) 2 years 6 months  
Vesting shares target lower (as a percent) 0.00%  
Vesting shares target upper (as a percent) 200.00%  
Grant date per value (in dollars per unit) $ 234.19  
Performance Stock Units | Maximum    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Option award vesting period (in years) 3 years  
Performance Stock Units, ROIC    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Nonvested stock awards granted (in shares) 17,970  
Grant date per value (in dollars per unit) $ 200.16  
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) - Performance Stock Units
 3 Months Ended
Mar. 31, 2024
$ / shares
shares
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]  
Grant date per value (in dollars per unit) | $ / shares $ 234.19
2024 Grants  
Number of PSUs granted (in shares) | shares 17,850
Risk-free interest rate 4.55%
Dividend yield 0.91%
Expected term (years) 3 years
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pension Benefits    
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]    
Service cost $ 109 $ 104
Interest cost 2,375 2,455
Expected return on plan assets (2,030) (1,997)
Actuarial loss (gain) amortization 127 101
Prior service cost (income) amortization 7 8
Net periodic benefit cost (income) 588 671
Other Postretirement Benefits    
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]    
Service cost 0 0
Interest cost 15 19
Expected return on plan assets 0 0
Actuarial loss (gain) amortization (29) (30)
Prior service cost (income) amortization 0 (4)
Net periodic benefit cost (income) $ (14) $ (15)
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Pension and Other Postretirement Benefits - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2024
USD ($)
Pension Benefits  
Defined Benefit Plan Disclosure [Line Items]  
Employer contributions $ 0.9
Expected future employer contributions, remainder of fiscal year 5.7
Other Postretirement Benefits  
Defined Benefit Plan Disclosure [Line Items]  
Expected future employer contributions, remainder of fiscal year $ 0.2
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other (expense) income, net (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Other Income and Expenses [Abstract]    
Non-income tax refunds and other related credits $ 2,155 $ 360
Income from third party license fees 225 325
Gain (loss) on disposals of property, plant, equipment and other assets, net 407 (19)
Foreign exchange losses, net (448) (3,326)
Pension and postretirement benefit costs, non-service components (465) (552)
Facility remediation recoveries, net 0 827
Product Liability Accrual, Period Expense (896) 0
Other non-operating income, net 102 146
Total other income (expense), net $ 1,080 $ (2,239)
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes and Uncertain Income Tax Positions - (Details)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Effective tax rate (as a percent) 27.30% 27.70%
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share - Basic (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Net income attributable to Quaker Chemical Corporation $ 35,227 $ 29,534
Less: income allocated to participating securities (159) (145)
Net income available to common shareholders $ 35,068 $ 29,389
Basic weighted average common shares outstanding (in shares) 17,908,814 17,866,670
Basic earnings per common share (in dollars per share) $ 1.96 $ 1.64
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share - Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Net income attributable to Quaker Chemical Corporation $ 35,227 $ 29,534
Less: income allocated to participating securities (158) (145)
Net income available to common shareholders $ 35,069 $ 29,389
Basic weighted average common shares outstanding (in shares) 17,908,814 17,866,670
Effect of dilutive securities (in shares) 30,048 32,076
Diluted weighted average common shares outstanding (in shares) 17,938,862 17,898,746
Diluted earnings per common share (in dollars per share) $ 1.95 $ 1.64
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings Per Share - Antidilutive Shares (Details) - shares
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Earnings Per Share [Abstract]    
Antidilutive shares (in share) 39,066 15,327
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 512,518
Goodwill additions 16,011
Currency translation adjustments (5,954)
Ending balance 522,575
Previously Reported  
Goodwill [Roll Forward]  
Beginning balance 512,518
Operating Segments | Americas  
Goodwill [Roll Forward]  
Goodwill additions 0
Currency translation adjustments (115)
Ending balance 282,988
Operating Segments | EMEA  
Goodwill [Roll Forward]  
Goodwill additions 16,011
Currency translation adjustments (663)
Ending balance 81,288
Operating Segments | Asia/Pacific  
Goodwill [Roll Forward]  
Goodwill additions 0
Currency translation adjustments (5,176)
Ending balance 158,299
Operating Segments | Previously Reported | Americas  
Goodwill [Roll Forward]  
Beginning balance 283,103
Operating Segments | Previously Reported | EMEA  
Goodwill [Roll Forward]  
Beginning balance 65,940
Operating Segments | Previously Reported | Asia/Pacific  
Goodwill [Roll Forward]  
Beginning balance $ 163,475
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 1,012,550 $ 1,009,067
Accumulated Amortization 316,628 305,527
Net Book Value 695,922 703,540
Customer lists and rights to sell    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 843,295 841,562
Accumulated Amortization 253,464 243,872
Net Book Value 589,831 597,690
Trademarks, formulations and product technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 163,391 161,613
Accumulated Amortization 57,411 55,879
Net Book Value 105,980 105,734
Other    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 5,864 5,892
Accumulated Amortization 5,753 5,776
Net Book Value $ 111 $ 116
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Other Intangible Assets - Amortization Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 14,472 $ 14,513
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]  
For the remainder of 2024 $ 43,248
For the year ended December 31, 2025 57,158
For the year ended December 31, 2026 56,470
For the year ended December 31, 2027 56,175
For the year ended December 31, 2028 55,835
Finite-Lived Intangible Asset, Expected Amortization, Year Five $ 55,373
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Goodwill and Other Intangible Assets - Indefinite Lived (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
Indefinite lived intangible assets $ 190.2  
Houghton Combination    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-lived trademarks   $ 193.2
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Outstanding Balance $ 769,632 $ 755,612
Less: debt issuance costs (1,434) (1,545)
Less: short-term and current portion of long-term debts (27,790) (23,444)
Long-term debt $ 740,408 $ 730,623
Revolver    
Debt Instrument [Line Items]    
Interest Rate 5.00% 5.13%
Outstanding Balance $ 51,806 $ 30,904
U.S. Term Loan    
Debt Instrument [Line Items]    
Interest Rate 6.54% 6.71%
Outstanding Balance $ 557,500 $ 561,250
Euro Term Loan    
Debt Instrument [Line Items]    
Interest Rate 5.00% 5.13%
Outstanding Balance $ 148,032 $ 152,366
Industrial development bonds    
Debt Instrument [Line Items]    
Interest Rate 5.26% 5.26%
Outstanding Balance $ 10,000 $ 10,000
Bank lines of credit and other debt obligations    
Debt Instrument [Line Items]    
Outstanding Balance $ 2,294 $ 1,092
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Narrative (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Interest rate swaps:        
Debt Instrument [Line Items]        
Derivative liability, notional amount   $ 300,000,000    
Derivative term (in years)   3 years    
Derivative, fixed interest rate (as a percent)   3.64%    
Derivative variable interest rate (as a percent) 5.30%      
Other Assets        
Debt Instrument [Line Items]        
Debt issuance costs $ 3,100,000   $ 3,300,000  
Euro Term Loan        
Debt Instrument [Line Items]        
Maximum borrowing capacity       $ 150,000,000
Debt issuance costs       700,000
U.S. Term Loan        
Debt Instrument [Line Items]        
Maximum borrowing capacity       600,000,000
Debt issuance costs       700,000
Revolver        
Debt Instrument [Line Items]        
Maximum borrowing capacity       $ 500,000,000
Credit faclity as percentage of consolidated EBITDA (as a percent)       100.00%
Debt issuance costs 1,400,000   1,500,000  
Revolver | Letter of Credit        
Debt Instrument [Line Items]        
Letters of credit outstanding amount $ 3,000,000      
Revolver | Other Assets        
Debt Instrument [Line Items]        
Debt issuance costs       $ 1,500,000
Amended Credit Facility        
Debt Instrument [Line Items]        
Maximum increase in borrowing capacity       300,000,000
Debt issuance costs       $ 2,200,000
Long-term debt term (in years)       5 years
Amended Credit Facility | Maximum        
Debt Instrument [Line Items]        
Commitment fee percentage (as a percent) 0.275%      
Amended Credit Facility | Minimum        
Debt Instrument [Line Items]        
Commitment fee percentage (as a percent) 0.15%      
Original Credit Facility and the Amended Credit Facility        
Debt Instrument [Line Items]        
Long-term debt, weighted average interest rate, over time (as a percent) 6.40%      
Original Credit Facility        
Debt Instrument [Line Items]        
Long-term debt interest rate (as a percent) 6.10%      
Corporate Bond Securities        
Debt Instrument [Line Items]        
Industrial development revenue bond $ 10,000,000   $ 10,000,000  
Bank lines of credit and other debt obligations        
Debt Instrument [Line Items]        
Letters of credit outstanding amount 5,000,000      
Remaining borrowing capacity 34,000,000      
Revolving Credit Facility | Letter of Credit        
Debt Instrument [Line Items]        
Unused borrowing capacity $ 445,000,000      
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Debt - Debt Related Expenses Included within Interest Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Debt related expenses included within Interest expense:    
Interest expense $ 11,282 $ 13,876
Amortization of debt issuance costs 353 353
Total $ 11,635 $ 14,229
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance $ (124,415)  
Other comprehensive (loss) income before Reclassifications (21,888) $ 15,190
Amounts reclassified from AOCI 143 36
Related tax amounts (827) (163)
Ending Balance (146,987)  
Currency Translation Adjustments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance (115,417) (132,161)
Other comprehensive (loss) income before Reclassifications (25,316) 14,465
Amounts reclassified from AOCI 0 0
Related tax amounts 0 0
Ending Balance (140,733) (117,696)
Defined Benefit Pension Plans    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance (10,738) (4,595)
Other comprehensive (loss) income before Reclassifications 320 (243)
Amounts reclassified from AOCI 150 76
Related tax amounts (116) 41
Ending Balance (10,384) (4,721)
Unrealized (Loss) Gain in Available-for- Sale Securities    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance 333 (1,484)
Other comprehensive (loss) income before Reclassifications 63 462
Amounts reclassified from AOCI (7) (40)
Related tax amounts (11) (88)
Ending Balance 378 (1,150)
Derivative Instruments    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance 1,407 0
Other comprehensive (loss) income before Reclassifications 3,045 506
Amounts reclassified from AOCI 0 0
Related tax amounts (700) (116)
Ending Balance 3,752 390
Accumulated Other Comprehensive Loss    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning Balance (124,415) (138,240)
Ending Balance $ (146,987) $ (123,177)
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Fair Value Measurements - Narrative (Details)
$ in Millions
 1 Months Ended
Jun. 30, 2023
USD ($)
Fair Value Disclosures [Abstract]  
Surrendered and liquidated life insurance policies $ 1.9
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details)
$ in Thousands
Mar. 31, 2024
USD ($)
Derivative [Line Items]  
Notional amount $ 56,000
Mexican Peso  
Derivative [Line Items]  
Notional amount 41,000
Japanese Yen  
Derivative [Line Items]  
Notional amount 7,200
China, Yuan Renminbi  
Derivative [Line Items]  
Notional amount $ 7,800
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Hedging Activities - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2024
Sep. 30, 2023
Foreign currency forward contracts:    
Derivative [Line Items]    
Derivative term (in years) 1 month  
Interest rate swaps:    
Derivative [Line Items]    
Derivative term (in years)   3 years
Derivative liability, notional amount   $ 300.0
XML 85 R74.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Hedging Activities - Balance Sheet Classification and Fair Values (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Jun. 30, 2023
Sep. 30, 2023
Derivative Instruments, Gain (Loss) [Line Items]        
Net gain (loss) reclassified from AOCI to earnings $ 2,229 $ 293    
Interest expense, net        
Derivative Instruments, Gain (Loss) [Line Items]        
Net gain (loss) reclassified from AOCI to earnings 1,286 0    
Other income (expense), net        
Derivative Instruments, Gain (Loss) [Line Items]        
Net gain (loss) reclassified from AOCI to earnings 943 $ 293    
Interest rate swaps:        
Derivative Instruments, Gain (Loss) [Line Items]        
Net unrealized loss deferred to AOCI 3,752   $ 1,407  
Other non-current assets | Interest rate swaps:        
Derivative Instruments, Gain (Loss) [Line Items]        
Fair Value 4,873   $ 1,828  
Other accrued liabilities | Foreign currency forward contracts:        
Derivative Instruments, Gain (Loss) [Line Items]        
Fair Value $ 687     $ 159
XML 86 R75.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Commitments and Contingencies (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Coral Chemical Company (Coral) | Minimum    
Loss Contingencies [Line Items]    
Loss contingency, estimate of possible loss $ 0  
Coral Chemical Company (Coral) | Maximum    
Loss Contingencies [Line Items]    
Loss contingency, estimate of possible loss 1,500  
Houghton Environmental Matters    
Loss Contingencies [Line Items]    
Loss contingency, estimate of possible loss $ 5,000 $ 5,000
XML 87 R9999.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Label Element Value
Dividends, Common Stock us-gaap_DividendsCommonStock $ 8,186,000
Dividends, Common Stock us-gaap_DividendsCommonStock 7,822,000
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross 2,443,000
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross 1,418,000
Noncontrolling Interest [Member]  
Other Comprehensive Income (Loss), Net of Tax us-gaap_OtherComprehensiveIncomeLossNetOfTax 3,000
Other Comprehensive Income (Loss), Net of Tax us-gaap_OtherComprehensiveIncomeLossNetOfTax (73,000)
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 667,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 561,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 677,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest us-gaap_ProfitLoss 31,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest us-gaap_ProfitLoss 7,000
AOCI Attributable to Parent [Member]  
Other Comprehensive Income (Loss), Net of Tax us-gaap_OtherComprehensiveIncomeLossNetOfTax (22,572,000)
Other Comprehensive Income (Loss), Net of Tax us-gaap_OtherComprehensiveIncomeLossNetOfTax 15,063,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest (146,987,000)
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest (123,177,000)
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest (138,240,000)
Retained Earnings [Member]  
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 469,920,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 577,682,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 491,632,000
Dividends, Common Stock us-gaap_DividendsCommonStock 8,186,000
Dividends, Common Stock us-gaap_DividendsCommonStock 7,822,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest us-gaap_ProfitLoss 35,227,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest us-gaap_ProfitLoss 29,534,000
Common Stock [Member]  
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 17,950,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 17,990,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 17,982,000
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross (2,000)
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross 32,000
Additional Paid-in Capital [Member]  
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 928,288,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 942,546,000
Equity, Including Portion Attributable to Noncontrolling Interest us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 929,674,000
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross 2,445,000
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross $ 1,386,000
EXCEL 88 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &*%HE@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !BA:)8._?[V>\ K @ $0 &1O8U!R;W!S+V-O&ULS9)1 M2\,P$,>_BN2]O32K(J'KB^+3!H(#Q;>0W+9@DX;DI-VWMXU;A^@'\#%W__SN M=W"-#E+W$9]C'S"2Q70SNLXGJ<.:'8F"!$CZB$ZE,!@M(? MZH @.+\#AZ2,(@4SL @+D;6-T5)'5-3',][H!1\^8Y=A1@-VZ-!3@JJL@+7S MQ' :NP:N@!E&&%WZ+J!9B+GZ)S9W@)V38[)+:AB&M[ ^ MD?(:IU_)2CH%7+/+Y-?5P^/NB;6"B[K@MP47.\%E+61]_SZ[_O"["KO>V+W] MQ\87P;:!7W?1?@%02P,$% @ 8H6B6)E&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" !BA:)8%4.P>-@% #)'@ & 'AL+W=OEY;:KU[%.CD?I3$?/T M6,Y$ E?&4L5R[@>IVY%Q'82(&BJ3S M..9J=2$BN3ROT=KVBV$XF6KS1:/;F?&)& G];390<-;(78(P%DD:RH0H,3ZO M]>@GSV5&D-WQ1RB6Z:MC8E">I'PV)]?!>(!YXJGP9/0]#/3TO-:JD4",^3S20[F\$AN@$^/GRRC- M_B?+];W-9HWX\U3+>".&$L1ALO[D+YL'\4K 6B4"MA&P=P):]@ON1N!FH.N2 M95A?N.;=CI)+HLS=X&8.LF>3J8$F3$PUCK2"JR'H=->3"Z%(G:13KD3::6CP M-%<:_D9_L=:S$KU+;F6BIRGI)X$(WNH;4):\0&Q;H N&&MYR=4Q<>D28PYJ6 M\GBXO#R']##G2@L5K?9GBU3<9A"LAF@O!YQKS&/4FM%HK**@*T< ML(46JI_H4*_(91@)/GX2R@>$>CD/KE#FT;8-#I17AVCE<>Q^XH9B$9AB% M:KSCL;6-XCX/WWI?^T/B7?5OK[W>#?'NAX/[8>_Q^O[.AHR:542F3C&Q.OM M7R>^5-!0N6FS1V2DH7<2J8@GYXE6*_@,K$]BA_N@9R/&15617V4)N@_R(W\A MUP'TUG <^ADWTJ1W6#*W[K3;[EG;L?*BXJJ\K.!E^_#V@@#09&**)I#_D/NF3,H\*-<)E9JW,Z3 M23J54^D_"YOS\^1(:B18BB>/;)6F\/WH++ M*7VK'.D1DHD5FHGC0N9$^5-Y@*A,L4^PP:;FLWG0<.]\A$A,M(A/%\\YC MJ"$MR3&A[->GW\A(^',%-6F%Q)T\&<1>1BGL+EU-YN<9_2%W!< M5Y6O2#]LK_33CX6:F([Y.SCH*62">,83>]7BAN6@A\@[K,@[#(\KVXJ<"JA( M# ^W*<<[1.YA1>YA>&39CK1O)O51ML!-[N<:(FUB)E K\4]*-)OGL'8[R=S, MALJB2\_:+?ACG<;"QEAD'[;7>I$/(ZJ"D!C;N6C>!?B[JGS,IP MB+##BK##\*RRG2['86K"[$I ,!-)0(*21&K) M5S@OUZ0_#.DE?&D=87>8E2WAXK*JC$4$N1ZWS#_-M^G[66[ MDXWB]O4F[RTW$V5*(C$&J7-\!B.=6N^;KD^TG&5;CT]2:QEGAU/! Z',#7!] M+*7>GI@?R'>ON_\"4$L#!!0 ( &*%HEB/L\!W0@4 (\3 8 >&PO M=V]R:W-H965T&ULM5AM;]LV$/XKA%L4+=#&(O5B*74,-&ZW M!5B[+&FW#\,^T!)M$Y5$E:22=+]^1TF6;(G2EK7[8KWX[O@\Q^,]%)?W0GY6 M>\8T>LC27%W,]EH7Y_.YBO7Y;+6LWEW+U5*4.N4YNY9(E5E&Y==+EHK[BQF>'5[<\-U>FQ?SU;*@.W;+ M]*?B6L+3O(V2\(SEBHL<2;:]F+W!YVM"C$-E\1MG]^KH'ADJ&R$^FX>KY&+F M&$0L9;$V(2A<[MB:I:F)!#B^-$%G[9C&\?C^$/V'BCR0V5#%UB+]G2=Z?S$+ M9RAA6UJF^D;<_\0:0KZ)%XM45;_HOK%U9B@NE199XPP(,I[75_K0).+( >+8 M'4CC0/H.WHB#VSBX%=$:647K+=5TM93B'DEC#=',396;RAO8\-Q,XZV6\"\' M/[U:BSR!26$)@CLE4IY0#0^W&BXP6UHAL46_%$Q2DW6%7J%/MV_1\Z%=Y+#+691+]\6:CM(2Z_=.6 MK#J89P]F%O.Y*FC,+F:P6A63=VRV>O8$!\YK&]/O%.R$M]?R]J:BKSY [U$T M9=:2J%V#RM5TF+N5%T0+/UK.[X[Q#\U\Q\%>V)J=(/-;9/XDLK50VI3S3HA$ M(2CV!#UG#W%:)CS?(9H)J?E?59TC]E"850'E?LL8^B T0]A]86-4#^D?025A MB*.@QVAHYI(@B$88!2VC8)+1CU(HA0HIMES;P 6#47&(_<#M@;.8+5S/=^S@ M%BVXQ22X6^C-D-B7:,=RZ!\I@CZ!: )-C)MU8-KW(<_66ED,41$/ATX/O,4, M1[X7V<&'+?AP$OP- XQEK$M9U08@ERRM6F.\IW+'U$N4,VO.0TO._44/]-#( MC1;$#CEJ(4>3D)LN#7!YU7ILX*+!N+[ODWZQ#JV\*"(C&<5.)S7.-$"]9[(! M9U9>-?4O1A/91#O)I#.8?HO5*T+<,;!'NH@GP5[EFD%SU(<2'8>)AP IY&@ M4Z V.Y=X([..28>4_ /2*J$;!ILZAC1]8*HJ6/:EY/JK46E ?D@[M#^JE(AY M7NO&?:D#/Q%2/J\AF:NYXWU:MS))YY4J=7'B@CT8G["[YM9N9:V MXCMAG]70+/)==X14IXUX6AROOB\7;YAZERP&E3VJK53 RWZ13 M?C*M_/\#_X2GI6F'C\A C3$\S8#?SX#-:C0#W8Z"3.\HWO([GC#XJD<)BP'L MXY#7L:,C3,Z9YP^@6\WP:W^AM02P,$% @ 8H6B6 ;'@'Q P J@P !@ M !X;"]W;W)K+Q\SHFT/D>+J3 MZDD7 (8\EUSHF5<8L[GV?9T54%)])3<@<& M-_<*9WYK)671F234L)/^#Y::8>6./Y+"B M%3=?Y.YGV#N46GN9Y+K^);N];."1K-)&EGME)"B9:)[T>1^( P6TXU:(]@K1 MJ4)R1B'>*]21\QNRVJT[:NA\JN2.*"N-UNR@CDVMC=XP8=/X8!3N,M0S\X44 M.28%X56*-%#9Y6R ?1"9+( /R^'!'+MY=DG>$ M"?);(2M-1:ZGOD$N:]W/]@RW#4-TAB$F'Z4PA28_(DM^K.^C/ZU3T8M3MU&O MP8]479$X?$^B($H;/41F%)_^6*7F,] M<5NWW_FUWM ,9AX:UJ"VX,V__RX!2-I )'W6YY_P6&*UQRXW M&]UAK6M/G^T\3J-T//6WA_Q=J6B2)F$K=026MF!I;X8^FP(4R8Y2<\&EUI=[ MWO=$0)T^0Y]=[.E;INB-C!U%8MA&8MB;HD6E%(CL*\%R%)K3YJS-_\:3J#X. M7,XW%M.#E RB-!Y/3C+7%0N39#AV9V[4\HYZ>>]@A2LY68+ D<&;Q3#5?&P; MCAZX>$<=D#A-3F"[,H,P&KI9QRWK^!MBBV"@F,Q)5E"Q!GMVKBA39$MY!;;$ M4GN[.>G'';(H3M(3_*Y0/ G<]).6?M)+_RBP3>#L7PSV&ML#8NMB2QFG M2PX#["<&FG(@&K)*,\*Q+'B9L\#%XON:"7_7^_;^>E%3CJ.AIV MB!UR81H,SQ1+>' SA_WE:#2VY:) O"35&L65E;*40(XF0N"&,DAQMK=$S WB0&:=O41@3%M8">VN648Y14!NIZD/3Z4W.Z$U M$YIP6*')X&J$059-8]Q,C-S4O>52&NQ4ZV&!?R9 60'<7TEI7B;V!>W?D_E_ M4$L#!!0 ( &*%HEC)L21>[P< )HB 8 >&PO=V]R:W-H965T&ULK9K[<]LV$L?_%8R:Z;0S=D0\^(IMS33V]:XS;2\7M]>?(0JV M,*$(A@1EY_[Z6Y"T*!$/)7?.C&-26H#?Q6,_NS"OGU3SJ=T*H='SKJS:F\56 MZ_K=5#-CFNX;1Z7;=T(OND;[.R6JRN^\\^ M-*MKU>E25N)#@]INM^/-E_>B5$\W"[QX^>"C?-QJ\\%R=5WS1W$O])_UAP;N MEH=>-G(GJE:J"C7BX6;Q$WYWRYAIT%O\6XJG]N@:&5?62GTR-[]L;A:1421* M46C3!8=?>W$KRM+T!#H^CYTN#L\T#8^O7WK_N7<>G%GS5MRJ\B^YT=N;1;9 M&_' NU)_5$__$*-#L>FO4&7;_X^>1MMH@8JNU6HW-@8%.UD-O_GS.!!'#3#S M-"!C _*U#>C8@/:.#LIZM^ZXYJOK1CVAQEA#;^:B'YN^-7@C*S.-][J!;R6T MTZM;56U@4L0&P56K2KGA&F[>\Y)7A4#WIN,67:(_[^_0#V]^1&^0K- ?6]6U MO-JTUTL-&DQ/RV)\WOOA><3SO-]X\Q91?(%(1)BC^6VX^9TH#LWI:?,E>'YP MGQS<)WU_U.=^US2BTHBW+?CI9S& MT?5R?^R/RXS%)#V8G2AE!Z4LJ/2GHE ="(,P40A0N2[%!:J$=@D=>HJ/%# 6 M13B;"769L?S(GQ.A\4%H'%P]OU1[&$#52.$EQ.['&&N.$83R;$I=9'C'/VDD/4M.@U+\ &I>RNJP; M58AV$/L@*PD1E7+'K-360E@4QS/)#C/,,NQ91=E!>,DM2G*3Y7+C#BL5'[IWHS@^Z\Z#N/Y3FY5=(S*V'YY1& M))]I=)B1-,MRMT@<38"+S@POY#R-_G*!:F":[D?71+\:DA%]@;A&A6J=L67L M^#1JQ-@*+BZ[F#+LDW[$9AR4_BNLX'<(PF&WZ\J>RQL!V[N0W*1 3LG8DG)) M&,DR2[/3,$ZBS"-Z(BH.4NS<>'OB^-CIL1Y /*%SXCCMTNPHNIS*GNB(PWCL M$UBD'E#7"E0*R P#2WKLZU@%S;"U[9QF"68>K1,?<1B0?X,P^F<^MH1D9I"2N6"'79ZD MQ#?S$]QPF&Z&XJTVJ[,UR2W(56:'P6XKU*[FE0=SV 98GF=6BN0PPQ'&L4_V M!#H<)MV=>! 0>C=(\^?04G5 "YZ?SF6ZS%+JH3&>V(;#IJL?!=B/6SG!#;/"1-,WG<^@RHU S>&;PJ-X,T_%0V]3\BRELG!)MQN$< MA1,!R=D2L>G& M" U)LSSIF]54-.W @M&V' B-:B$@_21 M)TK0"6TTC+8A2IS3: ,+4U/F60O$:9@3W[D*G=A&PVR[5;N=',NF/AM3E0:Z MB:H S>B'WY46"&<_.M7_#X>9R)6:OD)'I]Y/S*1),!/_V^=.ZB].YX*P_=;D M^[5Z.W5SPBL-X]5,,NSX5JOB$WJ#(1]LT)Z7G;A"O-.0FKD3A=BM17/2@IZTR#&TRL86SOEP5+9I;B7\'C/BV283]&D8^K>\EF9#RPJ) MY_Y(&LJ4PS Z!=M$SQF)K0,1IUT$Q;U'\D1^&B;_1Z$Y?+1!@C>5J;:<*FVH MQVF:9&2NTF$')&,>E6R"/PO#__A8=#PMAV*@$5M#J3TD ZIU"FP/8QP82!O?9B#3?+Z G889RXDG-+"C/W-^(^D/9^4>R'#!O;4!X?I15"^GT [2,WJ;@=3.\"#'<:%7W[Q*LE=9JUU]N!8>E:PS@ M^P<%V!]OS.L)A]=15O\%4$L#!!0 ( &*%HEA*>& \HP( &D' 8 M>&PO=V]R:W-H965T&ULK57+;MLP$/P50BV*!$BCEZW8J2P@ M<1"DAP)&C+:'H@=:6EM$*%(E*3OMUW=)*8*=*B^@/E@DM3.<6:Z6Z4ZJ.UT" M&')?<:%G7FE,?>[[.B^AHOI4UB#PS5JJBAJP\(MVY3&+OA96M,-+,%\K1<*9W[/ M4K *A&92$ 7KF7<1GL\3&^\"OC'8Z;TQL4Y64M[9R>=BY@56$'#(C66@^-C" M'#BW1"CC5\?I]5M:X/[X@?W:>4$Y_H$I=UZAL48NG\O-OTLMTT>F+3+U2= MDC@\(5$0C0;@\^?A5Y#W\/@0[J/]/@=1GX/(\<5/\"T->L;*-$2NR343Z)Q1 M3A92,U=J/RY6VB@LN)]#5EONT3"W_0C/=4USF'GXE6E06_"R#^_")/@T9/P_ MD1VD(>[3$#_'CJ505>@62RZ_.R$U561+>0/DB E22,ZITJ0&U9[Z\5 J6O[$ M\=OVLH/HMB );4PI%?N#A6S%MZN#BEOR\9Z>.&A_ MCX2_(O! _[C7/WZ[?J9U\[+V\3^2PK/I9#H)'B=],' :3B>38>U)KSUYNW:\ M*;2AHF!B\Y*!Y+4&!@.'#/A[C=!>0MAH-DQHPF&-T.#T##E4V]C;B9&UZXTK M:;#3NF&)=R$H&X#OUU*:AXEMM_WMFOT%4$L#!!0 ( &*%HEC:OY8H+0< M )@= 8 >&PO=V]R:W-H965T&ULK5EM;]LV$/XKA%<, M+1#7$O7J+#&0N"W6#^V"9MT^TQ)MZDFR9:R@#P+)?9X3\7)/,_YT.W$GQQO?V&:K M](W9XF9'-O21JN^[!P%7LUI+RG):2,8+).CZ=G+G7B^]0!\P$G\Q^B1//B-M MRHKS'_KB..#D >NP'<'4 =P_X P>\ZH!G#"V1&;,^$$46-X(_(:&E09O^8'QC M3H,UK-!A?%0"OF5P3BV6O$@A*#1%\$GRC*5$P<6C@G\0+2417Z,ED5OT"2(N MT11]?_R WKYYA]X@5J _MWPO29'*FYD"-%KG+*E^^;[\93SPRQ[ZP@NUE>@C M($C;YV=@16T*/IIRCT<5?B'B/?+<*X0=[%OP+%]_W!N!X]6>]8P^;\BSVFEK MX[2UX#F"RA-$L6)3IBY3C%J]5FKU[5IU55_+'4GH[03*5E)QH)/%K[^XH?.; MS>0+*6LYP*\=X(]I7WR%)L2*A.?49F9Y-C1G=:\Y++P !_'-['"*OR^%YX'O MUE(M8$$-+!B-S%WZ#Q16F=V*0S-*>)&PC**B1JSOZZM$!W$G^(%!CJ+5BS6* MUS;[@DN&\4+*6MX*:V^%HV&\R[E0[#]BNBXT@Y2NP$M2[DF14)1PJ:QI7"H- M6O'U.M$=EVFAC6JTT2C:#Q1HF47)L#MR$O=Z2 ?+LRJ:E# MP71>#G3?N =YZH91T#',(N7[SD"!S6O#YF>"L*9"5)"!78SSKS2[EK<5>:;2 M1(>K+17&'IL)\QZX(.QVB+[,%&-OP #7:6C1&37A<4L$G>H!H6V%E>>V&:$OA4T*S,%S!A4V6+%;;; ^3&0=2% MW9?RYA$>@(T;V'@4]D,U"=9)@';020153)BY ZUH0=?,WELJW:V@!X';16Z1 M\MU@ 'E#Z^XXKW^@"Z-&4'LLJLTT&E MI96;OM>+<%]J"LGI#X2XF0_<44)=?"X.$"TN!B:TZG3K9\,@"KOH+&)!-!\J MG8:/W7%"?A!T1QC0Q+/N2J>-M)-Z5NQ]SIVZ3M!K5A:Q, J'BJ=A9W>F M3'25B%;?.BD,*^H^_TZ],.QYW"*&(W^HQS8\[8X3=9VT._*B,[8<+))$[*'- MGH-N85CL^8[3Q=Z7"_T3MFM#;YC8':?BKZ\=8JW8^^2*(]POP[Z8%T7Q0*+C MAH.Q\U,;%(.RE*^ C4>I_6<;YJ6TM9W0\#L>Y_?/QNAR68&R@3!"\-3+%=IE M1%G^%Y\E)B/TXEL%B=,EY- M@R9)S3>B^S2@,L1"Y]B/Y_.N)7TY9\"*AO/Q*"M"R^4)I6F5AS"KP[#"C@O1 M<+.MM+8&V.[\:I$9@MN0+#Z_>1M_[O7X"EGSZLJQ$"J>>TZWXFUR(]G2$"\> MW\R[%;]F!6R9K\!]T6W[4MK:3FCX'9_A]V/)0&YEO-A,%16Y6;NMIEN8VH_< M7L2L8L[ MHT;0L?CA'[/!9PQV^K;707\'3*/> \\.^C0P;B<,H76)#D=?:VV MV-;L>6\9MXA-YU$TL(WCAN;Q.,TWCB^J>4H[?1AMG[%[7=6V7H?S : -J>,S M^_5Q[T=Z$+1BLZS%L1MW!R:;6!0[ P"]AKF]\>WY#^,]J7CRHV[\506_6)]Y M]G?CJ>O[W<#;Q+ ["+?A6&^<8ZU#TMNJ>;Y[=1?R^AP:!F'WH9=%2O-8.)"^ M7D.UWCC5?ERO:6*X=,T%99L"-H1R+44P[=%Z1>7EWFJUP,*Q'HZZ:6T1PVXP ML'9Y)P_,QUFV>F#XYOR\5SP<3J"%<;YQP MET-($5$(:@&MZ(85^J&>#H^^ 4,>,,U.WG'E5&S,JS^)S&)6OB.J M[]:O%^_,2[7._7OW>EF^)&S4E.\LOQ !49(HHVM0Z;R/ )HH7P.6%XKOS)NT M%5>*Y^;CEI*4"BT WZ\Y5\<+_0/UR]C%_U!+ P04 " !BA:)8]C\1L+<# M X#P & 'AL+W=OR"9LR:C,RW>S$9\5+E&8-[0619%%3\O(6<[\:6:[U^>,C6J=(? M[,EH0]?P".K;YEY@SZY9DJP )C/.B(#5V+IQKY>1MC<&WS/8R8,VT3MYXOQ9 M=^Z2L>7H!4$.L=(,%%];F$*>:R)6 MJ'1L75DD@14M<_7 =Y^@VD^H^6*>2_,DN\K6L4A<2L6+"HPK*#*V?].7R@\' M -<_ _ J@/=_ 7X%\!L WST#""I T)SAZ@P@K !AN"]^ M))[C!3C\[7%&WK_[0-YIT->4EY*R1(YLA6O6,]MQM;[;_?J\,^O[RA7-6V#3 M;MB4%[@\W :/GUO0L_] TTV&TYK]OL0@C1/NJ2#?:5Y""]^\F^\!%.8$]-*< M"I:Q=9L?%MT4-W%<%F5N@O.G2D%@O K,/:E."EL@?W#9QKKL9OW"68Q1%#S' MD36Y8PH$2'5,9*.D:EUYM:X\PQR<8;Z%=<;T7C%1Y)3%0*@B,XAKD?AM6MAS M1H93Y]#MQ/6O@J'GC>SM8?!;[ ;#8<-J=FHU#!S7<8_-YJ=F8>A$0<-L<6IV MX7I!X(;'=LM3N\CQ:YLC9_JU,WT#\L\X\X[%6&4DD/?H0=/ZH+5IU)WR/ $A M?WL]F7\_8# )IND=%O M5'02'W3SF6\51A]DLW[)%OT2;;LB>Q(&%$MC*A3&'.6-"KTT6]< MFQ*BE@H]Q.+;K-"=$[]5"GV2S?LD6_1)MNR);"\%^^!.H.^4&%G\(Y,DAQ72 M.Y<#%)[8W]/V'<4WYIKPQ!5>.DPSQ:LM"&V XRO.U6M'WSSJR_+D7U!+ P04 M " !BA:)8E6W\[:D" "L!P & 'AL+W=OBFK/1A+['/OM_/]Y&[B_=2;70.8,A#(4H]\G)CJB&E.LVA8+HG*RCQ M9B55P0R*:DUUI8!E#E0(&OC^%2T8+[TD=F=SE<1R:P0O8:Z(WA8%4X]C$'(_ M\OK>X>".KW-C#V@25VP-"S _JKE"B;8L&2^@U%R61,%JY%WWA[/(ZCN%GQSV M^FA/K"=+*3=6^)Z-/-\:! )28QD8+CN8@!"6",VX;SB]]DD+/-X?V&^<[^C+ MDFF82/&+9R8?>9\]DL&*;86YD_MOT/@SL'RI%-I]R;[1]3V2;K6110-&"PI> MUBM[:.)P!$">;D#0 (+G@.@%0-@ PG,!40.(S@4,&H!SG=:^N\!-F6%)K.2> M**N-;';CHN_0&"]>VO]D813>R<6<*;S-P?"4"7U)/I*WA!*=X[&.J4'++#]-&RO&M17! M"U:$Y%8BFR8SM"9[BJ?H4>M6<'!K')PDO&6J1\+^!Q+X0=1AS^0T? $5PGT' M#SO@T_-?[X+/SG\].!&,L,UQZ/C"E_@.R;2Y7!B9;G(I,E#Z_2&=OZ^7VB@L MVC]=N:O9HVYVV\B&NF(IC#SL5!K4#KSDW9O^E?^U*_"O239]3;+9*Y$]25'4 MIB@ZQ9Y,^8YC'68:FUPJL(@R]90CUV^'0%TNJI!_8F@S>S*VK9,"M6PQ][4B6Z5"EAY/1Z-6PDLKT MSD_3LQMW?FICT,K0C1,^5I5TFPO2=GW6&_?:!Y_48AGXP?#\M)8+NJ7PN;YQ MN!MV6DI5D?'*&N%H?M:;CM]>'+%\$OA-T=KO7 N.9&;M%[[YN3SKC=@ATE0$ MUB#Q;T67I#4K@AM_-3I[G4D^N'O=:G^?8D.H]Z?# +-\>%@T)BZRB'X(=SN? M)ZW/%Y-G%5Y+-Q"'X[Z8C"9'S^@[[')PF/0=/J'OHUM(H_Z?0N^+2VN\U:K< M9N)!:I"*]\I(4RBIQ2T>$B :O/AC.O/! 63_VY>A[,#1?@>X\=[Z6A9TUJO9 MEEM1[_SEB_&KT2J&,"$N<$?^U@;P(EO-? MHNGQ;EL)W.Q-.C2&)2S_&J4+Y/1&?*+:NB!@C9M6C$<__"I 76Q$U.24+04Q M# 5 5"P[%(D#%GCYXLUD,CK).M+-^.3[?CH+[95O!6#N"SGQP4:T/##3B(H= M'9>VJJ79=*^:QVOJGG!VFJ)43>U!:919B MUB93>O&52_!:(3\^SKPJE72*?#]9E-Y;9)$S6B07TYMH-.MA_POT*MTC@[AQ M:X7*./HK*M1U(/:7^2Z?:HI6[!9MWA7-;XNF3*$CEP &"/67CN" C*7B(^SD M4JY(S(B,0#O4>)]P(HO"NA+Z"!P9EF)!AIS4*#K>4)T.0R2:P,FI'>RH&G$U M&!.?33*0X./%09/[SX/;@?AI.KUIZYW@HI $IZJ= %P"!6MF#Q_KNZ4B.A60 MSB1P=5\LI5D0ZE95RJ<9UIJ\O;KLC#E:1)WRB/Q>D@N8H[">IVW;1'-K@T%_ MB%+Y0EL?D7YA6(2C[_*)DWL3_EP2N_!WDKXM)C)A*Q4XS#HZ'Z4)C$T?T3HN MZB;6!S'\G)-M:V6:GJ^DP7AG5W(K[?41N.=!+1"1D.6?&'SY.<-)^91WJ,HQ M0QBY=JD6.Z+KI8);C"9#!>",'2/54HJY5&YK++/&KA^U]2J3/Q*+<9XPCKTG MMUL.LI!^*>;887S')RU(,J\@=NZ$5D,K%):.2%1Y NZEGN2Q#9W7*M6T1-?S MPM)ZV^I%^F+3O5GV2QMUR0IX@6,\(+]_1I,W MI 0(5M:0%X-T_/H$9&U,A**&6^=*,S2V#/M+YP4[T 3Y#M%4,U!2$^>A. !- MR2J][>]297K9Z6H[8_#DZ+C;>BC6T&GS^,[X'O\X?I/JA:YH&)-Y 9;%#1GC M-WH%8;GESF*'5]/YP]'@:S85*G/C0ML9\J"1.V*.X#(!?BYAR%DN'R 2%6/A M=TZF%&F><[=)!V;*Q($]52,%N6\3LK=0@U*[@O+)L4A4EIE[7U'R@1NV\QDPQU!RKKT5_EBIL_\ZP'B.![RIT/1!HS0D=LF;'"581ZRQ#$-3F; M%I0^5,^!(H17GR+H9\SBG):WP25 C.J2NC$4[ MH?!M\(4"%VSF+$#J$HTB(N9$YAD>,NU4;"((FT9)R,T*)SDQG=B6@@1O5RH9 MRWRQD]H\?%.+ 3#ON9 %-^?=M>@GB*_0G$@Q!I=<;7:+G_TV<8[]+V9BJFN= M.IB+BH&8P,DC.?-!GB9RI@D.+5)SOA4'ZGLQ145QSI_@#K=7T0$+'":M7DEAS>R4'-5#,2'#7#V X9+)FOF1T(1 MP? @\JG#/ 7/R@XOK.;NY8O)\>0$Q=Q0]V)[:(T)GBD:#<$3_;$%@!Y5WXX9 M0FG2EYCX3P31)7)H6G:*F:WSD\DD<7&=1?5FP NCG?>;/OTH')=VUC/>K%W:4GV,"0\)X:-!I\6WNI M&7,/8WJ7L?*-8X(] %7VOX(LSW-(_VLT^!%]J'5#EPYPE[PI)-0OT*C9&<@= M/RV'Y<+S5-]NB=U0:!#-D.7I"U+;<-P@*UYN'L66I]#6;J,Y(:9SFI6C+SZF MC#-C5R0.>+9A^\ *B\3UV^WMZY0_\9GP\./@8T>L@WT?4L.=[V;TW2+].N S M\>9/Z.YI]P/$-']W;\7SKQ]X[0T;Z'Z6.?\;4$L#!!0 ( &*%HECVS)&4/P4 *L+ 9 M >&PO=V]R:W-H965T;JV[KMOB(*X:;7Q9UD30O=R//950ZWTN>W(X,O2NE8&/+K5V'>.9!V-6CTN M)I.C<2N5R1:G\=T'MSBU?=#*T D+;KLVR:;5]\5*LF\(OQXK23 M*_I$X4OWP>%IO$.I54O&*VN$H^59=CY]>3'G_7'#5T5K/U@+SJ2T]CL_7-5G MV80#(DU58 2)OVNZ)*T9"&'\V&!F.Y=L.%QOT=_$W)%+*3U=6OV[JD-SEAUG MHJ:E['7X:-=O:9//(>-55OOX*]9I[^$\$U7O@VTWQHB@52;]RYL-#P.#X\D# M!L7&H(AQ)T#?0>!%3C=8(3ADNRJ?@\%7!+BPN>H\WWHOS MZD>OO&*J_.DX )HWC*L-S$6"*1Z F8GWUH3&B]>FIOJN_1@A[>(JMG%=%(\" MOI1\/RU4HZ15[\\O3)<5%,3K CKJ8GOPK,$C$K\@*"UIHI?_WEXTC@Y<%L MGA]MWXZ$,I7N:XY*&CP@4*E%)7TC.GF+R1"$78KB^=YD#U2\R)_O@1#1-XP! M$:QPF$S(/@:;^HN3[:P/SRIM?716?\,'QO>8.UH&I Q+'B_\N9*="@B$$0RT MHR#Y$GLBI9JN27LAO5ACTO _26>>P:GHG+U6/G(]0&6"EQ"D5G\E47)*DV(6 M[>#.(TKG$(N^%>2#:J.A#&)^7]KS_,4^Z]!@F_),EBPUB3I5F N;)]W[?4T3 MUPS=(=";Z ':Q1@,5 ML0BFST\P*=Z_/A>>5LPS*M11I9@$2$89T6"8/NO(Q5/'5"1T7SI522X)>U_A M /+DAQ*Q3JV8QQA4%]4!TWZ)1NX=.9#L4.,E1[:Q3@1)AS@=\G4*^?8^;3.W*('83LHZ)9VXWJ/ .C M^K*U+J"B +K&ENF1N(6H_0G:?-#[0(&+NN?VI*HQ::(\A#'?8C#Q!Y-]D\<4 MG:R)R7_ ^C 90ZJ8_74=.;X[XAQ5=F6BQ<'TZ"Z!*VOK*.R-/.X*V%@,%>Q* M#8"N0R\AI\@LS[L@;YA^E'9;P1W>P*E-T$C$>)GN+=S .WG* (65?8C]C!SI M!GW#Y:XPP#:=8=>A$?[6D&,>N=,Y+ARHB&M[HJ:L-VIY6"!8(K$ *LELIQ35 M*7P<;[CY1&Q<$5VJ_D[A. +0A]R$FQDW;(,::HI]MQLZ&TI[(]',G,^EQ50U M/JV\U:J.JOX4\)&PO=V]R:W-H965TL5 ""&]];S*0S&13[SUOT+S%VQ+(2CL^,^DUFOCA) M#A/*>"UJY:_,YA=NX]D/>*E1+O[2II$]F"64ULZ;LE6&!Z74S;]X:'GH*1R. MWU"8M J3Z'=C*'IY+KQ8S*W9D W20 L/,=2H#>>D#DFY]A9O)?3\XHI3UEX] MTH5S-6>T3%-3:R]U3M=>Z$S8S,U''I:"_"AM44\;U,D;J%/Z:K0O'/VL,\Z> MZX_@8>?F9.OFZ>1=P*_"#FFZ-Z#)>#)[!V_:A3V->-,W\%X+DVZK3'@F'.FL M$#IGDKI/R*65.I658OICN7+>HJ+^?(V;QO3L==.ARXY<)5(^2=!&CNT])XN/ M'_8^C8_?"6S6!39[#_U?Y_._H]+?$OIF//V.6;/,3.4A=%,P?9%:@%BA7E3\?&7Y?5I?-P[WB7YCJ4VFUN]Y?5MIX8BFOXT/AC0-><8,!ZN M5\9&_9T;4\F4)H?CW2.Z*"MK[CF(./*F%1,K5,!6\URZ5!E7(Y.A6KX%\17; M:&*(Z*0C6"9^J."7HSC).A#7@F0="-Y^KZ5M3 ZHLA*C4H)37UA3YP6Q1F6F MB#GK&18KC%MR,M=R+5,!Q"TR[&* LAM&HGMV7,4IA*'L"_&^+@G(=X:V$A6^!)(D^#Q1YF$D+R6O"=\.*R&D&4W&(E^(.U(3^"@"U:U3X7J@ZI H* M\2N#^&CUV/D!D:#8P6SC1>2FMI 52IE4A"&/. /;;7Y1'L3K-X>F1A':TXEUH'G\7:P]5SE'1,Y]Y^'#W3 <:S1Q9BW"+4<(@+ MCI?2HYP;FL],B6P_!O-I;6W3%&V4 =L_3T4_Y636> U%U]9Q9"LH2&"F/A20 MA-@98C5*A@K/>OV#ZO M.)B-=^EE,SR)_M@$'6L_-$$;J*.J7BD KVJ'.>.0)/2NC[5HMKXBJUDF [L( M2^IF^PA< W];NQDAZYP;&U1C7@".=WY;B)93 V*4;%0CM]PK"0_?;:B\5AZD M^]H;^]C<[H2[=GS$B^=XW3B)9<09RET-(@8/(OVXQU(07(Y,^4#JD"[0/LJ9 M)S9R+%.AV#+V0JJVN*7.))JJJ=;6*DI'(KV1XQC>2Y^VD?"#CZW3*YP0?."U M@>"'E!D#2?38Q(QA5QB5];OH\\LN^D_KJ+<[E6SSN"'"R?!! M:=:H[K9;0I?-[O4DWFRP6%+ A2/%:ZB.AP?["=EF*VP.WE1Q$UL9C[TN/A98 MI-D& ;Q?&^.WAV"@6\T7?P%02P,$% @ 8H6B6, .-KVS!0 [@T !D M !X;"]W;W)K&ULG5?;;ALW$/V5@1H$%L!8>]5* MO@&VDZ9Y<&+8:?M0](%:C;1$=I<*25EVOKXSY$J674E("PA:WN;PS'#.&SJUI[W*N<6)X.!+2MLI#W6"VQI9J9-(QUUS7Q@%P;EU!LU]2") MHN&@D:KM79SYL5MS<::7KE8MWAJPRZ:1YND*:[TZ[\6]]<"=FE>.!P879PLY MQWMTOR]N#?4&&Y2I:K"U2K=@<';>NXQ/KC)>[Q?\H7!EM]K GDRT_L:=3]/S M7L2$L,;2,8*DQP->8UTS$-'XWF'V-ENRX79[C?ZK]YU\F4B+U[K^4TU===X; M]6"*,[FLW9U>_8:=/SGCE;JV_A]686V>]:!<6J>;SI@8-*H-3_G8Q6'+8!3M M,4@Z@\3S#AMYEN^EDQ=G1J_ \&I"XX9WU5L3.=7RH=P[0[.*[-S%U=+2B+5P MCW.*M;-G T>P/#DH.XBK )'L@4CA1K>NLO"AG>+TI?V Z&PX)6M.5\E!P!MI MCB&-!211DAW 2S<^IAXOW8/7N09WN-#&J78NX :E71KTP^^5+6O-70M_74ZL M,Y0J?^^*0]@FV[T-R^?$+F2)YSW2AT7S@+V+M[_$P^CT@!/9QHGL$/K/'=1! MB-T$_X4+7RN$:]TL9/OT]I=1$A>G%J@(&,FA ]LM$["J5%F!- BE)I%:Q\%< M*5>!(A3C@RTG-6Z9D.)8CN!H"XKSLG04== S/_!Z3]4Z-*VL@4J.;-4/R3(6 M?FF#KM)3F#QU)':9DX=Z:4HZ5*8HZUJ7TN$49#L-&+)MT;S$*"N%LRUGIU@J M7WX:^8W62FN1?SOW(R-?(]L2C[=C")5D X.X*R8G<*3Z<-F@4:6TI]2C[H>; M#Y>GGBAU>=HJ.;B5I9JI,F 'O#5(=PC-0EMRL MG2Q7=RIK])Z#.)SHHBBN@ M)(%LBW8+;GM';XMJ%EU!:O;G9C^,RSYC2< M*D.DZB<"K/UY76OKV':N]=2"U35%A8V3Z/3ZR\=[WXQ/^\*[>4_EW0M\CG2X ME#L\**=4.!7KVCN+CW2C\2FN8>X_OI7-XO1R#74,7Y[]7R]NM7OF)ITS:K(, M[CK]*MY$]G6 .Z<%77ZL&0LE4K#H)$IM*&[DZ"ZF);D>CN\.UW)A4CRR#D]9 M23-'TA;M+WS$F:EJRWI)U9@/V^X]5'*4F!O2*S;!0R;,649R>0(U)3/J$8R7 M]<\>>[5\PU8/MZ%;##BXB_ MT2?TEN%9;6GOO^0GY[3;J*D)MQCR+09T!]%!K2\A3YH:Z0E\WARSG^#!C7SA M#23)6!1YQJT\%EF<>C%#G(Y$EB00YXG(LO$+14,BF0TA*_:4>(^ MI],;R(8,.J96'D4BSD:'A+I%9C@411&%1ISD@0H1S(L8DL(_7A!)(Y$6!4\- M\Z3CL3][($X(/Q[1,Q8ID?JY)(6C6(SRH@]'J1@721\^Z_;=,_I!P>:9B LV MI=@61=R']TB94:J0#W3R6W*B0MV)1S9\[8?[@W;/19R/^KXQ+(;]+;%W"9GG M(D^&D(W%.!D?RE6(132*X"@123KN[\GWHS@2HR3C#5.19 FO\U@3I/RCY)./ M78W&[TOEGEBR;-?M2$Z1*YI]Y$#ZK%8A*W)1C!)JI!GEU @NZSK_69T8! M;*TL0]FOY /OB53]:T7Q]7@SHYMUL7JMCQT5VK/O="KB- ;2X:[7N<'6.SC!S_V7!M5YO6Q=>!W?C&X^9B[#._SS\O E1([- M5AX_3"O]%/M*/O ]^LZ(,,#2^@^9G6;MWA#3:?>!?_ M %!+ P04 " !BA:)8-%1><5X& J#P &0 'AL+W=O:S71,Y<=O4K3T>K9WK M7DTFMEA3(^U8=]3BRTJ;1CI,336QG2%9>J&FGJ1Q/)LT4K6CDR._=FE.CG3O M:M72I1&V;QII[LZHUC?'HV2T7;A2U=KQPN3DJ),5?23W:W=I,)L,6DK54&N5 M;H6AU?'H-'EUEO-^O^$W13=V9RS8DJ76GWGROCP>Q0R(:BH<:Y#XNZ9SJFM6 M!!A?-CI'PY$LN#O>:G_G;8_J]*MCT?SD2AI)?O:7>F;GVACSY3U M%;JV_E?#/,HWTLF3 M(Z-OA.'=T,8#;ZJ7!CC5LE,^.H.O"G+NY /\_E'69(5L2W%%U]3VA/]"5ZUB MWHXF#L?PYDFQ47D65*9/J,S$A6[=VHJW;4GE0_D)X T8TRW&L_19A1?2C$66 M1"*-T_P9?=E@<^;U94_HVUJY,KH1Y\!J$!O@W:W%N6>V4X6=#Q"HE@RUS0Z>?%=,HM?/X,^']#GSVG_;QY[5N5^P-\\1YP: M(]N*D*+.XH-%(JBV$JH5+'M%G39^X=2*3AHG]$JX-8'QII/MW8OOYFER^-J* M=W6ORD(:$I\NQ+*W &=M) HR#D4%(LJ4+UG!G>B,+GOXRGI<3F\RA Q 0KZ1 M+0I)*99WNP>-Q:?[B8!36[LB8[!OCVHK>D2M@;H=VTPP^F^(<"$1++$>8MS+8I!% M.,9VY"M7#4.&\$34%L2!&QPAK *^E2IDZX3'A=4GZ#;!DX$QU/':V^5S@;)2PPBA9>Z6R,JI Y/0&"_2E5QUS'OEO)1:7@%-I7=JQCR.@5[JW M]9THE2UJ;8'=!\G7AC*!@DNW2.*7/T=[]ZQ K*BEJ+=6UXE9E0R6QU"BFH 4)/8#W<# "!?&" MU;4VRMW]B)Y4Z+YUS#\TR ZDWRJT&CA;).GW?%X!C;I6I>1=''@A]GE_B!!_ MFD*4/C9CJYW/_%I]]HSV\7U5/+667'#_+TK"FTA]'+^;46L)48X(1]ZKQ596 M!EG.'E.&W&&I07L.(-%=0L8=UF,1M_ M!>:AH0?Y.'Z8E/EX.BS@#/3P4 XVF;'_:);\ZNS'^?GNWV;X@V@$Z4[9E<*N M+8G C9]M"H-(72C/4D?&W\28*;VL5>4K0'#03IE2+7)T:\\CI;*\]N*=O!O* M&\& 3'D/25'5>AGT^9[ 96^%:-(/ Z*BEHRW M/72'H)BN4:B /Z#<)16](Y1V7WDL5^\$%E/**U(5T9V:X6F3Q7' M18", MEHK@RXOO(2SGF8(QAON@;F7-Y9>PW/AA#4#CP'LZ#*FQ7T!ZK!.N[V M7&8\:99+\Q A>X'>U['EW< Q(WU,JF_>;/'NE?)Q:@Y=\?W@"7&*.8(&$A=O M3U'%E)QAKW\ MR/!5'&@U;#,BF67183I'EYE&LSAEN=EA"CUQ%&-Z(-*4Y7/6E,VC/.6U)$ZB MZ3S#*)_QU\4W['5R0HJQ3J84TKB.+V-1T)$UYF8>)TYU]#2^U MIA^ND6=D> .^K[1VVPD?,#R/3_X!4$L#!!0 ( &*%HEA;_NZ]K 0 +D+ M 9 >&PO=V]R:W-H965TW*UI ML:T7ORA-##1IBQ5HUJ#IU@_#/M#2V2(JB2I)V?%^_>Y(6W$2Q\OVP>:+[NUY M[H[DV5KI'Z9 M'!;E;4Y[Q76-J>#@IDKC_F'M94,2SEIC5;55I@@J6?M1W&YYV%.8 M#I]0B+8*D8O;.W)1OA=6S,ZT6H-F:;+&$P?5:5-PLN:DW%A-7R7IV=EG)$CF M;&#)%N\,LJW>A=>+GM"+X4K5MC#PHY0E1QR:W"'^%]C3KN8[[.70ZV("1*5HH25 MH&%>[@+*E+%$EFGG?BWK3%48 -&[D+6H,]QGG&.UA4:$RC<-XVJB74B8[&/]M6+:11.WIH'Q I-/W97TCEK3KU)-O=D*EY"'$R2 MV(UI/(:;0FE[PM0\$ S3%")*[4W;-"5R)1 AF3 %+,@78?=W@S^F2V(L9UZ? M#/G_<,)UP;C((H)>3"-X_OYF(O2E9V_RO][3AX0?)>']YAA-:=V MY(6[M)G!KL-VB(B,:1"F(S\9APE\(6]TVK1:,^O[(,(PF(93'M+Q"#ZK>KE? M=ON2$2$-4Q[2> +?%",]1@\Y3X(QB;I).HS@N[N7F7DZ4NB9 M/M*<2"0E)_H2PF$0)V$GPF%O.^=>GDAZ!&DP'2?/$1W#)!B-HN>(3B )0DK: M,T2G5*;)\%E64]?H<]PH&D9!-(ZVN?84-F)3N9,P3H/1=$R]9(@F636M=2U$ M*41CX35E/$G?P#5?BY2JE2A;/-CN=W5RZ"(?[#VG*M1+]VBD&X;S[U]6W6[W M+GWGGV-WXOY12ZE>RIJ;;$&JP_YDU /M'XI^857C'F=S9>FIYZ8%O:U1LP!] M7RAE=PMVT+W69_\ 4$L#!!0 ( &*%HEC-D]2B]P0 . + 9 >&PO M=V]R:W-H965T^=B2+J%3I<3:9'(TKJ^2%??7G?6?8^R(92D]75G]ARI">3XX&8B"5K+1X<9N M/U(;SR';RZWV\5=LD^P09A:Q5R"+NY"BB M?"^#7)PYNQ6.I6&-%S'4J UPRG!1;H/#5P6]L+@A'UR3A\8ILQ;2%.*&M Q4 MB O.EPJ*_-DXP!/+C_/6ZF6RFCUC=28^6Q-*+SZ8@HJ'^F,@[&%F'Q;MS7X@;/'GQ1)2Z)N_GLI AP>+-J^G1Y-T+\.<]_/E+UO]WU7[N@*O6WC$-8.[MVLA+!"E5ALR&A@D_"G7.*:H7#M,)< M97$ R94*,13? MID'O1N+7$O7?4XR6DM"2@!Z8(L25;5PHQ;=&ND". ^%$)VC( =W58#* Y@E M ZMJ3;Q7L2+SD?B $[LC OQ:NI3P)1E:<8HWH%S0%JCZ 2+69\!NL_W?BH 2FD5=B+7 MUG,[MSU4RA!!.LJM*U+AOA\YUXX<\+LU^:$PN)G;#FG'[:4B^@*ES+/72.UY\K'N7PX)-T,<1"2 MA32N='\*=H#:]R,5O;^GG&*UVC3.Q&LQ&\X.)_\V].GPY/!87$E?BEKN4E0_ MS89'1T=OQ157T>0[ 98V/G6QD,477)NM8';X]D5XCTK\&NX.IT=,@TF0/H%OZ# %KJ) MT3VDN->ST3%>(5K'1'N0FBX.@/2 D79,!U_$,_VHU:\=6$D5DXD%R4,'2'WLM: M0A@]=6>/]UY=%:%C^6WI$UNF!UA_VC]?+]*K[5X\O7U1O+5":VE:074R.CX< M")?>DVD3;!W?<$L;\"*,2[Y0R+$ OJ^L#=V&'?2/^L4_4$L#!!0 ( &*% MHECM'T6N$0< ((3 9 >&PO=V]R:W-H965T7FZ;QV,[=AYO[ )&0B#-), !HQ??K MN[L@*"J5?&GK+Q)?%OOV/+L+\&RCS8,MI'3PM2IK>SXJG&O>328V*V0E;*0; M6>.;E3:5<'AKUA/;&"ER7E25DVD'HP>3BK!%K>2?=Y^;&X-VDUY*K2M96Z1J,7)V/+I-W M5S.29X%_*KFQ@VN@2)9:/]#-A_Q\%)-#LI29(PT"_Q[EM2Q+4H1N?.ETCGJ3 MM'!X';3_C6/'6);"RFM=_DOEKC@?+4:0RY5H2W>K-W^773QSTI?ITO(O;+SL M+!U!UEJGJVXQ>E"IVO^+KUT>!@L6\8$%TV[!E/WVAMC+]\*)BS.C-V!(&K71 M!8?*J]$Y51,H=\[@6X7KW,5=(8P\NL*X3K?U\NK3-(D__L"][KGNW73:7SSC8BD^%Y >B?L):R_2Z5O]#&8>/5[K$TE7U M&BRO7O+J;+A:?J5K":H&Y2PJ0@K4WD9M=:ERX?#FSN$?I=J"7L&G1AI>;=&" M84NN,%)"Y6DDB4: ),B*G@4@ZIPNTG?^EBY1K0#=>URM(CN?X.TL3^%77 M1X_2DFW+0F(C3&Y9"Z+DC,JV[]J:7)^.Y^D0CA>+&?_/I\==5)^Z MJ"XY9;O)&*.I 51[M1I9&C2+4]8D8"*72.;F81#$\2:K1SI&L) MT4M@15$_$V&'VBQ*7PRUE%&S>V#[S'S^ZZC-DG%\DAZJNRU8A,5?Q(":V4HH M X^B;"4%B YAAMD5"\J"UX'))T^S4EO.!_H5I(/[Q(KD^-029!AR*!Z_D-H: MR;/>%P'^ .B#1#'RBVCQ8LB?!.2'K6P(/88EV'%,+8Y)7!1@V@.T)=U!30?5 MUOU0FJ'N;NX^VU!W$<-6M]624%P%IKM".-SP/ %NLQ3NPB0"C>$J:UL*S8*5 MSI5^@M, M]P%:X$[V0;HN4+=M]84NB=!&NM9L^\S]W6W?9BI)\'KPJ2%U-@?I(YL"_ X6 MM3<2%:Z-;ILQ3S K&V%\0O8X*_8 T7F#U%-A&&2B4>1T\/#VTX?K@8O"MD9Z M9&A30_71%5[@D)%?6IR3>3_$"5,JL6U=^H;!+&/'2:I3S=YNVN;_,6B(\^66&9C2K,V7,T'"(+IX#;D2QZ=_N,<0];\*9I$@ <7CT=HPGV, MO^O3O;7M>NXU)'+W1E3-Z0U\5#GR!69QC%T.YZD2I1V:(MENFX9(E+Z5^[:P MVRHJD6/DV '#X0P]R@HNU:UY&V(-YI,Y&K[&4ZG*4+EW$44Z*NT-ID\;YC#: MW?&&[KL*.5(VJ,IWYX.G#S?[P50A:BJ[TW=KP@&/$-1WCVCKW1<+%GNA62TN MX?[,V#=-B;$LRV^K*H(/WO1*&>O@"]+:^:YX>+XFQ^.3X]B'LE$.FR!0,6/G MKG/E3\#8YPX$@YI?85N,DK?D ??J,(*)!'O')0::O\38W"%HY_D0MV$$"#,[ MG$/+/@@^=*)984H-5E5MZ='=;^H^H'FT)P%]\_H^"SR(I^DL2DY^ES/<9FJ# MC<&/=4(:6TK5[;AQ8!'I'(EU,X@8L*0/)-VYYM=^"NXD!R%>S&.X5?;A:$4] M5>%CVB< 68)9-)^_QE/+H\+35PY/2I8YQ-%)\AI^1K)S=^!=\(_5TD:S<+6@Y/&(^_P'B?3Y-UV@T/QA"P-62S902[Y M7M6W&YFCL)'9#HQI-.^V+_N.V9/!=Y%*XJ"GKS_$R;9V_A-)_[3_P'3IOZML MQ?W7*4S06B%XI5SATC@ZGH_ ^"\^_L;IAK^R++5SNN++0F*;,R2 [U=:NW!# M!OK/;A>_ 5!+ P04 " !BA:)854+?R\P# #N" &0 'AL+W=O%=0?A;%*Q#3Z@_5PM->W"%B7G)4K# ME02-ZVDPCZ\7J9/W E\X;LW1&IPG*Z4>W>9#/@TB1P@%9M8A,)J>\!:%<$!$ MX]L>,VA-.L7C]0']-^\[^;)B!F^5^,IS6TR#40 YKEDM[+W:OL>]/P.'EREA M_ C;1C9- \AJ8U6Y5R8&)9?-S)[W<3A2&$6O*"1[A<3S;@QYEN^89;.)5EO0 M3IK0W,*[ZK6)')_Q^J_@W?_L91?>HHIRWU]!SZ?TO;_P0-GPJ$3)65DG1L0*U!4A>I M4'.5\PQ6C1R)& N77)(H=H!I!&9@K03U S=K("/TKQ&A; H&7<$ I3LKVGQ[ M/K3H7\.!84OD/$VO[32/5@^4#YYAP^T"XFCLQY3&MV]&29S<'*T^2(N4PKTG M2;<_'-"8#@80T]\8[IXKZC'$F*S76@)1JP2C"!J#9/\RZ4;]J .7<7<\'G9: MV,,\SVS--&<"A#(DOJ%62G$JE;;\;^8+,4Z&Q"XFJ#'A.+ E!9EZZ[$;WT-\ MK#J$46OI,NW [[].T04,1B,:KX8QC9=QVO'3H -W9274CF)]2XG2?%4[$P;F M/OFG^>K"1=0;4\L2XE!- LD]6U!DZ"INKT@U.X$KV!,2-934Z'(J#>4KY)8J MC MQ*X'G]@CEQO@D@P3,<-SU$TLLUIKITY]F)=U"1DSQ0EW0OI6[XT0[A'M@Z[8 M ?IR,07P>*0N)3VWNI@85';U")>N-?6D/>U-(VSU%[VC[F\^8-^R[>? E0(6TX MF1.X)M6H-QP$H)O7M=E85?D7;:4LO8]^6= '"6HG0/=KI>QAXPRTGSBS?P!0 M2P,$% @ 8H6B6 1NC8$]! M@D !D !X;"]W;W)K&ULE59-;]LX$/TK [4H',!KRY+MN(EC(.G7]M!NT'1W#XL]T-+( M(DJ1*DG%\;_?&5)VW45BI =;)#7SYKV9$+5NQP3OT?[:WEF;C THI&]1.&@T6JZOD M>G)Q,V7[8/"7Q*T[&@,K61OSC2F:,5QCEPC]LHVU^ MGD#1.6^:WID8-%+'IWCH\W#DL$B?<,AZARSPCH$"R[?"B]72FBU8MB8T'@2I MP9O(2K";")8] M 9;#)Z-][>"=+K'\V7],Q [LLCV[F^PDX"=A1Y!/AI"EV?0$7GY0FP>\_*3: MCT$C"%W"NZC;P3_7:^ M7I[@/#UPGIY"_]4*/0"4M;"400>54?1=\]," M6=//(D(3VP"Y#8"*6-2'*H:TTR"_B%,>PF>C?^O#>/' 'WNG2Q=,3>!@40E/ M6(7%4A*YEY -)[,9/?-YNB]H94U#!*0MH176[T#)@AE#A53A+)M!3K\/M%/! M0!GGSH"VA5*ZUCBA@N#6TFY'GD-HE=!^"/B]DRWM0?Z(BW .O8M9F*;G,)B\ M/@/:(F@#T( /12WT!H$#8&\UF$X79S#(AWDV/X/;?DMC1 KM+7II,019H\9* M>BJ#"Q$H+=Q.)..X,H/I?$9PLUE&<44AE22MC%!*X>-F69A[M'(?_]6+13;) M+F&1G<.M-657>,J-6$?/0@G9P&#QFKCM+6/E.3XGA%#UYKCQ8))F,)G.X:OQ M0O5Y>;Q/7L)DF"Y2>@ZR8993JMYVEN&H\-02?FLX\=PZ;TBAT+M X?S240:+ M(,?1B5%52)4_U =*T="1X;@#!DX+/Q"),%O^>A MXU Q_Z2)"E?RR!DERT#DO=1"%Y*R>.=I(9 ?/=E&D1_155UYK+YOBF-Y1]E@ M+H+9_@^3/\Z.V&ZEKRF!^%2KQ(.2T_<+]9J.'MN=QT=G*2%NPHV!(IA.^WBL M'E8/EY+K>!;_,(\W&HJVH;J"PHI&ULK57?;]HP$/Y73JG:)T0@T%*U@%3: M3>M#)=0?V\.T!Y-KVSN&1<1M.Q MM\WU=*QJ*[C$N093ER73ZQD*U4RB?K0UW/-E89TAGHXKML0'M$_57-,N;E$R M7J(T7$G0F$^BJ_[%;.C\O<-WCHW968.K9*'4L]O<9I.HYPBAP-0Z!$:?%[Q& M(1P0T?BSP8S:E"YP=[U%_^IKIUH6S."U$C]X9HM)=!Y!ACFKA;U7S3?=TCD6=XPRZ9C MK1K0SIO0W,*7ZJ.)')=N* ]6TRFG.#N]E:DJ$1[9"@TPF<&33%%;FB:\'L%< M&>Z::,:QI:0N-$XW"68A0?).@@'<*6D+ U]DAMG;^)C(MHR3+>-9H.W P.,-_MD!N.$F%BB&-0O&$U/COIGO"P0KE59,;D^.3I/^J-+ M YCGZ"\36,JDF24_D@>PY&L+C0AE&#FZD0,-+"W:B7G*M!A @]3G9-0=' ?; MJ#LZ[M!%-U5 %^ON!]-_(GO## BFEX0.F280"8LU,+I:*U Y(-.2RV5H;,-M M42B1D<&E0M,AE]R04E)(6C"YI,*I[74[ $>HVG:^&Y@305],QS,\0#[GVMBW M)1"CT*H=UIPP4TN5$0D*)=D)>;E,1>VTDFCN8>X*VG5/-6;$>W2J3RG#H; M2%4M;9"PUMH^ %=!]U[=P^M!8UYR(B4PI]!>=W0:@0Z*'#9655X%%\J2IOIE M08\8:N= Y[E2=KMQ"=IG&PO=V]R:W-H965T;2!.,VQ 6Z1)USX4>Z"EDT6$$C62BMO^]3U2LNH CI=A>^B+=/SQ???= M4NE[(S@#=XHT%U=,_5E@T+N5][$.TS<\EUE[$2P7K9L MAW=H_FQO%(V"D:7@-3::RP84EBOOF&KE91X4 M6+).F%NY_QV'>*:6+Y="NR?L^[UQZ$'>:2/K 4P*:M[T;_9YR,,1('L*$ V MR.GN'3F5KYAAZZ62>U!V-[%9PX7JT"2.-_90[HRB54XXL[YFJN'-3L,-*KBK MF,)E8(C7K@;YP+'I.:(G.&)X(QM3:;AN"BP>XP/2,XJ*#J(VT5G"-TQ=0#SQ M(0JCY Q?/ 89.[[XV4'"I\NM-HJ^B;].Q=O3):?I;)TL=,MR7'E4"!K5 WKK MGW^:I.&O9\0FH]CD'/LS3^0LQVF%)[+POD(HI:#*I 4P;"MP*$_^%37@ =$2 M0CM$SD3>"68K2A-4@2$*4RE$J/N/ .U' '2$>36>(;"FL$:\Z(?6A W3/'_L M(YH%&PKN.W=/V*[JA."F"*ZE:J9PJ> 'QU(^B M&1G1W)_&";Q&K1*&4^2_3*;SE_1,IB\? MZ7A@7!Q$'(NMI"A0Z=YYF&:]\SB;#U'NW>U 3MD#*KKL'H$UT&VI#>7(JIC, M_'F8^=DDL6:6IGXZ"_\Q62]@NIJ M"8XN_AK5SK4W32Q=8_H>,,Z.'?2R;QS?M_?MEPIVQZFF!98$#2]F4P]4W]+Z M@9&M:R-;::@I.;.BOP!4=@.MEU*:P\ Z&/\KUM\ 4$L#!!0 ( &*%HEA& M.BO!V 0 -4+ 9 >&PO=V]R:W-H965T-.=!1 &!@MJ1!8&O:YB#4F0(P_B\LQD<7)+B37IO_97/'7-9" MS MK?Z0C6O/@S)@#2S%H-P[O?D%=OED9*_6ROHGVXRR61*P>K!.=SMEC*"3_?@6 M7W9UN*%01M]1B'<*L8][=.2C?"FS9QZ(GD)_7.ZL5H-?Z.U82] MU;UK+;OL&VB^U9]@A(NN,HQ>TKN]T$*=VK6HX3S C;%@KB&8/GG$\^C% M/3FDAQS2^ZS_[];]O%4V;Y$!ELF>H02KA3%;V:^8Z/30.Z:7;+4W@[CA95QK M %@WC@706#!L:MT>NLHV@.46%C440H4]9;,.C*R1<_GVAQDO MV=>4FT825ECVY%$9\_@%"H<1Y\>?\\$8Z.LMP\'HK1(COC1_X[HB7F%]GG*> M/6-/\SS!9Q;R(O?O*DN?'05]5 .*. ZKLD2JY&'L"9Z585Q5%'&,$6/LKXVV M]KCLUK=,U/70#1@3%ACYQLE_QOBH$0A7LI<.GBN$P@;;=VBL&!M[JP>CI_G> MT^R&]5_QEW&!<,L^"C7 <2:WN_'S G./A\A1TN[2-82ZECG-$.D552U-L%B9 MIWB8Y3'5-,.6Y[ZZ>%H6Q,O**BP33E15A'D5L0]&-/C'P[]A2,7R:?IA(#]K MHYNA=LQ!W?9:Z=76#U)2<7SS,.<)RXHPQ>'(,O10,1YAO\O(OXLDW:T2GF$< M^*QB?!990L\B9QP5.<]W<_W#-N%,X"#B+&312$=5&.4%T@F.:![3U"3H.(N) MEU<82DQ)%U$29K@%'W AY[I;BWZ['Q+$'/1'E'AP#7[+ MI6&#A>6@&)FP)]\X,E!KTQR/)7S!^X6%_X 3U X_#C?GU)]X[NPNZUBD%+<^ M'HD,NW5IG>S&+>G[ 8LN5BL#*^3<'U_M=]^Q+0CC0['#PL+G@7A+3-H?(#+: M;\)[M=,V0!>E!JN%N[_;>!K8M#R(>,-CXL<;D-&,(1H\1#9G68X91P^1+4B6 M(ZX\0+;T YX\2+8BV:3 GMR%=52\6SL>>IO[D6D%C>$/Y]+WYK"]WK#_[$4' MA VX4P1>CWD5G<1XBU+* S:*(2OYR@JQ/W8-_J*HMB=W_:,G-ZY:B$0K?Z%$ M*"8 'F]=!^[ASCH;KVI?Q<<++Y9C)1%>%"Q1-3HILF"$L_V'TVM_<5MHA[#G MR1;OW6!( ,^76KO]!SDXW.2G_P)02P,$% @ 8H6B6(1G&B8U"@ 2AT M !D !X;"]W;W)K&ULQ5E9<^,V$OXK*,63FJGB MR"1UV)[#5?9,4LGNY-AXDGW8V@>(A"3L4(0"@):=7[]?-TB*E"EEDMW:?;#% M ^B[O^X&W^R,_>362GGQL"E*]W:T]G[[ZOS<96NUD6YLMJK$FZ6Q&^EQ:U?G M;FN5S'G3ICA/XWA^OI&Z'%V_X6<_VNLWIO*%+M6/5KAJLY'V\5859O=VE(R: M!S_IU=K3@_/K-UNY4G?*_[S]T>+NO*62ZXTJG3:EL&KY=G23O+J=TGI>\(M6 M.]>Y%J3)PIA/=/-M_G84DT"J4)DG"A(_]^J=*@HB!#%^K6F.6I:TL7O=4/^: M=8=^_79T.1*Y6LJJ\#^9W3>JUF=&]#)3./XO=F%M>C$26>6\ MV=2;(<%&E^%7/M1VZ&RXC(]L2.L-*OW:N'?G'M0HOOSK-YU&W:E1W9-Q'>F]&LGOBISE??WGT." M5HRT$>,V/4GP.VG'8I)$(HW3Z0EZDU:M"=.;G%!+O-(>Z?LO1I=?_E%,H]?GY!TVDHZ/47]J -^?Y?X MN%9B:0KDE2Y7PLM%H813WN&A]6OA\3HSFZTI58F'9LE/WN&)+!^__.(R32Y> M.T3PPK\2-_P>7LC6K1OJA^]5IC8+99OG$_%MZ14,X<4/E7=>ECFQ'WSXSJI< M>_&US'2AO5;NE?A)W9OB'N1FXSA^)L[$+(DNXSENDPG=3N+H*IZ*G\=W8_%1 MV8WX8&0IYN/9])F8S2ZB61SC[B+!W3R)TEDLOJJLZ2P-=)/I911/TIIL,DNC MR7P.(7.DE-6R@-[W0*0M\,6+A2ESAZ7I'$OC* :+WLVM+#\)<@$;) M*045A M8%'+)A1F4>B5)*1QXA=IM:F<2*/T:MK>)5%\E8J/QC-W;#D3%_.K: XI<36; M1?,D%1^4@Y'XM7:NDF5&3G3PW_,DFDZF+^AW-IV]J%>Z-7S]TI/V)%!664L: M;?&40 _B%J9SO^98QM#BZQ2"1E712L#T5N-LKJ3$;B^_%-6"1S(**FQ"9H%R@B MI8]"Z.1@*%%\.#7(=:)0P"K+(A7*0]&.+\G4RCYAQ:&U54@!IU>E]!#^AJM( M1T,7XN^.&7T@1A^8420R93VJHEA5TLK2&^LZ,1.D<4)QVL!*6(#70B(@M^#G+BI\GK%P*Y"L30*!VY M>'[S0DAQELSB<8PJ4Q04.ZR7^K72][(@@9PJM8%)%8(,>SA4"LJX+K=^,C;, M(O'\ECG,XRZ'SZ+81X(]1;+E\W=,=7:*JF7 (>^N@J4:K<># MM:2'"V(GB3,7IT(SQ.TT"I8LBF.&RLR]@ACH/\6=4N)[ V,E5[2:+AW)V]/^ MZR T8.W.X\&&*R!8#E5 KFG4XL&0+_\:G+OC;@Z$)&("N"+N >)<8'53YRPY M#%H3XB*K VW3*7X!PG#E1,46&U(L#^%%K_P:UA>;T%B%O#XHR&0WN87A'X ) M7@%1Y^/ILU,6[TO[9X40@UCBCY&%*IEHFBMR,*D XN MV\JB'RP:O MGD,> (H8)IL2)4Y857(PXVFC/<;N$!0&V*Z*WM&8CXC% [1GM MBP9R!0<(7A2E96'I+\1@+8DNG9H0"%"2<04Q%*:X2#*NM%78I@J5!TY M5)S,(63DQ-P18XG.DFS\E"N9M6_UL^ETUB1^A**J*>\%=J OG-O)+4,'G =[ MHZ7K]DU#&K=:\OY.[M3%NW;Y4C]0X>&46XK)>([>=5M4CM=L@7D9$T%=7U&* MN 9K\Q:B#NN$='N,^<.A=QP>]I5G$"C80-%!D0C*D41A+2O&Q XUBQ@X9N/) MLRYJ7QRB=HX1'Q1_%[\Y+J%L60_T'$OJ 67>-[(9%&%-[C\L];!K&J-@4-/@ M.XW3"3A&_P#9#D*QW^!2]FKTS@PAO4).=3H=I_LJO6RKKU]KF[\DW'P,+3N+ M8.Q0TP_?]5,W'E]T:?*(UY$A3 IHFZ&AQYRSJ&JHHX4'(#]OZ!^VU@$$W&?TC"VAI/I8"8N"SX9.F>I%]PZP;H^*W!I781_92(&R!/G&X-G/"3D9QAQ7]&H' PRD95? W^I M6C$[3Z<*!*9G2;="0\&VT6OFG;Q2 :'3RR;K HTU*JIP&GN1+NT,T*3](7BC M^),+%U@W_L-G-H M-PV 0C->@)I>P]B6^B.RAS,"73QR+Z"=[]:;W&R 0SIC41M!"K,[ M+/G[[NCED@>1JM3L)9CV9=,UTW0.R0N3/2FRNK;+296YX 5 19M"/41'CW%] M$G6T-<9R::F]KP>ZH>YU8%@YF[08R3U$=R:A.#K2..?*92@T^ZZL?Z"R5[L^ M,V!5FX\-%(318+L6? B(>;FHLS=\?>EI%EHNM;=FVP_M0[@^5U+*#0<+)^ Q MY8C,GD!O#ANV*E?>OEEG7:OVRUW$C6@WI]I)V?=.K3F6F^BJ-[?JMY X2#[: M#_2#X-B9_*'/#UMEZW1!:'[FP$U6(D!\%6[[I]]-93\321*EEW2*FTRBRXNY MN F]@/0G4'\RF_!?"'FF,9_,Z&(:I>D5\*O3\@]/5^[S)JM!?Y)F)TMH,T!) M7^/44"S[_6'V0;M8@QJ%"E4*A$NNETO%A],\F(.];&V57_!6/!A](&#YUM4_;#X4WX?O8?GGXRO@=3R8.&;'$5K33LU$X MN6MNO-GRU[*%\=YL^'*M) "(%N#]TJ#*U#?$H/U\>OUO4$L#!!0 ( &*% MHEA++7%DG , (H( 9 >&PO=V]R:W-H965TU*&Q B$12;TYL W:R80'6-DC3[<.P#[1$64(ET2/I.-VOWY&2 M56=-C '=%XHO=\\]]_#E-#](]4570AAX:IM.+[S*F-UE$.B\$BW7%W(G.EPI MI6JYP:':!GJG!"^<4]L$- R3H.5UYRWG;NY.+>=R;YJZ$W<*]+YMN?JZ%HT\ M+#SB'2?NZVUE[$2PG._X5GP2YO/N3N$H&%&*NA6=KF4'2I0+;T4NUY&U=P:_ MU>*@3_I@,]E(^<4.;HN%%UI"HA&YL0@%J19>YD$A2KYOS+T\_"*&?&*+E\M&NQ8.O6TR\R#?:R/; MP1D9M'77?_G3H,.)0Q:^XD '!^IX]X$]F92L-/72&*Y_X!&Q-G#H_] M4.(P^55J/?7A ]X/6<(#?X(_5AMM%!ZG/U^2I8\:O1S57K%+O>.Y6'@82POU M*+SENS=ULP?-,(#;K"'- ';W#> M<*WKLLZYO9 :2B5;X%V!2QHOD77:\(9W.;JAUOPDJG11\V=1ZV&'WKW)* VO M5A^O;UV77$TOX7JOE.CRKW C2LRF@,\=OEE-_3=V;X2J'[E]#>!!&M[ NH\* MW,6]$;EH-QAN.&T,WL*$D-B/2#IU_=!/66:[C-E%XD=AZA9HA$;Q=!#I.=U) M8T_2D?5&X(,JX/X[428T]AE)IL!H" D#YH=1C+/$SS*,N6KEOC/Z1$U,R EI M\P37> M09=P9*5@1U58%CE5TLRV?AK3WBCQ9]EW:/^6N;=EU"<)<8"1'\_B'MJ/>N0C M76>9^30*7];Z>#1ZR5_5FN!V)5;<"%.($@IQF*!T/IF%_U7H-$&BX3>A67)6 MYXB@LMETU#MA9T4>CE[J)[-DT"2E9- $]]BIC63=V6,^2=/I2\](<%(?6J&V MK@IJU RY]:5BG!T+[:JO+]_,^RJ-]+8U2M>($EW#BS3V0/65KQ\8N7/59B,- MUB[7K?!G02AK@.NEE.8XL '&WX_E/U!+ P04 " !BA:)8E,GNR<$" !+ M!@ &0 'AL+W=O*) M-6U2/@9MI98.;9.8$&SL8=J#F]PT%HX=;(?"O]^]3AN*!-W'2V)?WW/N.;%] M,UH9>^=*1 ^/E=)N')7>UZ=Q[+(2*^%ZID9-*X6QE? TMEYT \&=5BB3?H MO]=7EF9QQY++"K631H/%8AQ-!Z>S(>>'A%N)*[H3KOT<,E]FE M/6+6YZ3""K''>5&LP*:BD;M_B5L8N-!L!K0)$YJWI0;;VE5$LY/+H2T<"M4@W")PC46Z8M[ M-XH]D7-*G*V)9BU1\@91"I=&^]+!1YUC_A(?DZA.6;)1-DMV$EX*VX-T< !) M/QGNX$L[IVG@2__L="Y=I@R;=?!SNG#>TN'X]9KGEG+X.B5?F%-7BPS'$=T( MA_8!H\G^WN"H?[9#\+ 3/-S%_B];\U]$\*U$.#=5+?03//"R TGAK V]-RN- M.2A9($A-**$SA-HHF4G*%!X*Y@W 'LP;*_42OC0:>K10* M1&4:[9GT+RTYSJ5SEY7=P0MRYYAAM4"[B::D(\\EMQ6AU-,!.$3X:CS"X!BH M49+$'%UF9>V?76V4[N^=)(/C,T M*?+7WO4NVG7*:=L@GM/;-DOVEE0.%!8$[?>.#R.P;>MJ)][4H5TLC*?F$X8E M=7NTG$#KA2&CZPD7Z/X?D]]02P,$% @ 8H6B6'SF7Q) !P ?A( !D M !X;"]W;W)K&ULI5C;;N,X$OT5PA,,9@"W+[*3 MN',#DG0'D\7T)NCT[&*PV =:*EM$4Z*'I.)DOWY/E61929QTL/MB2Q19/%5U MZA2ED[7SWT-.%-5#8& M9R;Y,^(>A=>A<*_9D[MQW MOKG.3GLC!D26TL@6-/[NZ9*L94. \5=CL]=NR0N[UQOK5^([?)GK0)?._M-D M,3_MS7HJHX6N;/SJUK]1X\\^VTN=#?*KUO7< TQ.JQ!=T2P&@L*4];]^:.+0 M63 ;O;(@:18D@KO>2%!^TE&?G7BW5IYGPQI?B*NR&N!,R4FYBQY/#=;%L]\H M6YIRJWK2Q&^&.@'S+25VZ8J7+QY]_FB7CP^.@7+ET/&U>!5@- M&%B1UUQH0='#R@52)JKHU+WVQE5!>1.^A[XR96JKC%NF)Q-J@ M&SR5.3A5NJAR9S/E? VLQK43#&^IL)<$#)=A16EE:_2KRG.8L<55 _3S!NA5 M _2R!=I%46'1>YP#*,*=*YHHYF"&1%P9&$JC<@NYXPSKN;$F/@+[\QQ">5/R M$>T!,0U4!VT(7VRSB!F6$6]38@''LUVP 9E6WA."0W4\P\Y4H%S15KY3]B&Z M#W(5E8Z*-++I:>6\,"W#'@-U*0B9$>+!0AL/-VQ%&Y\J*)FWC[QBFPY)-UR( MEAH!P9X>,5J6YC\U'[$' M1_D+/8!U)8IT*1 MZXRUZUVNK4W,N7X1/@2S"T6R&+9IM#CL(/Q'ZK*F[F,'P\:W6_9M3TW'_=%H MM W!G\!RV,>AJO7M3_;ML#_#T)[:/Y#I_U! M<. IJX"$6FR!,>@D5SH5A=G*,S^\@QPRHVZ N^3SE[JJN0Y?!.8OC"$9'=_= M7'V5R_'QK_VV[(W']G]58#]<@+<(SN0I.YY0=F\R&@U&.(59RP?*E@BZ]4*II8QKH'P!,'KJY M-4MIO@.$A-3?'0;'4[;,E[(O>D'& B1=(3AK,HGS5:L-=Q$#VZ85GF>H]H#E M(J, ULERY"'5(4499\?<*+J:/Y/*BWE+?VJQ-N&%865^N9&B/,9 M=S$V5VM=+;_G-Y?7&QVCA\C22(L%R 'M?)N+OF+N8X;=2=$B^/6M;,&G^14 M('58MX:YMD@+@BXO9AO,J:XWAB/;WA%>(]!N(>]W=/]WNB>K$E60YO)LGO,3 M.?ZPB(4CM3T]AR=GDU<8==% OV/H0?WN&M1;#?I$*15SE!S?7+\DV5'3.DM7 M?JA;?]R<'2"7_=GA!/_C_BR9M4>?=".S+Q1P8TRGJ:\ KWOLD% EQVJ\_U'= M@GW:9!LBU&<[)TN?83B8';8KOW757D7)MYRE.4"<%#3[+H&9M_S22-[7!&3& M/@WQ#ZKK_6&LJV%/3?J'^XE$;#HZ_#%BZSHTXX%:WIAE[ R7X+-#SR[RO4*. MKGM!?'(6Y!$5BB_J-D\\_V?/VQL!9RKMQ?0]S7P77'G6\"!?FE?/D GSB7]>>!=K3]N')>?U/83J^_S""\2]9=2PLL'0T. M]WOHU_*UH[Z);B5?&.8N1E?(94X:>>0)>+YPZ$+-#6_0?G(Z^R]02P,$% M @ 8H6B6#BSTU7/!0 *0X !D !X;"]W;W)K&ULI5?;CMLV$/T5P@F"%'!\W4V"O1C82X,&18H@V[0/11\H:62QH4B%I.QU MO[YG2%FVM\YBFS[LFJ(X,V=FSLQ0%VOKOOB**(C[6AM_.:A":,[&8Y]75$L_ ML@T9O"FMJV7 HUN.?>-(%E&HUN/99/)Z7$ME!HN+N/?1+2YL&[0R]-$)W]:U M=)MKTG9].9@.MAN?U+(*O#%>7#1R27<4/C^F#K3A@(:F72K[SOXK G\';R#8%9)S"+N).AB/)6!KFX<'8M')^&-EY$ M5Z,TP"G#2;D+#F\5Y,+BQM:U"HAR\$*:0MQ8$Y19DLD5^8MQ@ D^.,X[===) MW>P;ZN;B Q147OQH"BH.Y<> UN.;;?%=SQY5^$&ZD9A/AV(VF9T\HF_>^SN/ M^N;?XZ^X53[7UK>.Q!]7F0\.I/GS6!22D9/C1KB0SGPC<[H M35]/SA]QX:1WX>0Q[?\]9?]#G;CR BZLE&V]WH@BQ8<*H8Q0$$!6YH++0TPG MKWX>BE 1%-2--!NA("I=V(A@14XNH$,(,BOEK&%K4H/'(9!+9BU$G= JJ*7D M>AV).R+QBPTD9J?"EG'I61< >JM5(0-PO%-& BF4W05L)#=@: _(BV=O9],W MYP_!CL1MZ^!H/!HJ!VMUXBXQ=P68EU<]]:)KH$4E5R0R(B.,%5XMC2I5+DT0 M>241M B0%99@CA?6B5RYO*U] $J\A1\<&OSPH:.1[8(R$E*0IS4=DUB.2&7?+8.E=O6J--?*+&NG#(/M#=6#8LO34R0R+(A\@'D1)D,^SB MH;:MB;X^"0P4YA986#9&&9< Z^C0-A,Q&<^MXUX@Q9*[5]ZWQDTD$H?">\4P MGF8\^7_(VY%X;W:\Q<[T02#PJXGKASD@\Z^M\BIJAZH;ZY"&&]S48GZW,B\Y MD[/)>7P=U]/S'X:,UZE5*JF*=#$4GT=WHU=\JXDD7:D"$*"VIA#98I2ON$9* MW:I"H.NVD13HS6WFT0- @VW#VP-VB)_9R\^XB>G8<;:H7_)N!_0NO=Q"36V6 M[W, !@- (K7ZF_HY@KB'5UR6C$X6?^&B%%O_05/W2!^,HU6YD/Q"=&<(0\F/ MI03G^227CD1"4)"=@\F!#A.,:Z#P+<.Q_M? X==;^C%\ ,PV^QX.^QSM M.)?Z2E3?S8'4-/K2=VR>U=-]DVY,J;6BG),Q+)Y/6/[Y=-2W[TAV610=3XKO MF,#2Q2%HT.N>,-)2>SXZUM: E((K=V&5!9H#I@.A=7,+/7Z32+T[1G?7*H?H M6;Y"K=@UUD!1]G<33F_*^K'[WWCO^EZ36\:/%(21F95N\OUN_QUTE:[_N^/I M(PHA6Z+I"$TE1">C-Z<#X=*'27H(MHD? QB@^+2(RPK?&ULK53O;],P$/U73F%"(,'2)FD'(XVT=DSP8:BL##Z[ MR;6QYOB"[;3;?X_MI*$;[8007QK_N/?NWM7WTBVI.UTB&KBOA-23H#2F/@]# MG9=8,7U*-4I[LR)5,6.W:AWJ6B$K/*@28308C,.*<1EDJ3^;JRREQ@@N<:Y M-U7%U,,4!6TGP3#8'=SP=6G<09BE-5OC LUM/5=V%_8L!:]0:DX2%*XFP<7P M?):X>!_PG>-6[ZW!*5D2W;G-YV(2#%Q!*# WCH'9SP9G*(0CLF7\[#B#/J4# M[J]W[%=>N]6R9!IG)'[PPI23X%T !:Y8(\P-;3]AIV?D^'(2VO_"MHT=C0+( M&VVHZL"V@HK+]LONNS[L 8;' %$'B)X"DB. N /$7FA;F9=UR0S+4D5;4"[: MLKF%[XU'6S5&:Y*FU/!1%E@\QH>VYK[P:%?X M-'J6\)JI4XB';R :1,F!>F9_#X^?*2?N^QA[OOA?^GBH72U=ZYKEF. MD\ .IT:UP2![^6(X'GPXI/4_D3U2GO3*D^?8LR_6:KC,J4)@QBB^; Q;"@1# M\+5A=ZA@9IV'YTS C%1-BKGY/=22-L_8YW'NL\GB412=I>%F7^N?4='[49ST M4:V(<&\D*E1K[Q0:#TS(ZX:EVCW1BJ_> MR=@Q]LO2&BTJ%V#O5T1FMW$)>NO.?@%02P,$% M @ 8H6B6";:+PY$ @ B@8 !D !X;"]W;W)K&ULG95=;YLP%$#_BL6D/;6%0#ZV#)"2;M/RT"E*N^W9P1>P:FQFF]#^^]F& ML&Q*J)278)M[C\]UY$O<"OFL2@"-7BK&5>*56M=+WU=9"156=Z(&;M[D0E98 MFZDL?%5+P,0E5

)-O./" MCA:EM@M^&M>X@$?0/^JM-#-_H!!: 5=4<"0A3[S59+E>V'@7\)-"JT[&R%:R M%^+93C8D\0(K! PR;0G8/ YP#XQ9D-'XW3.]84N;>#H^TK^ZVDTM>ZS@7K!? ME.@R\3YXB$".&Z9WHOT&?3TSR\L$4^X7M5UL]-%#6:.TJ/ID8U!1WCWQ2W\. M)PF&4I.GTXTY M7@(2/4E,*"_02DK,"S#'KE7L:[.#C?.SGK;N:.$%6H0>!->E0E\X ?)OOF_, M!KWPJ+<.1X$/6-ZA:'*#PB"LV>Z%-[W+#TGPL0-H \SX70A\G=H/A\Y/^ 5!+ M P04 " !BA:)81S?% %,% #I# &0 'AL+W=OTPO+2V=3^/SCU23M?6??$E41 WE3;^;%"&4+\ M4B7]T-9DL+*TKI(!KVXU\K4C642G2H^R\?C9J)+*#*:G\=NEFY[:)FAEZ-() MWU25=)MSTG9]-I@,N@\?U*H,_&$T/:WEBJXH?*HO'=Y&?91"562\LD8X6IX- M9I.7Y\=L'PW^4K3V.\^".UE8^X5?WA9G@S$71)KRP!$D_EW3G+3F0"CC:QMS MT*=DQ]WG+OKKV#MZ64A/./)D@$U:F$!?D9CM/V;([LAV*=]:$THM7IJ#BMO\(E??E9UWYY]F] =]) M-Q2'DP.1C;.C>^(=]G V\,&!;__N0R@5<+2_ )[!E[Z6.9T-:L[EKFDP??1@\FQ\ MB'8+L^M*Q"/,"NA%"LRY*36&UZA.CK# MI#%!F14\D4?5FCBA"*CQDXD)XH:!SH\>O,BR\K M1D<<_5#,R07H*;(GU>W8M[0V&!M(%,KGVOH&\ O#)MQ]CR<\]P)^'XA]^SN@ M;S<32-A*!6ZS;IQOI DB6"AY7@K7Z+;76SV\36#;6IEV5BII(/-FD?,0=H5+/, ;6+N[%CNFZ5"B+V60HAV+AK(E[*<52 M*K=-QH%NUU%;K]+D UC(>N0XSC^7FHI-YM*78HFSS,>@'* C"0R5+= [3T(7 MH3,*I2,259(_8OD3$"\4VJE7JMB&OFH5][10N>2#JZNVBPOX%R3HI@9:/&%M MFF4#X#;$LH@J_!TH^](VNN ?) S'X#OY\:DDS(2@H.!L[4T&R;IY/F)%S-C M&@3Z$$< D353PP@^'L5D_/3/O@HNH&WR MU4"W)=GX?BL02255Q-1&C'(2[V ML;K)&-XC>\>][!W?JU=O-MB:IYBFQ$XF!*%A4)K\/O7[^6ABYB!'H*GL06/2 M?'ST(#O.3MP7M:%^8>NTA@ FAA?$\UE^GZ$!7&YG2FFYI'BA$7\TX$G$=O(B M)IM!\G3ZDF61RG4RU9NAF#&G#UHU^4%F'NR2X==MCY1Z:] 69L(W"]2OP%MB M=JX(3H[E,IT1B#IY&!VRAQV7O^77K3,CV "N2>\I)! -KJA>0FR^[>FBB1KP M@U/&%8!IMYIB)8$XO1XV[ZF9)UC>N37&CL.,2+3+[AOJ_)\=GP76]IB+=YV\B1,7W1'!PS_#XB MCF/ 5B0>LS1 O)\<,' 'W>'W+>3S7N/GN^#OW&;0W/M> O=.XVCG^ED1R,&7 M;-Y-','I)MI_[>_QLW1]W9JG'P'8K!6WJFD)U_'P.4;1I8MU>@FVCI?9A0VX M&L?'$A)&C@VPSD=D]\()^E\WT_\!4$L#!!0 ( &*%HEC?Z,UF8P0 (D) M 9 >&PO=V]R:W-H965T M(76RU>:;72$Z>&SJUIY&*^?6QZ.1K5;82'NDU]C2RD*;1CH:FN7(K@W*>7!J MZI&(XWS42-5&DY,P=V,F)WKC:M7BC0&[:1IIGLZPUMO3B$?[B5NU7#D_,9J< MK.42[]#]N;XQ-!KU*'/58&N5;L'@XC2:\N.SU-L'@[\4;NV+/OA,9EI_\X.K M^6D4>T)88^4\@J3F <^QKCT0T?B^PXSZD-[Q97^/_CGD3KG,I,5S7?^MYFYU M&I41S'$A-[6[U=L_<)=/YO$J7=OPA6UGFZ415!OK=+-S)@:-:KM6/N[VX85# M&;_B('8.(O#N @66%]+)R8G16S#>FM!\)Z0:O(F<:OVAW#E#JXK\W.1L8VG& M6KC#)>VULS"XE[,:[?!DY C?6XVJ'=99AR5>P4K@6K=N9>&RG>/\9_\1\>K) MB3VY,_$FX+4T1Y!P!B(6Z1MX29]L$O"25_!V.<(MKK5QJETRN$9I-P;#](6R M5:W]T,(_TYEUAC3S[Z%]Z,*DA\/X.CJV:UGA:42%8M$\8#3Y\([G\:]I;'$KBS3"'D[A?(2QT397L8SDO M% BK7CCJ.33(&5T X,A\C29,MU5@[*?.=;.6[=.'=Z7@Q2=+M>W9!S"[5R'Y M!%NW,HC0=+I"KRL@552K7A8@V[GO),?PA>XP*TF[W8*?A&F#1E72PGL08LR* M+/6]C+.4)W!Y?3D%GI0L%0)X)EB:CF%JE1S=R$HM5 4\YBPK$QCG3)0YW&LG M:VC[..\AS3WHF'I9'#.>EOV9T+UI9#@3E*:EUKXDD^>L*.*NPT7642&"6<%! M%*'YB4@2LZ0H_%*>B1T/^WHD+@B?E]1REA"I6R0U;RJW,=[,;YG!6CK:S6HE MS1(M"UD-."NS8@B#A(T+,80ONOWXC.[=Y)PN(>5+P]^F@(_T.EC:B4&6,EYX M5]K;HN!#N$!21J4Z/=#)5]K0,5-,D-8B'7& :[QN?W1& YXQGI7#T,F+? A? M^]BJK72#D&4L$SFD8S868_A*"C'[I<&.R[!+A;.XC&$@F$C&0RH+AZ13MR>\ M3S=FI4A]P(2)5'B[@#5#TA^)3SYBQQ._;Y1[HE#!;Q>1DJ)4M,_1;V10M>I4 MD;&B%-1)4M)4"=.Z)B>B\'%_9K2!K97A9;*PD@\^)K: M:+]#7@+HQLZ4)+Z M[_71E\ZS% /+_?'[ZI$4D[9/Z;G=URBA4@:^K*@^'[ K8'L$A\JZ>Z75#[2_ M,#?X@.T&_U^)7AV&.ERO+*,:]6TIBJY "A;G,>0L'B>_U"GC"0>JPT,7[.C% M\TCPR_ 38.G -JWK7LI^MO_/F';/Z[-Y]Y-"B2T5G5B-"W*-CXHL M,]_-W MZ75X;&?:T=,=NBOZ5T+C#6A]H;7;#WR _N]K\A]02P,$% @ 8H6B6*6Q M/G4W P $0< !D !X;"]W;W)K&ULK551;]LV M$/XK![4H-H"()$J6Y=0VX+@=UH<,09)U#\,>:.DL$95(CZ3CYM_O2-E*"CCN MRUZD(WGW\?ONR./\H,TWVR(Z^-YWRBZBUKG==1S;JL5>V"N]0T4K6VUZX6AH MFMCN#(HZ!/5=S).DB'LA5;2NDPCL#=M_WPCS?8*)7N;/C"8?#-IQ%4>^MT?PPF!KU4PU]\ M/^;A54"9O!' CP$\\!XV"BP_"2>6Z43+D[9='L:'U7^>QH_U\5%P=L6\&;/X&=@:W M6KG6PF=58_UC?$P\1[+\1/:&7P2\%>8*LI0!3WA^ 2\;Q6\0]!8^22N:QF C0LUHYJCM'.F+L.=)/[:4)=W1 M%9:J 1=.!-0OFR(X\ECK?B?4\X=W)4^G'RTH.EPV'*[-,UALZ#*[<,ZJ4W:E MJLDTSU?PV!K$'PX,4+FK=JSW2TF^#$&2<%([4YD3>0("IWH++R'HF )+\C(."MY0L8D8;,T)2/-9VPZF0Z^OI=XJ9ZM)FT& MTB)C4UY"FDQ8D7 ?5TPYX20LH>%[X-S'YQXI*UG._5R:I&Q29F3EA5^=_51G M]C_I+%F:>2[9C*7)0( 5A1><3C)6SM[666:,3V>0IAG+\@(H*P5EC$S&)SY/ M]&5YF@4DSO)\1M:,%LLB9#-A:5["N?,=OVI3I*<)S=A"I??*#1UKG!W[_6IH M9%,V?.# \GG&VD^JX+1 ./52GT M?% 84T^'0YT56#%](6L4]&4E5<4,+=5ZJ&N%+'=.53D,1J-D6#$N!HN9V[M5 MBYEL3,D%WBK0354QM;W"4F[F W_PM/&5KPMC-X:+6(?F[_I6T6K8H^2\ M0J&Y%*!P-1]<^M.KV-H[@W\X;O3>'&PF2RF_V\6?^7PPLH2PQ,Q8!$;# UYC M65H@HO&CPQST(:WC_OP)_9/+G7)9,HW7LOS& 0= Z!X]T&28/_4?#$Z"HX"?B9J0L(?0^"41"=P O[#$.' M%Y[.\-_+I3:*1/#?L1Q;B.@XA+T84UVS#.<#4KY&]8"#Q;LW?C+Z<()@U!., M3J$O[NBBY4V)(%?@R'IP+;4Y1O,TT'V!D,FJE@*%T1;.T,XU[3"Q??=F$OCC M#QI*&P+PD:XUC4S1GX:5+.EZZJDKNOT)X4N-BADNU@<>;R'TQE'HQC1,X*Z0 MRKPWJ*H#0S]-(?!]N&OJND2ZR(:5D#%=P(IB 1=M2VEO=\D,YF#DRY0M2>4^ MFT(A0M7*#JWL@$23%;UJ@(F\38+K%[*[MCQJQG.'RBK9V))QD96-Q>/"1:HH M<*,<=UO.-K^2LR4ON>%(B+LJ]9E1/"4KD,_KIUW!DL1WXR0>PU]2O'=./\&V MO8J;[;051$Y):+1'NC349UM^^)@53*S1)2"H_1T$? 88>D%(F7N3,'Q^'DM6 M,I$AM/\!?OU,#@J\.X>/F&&U1.46KM?;"C:6EV/7943%F'A^&K>3Q(_@"T53 MU/J4LE7?3\+WO8D_L4.:Q' CQ7I?=ON6 67JIW9(PS'<2YOIJ?)0\,A+R-1- MTE$ WUP[MY5_(#>J,JF 2K]S=Y'/MLB4/H?X8D1__L]>.=>9E190:"23P(?? M(+I(:3C1.>*^<\2_T#FHH-0Z=H+L>LE-E^?6H],QC:+9L=9R,M+Q#MC!V0(2 M@5/U9<[BX))N\*#W?.KN=UOJG%1 3L[T+?@C+XS\WL36O;OZSX1&UC&DWB2) M7F.:P-B+X^ UIF.(/)]4]PK3"=VS:/0JU-1UJB5N)0VQ%R1!)]:VA#7;5JZ5 MAZD73Q)WQE/@5=T8UP-(@Z@-G)%DH_0<;NW)D-8>6-G@T7ZU$_HQ]0WWGA$5 MJK5[+&EP FY?%/UN_QZ[;)\A._/V,4='O>;"=HD5N8XNQB0OU3Z0VH61M7N4 M+*6A)XZ;%O2F1&4-Z/M*2O.TL 'Z5^KB?U!+ P04 " !BA:)8TR";":D" M #\!0 &0 'AL+W=OZ;2B/+&E I M_"@(QG[)N/226;/VJ).9JJW@$A\UF+HLF=XO4:C=W N]P\*:YX5U"WXRJUB. M3VB_58^:9G[/DO$2I>%*@L;MW%N$T^70Q3X$3 MA )3ZQ@8_5YPA4(X(I+QI^/T^I0.>#P^L']JO).7#3.X4N('SVPQ]R8>9+AE MM;!KM?N,G9^1XTN5,,T7=FWLD(+3VEA5=F!24'+9_MEK=PY'@$GP#B#J %&C MNTW4J+QGEB4SK7:@732QN4%CM4&3."[=I3Q93;N<<#99H[&Z3FVMN(8O[OW'#5_\/_Y_+C8410_HUZD3:!,,3R=P M134U%4MQ[E'5&-0OZ"67%^$XN#LC?]C+'YYC3YZH2+-:(*@MO&]EI8PUIZ2? M)U\53.9DGTNP!1)+63&YO[R81.'MG:&"2G7-A %J#<"MH1H]%E!IE6M6 M,( MS 4):@!F2N=*,!+U-IHBR,(]IEAN4!]N.(8/$ _B47#"G.[,I073I'( DEI8 M.)B,;F'%3 $5VU/S(%E7\6 \'E_#JM8:9;H'NDII"-QTA>PW%5D7&(VNS\JC MQY<6_>LC;>%@%(Y/7:-_5)$EDC[7=PRDJI:V+&ULC5;?;]LV$/Y7#EH[M(!C_;)B)[,-V&F'[2&M$:?;P[ '6CI91"A2 M(RD[WE^_(^4H#N"Z>Y%(ZNZ[[^X^DIKNE7XR%:*%YUI(,PLJ:YO;,#1YA34S M0]6@I"^ETC6S--7;T#0:6>&=:A$F470=UHS+8#[U:RL]GZK6"BYQI<&T=.[Q#(1P0T?CGB!GT(9WCZ?@% M_5>?.^6R80;OE/B3%[::!9, "BQ9*^R#VO^&QWP\P5P)XY^P[VROLP#RUEA5 M'YV)09:?F&7SJ59[T,Z:T-S I^J]B1R7 MKBEKJ^DK)S\[7U=,(RPIKP+N5$V]-LR7Z\,CVP@T'Z>AI3#..,R/D,L.,OD. M9 KW2MK*P&=98/'6/R1Z/,RN0AXS_00TG@ 292,+N"E?_SR7?88_.8[L]=&L:EN,LH$UB4.\PF/_\ M4WP=_7*!^:AG/KJ$/E_3GBQ:@:!*^$$6 VJGL; YP$HP>2Z1RZ$>*_2"8/) MFR]76\G_I4B6EDLE:"]SN07C.6P\A_Q4/?CLQ@A< K>&@$@*LM.8-$KP@EF: MK"V]'%GC$OK:H/;>AB)H'\E6&A'J3D[HY 0DAKSJU0!,%FZ0WG93-R18E3^! M:CJL=Q"/,WJ.TAB^*'FU0^-B&V_$]DP7QJ-0MZSF^>NW5CKJR2!+,WK&XQ@^ M<:J$)6Z=@=I+U*;B#3148D@CB"-8H?9'I%26B1^7[AVD M@\EDY-]9,KZ@GJQ73_;_U/.U]%N4&LRT4%1X'WA%V;NFWJL"!2RH)$X#"T/G M=5?*R8:+V 78-7ZV^F6RF@-2XZ>T/-\+H575WV MC'J9I*-A? .D%%_6 >PK3G+@,E>Z4=JKRN&R5]9@Z&JCEEAGUJG*G6RP<1?2 M439?VGI#D$3*$_*4"2D>#R99! _QK^'! ILU'2(?1N3:&)\=WC7KK+RE#JFBE[4[R?K6_ M!Q?=\?]JWEVBM#NVG'(66))K-!Q3?W1W,743JQI_&6R4I:O%#RNZRU$[ _I> M*F5?)BY _W&ULA55M;]HP$/XKI[2J0$+-"Z% "TBE[;1^ MZ(;:;OLP[8-)#F+5L3/;E&Z_?F%=0?A;%*Q-3Z@_5(M-.W"%B7G)4K# ME02-JVEP&9_/4R?O!;YRW)J]-3A/EDH]N\0J%<$!$ MXV>#&;0FG>+^>H?^P?M.OBR9P2LEOO'<%M-@%$".*[81]EYM/V+CS\#A94H8 M/\*VEAV0Q6QCK"H;9=J77-8S>VGBL*4!ZOIEI.>G2V:^#*9PV=;H(:%,E:CY1HI]A;F*''%K8'. M(UL*--U):,FNTPZSQL:\MI&\8Z,/=TK:PL"-S#'_6S\DOBWI9$=ZGAP$O&/Z M%/IQ#Y(H20_@]=L@]#U>_QV\^W_=[<$UFDSSRM?.]\LE!84JZ,=;WM?@Z=O@ M[E6=FXIE. WHV1C4SQC,3H[BL^CB /6TI9X>0I\]T"O--P)!K> 3MOSABK)H MWB)[&.ZQ0,A462E)P3 .5!)HA9JKG&>P;- S0H<.ER2*76 :@1E8*4%/W,T: MJ)+HKQ&AK%./+O5 BVH"!3N]QWXS7$^ZI#&+66.FG7Y_T_*3J&P6A$X]DPIK$3IUT_ M#;IOE6"XUTY*U&O?- TA;J2M.TM[VO;ER[H=O8K739T2ON;2@, 5J4:GPT$ MNFZ4]<:JRC>GI;+4ZORRH&\+:B= ]RNE[&[C#+1?J]D?4$L#!!0 ( &*% MHEA\%8W?90, "P' 9 >&PO=V]R:W-H965TB#[0TLHA2I$K2L?/W.R1E MQPNX?K!YT+I_H#^N_>=?%DS@Q^4 M^,IKVRZB600U-FPK[!>U^Q,'?R8.KU+"^'_8!=F2A*NML:H;E(E!QV58V7Z( MPXG"+/V%0CXHY)YW,.19?F26+>=:[4 [:4)S&^^JUR9R7+JD/%I-7SGIV>7? MMD4-,>XIRP9'P&6E.AR#I'J(G]A:H!G-$TN6G'Q2#:CW 37_!6H!GY6TK8$' M66/]?_V$&!YIY@>:]_E%P,],7T&1C2%/\_("7G%TN_!XQ46W/WEG@5;B(J$,,ZF>,EN_>9-/T_07.Y9%S>0E] M^4@-66\%@FH@\/]+2>I.S2R7&X@?#CD,;IVC?]G 4XM FKV2**UY-1-JXK5( M0G4P39$ST"A!C>U6#21-/XT(74@_NO0#):]JC]GSX:9-<1N.;NL\^6TP8]G> M=?M6UL:+*L]!HV"6L"J--2=R;R$?9Y,)K<4T/22RT:HC ES7T#-M7T#PRC&& M!BFS>3Z!@GY_T*B"6"AC1D!SH>:F5X8)[W"O74#MRQAZP:0= _[<\IZ&D#WA MPHQ!:T(4RO0:XNQF!#0C: )(P'W5,KE!< 9PD(K+A*!#K,Y'*SJ_3Q<*TO3U6];>LY0.P'Z MWBAE#P=GX/A +O\#4$L#!!0 ( &*%HEAHM#F\0P, '@( 9 >&PO M=V]R:W-H965TU*!I B&1)EF7/-A"G M*3:@';(DZQZ&/=#2R2)"B2I)Q>E^_8Z4K#I=ZG;8'O8B'2G>=]]WY/&TW$MU MKRM$ X^U:/3*JXQI%T&@\PIKIL]EBPU]*:6JF:&AV@6Z5<@*YU2+( K#-*@9 M;[SUTLU=J_52=D;P!J\5Z*ZNF?JT02'W*V_B'29N^*XR=B)8+UNVPULTO[;7 MBD;!B%+P&AO-90,*RY5W,5EL$KO>+?C <:^/;+!*ME+>V\%/Q=M&R9QDLI?N.%J59>YD&!)>N$N9'[ M'W'0,[5XN13:/6'?KYV&'N2=-K(>G(E!S9O^S1Z'/!PY9%]SB :'R/'N SF6 M;YAAZZ62>U!V-:%9PTEUWD2.-W93;HVBKYS\S/J*J88W.PW7J."V8@KA]1W; M"M1GR\!0 +LLR >P30\6?04LAO>R,96&JZ; XJE_0,1&=M&!W28Z"?B>J7.( M)SY$892\76VT4'8X_GM/;PR7/P]F"6>B6Y;CRJ"(TJ@?T MUJ]>3-+PAQ-DDY%L<@I]?4L%6'0"09;P=^(^;)CF.;"F@#=<=.;+A/<"3H9X M7L!=A5!*0>5*$<'8PS#4+/\3->"!2DM4M,MASD3>"6;+3).K D,0IE*(4/<' M NV! -K.O!KWTU$G(U[T0VL.HI[$R&5-*$.HG^F>X@U-(3!C%-]V/4$CX9>. MW=/R2[JV.#&"2ZE:J1PK> GQU(^B&1G1W)_&";Q#K1N3V='O;TN6LF..H&-:J=ZWF:4+K&](UAG!W;ZD7?33XO[WLR M%>R.4TT++,DU/)]-/5!]G^L'1K:NMVREH4[ES(I^#5#9!?2]E-(&ULK5=M;]LV$/XKA#L4#:!%HB3J);4-V$[2%EBVH,FZ#\,^ MT!(M+]^1\I67-?UW&U?I"-U[_?.CV[M5X*%LC M>,/N%=)M75.UF3(AUZ,!'NPVWO-J:>R&/QZN:,4>F/EU=:]@Y?=:2EZS1G/9 M(,46H\$$7TU3R^\8/G"VUGLTLI',I?QH%^_*T2"P#C'!"F,U4'A]9C,FA%4$ M;GS:ZAST)JW@/KW3?NMBAUCF5+.9%+_QTBQ'@VR 2K:@K3#OY?HMV\9#K+Y" M"NV>:-WQIN$ %:TVLMX*@P4T-'0^5 M7"-EN4&;)5RH3AJ%+A M'567*,(>"H,P/J$OZB./G+[HWT5^S74AI&X50[]/YMHHP,\?Q]+068F/6[$] M=:57M&"C 32-9NHS&XQ?OL!)\/I$#'$?0WQ*^_@!>K1LP6FY0+MXCOEX6LML M";$SC7B#S)*A@BJUX4V%:"W;QEC=U2Y7, 41%Z<$*()#C^ ,/=>U++GM?(U>OLA"'+X& M9B_ ^' Y:Y5B3;%!4.-&"]I-B_)/:#Z8/K8),"87Z%621/ D'DX3]\Y)?''@ M]$$.K,>AEV<94!GV0D=@DGEAGEN/0_ X)2=P0'HQ8F,!H[3X3SA#][0KL.^PHA MG:79SM)D3_O/<#Q-8;2C#U2T[##/7V/EOS/,W.R%'<'U-EQE)[Q&1B(X582M M:1Q!*8FCL$>2T%:< " 35WOXFJ5VCV2YET784GGJ)7F 'A4MX72%D]>SR7)A M.JA:.RLER[8PR+!BV4@AJXV#>91C>&,OP1$BJ1<#= D!"SG" : Q"]P[C6+T M"[2H0O -_(!G'L(S)9%]I@G"((AQLNVZ?RP3(!;:!)!*@HX.RB\>8*KBV;'('_2 MX/&A_0AC;R;K%6TV]\Q)&VU'=KVV\!]<;N38]JA!C&,O+ C M"(#A1(K3/L7I_S1 /'3;&GLJGIOJTX9OM.%U-T":I@4\TJI2K(*=T[DMW- V M:,.HT'8_P@LWMSR1FET#"?^WM41IEWE M+L@P[NV0[VZ1_6Y_!Y]T5\]G]NX"#]BN.(PPP18@&ERF<*ZH[E+<+8QD$#:*V[?*EM(+=B [1HD*3=A\4^T-+8(B*17I**T_WZ'5*RXBP<8Q\2<88S MAV=85HX+FIA5YXE3';61#HHL*&Z9'<.]^M6LYE:VHN\%:!;IN&J5\76,O=PHN\O>..;RIC'<%R MOF4;O$?S8WNKR H&E)(W*#27 A2N%]YY-+O(;+P+^,EQIP_&8"M92?EHC9MR MX866$-98&(O Z/.$EUC7%HAH_-UC>L.2-O%PO$?_XFJG6E9,XZ6L_^"EJ1;> MQ(,2UZRMS9W<_8Y]/8Y@(6OM_L.NB\U##XI6&]GTR<2@X:+[LN=^'PX2)F\E MQ'U"['AW"SF65\RPY5S)'2@;36AVX$IUV42."]N4>Z-HEE.>65[ARL"G![:J M49_- T.0=B(H^O2++CU^(SV!;U*82L.U*+%\G1\0E8%/O.=S$9\$_,;4")+( MASB,TQ-XR5!?XO"24_5=<5W44K<*X<_SE3:*SL)?QXKML-+C6%8?,[UE!2X\ M$H!&]83>\N.[* \_GV":#DS34^C+>]);V=8(<@V6]3%^)Q&.\WNH$-:R)O%Q ML0%C&PT:C2:G,A48FBYDLY4"!3EI;>NY) \3OSZ^F\31^+.F8[XR,SAW\]2A MHAI:U#NOL,!FA6KO3^!&&"02!KZW1ALF2KO\4>>EPI(;^,(*7G/#4<_@#I]D M_41PV2@,/\![R")_$N9D1HDUD]"?ABG\&-V/X %5 U\E$Y"/LO0#9-G8S\*0 MK'%$5A[Y<1;"=:OD06B'&Z43/TSB'C;*8C_)0_C?.KGQ))&6>;G40Q?4=,FN6FN='(W @ZI^@*&'S7S_0X M:3P0^#'5G%SL;=7T(@ NW(:53ADO4G(;H+!FAJ:P(Z)M<-W254C7N*FX>*': M1_@@T/@4UNN,KDWREG:D9"S4M(G5,[-&*$G\RSN&\L6?B'[8_%\?.6)(E[J\[$0XC M3S([2/TXGAX] ,'!"]6@VKAW6!-@*TSW6 W>X:D_[UZXE_#N=P(5NN&T%S6N M*34I/JB*\X-O#2BU3.O,F9W'02ZJ'C# M])7<\19/-E(US.!2;0.]4YR5SJD1012&:="PNO7F4[=WK^93N3>B;OF] KUO M&J:^+KF0AYE'O./&0[VMC-T(YM,=V_)';C[O[A6N@B%*63>\U;5L0?'-S%N0 MZV5L[9W!KS4_Z),YV$S64GZQB[MRYH66$!>\,#8"P\/I_!C])Y<[YK)FFJ^D^*TN337S<@]*OF%[81[DX0/O\TELO$(*[48X=+;I MQ(-BKXUL>F=DT-1M]V0OO0XG#GGXAD/4.T2.=P?D6-XRP^93)0^@K#5&LQ.7 MJO-&@. PD?9FDK#CVW)R]?^ 9(=&$='QLOH8L"/3%T! M)3Y$811?B$<'!:B+1_^G C]+K<<^_(*%(C?PQ%[@]\5:&X7WZH]SLG2H\7E4 M6VO7>L<*/O,02W/US+WY^W"6Z7_*[UPBEZ&> M*@X;*;"XZW8+QET3T!7R12PLVT(PK>M-73!;A1HV2C; VA*/-%:.=5HSP=H" MW9 M.V$K'=OB%=NZ9_O^71Y%XZ5X6WR%6[Y!FB5\;O%# M)>J_<'K+5?W,["< GJ1A I8=*C"'>\L+WJP1KK]9%'Z $2&)'Y-L[.:AG]'< M3BFUA\2/P\P=1#$:)>->W-=T1\*J>F2]YO@5Y?#PG2BC*/$I2<= HQ!2"M0/ MXP1WB9_GB+EHY+XU^D1-3,@):?,'*P");H D(8R0[;".*6)U6AJ\KZP/-SGXS@I"DT7&U=Z].H&7+K^L.P.W371==4OIEWK1GI;6N4 M3O -NH976>*!ZMI=MS!RYUK,6AIL6&Y:X1\"5]8 SS=2FN/" @S_'/._ 5!+ M P04 " !BA:)8D^%4&',$ #H"@ &0 'AL+W=O+ M*$6J)!4G^_6[HV3%:14W7R3Q1+Y[=_=XY&1K[%>7(GIXS)1V%ZW4^_RLTW%Q MBIEPQR9'37_6QF;"T]!N.BZW*)*P*%.=J-L]Z61"ZM9T$FP+.YV8PBNI<6'! M%5DF[-,E*K.]:/5:.\,GN4D]&SK322XVN$3_.5]8&G5JE$1FJ)TT&BRN+UJS MWMGED.>'"5\D;MW>-W D*V.^\N FN6AUF1 JC#TC"'H]X!R58B"B\:W";-4N M>>'^]P[].L1.L:R$P[E1?\G$IQ>M<0L27(M"^4]F^P&K> +!V"@7GK"MYG9; M$!?.FZQ:3 PRJ*SR\)8%4;4@"KQ+1X'EE?!B.K%F"Y9G$QI_A%##:B(G M-1=EZ2W]E;3.3S]@LI%Z S/.CO02'?QR+U8*W:^3CB<'/*T35V"7)5CT"E@? M;HWVJ8/?=8+)R_4=(E:SBW;L+J.#@+?"'D._UX:H&PT.X/7K:/L!K_\*WA5: M^2!8!W"CG;<%RB?=\P,A#>J0!H?0ITO:IDFA$,P:_C2L=*%@EIF" R/; M7>&=IP YMKWP%\9)GNR:XCGHL3F>67!&]8K3NF!M\"G"W&2YT$^0B@2XEP!U M$MHK&O Q3H7>(!NVPB80DW@XQX[V@$]![Z+Y?+P\AL0H)2P\"%5@\,78:S*: M+85V!O/"6M3QTQZ'6WR4L="P0&?@" :]=K?;A3\$T2':\#=Q&;6I>\$\E:6E M$&P:D^D(AB=A^H$2#>L2#=]TKAJB)4'@'QCX363.AEVJN2OG\WCGJCJC7DJ*E51E*PFIBLZA-SR%A<5EW'$[&HWKE_;[S)C M@PAMBU7&P6SH2D'G?FPV.D1$HR;QO2*.I:=7*1_N@CG:X,L1H@H3*"7-NN7* M!D\^M8B0E4<:\I'V78,+Q.FCOY_7MRCW57*UA@,\0S?FN[95&FJ'A''BH_$) MO7>BN?YYJRTU*W5LL@KF=-"'Z+0/]\93\SV"J!U%I_PF6U,W[.S=/C*TFW#' M(CUQ+_?9) .QZM@YVX%%NA]_8R>DP$+4(G1?P'8\S\SS MS,09]U=2O>H,P) ?.1=ZX&7&%'>^KY,,?7@W#B-KX';\Q6"EM\;$4IE)^6HGW]*! M%]B(@$-B+ 3%OR6,@7.+A''\4X-ZC4]KN#W>H/_AR".9&=4PEOQOEIILX-UX M)(4Y+;F9R-6?4!/J6;Q$&W@D*;61>6V,$>1,5/_T1RW$ED%\<\0@ MJ@VB/8,H.F(0UP:Q(UI%YF@]4$.'?2571-G=B&8'3AMGC6R8L&F<&H5/&=J9 MX8AJIHF"^DGM>E2YCHZXCLFC%";3Y(M((=VU]Y%&PR7:5=+ M\(:__A)>!;^W$.LVQ+KO)%9ISD#;2EEE+,D(,F)F3? <4M2 Y7D\,:/N3SRC MWA[1UE!.)-IKB/9:B=ZKA:4C*++8C,&]/"^E>F4Z(]-RIEG*J-7@$,%6_/=' M7TEQ)K =*:X:*:Y:I1B72H%(UIA-L03E3GF6HSOC3I=LC?G^S,2,K\^8?+M):T U7J2A'*=?02X4 M+?"E(&,I$K17U>$[8?KUD"2MX7RT5LX$MJ/<3:/<37NM[-!52)=<4$THP1JQ M#RX/L:\@PW"K(().$.X51*OC$VG=-K1NSUL04\KQ?P)+$"60)^S93JB*UI@^ M6A5G MN1+PS>6I'@_'518^X71K17&.VN3Z6VU66%[Z^-R=V4#9#?A\+J793*R#YA(X_ ]02P,$% @ 8H6B6)UEORI\!0 M8"P !D !X;"]W;W)K&ULM9I=;]LV%(;_"J$6 M10MDL4E+LITZ!A)+ZH(M0)!^[&+8!2,QMA!)=$DZ;H;]^.DKDADI;)2=W<06 MS?.0XBORB&^XV'-Q)S>,*?0C33)Y:FV4VIZ,1C+#AG"=^?6MAZ M++B.UQM5%(R6BRU=L\],?=U>B?QJU%"B.&69C'F&!+L]M<[P24#L(J"L\2UF M>WGP'16WH:[[_E=4WY!2\D">R_(OV55W7ME"X MDXJG=7#>@S3.JD_ZHQZ(@P!"G@D@=0!Y:<"D#IB\-,"N ^R7!CAU@//2 +<. M<,NQKP:K'&F/*KI<"+Y'HJB=TXHOI5QE=#[ <58\69^5R'^-\SBU/-_)O$1* M=!9^W\4R+N26Z!?TWF.*QHG\@-ZB.$-?-GPG:1;)(_3NS6SBVA^+TLLX28KZ MBY'*NU( 1V'=['G5+'FF68PN>:8V$OE9Q"(]?I3?0G,?Y/$^SHD1&+";8T3F M1XB,B8V^?O;0^[OJU&H+QOUZC]_7]]L$\,^R2BF,TP3_MDP_9I\ ,\UC8 M]&G2WR=M_"?-\#%THELJ_^IZ1"FGW(XLU]41N:9 P'Q(6 ,$TD>U&9-M$7W[B/-KG<[Y/2V/D4"TA M85X%DB8!PGS(6$!$$R3T6UD=.'72A=29$B8!PGS(6$!$$P3>=J(/#7.U:N= M"#?Y*R_:BCAD?8I..VO$Q';'8WU96E6U,#FL1HZ)7LLS]F6H!I"P BF:3!K M-)@9-2CGEV!1_JZJ:+:.;Q*&J)1,];ZQ5BSG8*"Q,^[H86QQZ-2!A/F0L ( MILDV;V2;O_HU8]X5R>V*9.0/%0D2YD/" B"8)A(>MSO'L5&F%94;M*4/*5<#8P-#YQ$HS:]IVO-A/WT\ J@V=0E(*P'Y^12I MIT74JP/IZC#KZF!L9; .D#0?E!9 T72]6A,#&[?/Q08+_8-6I>W&!+IF"2T- ML4V\[9]&H X&*,T#I?F@M "*ILO75*SC3**$W>;( M\?'4L9"HCK-6%XIOR^.7-UPIGI9?-RS/U:*HD/]^R[EZO"@:: X5+_\%4$L# M!!0 ( &*%HE@0V:$?-0( +\$ 9 >&PO=V]R:W-H965TH J;UNVAYZJEIM>YCV$,! ="%A M<2BW?[\D4-9)O;Y [/C[_-G8Q+U43U@#:/+<<(&)5VO=KGP?\QH:BC/9@C W MI50-U<94E8^M EHX4,/], CN_88RX:6Q\^U5&LM. MW#L[#JRJM77X:=S2"HZ@O[5[92Q_8BE8 P*9%$1!F7CK^6H3V7@7\)U!CQ=G M8BO)I'RRQMI!]BEY%'\@ZU;$:P4= P,;SI M\]B'"T 8O@ (1T#H= ^)G,HMU32-E>R)LM&&S1YD4>J%+7-(F^VH"GC^#;VM4EF(7X^$F\&XO %X@792:%K M))]$ <7_>-^(G)2&9Z6;\";ACJH96Q=2!A>-=O, [%DX. MT$JEF:CNR XH=@J<>\LPY]*:2'ZN,]3*#-*O:_T8TD37T]CE6F%+^OK5_#[X>*.(:"HBNL6>/G9-!HK(TBR*+8-F',X]PFMB![JEH[.+>TH7 ML7^Z5.!?#%4#JG*K@R27G=##?$W>:3O7PU#^"Q]6VWRZB@DD'$H##6;O35XU MK,M@:-FZ$:^E%*?#9M@^F>E?P%02P,$% @ 8H6B M6#T$5?GI!0 %R !D !X;"]W;W)K&ULM5K; M;N,V$/T5PET4";")15(7.W4,Y%8T0-,&2;=]*/K R+0MK"1Z23K)%OWX4A>+ MED31*ZS\$EOR\.C,:(9S2&;VQOAGL:94@O(Y_/V%;&44H?.1#;)"'\ MZS6-V=OE"(YV-YZBU5IF-\;SV8:LZ#.5GS:/7%V-*Y1%E-!41"P%G"XO1U?P MX@;[V8#)RY&2,:$Q#F4$0]?%*;V@<9TB*QY<2 M=%0],QNX_WV'_G/NO'+FA0AZP^*_HH5<7XXF(["@2[*-Y1-[^X66#GD97LAB MD?\%;Z6M,P+A5DB6E(,5@R1*BT_R7@9B;X#",0] Y0#4'.!V#,#E )P[6C#+ MW;HEDLQGG+T!GEDKM.Q+'IM\M/(F2K/7^"RY^C52X^3\>BO4'2' ,UVIMR,% M. ./E.?YD884L"5XHAO&)7F)J38ZN:621+$X5>:?GF_!R8=3\ %$*?ACS;:" MI LQ&TM%+WO(."RI7!=44 <5#!Y8*M<"W*4+NJB/'RNW*M_0SK=K9 5\(/P< M8/@1( >Y!CXWWSX<6^C@*M0XQ\,=>&7PRGA&Z0KGS,X\8(&:X,5G@;(3-JO2/OV M<++T3$WJG,@=:;)0\T2D7"'9# GHNYKRA3G_5W&/TI EU$1PTGJRYWG(;_!K6[G3*9J:Z4TK>E,[/;FFO*0& M3LH\..U,XFF+ W0F3H-HV^@,(=Q!%#JZ"SE6JO>II&JJD;ML[219XM3?I#/) MYO<:3Z,=1FY'M<&]?@D/,,W#^4+5U$V!).^T2%3Z91O)KUD+5,QW05=9K7*9 M94F>S2(LV9 T,I=B^=A:"GC!!#7]:IMAU^V:^2#2;J%O3.5=CS>2M(+T[4)# MH=5=UNT8'K,?PT$;\E!H]5#HE@R_HR>78[U#3=E@9^O*4+=E:._+NQ>EVQPE M/%6?9KKM-@N1'\!F2S#:0=Q)5S=D:._([5("_X&KA/(H)&;&5KS>J3006MU[ MW=1A<,RJLDJ&WJ$8"*T>"JT.H%T>V*NJW?(14E75:F0&.P^Z$'>DJ18'T*X. M>E95N_'[?A TY8'1#"+/3!9I?8#L^L!84WD<3US4%% F.P^Y;H>$15I.(&N/[EE/ M)5BMK*?>WI*J9&LP"[RNE1?2#1_9&[ZY1XF(C!])&"VCT,C9BMD[F09"JT= MBPKD';.NK(JE=R@&0JN'0@L6=& +P5I7[<4_=-0"&S/G+*3@+HZ2*"VRRBX# M[=B] MAD*KAT*+%_P=XJ4ZC?O7\.*F.*/6,,61^0/AJR@5(*9+!>F4+"C/#-3O2\;D[B)[0/6_ //_ 5!+ P04 " !BA:)8Y?0$.O(# M "%% &0 'AL+W=OVE!58R%.V MUJ,C=P/.F;H$SXBSG];4'MIS32N09@0>&>%44F/VS@IP>%X[OG"X\ M9KN]4!?><8 MJ:%L*'U6)Q_3A>.I'D$.B5 (+/\.L(8\5R39C[\;J-/&5,+N\8G^OAZ\',P& M*1'C] ,Z")XB4TY_4O.NJVUYZ#DHH+6C1BV8,B M(_H??VF,Z C"UP1!(PC.!$'PBB!L!.&90/9T6#!N!./OC3!I!/7073WVVK@( M"[R<,WI$3+66-'50NU^KI5\941/E23!Y-Y,ZL;R7<_$)Y\ 1)BEZA .0"N1_ M0GFPP2MA M0W1'B=AS%),4T@%]9-9/#7I76M#Z$)Q\6 5&X!UF(Q3Z/Z' "\;H\U.$KMZ\ M11QVP<&2YX\ .X"Q_ M_,&?>K\,>6\3%MF$Q99@O:R,VZR,3?3E:?$RO7C_A1153VX<'40WZNCJ.?,8>G?C&9S]]!-P4"KP!M=]UM%Q@Y?ZJTE6,_; M2>OMQ.AM!%M@3#K*M,E#QFG"M./(^,PT8XQ+YZU-6#SY-IWCT:3M?L^S:>O9 MU.C9?55LY.RCVV;RX4T.IXK*T5=#<5UI\*33F_#,2F/H2ZVT"8LMP7J67[>6 M7QLM_XV6Z+UZ4*_K-P=@RF?]>#]5!_7 _]K>1]^6\J%\&*->6KUMPB*;L-@2 MK)>Z69NZF>UGZLQF5FS"(INPV!*LEY6;-BLWQ@75SPI36;G"\ET9E<#4C:%W MNI41>6E>;,(B#?/]3F'U1G[0KZVQI9 ]PWWOY8/$,UK^";,=<&&[A)FC7IH5 MJ[3(*BVV1>OGK_-!Z=LN9 W15FYLTB*KM-@6K9^;X"4W@?UR9F9>G!V;M*BA MG54T[^QM,;855-ON=K9;9 ':U?M<'"6T(D+O.+17V[VT=_4.TMGUE7^[UCMB M+QB]074 MBM.)"M#N/"[_ U!+ P04 " !BA:)8H4YQ=FH% !K)0 &0 'AL+W=O M?AG.,'Y^'8TRVMOK 5 M(1Q\+?*2S9P5Y^MSUV7IBA0).Z-K4HI?GFE5)%R<5DN7K2N2+!JG(G>1YX5N MD62E,Y\VU^ZK^91N>)Z5Y+X";%,42?7/)K(R(Y27D-D8BO%W)%\KQ&$G'\W8(ZW3UKQ_WC5_0?F^1%,D\)(U&<'!7;=S@ MX0&\^XHN-BD'M^7N :SK^^?/P@C<L3Z*3]GZR0E,T<\QHQ4 M+\29?_L-#+T?=.E: E.2][OD?1-Z0S564TV7Y=E[H?Q)(BG[LM^ M_(=F@>=!/^K,E,B"+K+ &-FO:U*)P2B7X)$LQ1S%M2$:,<8.A"4P)=VP2S>T MSL+09O*6P)3D)UWRD[>S<.<:'&/AH9F)A5$76322A>!?<%&0*DL3;;1&N+%C M8@E,R3SN,H^M$S*VF;PE,"5YZ,F_8._ME&Q]]\F&D."DW^.DSBZ /L1Z4L(] M@0#'T_+F[N9"&ZT1:^RPV$)3,T/CR4TM0)2ML# M/D&MRAA;:&H!I)"!1JEPA*#A(?$\&$2X3]!#NSA$43C 3RDTH%EI:/EY)UZ: MF53UC"TTM@%0TT*@9CC S/F2F+_[3)WUF:NP" M',43/3615!S(K#@,U#RB.4_1+D%0XR+?/3ZL" MQQ::6@ I<)"Y,6/F9W! /(PBY/7YJ3&+H3?P7H2D]D!F[7%D#CVB0\W@HX?I M%!T5))4.FMCGJ56Y8PM-+8"4.\C$.\%0J$616 M(L,\K1=8ZNMUYY_R%:FTT5MMM-A"4[OO4O=@SW[_W:KBL86F%D J'FQNYAB) MVOJJ$ZKG>?TW>IV='Z( ZJF*I1S!9CDR@JI'9*KY1J,'[11M&+RW:'2"52.[ MRT:GT$%8ZB#\CI6CUE=Y20KQ!$5]UFKL(HPF WTH+$4*'KMZ9&+MD' UWV3T M@)VB+X.E-L+V5YBP545D"TTM@%1$^!VK3/AP_0AZ07@XSVKL(!93[0!CI5S! M;UAI&IYGCTA9\\U&#]PI^C98JB5L?RD*6Y5(MM#4-7HID?QW+$:UONKZ>SCI M$U=CYL[?3\2 M9K<-Z2ZIEEG)0$Z>!:1W-A$/4[7;V;,[X73=;(YYHIS3HCE&ULM59=3]LP%/TK5C9-3&+DJQ_ VDBT@(8$ M$Z*"/4Q[<)/;QB*)@^VV\.]W[:2A02&,*;PTMG//R3FG=G)'&R[N90R@R&.: M9')LQ4KEQ[8MPQA2*@]X#AG>67"14H53L;1E+H!&!I0FMNN@9@*NX8;.3.F&@K<\[O]>0B&EN.5@0)A$I34+RL80I) MHIE0QT-):E7/U,#=\9;]W)A',W,J8%HP7@EP#?&"V4 M&5NG5-%@)/B&"%V-;'I@LC%H=,,R_3?.E,"[#'$JN 3,0))OY"<5@NI(R=XI M*,H2^157;V>G9._SUY&M\%D:88&WMP1P6C\P1(HD,@(9>JR6]!,C D^JVR#IR1O=XUT5914]:OE/5;E0I.J_INJVBIJJ@:5JD&KJG,:LH0IAN?M#F(6)CB@642N:!ACJ7@R ML[.'%L#WKMW.B*K93&LLAA^U/D9=IE!1V2U# ZK# Y;]\,-Z.\L MRY;E 5(@4DGV6$:>@ K9^-9M9W3= MKDM!7YGTZ/*J='K;HN<6,WN6E%O?>O M[(BL9M!UGK^CSD=MZ)*YHQBZ8JOGL--/N)UOZCR)Z=Q>K$]T;VL:M&>:HC'&1F3),HGI+)#2.1CB9T84 MO68Q43PW[=J<*VS^S##&_AR$+L#["\[5=J(?4'7\P5]02P,$% @ 8H6B M6(637*UA! L1( !D !X;"]W;W)K&ULK5A= M;^(X%/TK5G:T:J69YI- NH#4DAWM2#O::IB/A]$^F.1"HDEBUC;0_ONUG320 M8-Q2\0)QXGNNS_'U];7'.T)_L0R H\>RJ-C$RCA?W]HV2S(H,;LA:ZC$ER6A M)>:B257WS)5QF7+^SI>(U7, ?^;?U 1 6JU/:7CX_(S^ M49$79!:8P8P4/_*49Q-K9*$4EGA3\"]D]Q+ 0.#H#;S&P.L;!"<,_,; [QEX_@F#H#$(E#(U%:5#C#F> MCBG9(2I["S3YH,14UH)^7LEYGW,JON;"CD__!B$:0Q_0?+->%R!FE.,"?:KJ MB)(S$]T[CWC("?,;U!OOL>>8X7:,8S>[VYKS&/S>8Q M)*?,.VS\=E)\A>>;)N4]FA'&T<^[!>-4+(]_=3+7.($>1^:,6[;&"4PLD108 MT"U8T]]_&::3J/! ML!=AQE&^48-1J\'(J(%*P2G"C %GB"S$%EB)MMCVX#')<+4")&(-5:*PZ8F" MBAPO\B+GN5Z?T3%USP]Z^HR.,HXW\GMI*38R>*,^4:M/]/H5N, %KA) =:5Z ML IU_*-+KKE+@L47 NOHZ3K[0LPQ1IPJN1%9HHV,(15)=?1IRRM'LX#<:- + M([/+<_5IT#K[X"AT][';97Y0@KKF?,,SH*+8I52$TTO+I\'J[%_NR!WUF1M= MGLU8>WOFGCG+D&IUN&V_Q-T[WI<],>U][D:G9W/7.8W\X0GN^QK7 M-9: TZ]$IHXSDV>#V0G!(/2'?04N6LIJG4:.=T*!?97JFLO4'^I0*G>9K1!! M["@4Y$E]+X:*C*LGP)1=:]4PXP^0,M7E3;/EV0*]:AS(1:4\]:$0I?B)F9+F MONYUS87OD81ISA*R$6E$1)6V_&T 7?]@-IT;9^#U2Q2SY[,ETKL-(K<71?;! M6;X$NE)W(@PI4O5YN'W;WKOK+''':7>45$T&V%)#. MS5",C=;W(W6#D[6Z,5@0SDFI'C/ *5#907Q?$L*?&])!>TLU_1]02P,$% M @ 8H6B6.C=\BM P 0P !D !X;"]W;W)K&ULK99M;]HP$,>_BI554RO1YCF0#B*U1=,FM1KJP_9BV@M##K":Q)EMH'S[ MG9,TI2&-*KHW$,?^W]WO;.=NN.'B42X!%'E*DTR.C*52^;EIRMD24BK/> X9 MSLRY2*G"H5B8,A= XT*4)J9C68&94I89T;!X-Q'1D*]4PC*8"")7:4K%]A(2 MOAD9MO'\XI8MEDJ_,*-A3A=P!^HAGP@ M5F*,(&59^4^?JD3L"&SO#8%3"9SW"MQ*X!:@960%UI@J&@T%WQ"A5Z,U_5#D MIE C#F= M M'F?5(^,5D-\74ZD$GLD_;>RE,Z_=F;ZHYS*G,Q@9>!,EB#48T>=/=F!]:WRWJ$-X>H)>#]U5^(&(0^*V]LV65I*BA,Z:_).K(MU[.'YGH7 MI]/A@3A>C>.]"V<+5!! GIC@28)TBF#5:?+;R$JK_@Y9. B\!EBGZP/!_!K, M_RA8T ;F[X'U?=]I@'6Z/A LJ,&"CX+UV\""/3#/#OP&6*?K \'Z-5C_HV"# M-K#^'ICC6M $MMZZ0>L3A9=^LX)2_.5PJUB MF0+THEHKNK6'<^J%7MC Z?9W*,].?V-W\DRTT4R1-4VP3F.Y*K6EH6MGL MO>+E>H';;[*U+0MW[E\9M+G3G^GF&+N=!![@+KKC_Z!U!+ P04 " !BA:)82!U["*D# M # #@ &0 'AL+W=O\0*8_K+D(L=*+\7* ME84 G%JAG+J!YT5NC@ESXK'=>Q#QF)>*$@8/ LDRS[%XG@+EZXGC.YN-.5EE MRFRX\;C *W@$]:5X$'KE-B@IR8%)PAD2L)PX=_[MS!\8 7OB#P)KV7I'ALJ" M\Z]F\2F=.)ZQ""@DRD!@_7B"&5!JD+0=_]:@3J/3"+;?-^@?+7E-9H$ES#C] MDZ0JFSC7#DIAB4NJYGS]"]2$A@8OX53:7[2NSD:!@Y)2*I[7PMJ"G+#JB;_5 MCF@)A/X1@: 6"/8$@F,:PEH@M$0KRRRM>ZQP/!9\C80YK=',B_6-E=9L"#-A M?%1"?R5:3L5SD$J4B2H%82N$68KF0+&"%-T9!Q-%0*+W]Z PH?(#>H<(0[]G MO)3ZJ!R[2IM@@-RD5C>MU 5'U(7H,VO7_W 15<$I,E'0;.OA\OW.#UV!DV?@XM;OA=?IYQJ6IG M2Q!/@/[Z59]'GQ3D\N\NKU;@@VYP<]5O98$3F#CZ+EM$)_[Q!S_R?NKRP)G M=OPP:/PPZ$./?ROS!0C$ETV,) )*=&;;I/NO+W33"GIHH4U]>HK]P!N[3VUR MO>I/)#=LR U[RJGK[*7$%+K85%A1BTTX\O;I]"H\D4[4 MT(E>D;--JLXYI4C7T#46:6>R1N=,UC.![3A@U#A@]$(\]XNCJ(MCDF&Q GF! M&*@N%XP.,_5Z.-J+[>@P 6Y&07-HQ^3KQN3K5Y@\J\SLLK 7YK5!.A/8#N.; MAO'-FV3IS3D=<":P'0?XWO8_W.L-^EV2B!),=K9<<8$6L"*,&:\L,,4LZ:Q" M-70[5<-PN%^&^@TXE6"K2?'?Z"+6P"_B):ERJ%HH7 M=N)8<*7G%_N:Z1$3A#F@OR\Y5YN%4= ,K?'_4$L#!!0 ( &*%HEC:S%#_ ML , ((1 9 >&PO=V]R:W-H965TU#<1.AQ58!Z-NUX=A#XQT;1&12(VD[71?/Y*29;$N\]//?P2+C49,_%@TP %'K,4B:G3J)4?N.Z,DH@(_**Y\#TS)J+C"A] M*3:NS 60V"9EJ>M[WM#-"&7.;&+O+<5LPK"A2; 1?U+8R]H8 MF5+N.7\P%Q_BJ>,91I!"I P$T7\[6$":&B3-XY\2U*G6-(GU\0']5UN\+N:> M2%CP]"N-53)UQ@Z*84VVJ?K$][]!65!H\"*>2ON+]F6LYZ!H*Q7/RF3-(*.L M^">/I1"U!(W3GN"7"?YIPN")A*!,"&RA!3-;UAU19#81?(^$B=9H9F"UL=FZ M&LK,-JZ4T+-4YZG9*B$"+N=:B!@M>*;=(8G5]Q(54_?G4^\?S1C0FSM0A*;R MK0[^LKI#;UZ]1:\09>ASPK>2L%A.7*4YFI7Q9# MW,QW=6U5@?ZAP+G?"?B1B"L4X OD>_Z@A<_B^].##CI!I7=@\8).O0M1E^2; M?B 4NA6"L V8\<5!W!AI_=""Y%21E/X+\06ZS?A61__UNX9$'Q1D\N\V?8OU M!^WKF[?"CM?\-![UR9.3V -J0:55(,N]-EGKDM'LB98 M5'8_M9L%XK#=_5R^M)2CT1U50@W)840X[*:\4CQX0SPW! M5O-WIC]W[>%P1'G<2_H.SRQU(I9E*:VBR)R*6=B>U/$K0Z#BW952U6KUSC>?N7T]@ M#3FN*SFN7]CJUWU*U1-80RKL'=L)[R>9O02N.]D/@U.[MT7AT1.&Q[4N"'?2 MOJ-"]Y5P9")C1'>4I8*]M.O.?N65]HS>K]8_7^"SN\)-"77#VA->4Z MMG"XL^WY$8\'9^X-O%.'G\=@[PE_'ULIW-U++4'8(Q^+X/_>V]U(S]ZJGM": M=1_[,1R^M+-[;>GZ0FO*=6SJ<&' 8 #(I 9 >&PO=V]R:W-H965TDS@5IZV9E//C=EM,9C0A MXHC-::H^N6<\(5*=\FE;S#DE81:4Q&T4!+UV0J*T-3K)KEWQT0E;R#A*Z14' M8I$DA#^=TYBM3ENP]7SA.IK.I+[0'IW,R93>4'D[O^+JK%VJA%%"4Q&Q%'!Z M?]HZ@\=C/-0!V1W?([H2E6.@K=PQ]J!/+L+35J SHC&=2"U!U+\E'=,XUDHJ MCW\*T5;Y3!U8/7Y6_S4SK\S<$4''+/X1A7)VVAJT0$COR2*6UVSU.RT,=;7> MA,4B^PM6Q;U!"TP60K*D"%89)%&:_R>/12$J :B[)0 5 6@M ':V!. B &=& M\\PR6Y^))*,3SE: Z[N5FC[(:I-%*S=1JIOQ1G+U::3BY.AF1CC]=*X*$8(Q M2U3O$"2K[R?PE7!.=)'!P6#MF2#P25+Y4R +VE(PWI\6SDK[:%G M>^?(*7A)^!' \!"@ '4L^8Q?'XX=Z>"RVCC3P\YJWV75OB)/:CA(<*:JG$ZI M/CX$7QYU"ZA/5?W F,PC2>+H7QH>@K.$+=3=?_VA),&%I(GXVU;?_/D=^_/U MG' LYF1"3UMJT O*E[0U^ODGV M^L17'DUBM5)VR5!V7>JU4DVK'I'F);.9S MQ5ZFJ.>OY0@/!JK9EU53EINZJ%_>5$NV6R;;?46RY]O;]=MQ&JEZI>EZCN[RVW*Z81-4^W>VKD/ >&A^4 !&"0Y:,$! M",F3;9X9NY6:E@>9\B!GIE_M[J>J/^F+N@HY?]K+D(MW*[/DH(_69DEW!DT= M&AB$3H"J+P/B!=[9TAVLWO'&"M'!&TN$.[FFY@W>03??K<^-X#]PJ3I_LDBL MEIQB;Q[XGM3JU@TLPNZ^YTFO5.E+K5XNPY70R6*CG)WS[@[T"- SY)SRB(4O MS85NX>W0X YLZMC@(73SH6ULD,>M8\,3[!76=X&.T+ C'.Q[;'@BPJ)?9;3SJAU>G2ZL[WO?#FHA7MM"Q9W-H;L+MD.&[9 ;P7:T=KD? MBO)0T"O6+FM?W04 8@. V V WPO,+7Y]E(1/J00Q6U$.#H@ 1 /P1 URJ_]" M',)*XZ\WO#N!I@8-XV'W'IW=X&(^?YU!N&EP?>/+G4!3@X;*L!N0?M-XH9!( M4NT$+$F\H%FW#5D-UIM67G= MW^7=FF_^_787X(4->.'.OG_M]KHMZ$NM7BZ#:MB-:LV_R[\@[/@N[XYL:ME0 M&G;OP&T9(X?@^MO%V.K4*W3Y4JN[-]"%^_L>'UZW!GVIU]]WU4+ M\1JM]H?]C:5_%\R'#?-A-WZ]^LFO0)URJOEBW]GV>MN:]?/X?$X?WW/R.1O$UXJ!(I2 6)ZKR2#H[YJ1IZ_ MH)>?2#;/WG&[8U*R)#N<41)2KF]0G]\S)I]/] /*UR1'_P-02P,$% @ M8H6B6,U,V%@: P ^ < !D !X;"]W;W)K&UL MM55M;]HP$/XKIVR:6JDE(8$"'40J;?3'CC/;@7;:C]_9 MH1F3TGR;A(A?[NYY[CG;-]TK_6"VB!8>I2C,+-A:6UZ&H%ZXXYNM=0MA.BW9!I=H[\N%IEG81,FYQ,)P58#&]2RXZE_.)\[>&WSEN#=' M8W"9K)1Z<)./^2R('"$4F%D7@=%GA]8@8-I',\'C]'?^=SIUQ6 MS."U$M]X;K>S8!Q CFM6"7NG]A_PD,_0QE4JSUH9TW1W,"GZKV)'"]<4996TRXG M/YLNMTSC^9SRRN%:2:JU85ZN<_BL"HMPS;10L.2R$O4&_=YK5E@@/(23&[2, M"W-*#@O4_I04&<+2JNP![@MNS32T1-3!A=F!U+PF%;] *O'86P.W18[YO_XA M)=AD&3]G.8\[ WYFN@=)_PSB*![ :PC!N+S-X=.!D#0Z)AXAZ=1QY75(D:=DQ45'I> M0*Z$8-KXU8J*?0J_C^1M2Z,&&GD@]V+LTC@9]/J3:;AK(3AL" X[Y?=U]2Q; M08?_0;N+AMI%IW9?*KDB==0:%LM[ QM'DHZ!4Z]6R6GVLEYU\.&17OW1>!BU MRS5J.(TZ.=UQ\W"^UHC B0PA6]!4W#;\.E _.2(0]:+!<-C.8-PP&'.(F\#'K<"1Y-^._"D 9YT KM[F+D"4-X23IZ0CN]I&WYWF 2\9]OY M"(]>8XEZXWN.@N>2._6AA<&!*[)->J-Z!SHNL_4 M$ZM*_[:OE*5.X8=;:LVHG0'MKY6RSQ,'T#3[] ]02P,$% @ 8H6B6!@@ MR&ULQ9C?;]LV M$,?_%4(KA@1H(E'RS\PVD#@MUH=N1K-N#\,>:.EL$Y5(CZ3C;'_]CK(L6S+- MK)V!O<02=7?ZW(GDEY?15JHO>@5@R$N1"ST.5L:L[\)0IRLHF+Z5:Q#X9"%5 MP0S>JF6HUPI85CH5>1A'42\L&!?!9%2.S=1D)#J;P+JRC9+P H;D41,%B'-S3NRD=6(?2XE<. M6WUT36PJ*G-=_B7;RC8*2+K11A:5 M,Q(47.Q^V4M5B",'C.-VB"N'N.W0.>.05 Y)F>B.K$SKD1DV&2FY)B17;Z[)&\(%^64E-QICZU%HD-:^ M,TPKLH<=67R&+"$?I3 K3=Z)#+*F?XA9UJG&^U0?8F_ CTS=DH2^)7$4=QP\ MTW_OGGAPDKKR21FO\TKE]P5V5<@;P:[P.[UF*8P#7,(:U#,$D^^_H[WH!U=Z M%PK62+93)]LIHR=GDGW$% 5D]:R9Y4R\]4VHJ8*,FVOR^_TE< MLCX7"M:H3[>N3]<[&9XP'D^!I)B\*]&==Z_TMCOS\X1&PU'X?,SOLNG4-@VL M7HW5\V)]$ 8P67.6:^?>/7IGG/2[+3"'4:?;=9/U:[*^E^S=RQJ% &<4;E4; M)0@NI#7.*<*T!O=:ZI]0W,11$K58'59T..R[80Y^:#5.3A"4X;^-1BX,:ET4'!(B^PW476^UUD7NTB#6ZG^$0G)-W!H$7K,.KUS]27 M'DDN]0)[==;)ZHWWM?ODB740<>K5P-?EH/)O[$=M-7#9#,^0'>23^O7SZ^6@"N@MH<^D M"7H05.I7U&^3 GHJH3=Q6_]=1LDYX(/.4K_0_AE)CA^">.;30@]Q2 MO]Y^HR(,3@Y0-[33YG49M<\RX5$_5H!:EFVJ1H*-,+M^I1ZM6^'[L@%LC3_8 M%KGL\PYA=OTU=B-++C3)88$AH]L^5E#M6M;=C9'KLNN;2X,]9'FYPC8?E#7 MYPLIS?[&OJ#^Q\'D'U!+ P04 " !BA:)8$(64-KL" Q" &0 'AL M+W=O>.\QW3K51/.@,P MY#GG0L^\S)CBPO=UG$%.=4<6(/ DE2JG!D6U]G6A@";.*.=^& 1#/Z=,>-'4 M[2U5-)6EX4S 4A%=YCE5+W/@ * M.+= 2./'#M.K75K#P_4>_<;%CK&LJ(8KR;^RQ&0S;^R1!%):B>M/G71X.#,+PB$&X,P@=[\J18[F@AD93 M);=$66U$LPL7JK-&$"7+'.$<0/?4-4K+ ?KQS/Z_Z#FON@-;?7><'E"Y9>C+6@ MV*HTQXJIPND&#LCVFTT4="93?]/@?5A['[9[?RZP0V#JTM+83$$CFW/L0+;' M)7@@4Y)B9BDG+T!5$\_*8[=_P'/0&37S'-4\1ZT\6V]G$XE6N'_\I..:[/A5 MRW'\"MPG-??)?R^(25/AAG\4A'_0QG-0:S>L-+HMA:DZ>KU;S\/+:@S\4J^& M*;;!-1.:<$C1-.B,\.:H:D!5@I&%&PHK:7#$N&6&,QV45<#S5$JS%ZR#^B\A M^@E02P,$% @ 8H6B6)3"DXGA P CPL !D !X;"]W;W)K&ULK5;;CMLV$/T50@V*7<"[NMFRO;4-["5M S2MD4W:AZ(/ MM#2VB$BD0M*7_'V'E%:KE6FA#WVQ16IF>,[1S' 61R&_JAQ DU-9<+7TB HYOMD*65.-2[GQ52:"9=2H+/PJ"Q"\IX]YJ8??6UTP M#FM)U+XLJ?S^ (4X+KW0>]GXQ':Y-AO^:E'1'3R#_E*M):[\-DK&2N"*"4XD M;)?>?7CW&$;&P5K\R>"H.L_$4-D(\=4L/F1++S"(H(!4FQ 4_P[P"$5A(B&. M;TU0KSW3.':?7Z+_;,DCF0U5\"B*OUBF\Z4W\T@&6[HO]"=Q_!4:0A,3+Q6% MLK_D6-M.IQY)]TJ+LG%&!"7C]3\]-4)T'#".VR%J'**^P_B"0]PXQ)9HCJ*:KA92'(DTUAC-/%AMK#>R8=Q\QFZC/BRZ< M%Y./@NM>Q__N'@_ B5L] M8QLO'M3S@U61H$3D?:VL(G_?;Y26F+;_N%2KHX[=44TMWZF*IK#TL%@5R -X MJQ]_")/@)Q?E_RG8&P'&K0#CH>BKWP6_J9.(:'HRE;['1+%2"*N-A()JR$@J M(6/:F4+U"8D]P?2APRH*)Y.%?^B2/#>*DZ"U>8-]TF*?#&)O/MM6BI+HG,F, M5%3J[Z1@J?F&9 O@Q%M'G73Q1GVXYS9QQ^8-W*2%FPS"_06[-+DJA,(*Q8Z8 M,54)10M%Q)94$CL]8A^1JJ!C@=1G$<)6ZDLQ;I M;!#INKG.C*(HO9:@F00K\@8X;)DF*6X;Z%@5IM(PD7"KK 1'(VK@=5A<:3-BY M;L-!V/7]8-+!U">*S'?=.]<)-CR#$091'ZO#:'PAOZ*PSA\&LGQ0.JYLHBON]P^^,-B7(G9WX%-;0GNMZ2&AWVZGRWLY2 MO?T',VW:D>DU3#VJX@BP8UR1 K88,KB=HHBRGO[JA1:5': V0N,X9A]SG)A! M&@-\OQ5"ORS, >T,OOH74$L#!!0 ( &*%HEA3=DNW7 ( +L% 9 M>&PO=V]R:W-H965TV&V,.D:F/P@'APDYO&FF,'VVVW?\^UG6;=U!4>>$G\<<_Q.=>^=[Q5^M[4 MB!8>&B'-)*JM;<_CV!0U-LP,5(N2=BJE&V9IJE>Q:36RTH,:$:=).6[,W!N=DJ=2]FUR5DRAQ@E!@81T#H]\& MYRB$(R(9OSO.J#_2 ??'._8OWCMY63*# M:%#F;5TPR_*Q5EO0+IK8W,#GQJ/)#9?N%F^MIEU..)M?R4(U"-_8 QI@LH0[ M6:"V=/WPM 4+9;C+NH$/<'*!M"W,NW%L28"CB8ONL%DX+'WEL RNE;2U@4M9 M8OD<'Y/P7GVZ4S]+CQ)>,SV ;/@>TB0='= S_W=X=D1.UBO.C8^SY956AKTFPY%\SBW#"Z$U!B[I :0^^ET Y# EU'6>3)X/TC"YC ML^_KE;"S/BPHCO?JH$&]\NW!0*'6TH9'U:_V'6CJ"^_%^HPZ4V@D3S2AK=&3 M67&J X$542:#,ZIK'5I%F%C5^FI;*DNUZX&)# P [P@ !D !X;"]W;W)K&ULK591;]LV$/XKA%8,"9!&LF3+:.EL M$:%(C:3L]M_O2-F:XS!&'O8BD<>[C]]W%.\TW4KUI"L 0W[67.A94!G37(6A M+BJHJ;Z4#0A<64E54X-3M0YUHX"6+JCF81Q%:5A3)H)\ZFQW*I_*UG FX$X1 MW=8U5;_FP.5V%@R"O>&>K2MC#6$^;>@:'L \-G<*9V&/4K(:A&92$ 6K67 ] MN%IDUM\Y?&.PU0=C8I4LI7RRD\_E+(@L(>!0&(M \;6!!7!N@9#&/SO,H-_2 M!AZ.]^@?G7;4LJ0:%I)_9Z6I9D$6D!)6M.7F7FX_P4[/R.(5DFOW)-N=;Q20 MHM5&UKM@9% ST;WISUT>#@(0QQ\0[P+BXX#A*P')+B!Q0CMF3M8--32?*KDE MRGHCFAVXW+AH5,.$/<4'HW"589S)/U EF%AK<@>*/%14 7E/YE2S@IS=@*&, MZW.T/#[<)PTO>GN,?UTMM%'[#?_O2U<$-_7#V7E_IAA8P"_#B:E ;"/+??QNDT1\^ MK?\3V#/EPU[Y\!1Z_B>6(28*60.AQBBV; U=] M#,YE00V45D-#E6$%:Y"U6!,-1:N88>"] MT>HP-J[P>CR1%_G]-PY*>?]O33 M-Y_!!N_S_@#04F,==;>YDKP$Y>6=>A(?I=D1\9=>\23))G[FXY[Y^"3SK@QM M727&A-,-*&PLSXAK@IU)&ZP[]@3.V-Y\[I,R?I'=P7@29=E@>*3&YYBE:3J. M_(*R7E#V!D&P+P<-?O^'8AS_4G).5;?HK%XIW3[C0X:7D_1(AL\I/;X,X4'O MJ$&M74O5R*L5IJNXO;7OVM>N61W9Y]C-N^;['TSW*X#U=,V$)AQ6"!E=CC&S MJFNOW<3(QG6HI338[]RPPC\24-8!UU=2FOW$;M#_X^3_ E!+ P04 " !B MA:)89'R>U(X# "#"@ &0 'AL+W=O2]:W4-A [*5I@MT@W37LH>J"EL46$$E62LK?_?H>4 MK74>3>3Z^4D, '6XT\& M.W4T)D;*2H@G,_FUFGF!800<2FT@*/YM80F<&R3D\>\>U!OW-(''XP/ZSU8\ MBEE1!4O!_V*5KF=>[I$*UK3G^K/8_0)[08G!*P57]I?L]KZ!1\I>:='L@Y%! MP]KAGW[9)^(H ''< >$^(#P-B%\)B/8!D14Z,+.R;JFF\ZD4.R*--Z*9@:BJ!?""WC/<:*G)Q"YHRKB[1]OAP M2R[>79)WQ"?*^"G"6O+8,JW>HQ''?]2B5[2MU-37R,S@^^6>Q6)@$;["(B*? M1*MK1>[:"JKG\3XJ&F6%!UF+\"S@)RJO2#1Y3\(@C!U\EF\/C\[0B<8L1Q8O M>GN6_[Y9*2WQ*_['E:X!+G;#F:M]K3I:PLS#NZM ;L&;__C#) U^C\O@<^OPWK$2L+44#A&HMV:K7=,6!:$%^[^D3IF.)A8F5E).ED)V0U-QN M5TJ&?5*[CRE.VWF4A&$V];?'6E]ZA442Q:/7,Q')*"(Y*^(C*'4]RN!&PO=V]R M:W-H965TTN@L-* MU5; 7%PDVEBK6,'VVF6?X\_TM NV6H/7!I[/._YO>EXDHZ+!UD!*/184R93 MKU*J6?B^S"NHL9SP!I@^V7-18Z6WHO1E(P 7%E13/PR"N5]CPKPLL;&-R!+> M*DH8; 22;5UC\7L%E'>I-_6.@7M25LH$_"QI< E;4%^;C= [?V I2 U,$LZ0 M@'WJ+:>+=6SR;<(W IT\62/C9,?Y@]E\*5(O,(* 0JX, ]:? ZR!4D.D9?SJ M.;WA2@,\71_9/UGOVLL.2UAS^IT4JDJ]]QXJ8(];JNYY]QEZ/S/#EW,J[2_J M7.X\\%#>2L7K'JP5U(2Y+W[LZW "T#SC@+ 'A$\!\3. J =$UJA39FW=8(6S M1/ ."9.MV\$(V.(?4TR]4@CB E[U^-9T''\>\_B>R,^?QX#R^Q)Z==8SL.X8P MM[P:L^[X9I;/C)I#%GT(YO/$/YQZ^C=K.HO"ZR'+B?5/^K\&4=JQ(%'.6Z9< M,PW18?(L[8-[$E_IB>0&R%\:-\YTJY2$241AKRF#R;76)-R(&PO=V]R:W-H965TF%L 6HL24J"\-V$9Z MSROIZ)$YDST77^2:$ 6^YAF34V^MU.;2]V6R)CF6%WQ#F/YER46.E;X5*U]N M!,%IT2G/?!0$L9]CRKS9I'AV+V83OE499>1> +G-KDC&]U,/>L\/'NAJ MKE0M/B=DKT\N 9F M* O.OYB;C^G4"XPCDI%$&0FLOW;DFF294=(^_JE$O3JFZ7AX_:S^H1B\'LP" M2W+-LS]HJM93;^2!E"SQ-E,/?/\KJ084&;V$9[+X!/NJ;>"!9"L5SZO.VD%. M6?F-OU83<= !H98.J.J "M]EH,+E#59X-A%\#X1IK=7,13'4HK\V8\_P#CX MV6%S4-L@@>\*]&,!$TPIUG2UD_:*^EK52ZMFI!3AT@O=,/E4BAPL; MM*RI93)T0[D+GBK);_@$80LFH&4T=$/Z-*#@,:'1"(U';9EM&0W=D&[,[-N[ MVWFC"Z=6UURQ&(?#WK+:>2)T=6K!#]WD/S.K1R\Y=J%E.G2RN%MFCX\S.X[# M9BO(8ANYL7TZL]$QLT<0M24VLLA&79 M*?;O<4*7-&DT\QK81A;;J#=LH]? M-K+81GU@&YV-;62QC?K'-FK =@2'<8L7RVWTO=Q_6D0;WN"6TY3;JP.V& M%\X3[RGN*%W3R!(=]49T]!I$1Y;HR$WTL]X_T3'0T2B$01M&+=&1F^@O6.VV ML]L=H>/\A?8@"(/>_JD[CY2N3NW!$;H/CK-6NM(X7.DX&@]:Z!;:$R!T:.U'4:#RHS_95F7J,V$]H3)>RA.A,>EV=@' Z.2@3^0350%Y&ULM5AM;]LV$/XKA%8, M+=!&HB3J);,-)#;:!>BVH&F[#\,^,!)M$Z5$CZ3B9K]^I*1(MD49*Z(@0"Q* M=P^?YW3DG3C;<_%-;@E1X'O!2CEWMDKM+EU79EM28'G!=Z343]9<%%CIH=BX M0D$6<^=*WBY]#WC4%M\I60O#ZZ! MD7+/^38UW2NBG5/NIQ0?.\SUE#. R!W^H+1'@IE2XW-![1L"5E$1)\ Y\$%Q*L,1" M/-)R ZX*7I7Z@7&ZRK*JJ!A6)#?WA:+_XOH-Z1P#*[*F)57D'=,O*[= OUX1 MA2F3;_0D7^Y6X/6K-^ 5H"7XO.65U/ARYBJMT[!ULU;3=:/)']'T&Q87((!O M@>_YH<5]>=Y]1;+./3AV=W5TNQ#[78C]&B\8P7O?1.#C2 3^^JCMP8TBA?S; MIK4!#^W@9I5?RAW.R-S1RU@2\4"=I;>L=R^]H3 JV[U"F$U5 L6!WLB9C?%9R!_-]HG CM3'G?KX)5=] M/&4<)@([BD/2Q2&99M4G@R1,PL!/T4FNVLP@BGQ[KJ8=RW2R-9\.&/@H"*/P MA*C%+ R2>(0H]/J"[3USU;< AU.C)$T">,+09I?&43JR[N%!3P'/4OPL<*Z[ M3=V)OC5=0!U8'9 HIDVY(SOGFT:C@[PX\N@*G0CN/1-P#P13L M.&D+,!7:<2SZ)@!.U 6T.(?9":,@2 =9;+/3?\%(%O=M )RN#X##"H_B$ ZX M6LQ0$J&PIJ-D4$^M5NE8.>T+/YRN\L-A34(_4$L#!!0 M ( &*%HE@;N_!.< ( .,% 9 >&PO=V]R:W-H965TX76U:7OJZS DJA342$W M-RLA2Z+-5JY]54DDN0.5S ^#X-PO">5>FKBS6YDFHM:,4LMO$NX"O% M1NVMP3I9"O%@-]?YV NL(&28:#,V3,$AD9/SM.KW_2 O?7._8/SKOQ MLB0*9X)]H[DNQMX[#W)7+!%/N%YHN-O @JY469084#8 <+'@/@)0-0!(F>T5>9LS8DF:2)% ])&&S:[<+EQ:..& M7PI1"U,H0J\;71:%_RLT[/M-43/J$G M@AO!=:'@BN>8'^)]XZTW&.X,3L-G"6^(/(5H] ;"((P'],Q>#H^>D1/U^8X< M7_22?/^;Z3E5&1.JE@C?)TNEI2GS'T-9;%^)AU^QK7^I*I+AV#.]K5!NT$M? MOQJ=!^^'4O"?R X2$O<)B9]C3P\J"]O*&C+BC\ZF98.W ^4O3CC]3-VO* M%3!<&2C*@ TV92\4B.GT'IQ[KHJ*Z"D MZDPLH,*>F9 EU5B5.9X" 0Z:- L7?"JZ =T@1N MEY_5)]8[>IE2!5>"?V>Y+D9.XI <9G3)]9U8?X3&3VCT,L&5_9)U,]9S2+94 M6I1-,!*4K*K_=-.LPU: [^\)\)L WW+7$UG*,=4T'4JQ)M*,1C53L%9M-,*Q MRFS*O9;8RS!.IQ^$R->,2JR7 M0FKVA]I%/AZ#IHRK$W)$6$6^%F*I4%D-78VP9DHW:\ N:S!_#]@-E6( M[_D#\G _)L=')R]E7/3:&O9;P[[5#?;H3EC%-)Q^PK.0[]KJD<^@>R\]O=]@ M!BCHD0E3&>7D!U!);BB:9_J)_+R8*BWQH>8_P IJS2A$.,XSS MSF(T*NL[OJYHL;#WZE1HO*5ML&ULM59=3]LP%/TK5H8FD$;SU78;2R-!*P82: C$]C#MP4UN&PO'[FRW8?]^ MUT[(4BU4,'4OC;_.\3W']KU-*JD>= %@R&/)A9YXA3&K$]_760$EU0.Y H$S M"ZE*:K"KEKY>*:"Y Y74"2]-W-B-2A.Y-IP)N%%$K\N2JE]GP&4U M\4+O:>"6+0MC!_PT6=$EW(&Y7]TH[/DM2\Y*$)I)010L)MYI>#(=V_5NP5<& ME>ZTB54RE_+!=B[SB1?8@(!#9BP#Q<\&IL"Y)<(P?C:<7KNE!7;;3^SG3CMJ MF5,-4\F_L=P4$^^#1W)8T#4WM[*Z@$;/R/)EDFOW2ZIF;>"1;*V-+!LP1E R M47_I8^-#!Q .GP%$#2!Z*2!N +$36D?F9,VHH6FB9$6478ULMN&\<6A4PX0] MQ3NC<)8ASJ2?I^'0W? 99"X^WX3Z:TCH3MT0PF'CX^#6H#7OKV33@./O4IWQ/9E@]QZT.\BSWM'#UW M7K _7E#G19_\FC,,'*E-)9LT_!@,HL3?=(7MW/H?A0U;8<.=PB[D&I\XII*I M+.=,4)M6^J3L9'GM2>Z);$OPJ!4\^I\W>K1/'_9$MN7#N/5A_,(;?5S?:*-H MCL41"V>?[IUDK]4][GL7<>==U(K\3D:WU11SXY()33@L$!<,WJ-_JJY0=(\UPAIP=*7OG.T($^)XF&9];.R'V][;-PQU),1_1/4( W8!BZ/.2"!PG_(M\^+9:@L^? MOH!/(,[ MQW-.N1//T:"K=[OD> MAV1NR7SBA!V(M?CQ!Q3 GW52!P+K"'=KX:X)??%'+KB0GS#.MN !)S@+B4YO M"1(4(&HU."S&P31PG9E]:"O1F/E^@!JS#D>OYN@9.3X3SN]E/LI/%'.>*XX@ MI%QHPZZ$\EL4[I#G>CVB.BO?\_4\_9JG?P5/OJ-,W G"4B#?J\Q;QE1$[>6H M6JMD4B4TVY8&2I-6A7_*SQF/I[ G0V?F>IZGUQ'4.@*SC@X_';W@]#M[T(.3 M'CV-F0L#E; Z>N.:WMA([Y4<:'(@3$?,Z'EK7@X$UA$YJ45.!EV0)D,*'PBL M(WQ:"Y\:O^Y3)B./< %>L= N1:4[0JVH@B/H]T*OLG)[5NA,["'8U$@XQ()9 MH;1CWT<3&/1H:LQ<.(5G$ABU*CDRLGP;K4;@FTKA9XHS+4$CP*T1,Q1:5VY3 MO=&PY1L-6K^'0NN*;RHX,I?PBQE3^?>3(?#[5?&GYM M"GFG*>2/?=@O@CH[V7/X\ S/IIPC2$+W132MZ;E]HA'NYC :"*V[BVRZ P<. MNX\T-ALW;R0'0NN*;YH.Q]QT7,RARO\D.9Q^6W2%89=C:Y]O+,;79E&%TLD. M5?OZ/"^9=5DV)=TQE_0'G+T#-8K6GU*:5 M>8:;(VL@M.[[:#H&QQLVK8P-R,WB!T+KBF_:$,?&PO=V]R:W-H965T,!;C")5$KT0[+; _?BE9,46'9J3=TXO&ELV']'ND MESHDQ:MG67VKGX10Y'N1E_7UY$FIS>5T6J^>1,'K<[D1I?[D458%5_IMM9[6 MFTKPM"U4Y--P-IM/"YZ5D\55>^QSM;B26Y5GI?AZ%^KKY7.EWTP,ES0I1UIDL224>KR:-#_E0D'0[_MU!)X.3;7'V1S[^)[@Y?7/^NC7>TK>_?3SU53IFIKO3U<=]79/#4]0(_)) MENJI)JQ,16J7G^H6'IH9OC3S-O0"/_'JG$3!&0EG8>QHS])?_%YL=/%96SQR M%*?^XE2L#K6[BK/AQ4-/,**#9E'+BT_P[DHE*E$KHB43I'[FF_K2I9&7TF2@ MRWK#5^)ZHE-,+:J=F"S^^I=@/ON;*\!(&$7"& AF21$?I(A;>N2[?.[*6E5; MG3T5^>='_05RIT11_\LE28R4! FC2!@#P2Q)DH,DB??JH*+*=OM.,E++IEWA.>"&WI7)IX\6.U68/F[>PIK/>+:)9]^]JNNL''EDM \&LP,\/ M@9\/#;S.3P5YEY7DA^!5[>Q O*RQT?8W+-HWPW76(UO!0# K^!>'X%\,#/X9 M>$DXVH5CI-.07Q\L<*LH<%4>_\GYW/HGE\=/(C*V4@F!7_ M]X?XOQ]Z\N]XI?-.+D8K\-X9M"2R8[;T-F1LVD?"& AF"?#A(, 'KP!_J"=1 MD9NZ%LIUI=]Z2X\]O9$PBH0Q$,R2()@9,S&#W@YU.) J4!J%TAB*9@O3(.W+.^P[ YUN% :A=)81TMZP;[P1=I8W,!O);^>WY^_T0- C2V41J$TAJ+9 M4AC#&UQ@>P"HP872*)3&4#1;&..$ [\5'MD#(!WH$DJC4!KK:/VD-'\U)FC' MW)C?P.]^A_8 4!<,I5$HC76TH3U :"QNZ'5JBR]B)_.=J%SA]1<=&UXHC4)I M#$6S13!V-@R@N3]$VM4EE$:A-(:BV<(8AQSZ'?*XW.^'C98%ZI:A--;1^G?_ MB3_WA\8*A_[IX&4ETDR11[YJIKH(KU\&F?E:$/FH>X.REGF6B?!MY?)76;]O?=@MRJ6O$R;?KBTVL?.JQCO<)Q M'H+Z7BB-H6AV[(WO#?V^MY>LWIJ,])-&7P]0TPNE,13-UL3XXO #-E%!#3*4 M1J$TAJ+9*QB-C8[\-GK@_9&?,GH-(]110VFLHSGF!]RWHI$QRY%_[O=&G_FI MOO7O?,*OVH[E)PR9GS0ZW%"?#*4Q%,W6Q/CD*(3FI0CJE*$T"J4Q%,T6IK>T MVF^F7P8PLE+?/_&Z6<0U<####QXM$7:]-7;!=?3*/;Y>W&K'W_CF".*;_931 MP8:::RB-1:_GC8(.LL,I5$H MC:%HMC#&;4=^M[V419&I5I-'(?I#WF^/;7?HH-^#S2LK3^8MJ+^&TBB4QE T^[$TXZ]C[$KL&&JTH30*I3$4 MS1;&N/'8[\;_G[S5H8^?$)D%QVG+WX;1\8V.GR%<^ILX6AZH M>T?1;'F,Q8_]/O54LG.&&VKNH30*I3$4S1;%&/X8.WD>0[T^E$:A-(:BV<(8 MKQ^_,7EN#XB-?7PW=C_T/ ^.\Q74U$-I#$6S%3"F/G[+U%<;V8;[5NK;L7NQ MVE:9RH1S#-C/&GU=0)T^E,90-%L5X_1C["1Z##7Y4!J%TAB*9F]T8DQ^XI]$ MORO3K58ETQU\*G8BEYM6GTJ_+K>"/.AKR*5/XIAJ=NY-LO37/S;V@^MEJ'KM MN!J/GO@]^BTOOY'F8'\A5>,/9;NNI^T=Y$.>K7FSJ8PS.?EK&'L-0&D42F,H MFJV5\?,)=B8]@7IV*(U":0Q%LX4QGCWQSZ3_KTL1D]>SRXD[.4%M.93&4#0[ M]L:6)WY;_D4T>T0V<1ZV=J'#63/ZL3OH4+,-I3$4S0YZ;]^Q(8O5FU"_GA(9 MLGK=CQ^=F: &'$IC*)HME#'@"=: )U ##J51*(VA:+8PQH G?@/^M=S6(AV: MLUXO68_C$ST%U'%#:0Q%VX=\VML)MA#5NMV"MR:KIK/=[[9Z.'K8YO>FW=SV MZ/AM<+G<;]9K,/N]@S_Q:IV5-K']FR2"['JV,R^@6Z_?M=.R "E: ][(;9SS_$Y)_AZ MO-7FQ18 R%Y+J>PD*!#7HS"T60$EMY=Z#8K>++4I.=+4K$*[-L!S#RIE&/5Z M25ARH8)T[-?N33K6%4JAX-XP6Y4E-[^F(/5V$O2#W<*#6!7H%L)TO.8K> 1\ M7M\;FH4M2RY*4%9HQ0PL)\%-?S1+7+TO^"Y@:_?&S#E9:/WB)K?Y).@Y02 A M0\? Z;&!&4CIB$C&SX8S:+=TP/WQCOVK]TY>%MS"3,L?(L=B$EP'+(2O30Y[ .+I!D0-(#H&#-X MQ T@]D9K9=[6G"-/QT9OF7'5Q.8&/AN/)C="N:_XB(;>"L)A.H<%LH_,/QY M'^?L_.R"G3&J M?"IT9;G*[3A$4NGV"K-&T;16%+VA*&9W6F%AV1=%6Q_B0W+76HQV%J?12<([ M;BY9W/_ HEXTZ- S^W=X?$).W"8>>[[X5.*FB1IV48NWHFXJ1EU!UAL-NC=R MYW]DUSR#24 'W(+90)"^?]=/>I^[4OA/9 >9#-I,!J?8TV.W769KAL0SN-ZT M2?O]Z#H:AYM]%QU5\?55TE8=R!NV\H8GY=V4VJ#XS7WCT4MJ$_0)A;455QFP M3%OL_)_7I,,]+?$P/M)[NN9 ;=*J34ZJ?=+(99>>I"/!)!X>*>JH&D31IR-- MX5[+*<&L?">VE$6EL#Z:[6K;[&]\CSM:G](E4/?LOS3U#4(';R6491*61-F[ MO**43-V5ZPGJM6]L"XW4)OVPH(L,C"N@]TNM<3=Q&[178_H'4$L#!!0 ( M &*%HEB)AGO>'08 "0B 9 >&PO=V]R:W-H965TB1MM_OU MHRX1+8FBG4S-2R+)AX??.2*_[Y#49,_X9[&F5((O29R*J\%:RLWE<"C"-4V( MN& ;FJI?5HPG1*I;_C@4&T[),F^4Q$/D./XP(5$ZF$[R9S=\.F%;&4% M;).$\*]S&K/]U0 .GA[<1H]KF3T83B<;\DCOJ+S?W'!U-ZR\+*.$IB)B*>!T M=368P"9M?*67>2YR5NK:*(T>XUWDJM?(]5.3F=AN$VV,9%T M"3[*->5@P1(U(-;9F]I1\#X-64+!.9A]7+P'MS2,B1#1*@I)]A8$.+NFDD2Q M>*M,[N^NP=F;M^ -B%+P:'%O@X"KG./>'NW*>I7(F M)8\>MI(\Q!1(!FX(IZE\!WY34Y>MP"?R!?QYR^(8J-&Z)WSYERF/13^NN9^, M 2[%AH3T:J#>J*!\1P?3[[^#OO.#*0D].:NEQ*U2XMJ\3^?T,4K3*'T$9+@[#,3:U0L#\:I /&L@Q1P*:W/H+&9"39"H MF$H/5)$O;4\E4\1%7]YAQ B.1J-&P%XK,="#8Z>RJD7B5Y'XUDAF"=NF4BBN M?@*J*&+%69)3@0FMWT(+7=R VK;!OAEG4.$,K#AO:<%>4LT84F V@0O:J1RA MH('.8 1];,8WJO"-K/@4B1T9UR-#KZX_'C716?MYX;@>5U&,K5$LMESQ4_@5 M?.(D%7$^9,%L^;=2*"7JYI1;/3Z7G7IR5@L>.EHEG5>B[+*CGK+2E[=Z6@Z* M!_C_:;OT41_?T'-AEIT10'M)<5IM&LJ*]38;1:/)CO7&W>QE"X8 MH+UBZ)ESQ^W"$;58HFUTCMR.^@UI\4=6%7T!WY8.:\SO-=$:C((.OD!:D9%= MD4^D7&34Y*: &:S<#BU&6HN178N/TRXRZ"MT\,AMPC/8N0'J0JCU%=GU]3[E ME,31ORJ-9[_F _9G$J79IL9L1Z(XXZ%S-7+/P1U1C'1'PRV/9$3-B>YUB=Z7 MMWIBM)XC]Y7H&/6T1B_3\BU6_$@7$LA>2)Q$QZA=(N!6'6$P4@7'P<"O(]15 M!+)7$?UR,6HOXOU6)&T;UT<=<>AZ -G7^B]@8L.2OKGN,-FX'>4ETB*-[")] M*A.;9!HV$1J,#G:!Z@BU0B.[0I_ Q ;5#9H%A,$H6]]U)!!KV<5VV;VF/-H1 M6>Q""\FWG1L-=D?/W@?]%FMJK!4ZFG190.VEPTGD2PV MK;B=YGPW6'4-UH,M?7O-T"_#XO9B'#MNEI]ZC#+#_@;S^?P&PO=V]R:W-H965TOFEII(R%0MK$0"8L5-3]>HW,E:4\6M M,VD3F9J0%P%4R2B)XU%4<:%8EH:]6\I2W5@I%-X2F*:J./V>H=2[">NSP\:= MV)36;T196O,-+M'>U[?DK*AC*42%R@BM@' ]8=/^>#;T_L'A0>#.'*W!9[+2 M^M$;7XL)B[T@E)A;S\#=;XM7**4G]IRL"^F!Q^L#^W7(W>6RX@:OM/PA M"EM.V$<&!:YY(^V=WMW@/I]+SY=K:<(7=JWO*&:0-\;J:@]V"BJAVC]_WM?A M") DKP"2/2 )NMM 0>6<6YZEI'= WMNQ^45(-:"=.*'\I2PMN5/A<#:[YH+@ M@_C.B;@O&9S/T7(AS06<@5"P$%*Z@IHTLDZ IXGR?;!9 M&RQY)5@?%EK9TL 756#Q+SYRPCOUR4']+#E)^*U1/1C$[R")DP'<+^=P?G9Q M@G?05640> ?_K\I@S2 M%EGV]DU_%'\^(7C8"1Z>8L^6#1&ZHA(6P%4!4CPUHN 6_7*-[MI9OU>Y_2:'NL+#IJM@II$T;*0*X;9=N^ZW:[J9VVS?K7 MO1WY!:>-4P82UPX:]SY<,J!VC%K#ZCJT[DI;-PAA6;J7!\D[N/.UUO9@^ #= M6Y;] 5!+ P04 " !BA:)8P46CQ,4" "+"0 &0 'AL+W=O8\/7$<\^4$C%4^LL041+DB>J!N^OL JH8'A"WDBBU]8 M5WL="\)<*IY68*T@I:S\)YNJ$ V YVT!>!6@*(1=!BI43HDB@2_X&H39K=G, MH$BU0&MQE!E7;I70JU3C5'"!T9*R)9R:ZE!%4<('N.:F8B2!TY3G3$G@"[C6 M;XBN@\Z2P:=-&!.V1#!HA!F7U D[$]1$9K( ]@#RN!;S'-)6"1]6VFM)J(= M5KK.2EW>%EU71!Q!SST$S_'Z<'<[A?V]@W]I;)UJG:]7Y^L5O+TMO%,4=$7, MFP _O^HUN%28RE]M DNB?CN1.2TG,B,A3BQ]'"2*%5K!^W?NT/G8(;-7R^QU ML0>U Z1PH$U>23 L",S96P6#H>,XOKUJB=NOX_8[XU[AAH:$P0PE;PO:B7YA M30:UML&NK!N\@@7 MUF1<:QOORKKQ&\@\KF4>O]:ZXV?6C;QMSKG.TR7L= 8^CRDCAW"?ZZ-W@TS? M\W/:>F=VTKRP.FZC5[B[LK%BVK'2IUO>[;R=_\?)BJ%Y@8[&SZRT&ZW5?*;H MOJ3[I80$%QKF'(WTJR#*SE].%,^*;COG2O?N8ACKKR449H->7W"N'B>F@=?? M7\%?4$L#!!0 ( &*%HE@7UT]@[@( (D* 9 >&PO=V]R:W-H965T MU3Q0*X,9P(> M%=&K+*-J,P(NBZ'7\G8-3VRQ-+;!CP6FN70N_9("G.ZXN9)%G>PY>E8OT1R[7Y)48[M M=CR2K+21V5:,$61,E/_T9;L.>X+6*4&X%82O!>T3@F@KB!QH&9G#FE!#XX&2 M!5%V-+K9@EL;IT8:)NPN3HW"7H8Z$]]!NF!B06[M<3 M,)1Q?8&MS],).3^[(&>$"?+ .,=MT /?8!36RT^V,X[*&<,3,T;D00JSU.23 M2"$]U/L8?840[A!&8:WA U57)&I=DC (VT?B&=?+IY"C/'#RJ":M8*JE"2(K?#8ZOZQ1:LUM7>YKW.:P-##RZI!K<&+ MW[]K=8./QX@;,CO@;U?\;><>G>"?@&+K\O3\^()]Y-Y IG\>8VXWR=R0V0%S MIV+NU.[Y'K,!E9%SO"$;H$I?',.N]VJ1S-Z/8XBUPO]$[%:(W=JP[@62@38$ MOPQ =$'SX^>XUN6M>]J0V0%PKP+N-76.>TTR-V1VP'Q=,5\W>(YKO=Z*71]8 M5(91@WA3(=[\*R)G=,8X,YM+(J1-*B@G-),K88[1UMJ^E;8TZSHSFVBMXR@( M!OYZ'\S?>]4S4 N7[&A\1C# \G6L6JM\ZM:E$:_:1YAGE6G17YLR2<.G$U]_ M33C,T3*XZN$71I6)3UDQ,G>YPTP:S$1<<8FY(B@[ /OG4II=Q4Y099_Q'U!+ M P04 " !BA:)876LG$-\$ !Q'P &0 'AL+W=O<+']ERI=,+]G2\IDNX!_UI?2?-F5U2YBP&KIC@ M1,)B8EVZ%X$[2@59B\\,-FKKF*13>1#B2WIR,Y]83CHBB"#4*8*:KT>8012E M)#..KP74*OM,A=O'S_3K;/)F,@]4P4Q$?[.Y7DVLH47FL*!)I#^*S3LH)M1+ M>:&(5/9)-D5;QR)AHK2("[$90 5 F]7T-TCZ!2"SFM[ MZ!:"[FL%O4*03=W.YYX%SJ>:3L=2;(A,6QM:>I!%/U.;>#&>+I1[+0CD/ENJLX@JQ18LI'EJ^9Q<4R;)9QHEIOF) M#YJR2)T:X:=[GYR\.25O"./DKY5(E&FMQK8V(TW[L\-B5%?YJ+P]H^J06\'U M2I& SV'>H/?;]?T?Z8-V_:A%;YL(EV'VGL-\Y;4";ZD\)QWWC'B.UVT8S^SU M\DY3.-KE?R3G@^2/=+4(,@-5UHFQGBT M.B._&U\C)^^%,FOIG_=&1&XTQ.K?IO63]]!M[B%UUPNUIB%,+&.?"N0C6--? M?W'[SF]-P<>$^9BP E62U.W3%.WC3[]T_SVEUE*HBPE$L+""6!.%E+$Y/+# M[(9H08!*;DRD\8>>]]'/^DC_M1ZGGN>-QO;C=@(:&HTZ]39^ZV /C2L2K!;7 M7AG77FM<;[@&0]4$GLS?O8(SPD$WA:X5<^@:QX3YF+ "5;+1;_,1?_H5M3' M3!,FS,>$!4BP6IH&99H&/\&*\CYZ6R[C>L/^CA6];.3L&%'K4 ^-*A*L%M5A M&=5A:U0_Z!5(\Z06BAC(2>%&IWOMJ!5VZ#K'A/F8L )5LO(J,S(Z.AV-,), M$R;,QX0%2+!:FERGJIJK)JHIKM[4HS*PIX1)HQ/XS9I3Z4_KF#*0T9\:04F-J3%#GA1EU!CUOUXU0 M:^6"MNUM;M<9U/L,L/JL![0J@]WV.CA_3.*"OPT3$T2NB7%ZT(I\)Z]V*LSB M=89*\U%I 1:MGJNJM'9[QW:CT@(L6CU95>WMMM:,T^HM<->/CE$*NU4M[+87P[D?T3"42>KOC#ZP*']S_YU< M"PELR4GN5.$WLA!R0^68" #@"P &0 'AL+W=O!:S:=63<09OV"3N$&[&UQI;$7UBYC)D :IB31,!D$'^*381PY M@9_QE<'2K+2)0QDI=>UL$!P%9 P3.N?V6BW/H +J.K]<<>-_R;*E\%8D40=[8(DDJ0_*L@K02I!RUWYK%.J:597ZLET6XVNKF& MCXU7(PV3[AAOK,:G#'4V&RHAF,5SL890.29#)2V34Y Y T-V3\%2QLT>>4=N M;T[)[LX>V2%,DB\S-3K?BQ7#'9LN(EU0KLM#9*\#D-0!2+Q?9VL -.5DB+>#Y:ZA1$'E ]GUXWOD%[EDDHFY MV 3:Z.PNX(DI: Z# &^8 ;V ('O[)NY%[S=AMV2V%H2T#D+JW=,M0;A0QCPY M^N\7.(><6Q#FQR;VM$WVELS6V#LU>Z<^;NW?F(HOZX6(5KG'Y%\)U:[CN?V8WO=^6W8W.SSWAELS6@M"K M@]!K.[M[;;*W9+;&?EBS'[YF=I?FW97LCKO1TP1OW,$+^8YJOJ-&OC,UQ^\T MU@.?Y()I)=V7#!/]DEH+>B-2H]]SC[8ELS7TXQK]N.VT/FZ3O26S-?8X^E.W M1*^9V)7[ZGL;$_MI9O]M5KGW<*7\7Y639L:KP M%=E(6:SO?'.&)3AH-P&?3Y2RCQU7Y-5%??8;4$L#!!0 ( &*%HE@">2"# MY@4 (@J 9 >&PO=V]R:W-H965T41K=Y;FQ7EO)>7ZY6!0S%,1W\@TR=E4.,4FRZCX\8JE M_/:\AWIW.ZZ2Y4KJ'8/Q:$V7[)K)O]93H;8&590XR5A>)#QW!%N<]R[0RPF) M=(/RC"\)NRWV?CM:RHSSKWKC?7S>&^J*6,KF4H>@ZM\-F[ TU9%4'=]V07M5 M3MUP__==]#]+\4K,C!9LPM._DUBNSGMASXG9@FY2><5OW[&=($_'F_.T*/\Z MM]MS@Z#GS#>%Y-FNL:H@2_+M?_I]9\1^@ZBF =XUP#\U0*2F =DU(*70;66E MK-=4TO%(\%M'Z+-5-/VC]*9,H]0DN;Z,UU*HHXEJ)\2I],"!CM6SC>;MZ0E"C&OUN)4>%RSC>D4%*YRW@N:2Q6=.>=W/G')W M_Y6Z[V)G2G_H/N1<"'72LNQ/9\Z,J:&).>H67;!$;@0[Y "<^LZ!4O*N@-<; MD>3+*1,)C\M2RD+T_1\K?]286% ]JKP5O"@.N>1:+F'7);4N>95+WNE<@E-W MX9)GN81<%-:ZY%?LO*RA43^C96L5=ZQKMAJN@Y MSYCSVP=EW>]GSB)?+@Y'GP365:KO MR&$E.>Q6,AS^L9)#2W(_J!<=5:(CL*HWWS:)_'&FA::;6'?-*1?,@(..6]NW;%TYB)8EM&5<2NAOT2/O/[!0#Y)Y%EE>\'M5:A MH>&,X?.;U9"S>[=V!>S;Y?FHWJX]+$,GL O.^0QV(;MW!4#O,C2(8(K3@\M/ MX\W3.M<.(J>"+Q+YH69ZW 6Y-_("?<6@(X*1KW/Q[8BS0?P!T*S7;C 3P;!W M<3EY;VF;*FK)83Z PSX0$)#A/@33UZ/GRX;XCYTPD8UR?8R]H/[! !F:0S#. M/5X['/_1VGT;8[VA7\\+R( A@M&MFU&]'2YV.*K;1-E'KA^%P UNP!+!Z->- M9>UPLT/+#A IP@1!DZ'!4G0"+FW(^0R6V63:1R3$[K#6,FSH%,.D>,4D5;MB MYPT5N2JD "?<6"V$^Z\:Q=DS8 MH6,V3WI!X(?UDS0V3(EAJ.O&L78@V:%C-H2Z$?()X)@A40R3Z#$KTNT6,%LO M2=NKD^":-#:8BF&,/$93.R!MKTA&T&)1[& M]72 #8-BF <[U]\.1QOTVTB)(X^X]?H-4&(8[O8[,CS+@W$>.LL;BL,GH+B& MG,\P ML4AX+(JY_DB6$XO5,&K D,N=TZ=01@/Y53D?5)&B*' M'O\'>Y\)ZF\T/U*Q3/+"2=E"M1R^")398OO9XW9#\G7Y">",2\FS\N>*475? MZ!/4\07G\FY#?XQ8?7PZ_A]02P,$% @ 8H6B6(@WX'=J P L!8 T M !X;"]S='EL97,N>&ULW5C1;MHP%/V5*%VG5IH:0M9 5D#:D"I-VJ9*[ M*D,V]>)TT&A5IS>SBE5 MSC+EHABZD4M*X@)(*?>ZG4[HI80) M=S00B_0Z584SS19"#=VH;G+,Y6,\=/WPK>L8N7$6TZ%[?_;ZVR)35Z\<M'!=36&28?[2>_41L5[>XGOD,:$^YO"9>]3 MK6-XIQ@MLOOY_?,7ZJC!_N*IU[%XTI/3V((*1O:MY!85(W;M43?#5G&]*H5' M@R03328'KFG0^B2ES@/A0W=,.)M(!JR$I(RO3',7&J89SZ2C]!;2 7UH*7X8 MV#>R\1'D M5.6[5:X=SB19^=U+MR&4%QUDDLF8RCJ,[ZZ;1@-.$[ CV6P.5Y7E'H!*9:DN MQ(S,,D%*#VM&5="R4\KY+=QZOB8;VLNDM7)EMHBZJ U512-C*J#?5C/:;=GP M6;I.SAXR]6&AAR/*.B0XO9$T8K]YS-1$K-X/<..!J0 M-<^99Y+]T-$@5::Z@4K7>:!2L6F[Y;LD^1U=JG4Z+1/<<_<(/?_;>9Y1027A M;=,Z]P]YEI_M..B]E.7RKK)MV.JQ.D\0PYV7NQ._M33/K'8+)[D":]ZDS9.KAN'%OK5@=>#X;N%WC=X$U09[)@7#%1 MU>8LCJEX='K5\HI,].OXAK[N'].$++BZJ\&AVY0_TY@MTJCN=0,34?5JRI]@ M>/HHO'XWT;&8B.F2QN.J*F>3LNCH@HY:?8"PC5R7'SN"<0QF1P##XF .,(YA M87'^I_'TT?$8#//6MR)]E--'.89E0\;E%XMCYT3Z8Q]I% 5!&&(S.AY;'8RQ M>0M#^+.K8=Z @<6!2$^;:WRU\0S9G0?8FN[*$&RD>"9B(\7G&A#[O $CBNRK MC<4!!K8*6.Y ?'LXZ&(3([(7SMZX/MDB"( M(CL"F-U!$& ([$8-/E_G;@2=&A(E@6 MFD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L# M!!0 ( &*%HEA*R)QY_@4 $@R / >&PO=V]R:V)O;VLN>&ULQ9O; M;MLX$$!_A?!3"FS6MBS);=$42.M> O02Q-F^+AB)MHE2I)>4DK1?OT,JSHYJ M=[ O$S\YEA3Y>$3.&5[\ZL[Y[S?.?1?WC;'A;+1IV^W+\3A4&]7(\*?;*@MG M5LXWLH6W?CT.6Z]D'39*M8T99Y-).6ZDMJ/7KW;WNO1C_,:UJFJULW P'OBF MU5WX[WQ\*VYUT#?:Z/;'V2C];=1(--KJ1O]4]=EH,A)AX^X^.J]_.MM*LZR\ M,^9L-.U/?%.^U=7>X66$O)8W(1UIYT4O%9N;>%)8TQ*,%-FPWQ2,JA!T"B33)E5GD&-2$FS@3B%=A/DHC4R9/7()0+M\][7=*"\N'016M=K_ M4H!-*9%,F4W2HYVH^QA ]4QH6[E&_2&L:C$BI9$ILT0H\)XA("FEHG+K(IC63,&OG@7'VGC4%M\0)T;->1 M0YQC3$HC&;-&%NH&M[F,')@PFP-,VS5=G_;ZB,4X3?DD_7L<;2YTJ(R+#QI#4@+)F 5R 1VBAOYQ M[66=GK7WD%GVVR%ED.R8(Y'!Z#BC#)(]U5AD5T>+DVL)".$9G@FA3#)C-@E9 M4 \G;"B3S)A-TA?4!Z-'267&+!6RLAY&CYSO8I9*JEW$?F7]$$^,21I,RS8S9-$2!'0.*,2G7S)A=LU^]'NP^E&EFS*89E+&X@ U!0:[$F)1L M9LRRB67LP=A1:IDQJX6L9P>=):?\DC/[9;]@/!3)G')+SCW91=82>!([IUR3 M,[OFX+RF.!4G"P4C9X,Q*=?DS*[9+WE.Q1<))614@@IF!9&CL@46>D$IJ&"?7".6/H;;.B@+%VU75$Q4XO M*0N5S!8B5Y4&;;.D+%0R6XC&'&PZHBQ4,EN(QL1YLZ0L5#);B,;$&X]*RD(E MLX5HS!)CDEO-F"V4IHJ@:(-;U9U1L23N9X_V!NDE9:&2V4(/F/0PJ*0$5#[% MG-MI'[Q=R?ZN=WN )X\Q*0&51YV%P[EH3@EHSBR@WZPJ[YH QJ0$-&<6T(') M0B!T\3H8 ^-M#7-*0'-F 1W&?.Q+&),2T)Q90 25-=>A%?TNZG+"_B#JA59\Q;./;5?G*RWOT08O24'XIM$-!* MLONVG(%]4 ]Z$G%&J$!<_@F?$/#X4@[-N&]/PV[?#8O/X^$TK*K=.':_ZGI8 M[\JQ&>[:KIS.1S9M?VS&\[+?UEVS?F^VI9;E,NK^=D;U]'@[<_'ZU97_F=AN M-OMU^=VN_QS+:?S'X/JC[=^'72ECM7AM^FT95U7]>;CN'NK+)MV=)U>+Y[=5 MU3^_I:J>.T@@2.8/4@C2^8,,@FS^((<@GS\H("CF#\H0E.@^_F#'B#H M8?Z@M$09EP1)$ZP)M$[(=2+P.B'8B4#LA&0G K,3HIT(U$[(=B)P.R'@N!WH)Z"X'>@GH+@=Z">@N! MWH)Z"X'>@GH+@=Z">@N!WHIZ*X'>BGHK@=Z*>BN!WCIY64*@MZ+>2J"WHMY* MH+>BWDJ@MZ+>2J"WHMY*H+>BWDJ@MZ'>1J"WH=Y&H+>AWD:@MZ'>1J"W35YV M$^AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z&VHMQ'H[:BW$^CMJ+<3Z.VHMQ/H[:BW M$^CMJ+<3Z.V3CY4$>COJ[01Z.^KM!'H[ZNT$>COJ[01Z!^H=!'H'ZAT$>@?J M'01Z!^H=!'H'ZAT$>@?J'01ZQ^1G$P*] _4. KT#]0X"O0/U#@*],^J="?3. MJ'Q0X=B^G842S/E_B@1[?=MC4U MKG[H\Y$R^D"VB3NBU'?EJ>C5^>24;YA.G_SB_*G,N<"\&UL4$L! A0#% @ 8H6B6!5#L'C8!0 MR1X !@ ("!#@@ 'AL+W=O M ?$# "J# & @(&4$P >&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6,FQ)%[O!P FB( !@ M ("!NQ< 'AL+W=O& \HP( &D' 8 " @> ? !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% M @ 8H6B6/8_$;"W P . \ !@ ("!'"H 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 8H6B6/;,D90_!0 MJPL !D ("!?S@ 'AL+W=O4V;$$ "F"P &0 @('U M/0 >&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6#147G%>!@ *@\ !D M ("!QT@ 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ 8H6B6.T?1:X1!P @A, !D ("!;5D 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B M6&*3,9[W @ (@< !D ("!+&D 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6(1G&B8U"@ 2AT M !D ("!S'0 'AL+W=O&PO=V]R:W-H965T[) MP0( $L& 9 " @0N# !X;"]W;W)K&UL4$L! A0#% @ 8H6B6'SF7Q) !P ?A( !D M ("! X8 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ 8H6B6";:+PY$ @ B@8 !D ("!%Y8 'AL+W=O M&PO=V]R:W-H965T M !X;"]W;W)K&UL4$L! A0#% @ 8H6B6*6Q M/G4W P $0< !D ("!MJ( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6#QN,IJV P *0@ !D M ("!>ZT 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ 8H6B6&BT.;Q# P > @ !D ("! M1+@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ 8H6B6!&-4"&J P ?P@ !D ("!",4 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6)UEORI\ M!0 8"P !D ("!&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6.7T!#KR P A10 !D M ("!L=\ 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ 8H6B6(637*UA! L1( !D ("!NNP M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M8H6B6-K,4/^P P @A$ !D ("!J?@ 'AL+W=O," 0!X;"]W M;W)K&UL4$L! A0#% @ 8H6B6!@@R&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6%-V2[=< @ NP4 !D M ("!9A$! 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ 8H6B6.BDM6Q+ @ LP4 !D ("!.!L! 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B M6!N[\$YP @ XP4 !D ("!EB8! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6%/)^YQ[! IA8 M !D ("!^RX! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6(F&>]X=!@ )"( !D M ("!MC\! 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ 8H6B6!?73V#N @ B0H !D ("!B4L! 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ 8H6B6 )Y M((/F!0 B"H !D ("!X58! 'AL+W=O&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !B MA:)8SA7,7P\" #J*P $P @ $P:@$ 6T-O;G1E;G1?5'EP =97-=+GAM;%!+!08 5 !4 ,7 !P; $ ! end XML 89 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 92 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 203 290 1 false 72 0 false 8 false false R1.htm 0000001 - Document - Cover Sheet http://www.quakerchem.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 2 false false R3.htm 0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 0000004 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 4 false false R5.htm 0000005 - Statement - Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals Condensed Consolidated Balance Sheets (Parentheticals) Statements 5 false false R6.htm 0000006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Statement - Condensed Consolidated Statements of Changes in Equity Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity Condensed Consolidated Statements of Changes in Equity Statements 7 false false R8.htm 0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals) Sheet http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquityParentheticals Condensed Consolidated Statements of Changes in Equity (Parentheticals) Statements 8 false false R9.htm 0000009 - Disclosure - Basis of Presentation and Description of Business Sheet http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusiness Basis of Presentation and Description of Business Notes 9 false false R10.htm 0000010 - Disclosure - Business Acquisitions Sheet http://www.quakerchem.com/role/BusinessAcquisitions Business Acquisitions Notes 10 false false R11.htm 0000011 - Disclosure - Recently Issued Accounting Standards Sheet http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards Recently Issued Accounting Standards Notes 11 false false R12.htm 0000012 - Disclosure - Business Segments Sheet http://www.quakerchem.com/role/BusinessSegments Business Segments Notes 12 false false R13.htm 0000013 - Disclosure - Net Sales and Revenue Recognition Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognition Net Sales and Revenue Recognition Notes 13 false false R14.htm 0000014 - Disclosure - Leases Sheet http://www.quakerchem.com/role/Leases Leases Notes 14 false false R15.htm 0000015 - Disclosure - Restructuring and Related Activities Sheet http://www.quakerchem.com/role/RestructuringandRelatedActivities Restructuring and Related Activities Notes 15 false false R16.htm 0000016 - Disclosure - Share-Based Compensation Sheet http://www.quakerchem.com/role/ShareBasedCompensation Share-Based Compensation Notes 16 false false R17.htm 0000017 - Disclosure - Pension and Other Postretirement Benefits Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits Pension and Other Postretirement Benefits Notes 17 false false R18.htm 0000018 - Disclosure - Other (expense) income, net Sheet http://www.quakerchem.com/role/Otherexpenseincomenet Other (expense) income, net Notes 18 false false R19.htm 0000019 - Disclosure - Income Taxes and Uncertain Income Tax Positions Sheet http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions Income Taxes and Uncertain Income Tax Positions Notes 19 false false R20.htm 0000020 - Disclosure - Earnings Per Share Sheet http://www.quakerchem.com/role/EarningsPerShare Earnings Per Share Notes 20 false false R21.htm 0000021 - Disclosure - Goodwill and Other Intangible Assets Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssets Goodwill and Other Intangible Assets Notes 21 false false R22.htm 0000022 - Disclosure - Debt Sheet http://www.quakerchem.com/role/Debt Debt Notes 22 false false R23.htm 0000023 - Disclosure - Accumulated Other Comprehensive Income Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome Accumulated Other Comprehensive Income Notes 23 false false R24.htm 0000024 - Disclosure - Fair Value Measurements Sheet http://www.quakerchem.com/role/FairValueMeasurements Fair Value Measurements Notes 24 false false R25.htm 0000025 - Disclosure - Hedging Activities Sheet http://www.quakerchem.com/role/HedgingActivities Hedging Activities Notes 25 false false R26.htm 0000026 - Disclosure - Commitments and Contingencies Sheet http://www.quakerchem.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 26 false false R27.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 27 false false R28.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 28 false false R29.htm 9954471 - Disclosure - Basis of Presentation and Description of Business (Policies) Sheet http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies Basis of Presentation and Description of Business (Policies) Policies http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards 29 false false R30.htm 9954472 - Disclosure - Business Segments (Tables) Sheet http://www.quakerchem.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.quakerchem.com/role/BusinessSegments 30 false false R31.htm 9954473 - Disclosure - Net Sales and Revenue Recognition (Tables) Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognitionTables Net Sales and Revenue Recognition (Tables) Tables http://www.quakerchem.com/role/NetSalesandRevenueRecognition 31 false false R32.htm 9954474 - Disclosure - Leases (Tables) Sheet http://www.quakerchem.com/role/LeasesTables Leases (Tables) Tables http://www.quakerchem.com/role/Leases 32 false false R33.htm 9954475 - Disclosure - Restructuring and Related Activities (Tables) Sheet http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables Restructuring and Related Activities (Tables) Tables http://www.quakerchem.com/role/RestructuringandRelatedActivities 33 false false R34.htm 9954476 - Disclosure - Share Based Compensation (Tables) Sheet http://www.quakerchem.com/role/ShareBasedCompensationTables Share Based Compensation (Tables) Tables 34 false false R35.htm 9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables) Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsTables Pension and Other Postretirement Benefits (Tables) Tables http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits 35 false false R36.htm 9954478 - Disclosure - Other (expense) income, net (Tables) Sheet http://www.quakerchem.com/role/OtherexpenseincomenetTables Other (expense) income, net (Tables) Tables http://www.quakerchem.com/role/Otherexpenseincomenet 36 false false R37.htm 9954479 - Disclosure - Earnings Per Share (Tables) Sheet http://www.quakerchem.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.quakerchem.com/role/EarningsPerShare 37 false false R38.htm 9954480 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables 38 false false R39.htm 9954481 - Disclosure - Debt (Tables) Sheet http://www.quakerchem.com/role/DebtTables Debt (Tables) Tables http://www.quakerchem.com/role/Debt 39 false false R40.htm 9954482 - Disclosure - Accumulated Other Comprehensive Income (Tables) Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables Accumulated Other Comprehensive Income (Tables) Tables http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome 40 false false R41.htm 9954483 - Disclosure - Hedging Activities (Tables) Sheet http://www.quakerchem.com/role/HedgingActivitiesTables Hedging Activities (Tables) Tables http://www.quakerchem.com/role/HedgingActivities 41 false false R42.htm 9954484 - Disclosure - Basis of Presentation and Description of Business (Details) Sheet http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails Basis of Presentation and Description of Business (Details) Details http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies 42 false false R43.htm 9954485 - Disclosure - Business Acquisitions - (Details) Sheet http://www.quakerchem.com/role/BusinessAcquisitionsDetails Business Acquisitions - (Details) Details http://www.quakerchem.com/role/BusinessAcquisitions 43 false false R44.htm 9954486 - Disclosure - Business Segments - Narrative (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails Business Segments - Narrative (Details) Details 44 false false R45.htm 9954487 - Disclosure - Business Segments - Performance of Reportable Segments (Details) Sheet http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails Business Segments - Performance of Reportable Segments (Details) Details 45 false false R46.htm 9954488 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details) Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails Net Sales and Revenue Recognition - Narrative (Details) Details 46 false false R47.htm 9954489 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details) Sheet http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails Net Sales and Revenue Recognition - Disaggregated Revenue (Details) Details 47 false false R48.htm 9954490 - Disclosure - Leases - Narrative (Details) Sheet http://www.quakerchem.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 48 false false R49.htm 9954491 - Disclosure - Leases - Supplemental Information (Details) Sheet http://www.quakerchem.com/role/LeasesSupplementalInformationDetails Leases - Supplemental Information (Details) Details 49 false false R50.htm 9954492 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details) Sheet http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails Leases - Maturities of Operating Lease Liabilities (Details) Details 50 false false R51.htm 9954493 - Disclosure - Restructuring and Related Activities (Details) Sheet http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails Restructuring and Related Activities (Details) Details http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables 51 false false R52.htm 9954494 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails Share-Based Compensation - Share-based Compensation Expense (Details) Details 52 false false R53.htm 9954495 - Disclosure - Share-Based Compensation - Narrative (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails Share-Based Compensation - Narrative (Details) Details 53 false false R54.htm 9954496 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) Sheet http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details) Details 54 false false R55.htm 9954497 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details) Details 55 false false R56.htm 9954498 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details) Sheet http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails Pension and Other Postretirement Benefits - Narrative (Details) Details 56 false false R57.htm 9954499 - Disclosure - Other (expense) income, net (Details) Sheet http://www.quakerchem.com/role/OtherexpenseincomenetDetails Other (expense) income, net (Details) Details http://www.quakerchem.com/role/OtherexpenseincomenetTables 57 false false R58.htm 9954500 - Disclosure - Income Taxes and Uncertain Income Tax Positions - (Details) Sheet http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails Income Taxes and Uncertain Income Tax Positions - (Details) Details http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions 58 false false R59.htm 9954501 - Disclosure - Earnings Per Share - Basic (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareBasicDetails Earnings Per Share - Basic (Details) Details 59 false false R60.htm 9954502 - Disclosure - Earnings Per Share - Diluted (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareDilutedDetails Earnings Per Share - Diluted (Details) Details 60 false false R61.htm 9954503 - Disclosure - Earnings Per Share - Antidilutive Shares (Details) Sheet http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails Earnings Per Share - Antidilutive Shares (Details) Details 61 false false R62.htm 9954504 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details) Details 62 false false R63.htm 9954505 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details) Details 63 false false R64.htm 9954506 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails Goodwill and Other Intangible Assets - Amortization Expense (Details) Details 64 false false R65.htm 9954507 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details) Details 65 false false R66.htm 9954508 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details) Sheet http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails Goodwill and Other Intangible Assets - Indefinite Lived (Details) Details 66 false false R67.htm 9954509 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.quakerchem.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 67 false false R68.htm 9954510 - Disclosure - Debt - Narrative (Details) Sheet http://www.quakerchem.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 68 false false R69.htm 9954511 - Disclosure - Debt - Debt Related Expenses Included within Interest Expense (Details) Sheet http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails Debt - Debt Related Expenses Included within Interest Expense (Details) Details 69 false false R70.htm 9954512 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) Sheet http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails Accumulated Other Comprehensive Income - AOCI Reclassifications (Details) Details 70 false false R71.htm 9954513 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.quakerchem.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 71 false false R72.htm 9954514 - Disclosure - Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details) Details 72 false false R73.htm 9954515 - Disclosure - Hedging Activities - Narrative (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails Hedging Activities - Narrative (Details) Details 73 false false R74.htm 9954516 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details) Sheet http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails Hedging Activities - Balance Sheet Classification and Fair Values (Details) Details 74 false false R75.htm 9954517 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.quakerchem.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.quakerchem.com/role/CommitmentsandContingencies 75 false false R9999.htm Uncategorized Items - kwr-20240331.htm Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - kwr-20240331.htm Cover 76 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 - kwr-20240331.htm 4 kwr-20240331.htm kwr-20240331.xsd kwr-20240331_cal.xml kwr-20240331_def.xml kwr-20240331_lab.xml kwr-20240331_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 95 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "kwr-20240331.htm": { "nsprefix": "kwr", "nsuri": "http://www.quakerchem.com/20240331", "dts": { "inline": { "local": [ "kwr-20240331.htm" ] }, "schema": { "local": [ "kwr-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "kwr-20240331_cal.xml" ] }, "definitionLink": { "local": [ "kwr-20240331_def.xml" ] }, "labelLink": { "local": [ "kwr-20240331_lab.xml" ] }, "presentationLink": { "local": [ "kwr-20240331_pre.xml" ] } }, "keyStandard": 272, "keyCustom": 18, "axisStandard": 23, "axisCustom": 0, "memberStandard": 49, "memberCustom": 23, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 2 }, "contextCount": 203, "entityCount": 1, "segmentCount": 72, "elementCount": 575, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 675, "http://xbrl.sec.gov/dei/2023": 29, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.quakerchem.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "longName": "0000002 - Statement - Condensed Consolidated Statements of Operations", "shortName": "Condensed Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R3": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "longName": "0000003 - Statement - Condensed Consolidated Statements of Comprehensive Income", "shortName": "Condensed Consolidated Statements of Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R4": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals", "longName": "0000005 - Statement - Condensed Consolidated Balance Sheets (Parentheticals)", "shortName": "Condensed Consolidated Balance Sheets (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "longName": "0000006 - Statement - Condensed Consolidated Statements of Cash Flows", "shortName": "Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R7": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity", "longName": "0000007 - Statement - Condensed Consolidated Statements of Changes in Equity", "shortName": "Condensed Consolidated Statements of Changes in Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-25", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R8": { "role": "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquityParentheticals", "longName": "0000008 - Statement - Condensed Consolidated Statements of Changes in Equity (Parentheticals)", "shortName": "Condensed Consolidated Statements of Changes in Equity (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-32", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R9": { "role": "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusiness", "longName": "0000009 - Disclosure - Basis of Presentation and Description of Business", "shortName": "Basis of Presentation and Description of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.quakerchem.com/role/BusinessAcquisitions", "longName": "0000010 - Disclosure - Business Acquisitions", "shortName": "Business Acquisitions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards", "longName": "0000011 - Disclosure - Recently Issued Accounting Standards", "shortName": "Recently Issued Accounting Standards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.quakerchem.com/role/BusinessSegments", "longName": "0000012 - Disclosure - Business Segments", "shortName": "Business Segments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognition", "longName": "0000013 - Disclosure - Net Sales and Revenue Recognition", "shortName": "Net Sales and Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.quakerchem.com/role/Leases", "longName": "0000014 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.quakerchem.com/role/RestructuringandRelatedActivities", "longName": "0000015 - Disclosure - Restructuring and Related Activities", "shortName": "Restructuring and Related Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.quakerchem.com/role/ShareBasedCompensation", "longName": "0000016 - Disclosure - Share-Based Compensation", "shortName": "Share-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits", "longName": "0000017 - Disclosure - Pension and Other Postretirement Benefits", "shortName": "Pension and Other Postretirement Benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.quakerchem.com/role/Otherexpenseincomenet", "longName": "0000018 - Disclosure - Other (expense) income, net", "shortName": "Other (expense) income, net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions", "longName": "0000019 - Disclosure - Income Taxes and Uncertain Income Tax Positions", "shortName": "Income Taxes and Uncertain Income Tax Positions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.quakerchem.com/role/EarningsPerShare", "longName": "0000020 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssets", "longName": "0000021 - Disclosure - Goodwill and Other Intangible Assets", "shortName": "Goodwill and Other Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.quakerchem.com/role/Debt", "longName": "0000022 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome", "longName": "0000023 - Disclosure - Accumulated Other Comprehensive Income", "shortName": "Accumulated Other Comprehensive Income", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.quakerchem.com/role/FairValueMeasurements", "longName": "0000024 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.quakerchem.com/role/HedgingActivities", "longName": "0000025 - Disclosure - Hedging Activities", "shortName": "Hedging Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.quakerchem.com/role/CommitmentsandContingencies", "longName": "0000026 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": null }, "R28": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies", "longName": "9954471 - Disclosure - Basis of Presentation and Description of Business (Policies)", "shortName": "Basis of Presentation and Description of Business (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.quakerchem.com/role/BusinessSegmentsTables", "longName": "9954472 - Disclosure - Business Segments (Tables)", "shortName": "Business Segments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionTables", "longName": "9954473 - Disclosure - Net Sales and Revenue Recognition (Tables)", "shortName": "Net Sales and Revenue Recognition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.quakerchem.com/role/LeasesTables", "longName": "9954474 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables", "longName": "9954475 - Disclosure - Restructuring and Related Activities (Tables)", "shortName": "Restructuring and Related Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationTables", "longName": "9954476 - Disclosure - Share Based Compensation (Tables)", "shortName": "Share Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsTables", "longName": "9954477 - Disclosure - Pension and Other Postretirement Benefits (Tables)", "shortName": "Pension and Other Postretirement Benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.quakerchem.com/role/OtherexpenseincomenetTables", "longName": "9954478 - Disclosure - Other (expense) income, net (Tables)", "shortName": "Other (expense) income, net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.quakerchem.com/role/EarningsPerShareTables", "longName": "9954479 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables", "longName": "9954480 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.quakerchem.com/role/DebtTables", "longName": "9954481 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables", "longName": "9954482 - Disclosure - Accumulated Other Comprehensive Income (Tables)", "shortName": "Accumulated Other Comprehensive Income (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.quakerchem.com/role/HedgingActivitiesTables", "longName": "9954483 - Disclosure - Hedging Activities (Tables)", "shortName": "Hedging Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "longName": "9954484 - Disclosure - Basis of Presentation and Description of Business (Details)", "shortName": "Basis of Presentation and Description of Business (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:NumberOfCountriesInWhichEntityOperates", "unitRef": "country", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R43": { "role": "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "longName": "9954485 - Disclosure - Business Acquisitions - (Details)", "shortName": "Business Acquisitions - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-46", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R44": { "role": "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails", "longName": "9954486 - Disclosure - Business Segments - Narrative (Details)", "shortName": "Business Segments - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "longName": "9954487 - Disclosure - Business Segments - Performance of Reportable Segments (Details)", "shortName": "Business Segments - Performance of Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "kwr:NonoperatingCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R46": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails", "longName": "9954488 - Disclosure - Net Sales and Revenue Recognition - Narrative (Details)", "shortName": "Net Sales and Revenue Recognition - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "kwr:Netreportingamount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "kwr:Netreportingamount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails", "longName": "9954489 - Disclosure - Net Sales and Revenue Recognition - Disaggregated Revenue (Details)", "shortName": "Net Sales and Revenue Recognition - Disaggregated Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-73", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R48": { "role": "http://www.quakerchem.com/role/LeasesNarrativeDetails", "longName": "9954490 - Disclosure - Leases - Narrative (Details)", "shortName": "Leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:SubleaseIncome", "us-gaap:SubleaseIncome", "us-gaap:VariableLeaseCost", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:VariableLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:SubleaseIncome", "us-gaap:SubleaseIncome", "us-gaap:VariableLeaseCost", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails", "longName": "9954491 - Disclosure - Leases - Supplemental Information (Details)", "shortName": "Leases - Supplemental Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails", "longName": "9954492 - Disclosure - Leases - Maturities of Operating Lease Liabilities (Details)", "shortName": "Leases - Maturities of Operating Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails", "longName": "9954493 - Disclosure - Restructuring and Related Activities (Details)", "shortName": "Restructuring and Related Activities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated", "unitRef": "position", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated", "unitRef": "position", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "longName": "9954494 - Disclosure - Share-Based Compensation - Share-based Compensation Expense (Details)", "shortName": "Share-Based Compensation - Share-based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-91", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R53": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "longName": "9954495 - Disclosure - Share-Based Compensation - Narrative (Details)", "shortName": "Share-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-99", "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R54": { "role": "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "longName": "9954496 - Disclosure - Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details)", "shortName": "Share-Based Compensation - Monte Carlo Simulation on Grant Date (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-110", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "kwr:ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTableTextBlock", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-97", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R55": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails", "longName": "9954497 - Disclosure - Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "shortName": "Pension and Other Postretirement Benefits - Net Periodic Benefit Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-111", "name": "kwr:DefinedBenefitPlanServiceCostNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-111", "name": "kwr:DefinedBenefitPlanServiceCostNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "longName": "9954498 - Disclosure - Pension and Other Postretirement Benefits - Narrative (Details)", "shortName": "Pension and Other Postretirement Benefits - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-111", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-111", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R57": { "role": "http://www.quakerchem.com/role/OtherexpenseincomenetDetails", "longName": "9954499 - Disclosure - Other (expense) income, net (Details)", "shortName": "Other (expense) income, net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "kwr:ProceedsFromNonIncomeTaxRefunds", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "kwr:ProceedsFromNonIncomeTaxRefunds", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails", "longName": "9954500 - Disclosure - Income Taxes and Uncertain Income Tax Positions - (Details)", "shortName": "Income Taxes and Uncertain Income Tax Positions - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "longName": "9954501 - Disclosure - Earnings Per Share - Basic (Details)", "shortName": "Earnings Per Share - Basic (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R60": { "role": "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails", "longName": "9954502 - Disclosure - Earnings Per Share - Diluted (Details)", "shortName": "Earnings Per Share - Diluted (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R61": { "role": "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails", "longName": "9954503 - Disclosure - Earnings Per Share - Antidilutive Shares (Details)", "shortName": "Earnings Per Share - Antidilutive Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "0", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "longName": "9954504 - Disclosure - Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "shortName": "Goodwill and Other Intangible Assets - Changes in Carrying Amount of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R63": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails", "longName": "9954505 - Disclosure - Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "shortName": "Goodwill and Other Intangible Assets - Gross Carrying Amounts and Accumulated Amortization for Definite-lived Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails", "longName": "9954506 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details)", "shortName": "Goodwill and Other Intangible Assets - Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails", "longName": "9954507 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "shortName": "Goodwill and Other Intangible Assets - Intangible Assets - Future Amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails", "longName": "9954508 - Disclosure - Goodwill and Other Intangible Assets - Indefinite Lived (Details)", "shortName": "Goodwill and Other Intangible Assets - Indefinite Lived (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.quakerchem.com/role/DebtScheduleofDebtDetails", "longName": "9954509 - Disclosure - Debt - Schedule of Debt (Details)", "shortName": "Debt - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DebtAndCapitalLeaseObligations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DebtAndCapitalLeaseObligations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfDebtTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.quakerchem.com/role/DebtNarrativeDetails", "longName": "9954510 - Disclosure - Debt - Narrative (Details)", "shortName": "Debt - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-151", "name": "us-gaap:DerivativeLiabilityNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-151", "name": "us-gaap:DerivativeFixedInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R69": { "role": "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails", "longName": "9954511 - Disclosure - Debt - Debt Related Expenses Included within Interest Expense (Details)", "shortName": "Debt - Debt Related Expenses Included within Interest Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestExpenseDebt", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "longName": "9954512 - Disclosure - Accumulated Other Comprehensive Income - AOCI Reclassifications (Details)", "shortName": "Accumulated Other Comprehensive Income - AOCI Reclassifications (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "unique": true } }, "R71": { "role": "http://www.quakerchem.com/role/FairValueMeasurementsNarrativeDetails", "longName": "9954513 - Disclosure - Fair Value Measurements - Narrative (Details)", "shortName": "Fair Value Measurements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-185", "name": "us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-185", "name": "us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails", "longName": "9954514 - Disclosure - Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details)", "shortName": "Hedging Activities - Notional Amounts of Net Foreign Exchange Hedge Positions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "longName": "9954515 - Disclosure - Hedging Activities - Narrative (Details)", "shortName": "Hedging Activities - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-189", "name": "us-gaap:DerivativeTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-189", "name": "us-gaap:DerivativeTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "longName": "9954516 - Disclosure - Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "shortName": "Hedging Activities - Balance Sheet Classification and Fair Values (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails", "longName": "9954517 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-202", "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-202", "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true, "unique": true } }, "R9999": { "role": "http://xbrl.sec.gov/role/uncategorizedFacts", "longName": "Uncategorized Items - kwr-20240331.htm", "shortName": "Uncategorized Items - kwr-20240331.htm", "isDefault": "false", "groupType": "", "subGroupType": "", "menuCat": "Cover", "order": "76", "firstAnchor": { "contextRef": "c-32", "name": "us-gaap:DividendsCommonStock", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "kwr-20240331.htm", "first": true }, "uniqueAnchor": null } }, "tag": { "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "country_AR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AR", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ARGENTINA", "label": "ARGENTINA" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r25", "r814" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r299", "r300" ] }, "us-gaap_AccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Accrued Liabilities [Member]", "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered." } } }, "auth_ref": [ "r29" ] }, "us-gaap_AccruedSalariesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedSalariesCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Accrued Salaries, Current", "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r29", "r782" ] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Pension Plans", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r7", "r19", "r39", "r919", "r920", "r921" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r63", "r187", "r642" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r201", "r209", "r210", "r554", "r784", "r919" ] }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized (Loss) Gain in Available-for- Sale Securities", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]", "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent." } } }, "auth_ref": [ "r197", "r198", "r199", "r201", "r209", "r210", "r919" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "periodStartLabel": "Beginning Balance", "periodEndLabel": "Ending Balance", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r38", "r39", "r125", "r194", "r638", "r667", "r671" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "lang": { "en-us": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r208", "r209", "r587", "r589", "r590", "r591", "r592", "r593" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r19", "r39", "r563", "r566", "r615", "r662", "r663", "r919", "r920", "r921", "r927", "r928", "r929" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency Translation Adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r5", "r19", "r39", "r209", "r210", "r589", "r590", "r591", "r592", "r593", "r919" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, amortization period", "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r142" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r867" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Capital in excess of par value", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r120" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Capital in Excess of Par Value", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r523", "r524", "r525", "r683", "r927", "r928", "r929", "r974", "r1006" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r873" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r873" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r873" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r873" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r838", "r849", "r859", "r884" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r841", "r852", "r862", "r887" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r873" ] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "AllCurrenciesDomain", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Currencies [Domain]", "label": "All Currencies [Domain]" } } }, "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r880" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r845", "r853", "r863", "r880", "r888", "r892", "r900" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r898" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total share-based compensation expense", "terseLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r518", "r526" ] }, "kwr_AmendedCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "AmendedCreditFacilityMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended Credit Facility", "label": "Amended Credit Facility [Member]", "documentation": "Amended Credit Facility" } } }, "auth_ref": [] }, "kwr_AmendedEuroTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "AmendedEuroTermLoanMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro Term Loan", "label": "Amended EURO Term Loan [Member]", "documentation": "Amended EURO Term Loan" } } }, "auth_ref": [] }, "kwr_AmendedRevolverMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "AmendedRevolverMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolver", "label": "Amended Revolver [Member]", "documentation": "Amended Revolver" } } }, "auth_ref": [] }, "kwr_AmendedUsTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "AmendedUsTermLoanMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Term Loan", "label": "Amended U.S. Term Loan [Member]", "documentation": "Amended U.S. Term Loan" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "srt_AmericasMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AmericasMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Americas", "label": "Americas [Member]" } } }, "auth_ref": [ "r1008", "r1009", "r1010", "r1011" ] }, "us-gaap_AmortizationOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCosts", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails": { "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0, "order": 2.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt issuance costs", "label": "Amortization of Debt Issuance Costs", "documentation": "Amount of amortization expense attributable to debt issuance costs." } } }, "auth_ref": [ "r128", "r384", "r595", "r924" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r13", "r57", "r61" ] }, "us-gaap_AmountRecognizedInIncomeDueToInflationaryAccounting": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmountRecognizedInIncomeDueToInflationaryAccounting", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Currency conversion impacts of hyper-inflationary accounting", "label": "Amount Recognized in Income Due to Inflationary Accounting", "documentation": "The amount that will be recognized through the income statement (as well as the impact on the other financial statements) as part of highly inflationary accounting." } } }, "auth_ref": [ "r594" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareAntidilutiveSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive shares (in share)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r266" ] }, "kwr_ArgentineAndTurkishSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "ArgentineAndTurkishSubsidiariesMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Argentine and Turkish Subsidiaries", "label": "Argentine and Turkish Subsidiaries [Member]", "documentation": "Argentine and Turkish Subsidiaries" } } }, "auth_ref": [] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia/Pacific", "label": "Asia Pacific [Member]" } } }, "auth_ref": [ "r1008", "r1009", "r1010", "r1011" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r164", "r191", "r222", "r275", "r284", "r290", "r303", "r349", "r350", "r352", "r353", "r354", "r356", "r358", "r360", "r361", "r550", "r555", "r580", "r634", "r711", "r814", "r829", "r961", "r962", "r992" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsAndLiabilitiesLesseeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAndLiabilitiesLesseeAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets and Liabilities, Lessee [Abstract]", "label": "Assets and Liabilities, Lessee [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r183", "r195", "r222", "r303", "r349", "r350", "r352", "r353", "r354", "r356", "r358", "r360", "r361", "r550", "r555", "r580", "r814", "r961", "r962", "r992" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsTotalMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets Total", "label": "Assets, Total [Member]", "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date." } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r895" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r896" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r891" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r891" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r894" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r893" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r892" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r892" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r94", "r98" ] }, "kwr_BankLinesOfCreditAndOtherDebtObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "BankLinesOfCreditAndOtherDebtObligationsMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank lines of credit and other debt obligations", "label": "Bank lines of credit and other debt obligations [Member]", "documentation": "Bank lines of credit and other debt obligations." } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r545", "r803", "r806" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r75", "r76", "r545", "r803", "r806" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r545" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r0", "r1", "r17" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnouts", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r2", "r82", "r548" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitions" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisitions", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r158", "r546" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash acquired", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r78" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired intangible assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date." } } }, "auth_ref": [ "r77", "r78" ] }, "currency_CNY": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "CNY", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China, Yuan Renminbi", "label": "China, Yuan Renminbi" } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r44", "r185", "r781" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents at the beginning of the period", "periodEndLabel": "Cash and cash equivalents at the end of the period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r44", "r137", "r219" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r137" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r871" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r872" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r872" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 18)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r35", "r113", "r636", "r698" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r149", "r340", "r341", "r765", "r955" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquityParentheticals", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declared (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r154" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r817", "r818", "r819", "r821", "r822", "r823", "r826", "r927", "r928", "r974", "r1004", "r1006" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r119" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r119", "r699" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r119" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheetsParentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r20", "r119", "r699", "r717", "r1006", "r1007" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock $1 par value; authorized 30,000,000 shares; issued and outstanding March\u00a031, 2024 \u2013 17,989,801 shares; December\u00a031, 2023 \u2013 17,991,988 shares", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r119", "r637", "r814" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r877" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r876" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r878" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r875" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income attributable to Quaker Chemical Corporation", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r40", "r205", "r207", "r214", "r630", "r651" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Comprehensive loss (income) attributable to noncontrolling interest", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r11", "r85", "r88", "r205", "r207", "r213", "r629", "r650" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r88", "r160", "r205", "r207", "r212", "r628", "r649" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r47", "r50", "r107", "r108", "r298", "r764" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r47", "r50", "r107", "r108", "r298", "r672", "r764" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r47", "r50", "r107", "r108", "r298", "r764", "r908" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r764" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk (as a percent)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r47", "r50", "r107", "r108", "r298" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r46", "r47", "r50", "r51", "r107", "r163", "r764" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r47", "r50", "r107", "r108", "r298", "r764" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Axis]", "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r224", "r550", "r551", "r555", "r556", "r617", "r775", "r960", "r963", "r964" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Entities [Domain]", "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r224", "r550", "r551", "r555", "r556", "r617", "r775", "r960", "r963", "r964" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r224", "r277", "r282", "r283", "r284", "r285", "r286", "r288", "r292", "r349", "r350", "r351", "r352", "r354", "r355", "r357", "r359", "r360", "r961", "r962" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r224", "r277", "r282", "r283", "r284", "r285", "r286", "r288", "r292", "r349", "r350", "r351", "r352", "r354", "r355", "r357", "r359", "r360", "r961", "r962" ] }, "kwr_CoralChemicalCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "CoralChemicalCompanyMember", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Coral Chemical Company (Coral)", "label": "Coral Chemical Company (Coral) [Member]", "documentation": "Business acquisition of Coral, a privately held, U.S.-based provider of metal finishing fluid solutions." } } }, "auth_ref": [] }, "us-gaap_CorporateBondSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateBondSecuritiesMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate Bond Securities", "label": "Corporate Bond Securities [Member]", "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount)." } } }, "auth_ref": [] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of goods sold (excluding amortization expense - See Note 13)", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r130", "r620" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "kwr_CreditFacilityAsPercentageOfConsolidatedEBITDA": { "xbrltype": "percentItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "CreditFacilityAsPercentageOfConsolidatedEBITDA", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit faclity as percentage of consolidated EBITDA (as a percent)", "label": "Credit facility as percentage of consolidated EBITDA", "documentation": "Credit facility as percentage of consolidated EBITDA" } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CurrencyAxis", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency [Axis]", "label": "Currency [Axis]" } } }, "auth_ref": [ "r983" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current fiscal year end date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r48", "r298" ] }, "us-gaap_CustomerListsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerListsMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer lists and rights to sell", "label": "Customer Lists [Member]", "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information." } } }, "auth_ref": [ "r80" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r81" ] }, "us-gaap_DebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtAndCapitalLeaseObligations", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Balance", "label": "Debt and Lease Obligation", "documentation": "Amount of short-term and long-term debt and lease obligation." } } }, "auth_ref": [ "r168" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings and current portion of long-term debt", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r192" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/Debt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r150", "r220", "r362", "r368", "r369", "r370", "r371", "r372", "r373", "r378", "r385", "r386", "r388" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r31", "r364" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r224", "r363", "r364", "r365", "r366", "r367", "r369", "r374", "r375", "r376", "r377", "r379", "r380", "r381", "r382", "r383", "r384", "r387", "r596", "r790", "r791", "r792", "r793", "r794", "r925" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r33", "r68", "r69", "r109", "r110", "r112", "r114", "r152", "r153", "r224", "r363", "r364", "r365", "r366", "r367", "r369", "r374", "r375", "r376", "r377", "r379", "r380", "r381", "r382", "r383", "r384", "r387", "r596", "r790", "r791", "r792", "r793", "r794", "r925" ] }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused borrowing capacity", "label": "Debt Instrument, Unused Borrowing Capacity, Amount", "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date." } } }, "auth_ref": [ "r32" ] }, "us-gaap_DeferredFinanceCostsCurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsCurrentNet", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs", "label": "Debt Issuance Costs, Current, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r111" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: debt issuance costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r111", "r966" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r528", "r529" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r528", "r529", "r635" ] }, "us-gaap_DeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRevenue", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Revenue", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r916" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfGainsLosses", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Actuarial loss (gain) amortization", "label": "Defined Benefit Plan, Amortization of Gain (Loss)", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan." } } }, "auth_ref": [ "r417", "r455", "r476", "r801", "r802" ] }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior service cost (income) amortization", "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)", "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan." } } }, "auth_ref": [ "r417", "r456", "r477", "r801", "r802" ] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employer contributions", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r432", "r442", "r480", "r799", "r800", "r801", "r802" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected future employer contributions, remainder of fiscal year", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Remainder of Fiscal Year", "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year." } } }, "auth_ref": [ "r480", "r802" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r417", "r454", "r475", "r801", "r802" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r417", "r421", "r453", "r474", "r801", "r802" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net periodic benefit cost (income)", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r451", "r472", "r801", "r802" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]" } } }, "auth_ref": [] }, "kwr_DefinedBenefitPlanServiceCostNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "DefinedBenefitPlanServiceCostNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost, Net", "documentation": "Defined Benefit Plan, Service Cost, Net" } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r688", "r690", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r712", "r713", "r714", "r715", "r726", "r727", "r728", "r729", "r732", "r733", "r734", "r735", "r750", "r752", "r756", "r758", "r817", "r819" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, fixed interest rate (as a percent)", "label": "Derivative, Fixed Interest Rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r95", "r97", "r99", "r102", "r688", "r690", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r712", "r713", "r714", "r715", "r726", "r727", "r728", "r729", "r732", "r733", "r734", "r735", "r750", "r752", "r756", "r758", "r783", "r817", "r819" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/HedgingActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Activities", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r162", "r560", "r569" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Table]", "label": "Derivative Instruments, Gain (Loss) [Table]", "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r21", "r95", "r99", "r102", "r105", "r106", "r559" ] }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossLineItems", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r559" ] }, "us-gaap_DerivativeLiabilityNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNotionalAmount", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, notional amount", "label": "Derivative Liability, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative liability." } } }, "auth_ref": [ "r751", "r753", "r754", "r757", "r971", "r972", "r973" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r569" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r972", "r973" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r21", "r89", "r90", "r92", "r93", "r96", "r99", "r103", "r104", "r106", "r569" ] }, "us-gaap_DerivativeTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTermOfContract", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative term (in years)", "label": "Derivative, Term of Contract", "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DerivativeVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeVariableInterestRate", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative variable interest rate (as a percent)", "label": "Derivative, Variable Interest Rate", "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative." } } }, "auth_ref": [] }, "kwr_DirectorsStockOwnershipPlanCompensationExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "DirectorsStockOwnershipPlanCompensationExpenseMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Director stock ownership plan", "label": "Directors Stock Ownership Plan Compensation Expense [Member]", "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the company's board of director's stock plan." } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r967" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r489", "r491", "r519", "r520", "r522", "r810" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends declared", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r10", "r154" ] }, "us-gaap_DividendsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends payable", "label": "Dividends Payable, Current", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r29" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r833" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r866" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EMEAMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EMEA", "label": "EMEA [Member]", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r1008", "r1009", "r1010", "r1011" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Per share data:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to Quaker Chemical Corporation common shareholders \u2013 basic (in dollars per share)", "verboseLabel": "Basic earnings per common share (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r215", "r234", "r235", "r237", "r238", "r240", "r247", "r250", "r261", "r264", "r265", "r269", "r574", "r575", "r631", "r652", "r785" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net income attributable to Quaker Chemical Corporation common shareholders \u2013 diluted (in dollars per share)", "verboseLabel": "Diluted earnings per common share (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r215", "r234", "r235", "r237", "r238", "r240", "r250", "r261", "r264", "r265", "r269", "r574", "r575", "r631", "r652", "r785" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r246", "r266", "r267", "r268" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of foreign exchange rate changes on cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r980" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective tax rate (as a percent)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r531" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining life, nonvested stock awards (in years)", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r521" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized share-based compensation expense, nonvested stock award", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r970" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense, options", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r970" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity central index key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r831" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r831" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r831" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r905" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r831" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r831" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r831" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r831" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r20", "r179", "r208", "r209", "r210", "r225", "r226", "r227", "r231", "r241", "r243", "r270", "r304", "r309", "r402", "r523", "r524", "r525", "r535", "r536", "r562", "r563", "r564", "r565", "r566", "r568", "r573", "r587", "r589", "r590", "r591", "r592", "r593", "r615", "r662", "r663", "r664", "r683", "r738" ] }, "us-gaap_EquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestments", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in associated companies", "label": "Equity Method Investments", "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized." } } }, "auth_ref": [ "r280", "r302", "r914", "r933" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r874" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r838", "r849", "r859", "r884" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r835", "r846", "r856", "r881" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r880" ] }, "kwr_FacilitiesVehiclesAndMachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "FacilitiesVehiclesAndMachineryAndEquipmentMember", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Facilities Vehicles and Machinery and Equipment", "label": "Facilities Vehicles and Machinery and Equipment [Member]", "documentation": "Operating leases for certain facilities, vehicles and machinery and equipment." } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r579" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r189", "r324" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r144" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the remainder of 2024", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-lived Intangible Assets Amortization Expense", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r144" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r144" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r144" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsFutureAmortizationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r144" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r322", "r323", "r324", "r325", "r621", "r625" ] }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r143", "r625" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r621" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r58", "r60" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Book Value", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r143", "r621" ] }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossRealized", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange losses, net", "label": "Realized Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r719", "r827", "r978", "r979", "r1005" ] }, "us-gaap_ForeignExchangeForwardMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeForwardMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency forward contracts:", "label": "Foreign Exchange Forward [Member]", "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate." } } }, "auth_ref": [ "r705", "r709", "r714", "r728", "r734", "r754", "r755", "r756", "r819" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r842", "r853", "r863", "r888" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r842", "r853", "r863", "r888" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r842", "r853", "r863", "r888" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r842", "r853", "r863", "r888" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r842", "r853", "r863", "r888" ] }, "us-gaap_GainLossOnDispositionOfAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on disposals of property, plant, equipment and other assets, net", "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property." } } }, "auth_ref": [ "r924", "r949", "r950" ] }, "kwr_GainOnInsuranceRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "GainOnInsuranceRecoveries", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Facility remediation recoveries, net", "label": "Gain On Insurance Recoveries", "documentation": "Gain On Insurance Recoveries" } } }, "auth_ref": [] }, "us-gaap_GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralDiscussionOfPensionAndOtherPostretirementBenefitsAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits, Description [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographic Concentration Risk", "label": "Geographic Concentration Risk [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r49", "r764" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r188", "r310", "r626", "r789", "r814", "r939", "r946" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill additions", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r313", "r789" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Other Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r141" ] }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustments", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r317" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r789" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillRollForward", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r129", "r222", "r275", "r283", "r289", "r292", "r303", "r349", "r350", "r352", "r353", "r354", "r356", "r358", "r360", "r361", "r580", "r787", "r961" ] }, "kwr_HoughtonCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "HoughtonCombinationMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Houghton Combination", "label": "Houghton Combination [Member]", "documentation": "Hougton, a business combination." } } }, "auth_ref": [] }, "kwr_HoughtonEnvironmentalMattersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "HoughtonEnvironmentalMattersMember", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Houghton Environmental Matters", "label": "Houghton Environmental Matters [Member]", "documentation": "Houghton environmental matters." } } }, "auth_ref": [] }, "kwr_HyperInflationaryEconomiesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "HyperInflationaryEconomiesPolicyTextBlock", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Hyper-inflationary economies", "label": "Hyper-inflationary economies [Policy Text Block]", "documentation": "Hyper-inflationary economies policy." } } }, "auth_ref": [] }, "kwr_I.K.V.TribologieIKVTMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "I.K.V.TribologieIKVTMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IKV", "label": "I.K.V. Tribologie IKVT [Member]", "documentation": "I.K.V. Tribologie IKVT" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income before taxes and equity in net income of associated companies", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments." } } }, "auth_ref": [ "r275", "r283", "r289", "r292", "r653", "r787" ] }, "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income before equity in net income of associated companies", "label": "Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments", "documentation": "Income Loss From Continuing Operations Before Noncontrolling Interests and Income Loss From Equity Method Investments" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in net income of associated companies", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r13", "r126", "r169", "r278", "r302", "r644" ] }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Equity in undistributed earnings of associated companies, net of dividends", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r326", "r331", "r723" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r331", "r723" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/IncomeTaxesandUncertainIncomeTaxPositions" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes and Uncertain Income Tax Positions", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r223", "r527", "r532", "r533", "r534", "r540", "r542", "r543", "r544", "r680" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "kwr_IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Taxes on income before equity in net income of associated companies", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r172", "r176", "r242", "r243", "r279", "r530", "r541", "r654" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r12" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r12" ] }, "kwr_IncreaseDecreaseInDeferredCompensationAndOtherNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "IncreaseDecreaseInDeferredCompensationAndOtherNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation, deferred taxes and other, net", "label": "Increase Decrease In Deferred Compensation And Other Net", "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future and other certain items." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r12" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease in cash from changes in current assets and current liabilities, net of acquisitions:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r12" ] }, "us-gaap_IncreaseDecreaseInRestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInRestructuringReserve", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Change in restructuring liabilities", "label": "Increase (Decrease) in Restructuring Reserve", "documentation": "The increase (decrease) during the period in the carrying amount (including both current and noncurrent portions of the accrual) of the liability pertaining to the exit from or disposal of business activities or restructuring pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination and to asset retirement obligations." } } }, "auth_ref": [ "r923" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of dilutive securities (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r251", "r252", "r253", "r265", "r490" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite lived intangible assets", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r145" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract", "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedTrademarks": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedTrademarks", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived trademarks", "label": "Indefinite-Lived Trademarks", "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit." } } }, "auth_ref": [ "r145" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r845", "r853", "r863", "r880", "r888", "r892", "r900" ] }, "kwr_IndustrialDevelopmentBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "IndustrialDevelopmentBondsMember", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Industrial development bonds", "label": "Industrial development bonds [Member]", "documentation": "Industrial development bonds." } } }, "auth_ref": [] }, "kwr_Industrialdevelopmentrevenuebond": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "Industrialdevelopmentrevenuebond", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Industrial development revenue bond", "label": "Industrial Development Revenue Bond", "documentation": "This element represents an Industrial Development Revenue Bond used to fund the expansion of the company's Middletown, Ohio manufacturing facility." } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r898" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r834", "r904" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r834", "r904" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r834", "r904" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r56", "r59" ] }, "us-gaap_InterestAndDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpense", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Interest and Debt Expense", "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity." } } }, "auth_ref": [ "r16" ] }, "us-gaap_InterestAndDebtExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndDebtExpenseAbstract", "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt related expenses included within Interest expense:", "label": "Interest and Debt Expense [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails": { "parentTag": "us-gaap_InterestAndDebtExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/DebtDebtRelatedExpensesIncludedwithinInterestExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r134", "r382", "r389", "r793", "r794" ] }, "us-gaap_InterestExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Expense [Member]", "documentation": "Primary financial statement caption encompassing interest expense." } } }, "auth_ref": [ "r22" ] }, "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest Income and Interest Expense Disclosure", "label": "Interest Income and Interest Expense Disclosure [Table Text Block]", "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, net", "label": "Interest Income (Expense), Net", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r171" ] }, "us-gaap_InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized loss deferred to AOCI", "label": "Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net", "documentation": "The amount of net gains or losses on interest rate cash flow hedges reclassified during the period to earnings from accumulated other comprehensive income upon the hedged transaction affecting earnings." } } }, "auth_ref": [ "r101" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails", "http://www.quakerchem.com/role/HedgingActivitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate swaps:", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r778", "r824", "r825" ] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intersegment Sales Elimination", "label": "Intersegment Eliminations [Member]", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r277", "r282", "r283", "r284", "r285", "r286", "r288", "r292" ] }, "us-gaap_InventoryFinishedGoodsAndWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsAndWorkInProcess", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Work-in-process and finished goods", "label": "Inventory, Finished Goods and Work in Process, Gross", "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale." } } }, "auth_ref": [ "r917" ] }, "us-gaap_InventoryNetAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNetAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory, Net [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryRawMaterialsAndSupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsAndSupplies", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials and supplies", "label": "Inventory, Raw Materials and Supplies, Gross", "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed." } } }, "auth_ref": [ "r917" ] }, "currency_JPY": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "JPY", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japanese Yen", "label": "Japan, Yen" } } }, "auth_ref": [] }, "us-gaap_LandMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandMember", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Land", "label": "Land [Member]", "documentation": "Part of earth's surface not covered by water." } } }, "auth_ref": [ "r968" ] }, "kwr_LargestCustomerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "LargestCustomerMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Largest Customers", "label": "Largest customer [Member]", "documentation": "Reflects the percentage that revenues in the period from the entity's largest customer is to net revenues." } } }, "auth_ref": [] }, "us-gaap_LeaseCostAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease, Cost [Abstract]", "label": "Lease, Cost [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Lease, Cost", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r985" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Line Items]", "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r604" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Table]", "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r604" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Lessee, Operating Lease, Liability, Maturity", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r986" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r613" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r613" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r613" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r613" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r613" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the remainder of 2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r986" ] }, "kwr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "For the year ended December 31, 2029 and beyond", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four", "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r613" ] }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining lease terms (in years)", "label": "Lessee, Operating Lease, Remaining Lease Term", "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r984" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.quakerchem.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r600" ] }, "us-gaap_LetterOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LetterOfCreditMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letter of Credit", "label": "Letter of Credit [Member]", "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)." } } }, "auth_ref": [] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit outstanding amount", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r28", "r222", "r303", "r349", "r350", "r352", "r353", "r354", "r356", "r358", "r360", "r361", "r551", "r555", "r556", "r580", "r697", "r786", "r829", "r961", "r992", "r993" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r124", "r167", "r641", "r814", "r926", "r934", "r977" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r30", "r184", "r222", "r303", "r349", "r350", "r352", "r353", "r354", "r356", "r358", "r360", "r361", "r551", "r555", "r556", "r580", "r814", "r961", "r992", "r993" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LifeInsuranceCorporateOrBankOwnedChangeInValue", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/FairValueMeasurementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Surrendered and liquidated life insurance policies", "label": "Life Insurance, Corporate or Bank Owned, Change in Value", "documentation": "The change in cash surrender or contract value during the period which adjusted the amount of premiums paid in determining the expense or income recognized under the contract for the period." } } }, "auth_ref": [ "r935" ] }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityCommitmentFeePercentage", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment fee percentage (as a percent)", "label": "Line of Credit Facility, Commitment Fee Percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r26" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining borrowing capacity", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r26" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r193" ] }, "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtPercentageBearingVariableInterestRate", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt interest rate (as a percent)", "label": "Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate", "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time." } } }, "auth_ref": [ "r31" ] }, "us-gaap_LongTermDebtTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTerm", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt term (in years)", "label": "Long-Term Debt, Term", "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r976" ] }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, weighted average interest rate, over time (as a percent)", "label": "Long-Term Debt, Weighted Average Interest Rate, over Time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r33" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r33", "r67" ] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency Nature [Axis]", "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r342", "r343", "r344", "r348", "r956", "r957" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r342", "r343", "r344", "r348", "r956", "r957" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r342", "r343", "r344", "r348", "r956", "r957" ] }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyEstimateOfPossibleLoss", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, estimate of possible loss", "label": "Loss Contingency, Estimate of Possible Loss", "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date." } } }, "auth_ref": [ "r343", "r344", "r347", "r348" ] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Nature [Domain]", "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r342", "r343", "r344", "r348", "r956", "r957" ] }, "currency_MXN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "MXN", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesNotionalAmountsofNetForeignExchangeHedgePositionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mexican Peso", "label": "Mexico, Pesos" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [ "r298", "r798", "r967", "r1002", "r1003" ] }, "kwr_MaximumIncreaseInBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "MaximumIncreaseInBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum increase in borrowing capacity", "label": "Maximum increase in borrowing capacity", "documentation": "Maximum increase in borrowing capacity" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r343", "r344", "r345", "r346", "r487", "r619", "r661", "r689", "r690", "r743", "r745", "r747", "r748", "r759", "r776", "r777", "r788", "r795", "r809", "r816", "r965", "r994", "r995", "r996", "r997", "r998", "r999" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r872" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r872" ] }, "kwr_MetalsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "MetalsMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Metals", "label": "Metals [Member]", "documentation": "Metals product line." } } }, "auth_ref": [] }, "kwr_MetalworkingAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "MetalworkingAndOtherMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Metalworking and other", "label": "Metalworking and Other [Member]", "documentation": "Metals product line." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r343", "r344", "r345", "r346", "r487", "r619", "r661", "r689", "r690", "r743", "r745", "r747", "r748", "r759", "r776", "r777", "r788", "r795", "r809", "r816", "r965", "r994", "r995", "r996", "r997", "r998", "r999" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r37", "r166", "r222", "r303", "r349", "r352", "r353", "r354", "r360", "r361", "r580", "r640", "r701" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r891" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r899" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [ "r298", "r798", "r967", "r1002", "r1003" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r873" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r218" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r218" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r137", "r138", "r139" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net income attributable to Quaker Chemical Corporation", "terseLabel": "Net income attributable to Quaker Chemical Corporation", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r127", "r139", "r170", "r182", "r203", "r206", "r210", "r222", "r230", "r234", "r235", "r237", "r238", "r242", "r243", "r258", "r275", "r283", "r289", "r292", "r303", "r349", "r350", "r352", "r353", "r354", "r356", "r358", "r360", "r361", "r575", "r580", "r647", "r720", "r736", "r737", "r787", "r827", "r961" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Less: Net income attributable to noncontrolling interest", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r87", "r161", "r203", "r206", "r242", "r243", "r646", "r921" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r216", "r234", "r235", "r237", "r238", "r247", "r248", "r260", "r265", "r275", "r283", "r289", "r292", "r787" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income available to common shareholders", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r216", "r249", "r254", "r255", "r256", "r257", "r260", "r265" ] }, "kwr_Netreportingamount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "Netreportingamount", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized under net reporting arrangements", "label": "Net Reporting Amount", "documentation": "Amount recognized as revenue under net reporting arrangements" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://www.quakerchem.com/role/RecentlyIssuedAccountingStandards" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Standards", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r174", "r175", "r177", "r181", "r228", "r229", "r232", "r233", "r244", "r245", "r305", "r306", "r537", "r538", "r539", "r567", "r572", "r576", "r577", "r578", "r581", "r582", "r583", "r598", "r599", "r616", "r622", "r623", "r624", "r666", "r667", "r668", "r669", "r671" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r872" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r842", "r853", "r863", "r880", "r888" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r870" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r869" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r880" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r899" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r83", "r402", "r927", "r928", "r929", "r1006" ] }, "kwr_NonoperatingCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "NonoperatingCharges", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Non-operating and administrative expenses", "label": "Nonoperating Charges", "documentation": "The aggregate amount of non-operating charges recurring against earnings in the period, which are not directly related to or being allocated to a specific segment." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 3.0 }, "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "totalLabel": "Total other income (expense), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r133" ] }, "us-gaap_NonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "label": "Nonoperating Income (Expense) [Member]", "documentation": "Primary financial statement caption encompassing nonoperating income (expense)." } } }, "auth_ref": [] }, "kwr_NonvestedStockAwardsCompensationExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "NonvestedStockAwardsCompensationExpenseMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-vested stock awards and restricted stock units", "label": "Nonvested Stock Awards Compensation Expense [Member]", "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for nonvested stock and restricted stock unit awards." } } }, "auth_ref": [] }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfCountriesInWhichEntityOperates", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries in which entity operates", "label": "Number of Countries in which Entity Operates", "documentation": "The number of countries in which the entity operates as of balance sheet date." } } }, "auth_ref": [] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportableSegments", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsNarrativeDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r932" ] }, "kwr_OldCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "OldCreditFacilityMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original Credit Facility", "label": "Previous Credit Facility [Member]", "documentation": "Syndicated multicurrency, unsecured revolving credit facility with a group of lenders." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r275", "r283", "r289", "r292", "r787" ] }, "kwr_OperatingIncomeLossSegmentReporting": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "OperatingIncomeLossSegmentReporting", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Segment operating earnings", "label": "Operating Income Loss Segment Reporting", "documentation": "The net result for the period of deducting operating expenses from operating revenues before amortization and non-operating charges." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r605", "r813" ] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/LeasesMaturitiesofOperatingLeaseLiabilitiesDetails", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease liabilities", "terseLabel": "Present value of lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r602" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other current liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r602" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r602" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating cash flows from operating leases", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r603", "r609" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use lease assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r601" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r612", "r813" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r611", "r813" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r282", "r283", "r284", "r285", "r286", "r292" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Description of Business", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r115", "r159", "r673", "r674" ] }, "kwr_OriginalCreditFacilityAndTheAmendedCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "OriginalCreditFacilityAndTheAmendedCreditFacilityMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original Credit Facility and the Amended Credit Facility", "label": "Original Credit Facility and the Amended Credit Facility [Member]", "documentation": "Original Credit Facility and the Amended Credit Facility" } } }, "auth_ref": [] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r94", "r105" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r190" ] }, "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income, net of tax", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r6", "r125", "r584", "r585", "r586" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income before Reclassifications", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r209", "r587", "r590", "r593", "r648", "r919" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Current period change in fair value of derivatives", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r196", "r200" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r196", "r200", "r557", "r558", "r561" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net gain (loss) reclassified from AOCI to earnings", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax", "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r173", "r200", "r202" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive (loss) income", "terseLabel": "Amounts reported in other comprehensive income", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r20", "r24", "r204", "r207", "r211", "r587", "r588", "r593", "r627", "r648", "r919", "r920" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Defined benefit retirement plans", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r8", "r125" ] }, "us-gaap_OtherComprehensiveIncomeLossTaxPortionAttributableToParent1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTaxPortionAttributableToParent1", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related tax amounts", "label": "Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r11", "r18", "r160" ] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized gain on available-for-sale securities", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r197", "r200", "r301" ] }, "us-gaap_OtherDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherDepreciationAndAmortization", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation of corporate assets and amortization", "label": "Other Depreciation and Amortization", "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other." } } }, "auth_ref": [ "r13", "r62", "r131" ] }, "us-gaap_OtherIncomeAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndExpensesAbstract", "lang": { "en-us": { "role": { "label": "Other Income and Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/Otherexpenseincomenet" ], "lang": { "en-us": { "role": { "terseLabel": "Other (expense) income, net", "label": "Other Income and Other Expense Disclosure [Text Block]", "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions." } } }, "auth_ref": [ "r155", "r157" ] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r29", "r814" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r34" ] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesBalanceSheetClassificationandFairValuesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Other Noncurrent Assets [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-operating income, net", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r872" ] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other Postretirement Benefits", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r415", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r446", "r447", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r468", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r484", "r485", "r486", "r801", "r802", "r803", "r804", "r805" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r840", "r851", "r861", "r886" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r843", "r854", "r864", "r889" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r843", "r854", "r864", "r889" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r868" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r330", "r922" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r42" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payments to acquire businesses", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r41", "r547" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments related to acquisitions, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r41" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Investments in property, plant and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r136" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r871" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r871" ] }, "us-gaap_PensionAndOtherPostretirementBenefitExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitExpense", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and other postretirement benefits", "label": "Pension and Other Postretirement Benefits Cost (Reversal of Cost)", "documentation": "Amount of cost (reversal of cost) for pension and other postretirement benefits." } } }, "auth_ref": [] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Other Postretirement Benefits", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r414", "r439", "r441", "r447", "r464", "r466", "r467", "r468", "r469", "r470", "r482", "r483", "r484", "r801" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued pension and postretirement benefits", "label": "Liability, Defined Benefit Plan, Current", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current." } } }, "auth_ref": [ "r117", "r415", "r416", "r438", "r801" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current accrued pension and postretirement benefits", "label": "Liability, Defined Benefit Plan, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent." } } }, "auth_ref": [ "r118", "r415", "r416", "r438", "r801" ] }, "kwr_PensionAndPostretirementBenefitIncomeNonServiceComponents": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "PensionAndPostretirementBenefitIncomeNonServiceComponents", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and postretirement benefit costs, non-service components", "label": "Pension And Postretirement Benefit Income, Non-Service Components", "documentation": "Other income related to non-service pension cost components" } } }, "auth_ref": [] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Pension Benefits", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r415", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r468", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r484", "r485", "r488", "r801", "r802", "r806", "r807", "r808" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r870" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r880" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r873" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r869" ] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance stock units", "verboseLabel": "Performance Stock Units", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "kwr_PerformanceStockUnitsROICMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "PerformanceStockUnitsROICMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Stock Units, ROIC", "label": "Performance Stock Units, ROIC [Member]", "documentation": "Performance Stock Units, ROIC" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r918" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other stock related activity", "label": "Proceeds from Issuance or Sale of Equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r9", "r677" ] }, "kwr_ProceedsFromNonIncomeTaxRefunds": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "ProceedsFromNonIncomeTaxRefunds", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-income tax refunds and other related credits", "label": "Proceeds From Non Income Tax Refunds", "documentation": "The amount of cash received during the period as refunds for the overpayment of non-income taxes." } } }, "auth_ref": [] }, "kwr_ProceedsFromRepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "ProceedsFromRepaymentsOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings (payments) on revolving credit facilities, net", "label": "Proceeds from (Repayments of) Long-Term Debt", "documentation": "Proceeds from (Repayments of) Long-Term Debt" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfOtherDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfOtherDebt", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Payments on other debt, net", "label": "Proceeds from (Repayments of) Other Debt", "documentation": "Amount of cash inflow (outflow) for debt classified as other." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from disposition of assets", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r135" ] }, "us-gaap_ProductInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductInformationLineItems", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Information [Line Items]", "label": "Product Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ProductLiabilityAccrualPeriodExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductLiabilityAccrualPeriodExpense", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Product Liability Accrual, Period Expense", "label": "Product Liability Accrual, Period Expense", "documentation": "The amount of loss reported during the period pertaining to product liability." } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r294", "r620", "r655", "r656", "r657", "r658", "r659", "r660", "r779", "r796", "r815", "r910", "r958", "r959", "r967", "r1002" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r294", "r620", "r655", "r656", "r657", "r658", "r659", "r660", "r779", "r796", "r815", "r910", "r958", "r959", "r967", "r1002" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofComprehensiveIncome", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r182", "r203", "r206", "r217", "r222", "r230", "r242", "r243", "r275", "r283", "r289", "r292", "r303", "r349", "r350", "r352", "r353", "r354", "r356", "r358", "r360", "r361", "r549", "r552", "r553", "r575", "r580", "r632", "r645", "r682", "r720", "r736", "r737", "r787", "r811", "r812", "r828", "r921", "r961" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r14" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment, at cost", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r146", "r186", "r643" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Property, plant and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r14", "r633", "r643", "r814" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r146" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r868" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r868" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r343", "r344", "r345", "r346", "r439", "r487", "r514", "r515", "r516", "r618", "r619", "r661", "r689", "r690", "r743", "r745", "r747", "r748", "r759", "r776", "r777", "r788", "r795", "r809", "r816", "r819", "r951", "r965", "r995", "r996", "r997", "r998", "r999" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.quakerchem.com/role/CommitmentsandContingenciesDetails", "http://www.quakerchem.com/role/DebtNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r343", "r344", "r345", "r346", "r439", "r487", "r514", "r515", "r516", "r618", "r619", "r661", "r689", "r690", "r743", "r745", "r747", "r748", "r759", "r776", "r777", "r788", "r795", "r809", "r816", "r819", "r951", "r965", "r995", "r996", "r997", "r998", "r999" ] }, "us-gaap_RealEstateHeldforsale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateHeldforsale", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Real estate, held-for-sale", "label": "Real Estate, Held-for-Sale", "documentation": "Amount of investment in land and building held for sale. Excludes real estate considered inventory." } } }, "auth_ref": [ "r1000" ] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts reclassified from AOCI", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r209", "r587", "r592", "r593", "r648", "r919" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r835", "r846", "r856", "r881" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r43", "r678" ] }, "srt_RestatementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementAxis", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Axis]", "label": "Revision of Prior Period [Axis]" } } }, "auth_ref": [ "r180", "r225", "r226", "r227", "r230", "r231", "r234", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r269", "r307", "r308", "r536", "r571", "r573", "r574", "r575", "r597", "r614", "r615", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r675" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r836", "r847", "r857", "r882" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r837", "r848", "r858", "r883" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r844", "r855", "r865", "r890" ] }, "srt_RestatementDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RestatementDomain", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revision of Prior Period [Domain]", "label": "Revision of Prior Period [Domain]" } } }, "auth_ref": [ "r180", "r225", "r226", "r227", "r230", "r231", "r234", "r235", "r236", "r237", "r239", "r240", "r241", "r242", "r243", "r244", "r269", "r307", "r308", "r536", "r571", "r573", "r574", "r575", "r597", "r614", "r615", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r675" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r45" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivities" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r327", "r328", "r330", "r333", "r339" ] }, "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of positions eliminated", "label": "Restructuring and Related Cost, Number of Positions Eliminated", "documentation": "The number of positions eliminated during the period as a result of restructuring activities." } } }, "auth_ref": [] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related charges, net", "verboseLabel": "Restructuring and related charges, net", "negatedLabel": "Restructuring and related charges, net", "netLabel": "Restructuring and related charges, net", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r13", "r334", "r336", "r952" ] }, "us-gaap_RestructuringChargesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringChargesMember", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Charges", "label": "Restructuring Charges [Member]", "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included." } } }, "auth_ref": [ "r147", "r148" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r336", "r337", "r338" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Axis]", "label": "Restructuring Plan [Axis]", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Domain]", "label": "Restructuring Plan [Domain]", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accrued restructuring, beginning balance", "periodEndLabel": "Accrued restructuring, ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r330", "r335" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveCurrent", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued restructuring", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r915", "r953", "r954" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveTranslationAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveTranslationAdjustment", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Currency translation adjustments", "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve." } } }, "auth_ref": [ "r953", "r954" ] }, "us-gaap_ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResultsOfOperationsDepreciationDepletionAmortizationAndAccretion", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Results of Operations, Depreciation, Depletion, Amortization and Accretion", "documentation": "Depreciation, depletion, amortization, and accretion related to oil and gas producing activities." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r121", "r154", "r639", "r666", "r671", "r679", "r700", "r814" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r179", "r225", "r226", "r227", "r231", "r241", "r243", "r304", "r309", "r523", "r524", "r525", "r535", "r536", "r562", "r564", "r565", "r568", "r573", "r662", "r664", "r683", "r1006" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r415", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r468", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r484", "r485", "r486", "r488", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r415", "r418", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r434", "r435", "r436", "r437", "r438", "r439", "r440", "r442", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r465", "r468", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r484", "r485", "r486", "r488", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r276", "r277", "r282", "r287", "r288", "r294", "r296", "r298", "r411", "r412", "r620" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/OtherexpenseincomenetDetails": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income from third party license fees", "label": "Revenue from Contract with Customer, Including Assessed Tax", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r276", "r277", "r282", "r287", "r288", "r294", "r296", "r298", "r411", "r412", "r620" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Net Sales and Revenue Recognition", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r178", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r413" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "lang": { "en-us": { "role": { "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r610", "r813" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r899" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r899" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales Revenue Net", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r298", "r907" ] }, "srt_ScenarioPreviouslyReportedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioPreviouslyReportedMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Previously Reported", "label": "Previously Reported [Member]" } } }, "auth_ref": [ "r180", "r225", "r227", "r230", "r231", "r234", "r235", "r243", "r269", "r536", "r571", "r573", "r574", "r597", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r675", "r909", "r911", "r912", "r913", "r930", "r936", "r937", "r975", "r987", "r988" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r39", "r981", "r982" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r75", "r76", "r545" ] }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Balance Sheet Classification and Fair Values of Derivative Instruments", "label": "Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position." } } }, "auth_ref": [ "r100" ] }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-Based Payment Arrangement, Cost by Plan", "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]", "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit." } } }, "auth_ref": [ "r74" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNarrativeDetails", "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsNetPeriodicBenefitCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r15", "r70", "r71", "r72", "r73" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r931" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r74" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r58", "r60", "r621" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r58", "r60" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r789" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r789", "r938", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r947", "r948" ] }, "kwr_ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "ScheduleOfMonteCarloOptionPricingModelAndTheAssumptionsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Monte Carlo Option Pricing Model And The Assumptions", "label": "Schedule of Monte Carlo option pricing model and the assumptions [Table Text Block]", "documentation": "Schedule of Monte Carlo option pricing model and the assumptions" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/PensionandOtherPostretirementBenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Benefit Costs", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r156" ] }, "us-gaap_ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNotionalAmountsOfOutstandingDerivativePositionsTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/HedgingActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Notional Amounts of Outstanding Derivative Positions", "label": "Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]", "documentation": "Tabular disclosure of the notional amounts of outstanding derivative positions." } } }, "auth_ref": [ "r91" ] }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/OtherexpenseincomenetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other Nonoperating (Expense) Income", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductInformationTable", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Product Information [Table]", "label": "Schedule of Product Information [Table]", "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r329", "r330", "r331", "r332", "r336", "r337", "r338" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.quakerchem.com/role/RestructuringandRelatedActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r64", "r65", "r66" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r52", "r53", "r54", "r55" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r52", "r53", "r54", "r55" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.quakerchem.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r60" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r830" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r832" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r296", "r297", "r685", "r686", "r687", "r744", "r746", "r749", "r760", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r780", "r797", "r819", "r967", "r1002" ] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/BusinessSegments" ], "lang": { "en-us": { "role": { "terseLabel": "Business Segments", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r271", "r272", "r273", "r274", "r275", "r281", "r286", "r290", "r291", "r292", "r293", "r294", "r295", "r298" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingMeasurementDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingMeasurementDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting, Measurement Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r132" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Option award vesting period (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r810" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nonvested stock awards granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r506" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant date per value (in dollars per unit)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r503", "r504" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "2024 Grants", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r515" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r516" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of PSUs granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r499" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails", "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails", "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationMonteCarloSimulationonGrantDateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r513" ] }, "us-gaap_ShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermBorrowings", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: short-term and current portion of long-term debts", "label": "Short-Term Debt", "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r116", "r165", "r814", "r1001" ] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Axis]", "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.quakerchem.com/role/DebtNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Domain]", "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r25" ] }, "us-gaap_ShortTermLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermLeaseCost", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease expense", "label": "Short-Term Lease, Cost", "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less." } } }, "auth_ref": [ "r606", "r813" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r20", "r36", "r179", "r208", "r209", "r210", "r225", "r226", "r227", "r231", "r241", "r243", "r270", "r304", "r309", "r402", "r523", "r524", "r525", "r535", "r536", "r562", "r563", "r564", "r565", "r566", "r568", "r573", "r587", "r589", "r590", "r591", "r592", "r593", "r615", "r662", "r663", "r664", "r683", "r738" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/BusinessSegmentsPerformanceofReportableSegmentsDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsChangesinCarryingAmountofGoodwillDetails", "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsIndefiniteLivedDetails", "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionDisaggregatedRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r296", "r297", "r685", "r686", "r687", "r744", "r746", "r749", "r760", "r763", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r780", "r797", "r819", "r967", "r1002" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncomeAOCIReclassificationsDetails", "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r225", "r226", "r227", "r270", "r620", "r676", "r684", "r691", "r692", "r693", "r694", "r695", "r696", "r699", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r712", "r713", "r714", "r715", "r716", "r718", "r721", "r722", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r738", "r820" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r225", "r226", "r227", "r270", "r620", "r676", "r684", "r691", "r692", "r693", "r694", "r695", "r696", "r699", "r702", "r703", "r704", "r705", "r706", "r707", "r708", "r709", "r710", "r712", "r713", "r714", "r715", "r716", "r718", "r721", "r722", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r738", "r820" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r839", "r850", "r860", "r885" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "verboseLabel": "Share issuance and equity-based compensation plans", "label": "Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture", "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [] }, "kwr_StockOptionsCompensationExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "StockOptionsCompensationExpenseMember", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationSharebasedCompensationExpenseDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock options", "label": "Stock Options Compensation Expense [Member]", "documentation": "The amount of equity based compensation cost recognized during the period in selling, general and administrative expense for the stock options plan." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Quaker shareholders\u2019 equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r119", "r122", "r123", "r140", "r701", "r717", "r739", "r740", "r814", "r829", "r926", "r934", "r977", "r1006" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets", "http://www.quakerchem.com/role/CondensedConsolidatedStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r83", "r84", "r86", "r179", "r180", "r209", "r225", "r226", "r227", "r231", "r241", "r304", "r309", "r402", "r523", "r524", "r525", "r535", "r536", "r562", "r563", "r564", "r565", "r566", "r568", "r573", "r587", "r589", "r593", "r615", "r663", "r664", "r681", "r701", "r717", "r739", "r740", "r761", "r828", "r926", "r934", "r977", "r1006" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.quakerchem.com/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.quakerchem.com/role/AccumulatedOtherComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r151", "r221", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r570", "r741", "r742", "r762" ] }, "us-gaap_SubleaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubleaseIncome", "crdr": "credit", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sublease income", "label": "Sublease Income", "documentation": "Amount of sublease income excluding finance and operating lease expense." } } }, "auth_ref": [ "r608", "r813" ] }, "srt_SubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SubsidiariesMember", "presentation": [ "http://www.quakerchem.com/role/BasisofPresentationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Argentina", "label": "Subsidiaries [Member]" } } }, "auth_ref": [ "r969", "r989", "r990", "r991" ] }, "kwr_SupplementalBalanceSheetInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "SupplementalBalanceSheetInformationAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental balance sheet information", "label": "Supplemental balance sheet information", "documentation": "Supplemental balance sheet information" } } }, "auth_ref": [] }, "kwr_SupplementalCashFlowInformationRelatedToLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "SupplementalCashFlowInformationRelatedToLeasesAbstract", "presentation": [ "http://www.quakerchem.com/role/LeasesSupplementalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental cash flow information related to leases", "label": "Supplemental cash flow information related to leases", "documentation": "Supplemental cash flow information related to leases" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r879" ] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product technologies", "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r23" ] }, "kwr_TopFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "TopFiveMember", "presentation": [ "http://www.quakerchem.com/role/NetSalesandRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Top Five Customers", "label": "Customer Concentration Risk Top Five [Member]", "documentation": "Reflects the percentage that revenues in the period from the entity's top five customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r871" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r878" ] }, "kwr_TrademarksFormulationsandproducttechnologymemberMember": { "xbrltype": "domainItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "TrademarksFormulationsandproducttechnologymemberMember", "presentation": [ "http://www.quakerchem.com/role/GoodwillandOtherIntangibleAssetsGrossCarryingAmountsandAccumulatedAmortizationforDefinitelivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks, formulations and product technology", "label": "Trademarks Formulations And Product Technology [Member]", "documentation": "Trademarks Formulations And Product Technology [Member]" } } }, "auth_ref": [] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://www.quakerchem.com/role/BusinessAcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks", "label": "Trademarks [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r79" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r898" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r900" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.quakerchem.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r901" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r902" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r900" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r900" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r903" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r901" ] }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareBasicDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: income allocated to participating securities", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic", "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r259", "r262", "r263" ] }, "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted", "crdr": "debit", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: income allocated to participating securities", "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted", "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method." } } }, "auth_ref": [ "r259", "r262", "r263", "r906" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r897" ] }, "us-gaap_VariableLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableLeaseCost", "crdr": "debit", "presentation": [ "http://www.quakerchem.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable lease cost", "label": "Variable Lease, Cost", "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases." } } }, "auth_ref": [ "r607", "r813" ] }, "kwr_Vestingsharestargetlowerpercent": { "xbrltype": "percentItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "Vestingsharestargetlowerpercent", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting shares target lower (as a percent)", "label": "Vesting Shares Target Lower Percent", "documentation": "Vesting Shares Target Lower Percent" } } }, "auth_ref": [] }, "kwr_Vestingsharestargetupperpercent": { "xbrltype": "percentItemType", "nsuri": "http://www.quakerchem.com/20240331", "localname": "Vestingsharestargetupperpercent", "presentation": [ "http://www.quakerchem.com/role/ShareBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting shares target upper (as a percent)", "label": "Vesting Shares Target Upper Percent", "documentation": "Vesting Shares Target Upper Percent" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Diluted weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r249", "r265" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.quakerchem.com/role/EarningsPerShareBasicDetails", "http://www.quakerchem.com/role/EarningsPerShareDilutedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic weighted average common shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r247", "r265" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479613/805-30-35-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "835", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-6" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "610", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//610/tableOfContent" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "720", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//720/tableOfContent" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.13,16)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "40", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "65", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-65" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "66", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-66" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//420/tableOfContent" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r779": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r780": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r781": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8" }, "r783": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r784": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r785": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r786": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r787": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r788": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r789": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r790": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r791": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r792": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r793": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r794": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r795": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r796": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r797": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r798": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r799": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r802": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r803": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r804": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r805": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r806": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r807": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r808": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r809": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r810": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r811": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r812": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r813": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r814": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r815": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r816": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r817": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r819": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r823": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r824": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r825": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r826": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r827": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r828": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r829": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r843": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r844": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r845": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r846": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r847": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r848": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r849": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r850": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r851": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r852": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r853": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r854": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r855": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r856": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r857": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r858": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r859": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r860": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r861": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r862": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r863": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r864": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r865": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r866": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r867": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r868": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r869": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r870": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r871": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r872": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r873": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r874": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r875": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r876": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r877": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r878": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r879": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r880": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r881": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r882": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r883": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r884": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r885": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r886": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r887": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r888": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r889": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r890": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r891": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r892": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r893": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r894": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r895": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r896": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r897": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r898": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r899": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r900": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r901": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r902": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r903": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r904": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r905": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r906": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "325", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481551/325-30-35-2" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r943": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r944": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r945": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r946": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r947": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r948": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r949": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5" }, "r950": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r951": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r952": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r953": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r954": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r955": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r956": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r957": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r958": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r959": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r960": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r961": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r962": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r963": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r964": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r965": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r966": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r967": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r968": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r969": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r970": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r971": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r972": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r973": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r974": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r975": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r976": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r977": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r978": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r979": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r980": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r981": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r982": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r983": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1" }, "r984": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r985": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r986": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r987": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r988": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r989": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r990": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r991": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r992": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r993": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r994": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r995": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r996": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r997": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r998": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r999": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1000": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1001": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1002": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1003": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r1004": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1005": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r1006": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1007": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1008": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1009": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 96 0000081362-24-000058-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000081362-24-000058-xbrl.zip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end XML 98 kwr-20240331_htm.xml IDEA: XBRL DOCUMENT 0000081362 2024-01-01 2024-03-31 0000081362 2024-04-30 0000081362 2023-01-01 2023-03-31 0000081362 2024-03-31 0000081362 2023-12-31 0000081362 2022-12-31 0000081362 2023-03-31 0000081362 us-gaap:CommonStockMember 2022-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000081362 us-gaap:RetainedEarningsMember 2022-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2022-12-31 0000081362 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2022-07-01 2022-09-30 0000081362 2022-07-01 2022-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0000081362 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000081362 us-gaap:CommonStockMember 2022-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000081362 us-gaap:RetainedEarningsMember 2022-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2022-09-30 0000081362 2022-09-30 0000081362 us-gaap:CommonStockMember 2023-12-31 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000081362 us-gaap:RetainedEarningsMember 2023-12-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000081362 us-gaap:NoncontrollingInterestMember 2023-12-31 0000081362 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0000081362 2023-07-01 2023-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000081362 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000081362 us-gaap:CommonStockMember 2023-09-30 0000081362 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000081362 us-gaap:RetainedEarningsMember 2023-09-30 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0000081362 us-gaap:NoncontrollingInterestMember 2023-09-30 0000081362 2023-09-30 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-03-31 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-03-31 0000081362 srt:SubsidiariesMember kwr:ArgentineAndTurkishSubsidiariesMember 2024-01-01 2024-03-31 0000081362 srt:SubsidiariesMember country:AR 2023-01-01 2023-03-31 0000081362 kwr:I.K.V.TribologieIKVTMember 2024-02-01 2024-02-29 0000081362 kwr:I.K.V.TribologieIKVTMember 2024-02-29 0000081362 kwr:I.K.V.TribologieIKVTMember us-gaap:CustomerRelationshipsMember 2024-02-29 0000081362 kwr:I.K.V.TribologieIKVTMember us-gaap:CustomerRelationshipsMember 2024-02-01 2024-02-29 0000081362 kwr:I.K.V.TribologieIKVTMember us-gaap:TechnologyBasedIntangibleAssetsMember 2024-02-29 0000081362 kwr:I.K.V.TribologieIKVTMember us-gaap:TechnologyBasedIntangibleAssetsMember 2024-02-01 2024-02-29 0000081362 kwr:I.K.V.TribologieIKVTMember us-gaap:TrademarksMember 2024-02-29 0000081362 kwr:I.K.V.TribologieIKVTMember us-gaap:TrademarksMember 2024-02-01 2024-02-29 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2024-01-01 2024-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AmericasMember 2023-01-01 2023-03-31 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2024-01-01 2024-03-31 0000081362 us-gaap:IntersegmentEliminationMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2024-01-01 2024-03-31 0000081362 us-gaap:IntersegmentEliminationMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0000081362 kwr:TopFiveMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0000081362 kwr:LargestCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-06-30 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AmericasMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember us-gaap:EMEAMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AsiaPacificMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember 2024-01-01 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AmericasMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalsMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AmericasMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember us-gaap:EMEAMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember srt:AsiaPacificMember 2023-01-01 2023-03-31 0000081362 us-gaap:OperatingSegmentsMember kwr:MetalworkingAndOtherMember 2023-01-01 2023-03-31 0000081362 kwr:FacilitiesVehiclesAndMachineryAndEquipmentMember 2024-03-31 0000081362 us-gaap:LandMember 2024-03-31 0000081362 us-gaap:RestructuringChargesMember 2023-12-31 0000081362 us-gaap:RestructuringChargesMember 2024-01-01 2024-03-31 0000081362 us-gaap:RestructuringChargesMember 2024-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2024-01-01 2024-03-31 0000081362 kwr:StockOptionsCompensationExpenseMember 2023-01-01 2023-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2024-01-01 2024-03-31 0000081362 kwr:NonvestedStockAwardsCompensationExpenseMember 2023-01-01 2023-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2024-01-01 2024-03-31 0000081362 kwr:DirectorsStockOwnershipPlanCompensationExpenseMember 2023-01-01 2023-03-31 0000081362 us-gaap:PerformanceSharesMember 2024-01-01 2024-03-31 0000081362 us-gaap:PerformanceSharesMember 2023-01-01 2023-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2024-03-31 0000081362 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-03-31 0000081362 us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000081362 srt:MinimumMember us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000081362 srt:MaximumMember us-gaap:RestrictedStockMember 2024-01-01 2024-03-31 0000081362 us-gaap:RestrictedStockMember 2024-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0000081362 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0000081362 srt:MaximumMember us-gaap:PerformanceSharesMember 2024-01-01 2024-03-31 0000081362 kwr:PerformanceStockUnitsROICMember 2024-01-01 2024-03-31 0000081362 kwr:PerformanceStockUnitsROICMember 2024-03-31 0000081362 us-gaap:PerformanceSharesMember 2024-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2024-01-01 2024-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2023-01-01 2023-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-01-01 2024-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2023-01-01 2023-03-31 0000081362 us-gaap:PensionPlansDefinedBenefitMember 2024-03-31 0000081362 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember srt:AmericasMember 2023-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember us-gaap:EMEAMember 2023-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:ScenarioPreviouslyReportedMember srt:AsiaPacificMember 2023-12-31 0000081362 srt:ScenarioPreviouslyReportedMember 2023-12-31 0000081362 us-gaap:OperatingSegmentsMember srt:AmericasMember 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember us-gaap:EMEAMember 2024-03-31 0000081362 us-gaap:OperatingSegmentsMember srt:AsiaPacificMember 2024-03-31 0000081362 us-gaap:CustomerListsMember 2024-03-31 0000081362 us-gaap:CustomerListsMember 2023-12-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2024-03-31 0000081362 kwr:TrademarksFormulationsandproducttechnologymemberMember 2023-12-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2024-03-31 0000081362 us-gaap:OtherIntangibleAssetsMember 2023-12-31 0000081362 kwr:HoughtonCombinationMember 2023-12-31 0000081362 kwr:AmendedRevolverMember 2024-03-31 0000081362 kwr:AmendedRevolverMember 2023-12-31 0000081362 kwr:AmendedUsTermLoanMember 2024-03-31 0000081362 kwr:AmendedUsTermLoanMember 2023-12-31 0000081362 kwr:AmendedEuroTermLoanMember 2024-03-31 0000081362 kwr:AmendedEuroTermLoanMember 2023-12-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2024-03-31 0000081362 kwr:IndustrialDevelopmentBondsMember 2023-12-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2024-03-31 0000081362 kwr:BankLinesOfCreditAndOtherDebtObligationsMember 2023-12-31 0000081362 kwr:AmendedEuroTermLoanMember 2022-12-31 0000081362 kwr:AmendedUsTermLoanMember 2022-12-31 0000081362 kwr:AmendedRevolverMember 2022-12-31 0000081362 kwr:AmendedCreditFacilityMember 2022-12-31 0000081362 kwr:OriginalCreditFacilityAndTheAmendedCreditFacilityMember 2024-01-01 2024-03-31 0000081362 kwr:OldCreditFacilityMember 2024-03-31 0000081362 srt:MinimumMember kwr:AmendedCreditFacilityMember 2024-01-01 2024-03-31 0000081362 srt:MaximumMember kwr:AmendedCreditFacilityMember 2024-01-01 2024-03-31 0000081362 us-gaap:RevolvingCreditFacilityMember us-gaap:LetterOfCreditMember 2024-03-31 0000081362 kwr:AmendedRevolverMember us-gaap:LetterOfCreditMember 2024-03-31 0000081362 us-gaap:InterestRateSwapMember 2023-09-30 0000081362 us-gaap:InterestRateSwapMember 2023-07-01 2023-09-30 0000081362 us-gaap:InterestRateSwapMember 2024-03-31 0000081362 us-gaap:OtherAssetsMember kwr:AmendedRevolverMember 2022-12-31 0000081362 us-gaap:OtherAssetsMember 2024-03-31 0000081362 us-gaap:OtherAssetsMember 2023-12-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2024-03-31 0000081362 us-gaap:CorporateBondSecuritiesMember 2023-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-01-01 2024-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-01-01 2024-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-01-01 2024-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2024-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2024-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-12-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-01-01 2023-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-01-01 2023-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0000081362 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0000081362 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0000081362 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2023-03-31 0000081362 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0000081362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000081362 2023-06-01 2023-06-30 0000081362 currency:MXN 2024-03-31 0000081362 currency:JPY 2024-03-31 0000081362 currency:CNY 2024-03-31 0000081362 us-gaap:ForeignExchangeForwardMember 2024-01-01 2024-03-31 0000081362 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2024-01-01 2024-03-31 0000081362 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2023-01-01 2023-06-30 0000081362 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2023-01-01 2023-09-30 0000081362 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2024-01-01 2024-03-31 0000081362 us-gaap:InterestRateSwapMember 2024-01-01 2024-03-31 0000081362 us-gaap:InterestRateSwapMember 2023-01-01 2023-06-30 0000081362 us-gaap:InterestExpenseMember 2024-01-01 2024-03-31 0000081362 us-gaap:InterestExpenseMember 2023-01-01 2023-03-31 0000081362 us-gaap:NonoperatingIncomeExpenseMember 2024-01-01 2024-03-31 0000081362 us-gaap:NonoperatingIncomeExpenseMember 2023-01-01 2023-03-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2023-12-31 0000081362 kwr:HoughtonEnvironmentalMattersMember 2024-03-31 0000081362 srt:MinimumMember kwr:CoralChemicalCompanyMember 2024-03-31 0000081362 srt:MaximumMember kwr:CoralChemicalCompanyMember 2024-03-31 shares iso4217:USD iso4217:USD shares kwr:country kwr:segment pure iso4217:EUR kwr:position 0000081362 --12-31 2024 Q1 false P1Y P1Y 10-Q true 2024-03-31 false 001-12019 QUAKER CHEMICAL CORPORATION PA 23-0993790 901 E. Hector Street Conshohocken PA 19428 – 2380 610 832-4000 Common Stock, $1 par value KWR NYSE Yes Yes Large Accelerated Filer false false false 17989892 469759000 500148000 288196000 326698000 181563000 173450000 124180000 119549000 1857000 3972000 55526000 49929000 1080000 -2239000 -10824000 -13242000 45782000 34448000 12508000 9533000 33274000 24915000 1984000 4626000 35258000 29541000 31000 7000 35227000 29534000 1.96 1.64 1.95 1.64 0.455 0.435 35258000 29541000 -25389000 14468000 -354000 126000 2345000 390000 45000 334000 -22645000 15066000 12613000 44607000 -42000 10000 12655000 44597000 195750000 194527000 440018000 444950000 116411000 119047000 124055000 114810000 56795000 54555000 933029000 927889000 445118000 453419000 242888000 245608000 202230000 207811000 38195000 38614000 522575000 512518000 886146000 896721000 99850000 101151000 10117000 10737000 22228000 18770000 2714370000 2714211000 27790000 23444000 191161000 184813000 8185000 8186000 28024000 55194000 1516000 3350000 2210000 2208000 91341000 90315000 350227000 367510000 740408000 730623000 22819000 22937000 150618000 146957000 28931000 29457000 29575000 31805000 1322578000 1329289000 1 1 30000000 30000000 17989801 17989801 17991988 17991988 17990000 17992000 942546000 940101000 577682000 550641000 -146987000 -124415000 1391231000 1384319000 561000 603000 1391792000 1384922000 2714370000 2714211000 35258000 29541000 353000 353000 20802000 20246000 1675000 4401000 568000 -2231000 3884000 3527000 1857000 3972000 -551000 -415000 -1431000 3974000 6576000 5792000 1054000 6765000 -3666000 -2747000 -23400000 6468000 27231000 37782000 4460000 6161000 24899000 0 58000 0 -29301000 -6161000 4711000 4703000 20902000 -9776000 0 -469000 8186000 7809000 -1442000 -2109000 6563000 -24866000 -3270000 2154000 1223000 8909000 194527000 180963000 195750000 189872000 17950000 928288000 469920000 -138240000 667000 1278585000 29534000 7000 29541000 15063000 3000 15066000 0.435 7822000 7822000 32000 1386000 1418000 17982000 929674000 491632000 -123177000 677000 1316788000 17992000 940101000 550641000 -124415000 603000 1384922000 35227000 31000 35258000 -22572000 -73000 -22645000 0.455 8186000 8186000 -2000 2445000 2443000 17990000 942546000 577682000 -146987000 561000 1391792000 Basis of Presentation and Description of Business<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in these Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the “Report”), the terms “Quaker Houghton,” the “Company,” “we,” and “our” refer to Quaker Chemical Corporation (doing business as Quaker Houghton), its subsidiaries, and associated companies, unless the context otherwise requires.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting of normal recurring adjustments which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2023 (as amended, the “2023 Form 10-K”).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of Business</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was organized in 1918 and incorporated as a Pennsylvania business corporation in 1930. Quaker Houghton is the global leader in industrial process fluids. With a presence around the world, including operations in over 25 countries, the Company’s customers include thousands of the world’s most advanced and specialized steel, aluminum, automotive, aerospace, offshore, container, mining, and metalworking companies. Quaker Houghton develops, produces, and markets a broad range of formulated chemical specialty products and offers chemical management services, which the Company refers to as Fluidcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for various heavy industrial and manufacturing applications sold in its three reportable segments: (i) Americas; (ii) Europe, Middle East and Africa (“EMEA”); and (iii) Asia/Pacific.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hyper-inflationary economies</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three months ended March 31, 2024, the Company's Argentine and Turkish subsidiaries together represented 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three months ended March 31, 2024 and 2023, the Company recorded $0.9 million of remeasurement gains and $0.5 million of remeasurement losses associated with the applicable currency conversions, respectively. These gains and losses were recorded within Other income (expense), net, in the Company’s Condensed Consolidated Statements of Operations.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements included herein are unaudited and have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial reporting and the United States Securities and Exchange Commission (“SEC”) regulations. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the financial statements reflect all adjustments consisting of normal recurring adjustments which are necessary for a fair statement of the financial position, results of operations and cash flows for the interim periods. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the Company’s Annual Report filed on Form 10-K for the year ended December 31, 2023 (as amended, the “2023 Form 10-K”).</span></div> 25 3 <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hyper-inflationary economies</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Argentina’s and Türkiye’s economies were considered hyper-inflationary under U.S. GAAP effective July 1, 2018 and April 1, 2022, respectively. As of, and for the three months ended March 31, 2024, the Company's Argentine and Turkish subsidiaries together represented 1% and 2% of the Company’s consolidated total assets and net sales, respectively. During the three months ended March 31, 2024 and 2023, the Company recorded $0.9 million of remeasurement gains and $0.5 million of remeasurement losses associated with the applicable currency conversions, respectively. These gains and losses were recorded within Other income (expense), net, in the Company’s Condensed Consolidated Statements of Operations.</span></div> 0.01 0.01 0.02 0.02 -900000 500000 Business Acquisitions<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During February 2024, the Company acquired I.K.V. Tribologie IKVT and its subsidiaries (“IKV”) for 32.2 million EUR, or $34.6 million, including an initial cash payment of 27.6 million EUR, or $29.7 million, subject to routine and customary post-closing adjustments related to working capital and net indebtedness levels as well as earn-out provisions related to the finalization of 2023 earnings currently estimated at 4.6 million EUR, or $4.9 million, that is payable during 2024. Assets acquired included approximately $4.8 million of cash and cash equivalents. IKV, which will be part of the Company’s EMEA segment, specializes in high-performance lubricants and greases, including original equipment manufacturer first-fill greases that are primarily used in the automotive, aerospace, electronics, and other industrial markets. The acquisition of IKV strengthens the Company’s position in first-fill greases. The Company preliminarily allocated $15.0 million of the purchase price to intangible assets, comprised of approximately $11.1 million of customer relationships to be amortized over 16 years; $3.2 million of product technologies to be amortized over 14 years; and $0.7 million of trademarks to be amortized over 5 years. In addition, the Company recognized $16.0 million of goodwill in the EMEA segment, none of which is deductible for tax purposes. The goodwill recognized on the transaction is primarily attributable to expected cost and growth synergies. As of March 31, 2024, the allocation of the purchase price has not been finalized.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations of IKV subsequent to the acquisition date are included in the unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2024.</span></div> 32200000 34600000 27600000 29700000 4600000 4900000 4800000 15000000 11100000 P16Y 3200000 P14Y 700000 P5Y 16000000 Recently Issued Accounting Standards<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards Not Yet Adopted</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in November 2023. This ASU expands on reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The disclosure specifies that significant segment expenses are expenses that are regularly provided to the chief operating decision maker and are used to evaluate performance by segment to make decisions about resource allocations. ASU 2023-07 is effective for annual reports for fiscal years beginning after December 15, 2023, with early adoption permitted. The Company is currently evaluating the disclosure requirements of this standard and the impact on its Consolidated Financial Statements and related disclosures.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FASB issued ASU 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in December 2023. This ASU requires public business entities to disclose additional information in specified categories with respect to the reconciliation of the effective tax rate to the statutory rate (the “rate reconciliation”) for federal, state, and foreign income taxes. It also requires greater detail about individual reconciling items in the rate reconciliation to the extent the impact of those items exceeds a specified threshold. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The Company is currently evaluating the disclosure requirements of this standard and the impact on its Consolidated Financial Statements.</span></div> Business Segments<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating segments, which are consistent with its reportable segments, reflect the structure of the Company’s internal organization, the method by which the Company’s resources are allocated and the manner by which the chief operating decision maker assesses the Company’s performance. The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific. The three segments are composed of the net sales and operations in each respective region.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related Cost of goods sold (“COGS”), and Selling, general and administrative expenses (“SG&amp;A”). Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs and Restructuring and related charges, net, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense, net and Other income (expense), net.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the performance of the Company’s reportable segments for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:73.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">251,413 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138,422 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,449 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">469,759 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500,148 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment operating earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total segment operating earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,718 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121,348 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related charges, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-operating and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(54,177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of corporate assets and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,526 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,929 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income before taxes and equity in net income of associated companies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,782 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,448 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables. The following table summarizes inter-segment revenues for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:73.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.898%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inter-segment revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,827 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 3 3 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about the performance of the Company’s reportable segments for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:73.587%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">251,413 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138,422 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,449 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total net sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">469,759 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500,148 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment operating earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,770 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,377 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total segment operating earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,718 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121,348 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related charges, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,972)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-operating and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(54,177)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51,771)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation of corporate assets and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,526 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,929 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,080 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13,242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income before taxes and equity in net income of associated companies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45,782 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,448 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All inter-segment transactions have been eliminated from each reportable segment’s net sales and earnings for all periods presented in the above tables. The following table summarizes inter-segment revenues for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:73.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.898%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inter-segment revenues</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,827 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,093 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 229754000 251413000 138422000 152449000 101583000 96286000 469759000 500148000 66770000 66125000 29571000 27571000 30377000 27652000 126718000 121348000 1857000 3972000 54177000 51771000 15158000 15676000 55526000 49929000 1080000 -2239000 -10824000 -13242000 45782000 34448000 2513000 2827000 7060000 6093000 1131000 59000 Net Sales and Revenue Recognition<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements Resulting in Net Reporting</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company’s Fluidcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business, certain third-party product sales to customers are managed by the Company. The Company transferred third-party products under arrangements recognized on a net reporting basis of $19.8 million and $20.7 million for the three months ended March 31, 2024 and 2023, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Customer Concentration</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of the Company’s revenues are realized from the sale of process fluids and services to manufacturers of steel, aluminum, automobiles, aerospace, industrial and agricultural equipment, and durable goods. As previously disclosed in the Company’s 2023 Form 10-K, the Company’s five largest customers combined (each composed of multiple subsidiaries or divisions with semiautonomous purchasing authority) accounted for approximately 12% of consolidated net sales for 2023, with its largest customer accounting for approximately 3% of consolidated net sales.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no material contract assets recorded on its Condensed Consolidated Balance Sheets as of March 31, 2024 or December 31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had approximately $4.0 million and $4.5 million of deferred revenue as of March 31, 2024 and December 31, 2023, respectively. For the three months ended March 31, 2024, the Company satisfied materially all of the associated performance obligations and recognized into revenue materially all advance payments received and recorded as of December 31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells its various industrial process fluids, its specialty chemicals and its technical expertise as a global product portfolio. The Company generally manages and evaluates its performance by reportable segment first, and then by customer industries. Net sales of each of the Company’s major product lines are generally spread throughout all three of the Company’s geographic regions, and in most cases, are approximately proportionate to the level of total sales in each region.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company’s net sales by segment and customer industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,820 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,728 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138,422 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101,583 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">469,759 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,660 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153,897 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">183,279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113,346 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">346,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">251,413 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,449 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96,286 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500,148 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 19800000 20700000 0.12 0.03 4000000 4500000 3 <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables disaggregate the Company’s net sales by segment and customer industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66,026 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,820 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,911 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,728 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,602 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50,672 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320,002 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229,754 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138,422 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101,583 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">469,759 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.969%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Customer Industries</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated<br/>Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,103 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46,660 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153,897 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metalworking and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">183,279 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113,346 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">346,251 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">251,413 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,449 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96,286 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500,148 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 66026000 32820000 50911000 149757000 163728000 105602000 50672000 320002000 229754000 138422000 101583000 469759000 68134000 39103000 46660000 153897000 183279000 113346000 49626000 346251000 251413000 152449000 96286000 500148000 Leases<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for certain facilities, vehicles, and machinery and equipment with remaining lease terms up to 11 years. Operating lease expense is recognized on a straight-line basis over the lease term. In addition, the Company has certain land use leases with remaining lease terms up to 91 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no material variable lease costs, sublease income, or finance leases for the three months ended March 31, 2024 and 2023. The components of the Company’s lease expense are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:73.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,936 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company’s leases for the three months ended March 31, 2024 and 2023 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:73.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-cash lease liabilities activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to the Company’s leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:73.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,614 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,818 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,965 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,902 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of March 31, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,864 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,165 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,402 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2029 and beyond</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,586 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,637 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P11Y P91Y 0 0 0 0 0 0 0 0 The components of the Company’s lease expense are as follows:<div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:73.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,936 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">199 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">211 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company’s leases for the three months ended March 31, 2024 and 2023 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:73.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-cash lease liabilities activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,833 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to the Company’s leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:73.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right of use lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,195 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,614 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,818 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,965 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,937 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,637 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,902 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.91 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div> 3743000 3936000 199000 211000 3661000 3857000 3234000 2833000 38195000 38614000 11818000 11965000 22819000 22937000 34637000 34902000 P5Y P5Y1M6D 0.0521 0.0491 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of operating lease liabilities as of March 31, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.938%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.862%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,864 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,552 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,165 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,402 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2029 and beyond</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,262 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,586 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34,637 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 10341000 9864000 7552000 4165000 2402000 5262000 39586000 4949000 34637000 Restructuring and Related Activities<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the Company initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. As of March 31, 2024, the program included restructuring and associated severance costs to reduce headcount by approximately 120 positions globally. These headcount reductions began in the fourth quarter of 2022 and are expected to be completed in 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee separation benefits vary depending on local regulations within certain foreign countries and include severance and other benefits. The exact timing to complete, and final costs associated with, all actions will depend on a number of factors and are subject to change. Restructuring costs incurred during the three months ended March 31, 2024 and 2023 include employee severance and facility closure costs that are recorded in Restructuring and related charges, net in the Company’s Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company’s accruals for its restructuring program are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:86.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued restructuring as of December 31, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 2.62pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,350</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,666)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued restructuring as of March 31, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,516</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the plans for closure of certain manufacturing and non-manufacturing facilities, the Company has made available for sale certain facilities and property. As of March 31, 2024, the Company classified certain properties with aggregate book value of approximately $3.7 million as held-for-sale. These assets are recorded in Prepaid expenses and other current assets on the Company’s Condensed Consolidated Balance Sheets. The Company expects to complete the sale of these properties over the next 12 months.</span></div> 120 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company’s accruals for its restructuring program are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:86.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued restructuring as of December 31, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 2.62pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,350</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and related charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,666)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued restructuring as of March 31, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,516</span></td></tr></table></div> 3350000 1857000 3666000 25000 1516000 3700000 Share-Based Compensation<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:74.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">431</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested stock awards and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,535</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,171</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director stock ownership plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,144</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">915</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,884</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,527</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, unrecognized compensation expense related to unvested stock options was $0.1 million, to be recognized over a weighted average remaining period of 1.0 year.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Awards</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, the Company granted 872 non-vested restricted share awards under its long-term incentive plan (“LTIP”)</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which are subject to time-based vesting, generally over <span style="-sec-ix-hidden:f-441">one</span> to three years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of March 31, 2024, unrecognized compensation expense related to the non-vested restricted shares was $4.3 million, to be recognized over a weighted average remaining period of 1.3 years.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Restricted Stock Units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, the Company granted 41,093 restricted stock units under its LTIP</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which are subject to time-based vesting, generally over <span style="-sec-ix-hidden:f-446">one</span> to three years.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of these grants is based on the closing price of the Company’s common stock on the date of grant. As of March 31, 2024, unrecognized compensation expense related to non-vested restricted stock units was $8.8 million, to be recognized over a weighted average remaining period of 1.9 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Stock Units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a component of its LTIP, the Company grants performance-based stock unit awards (“PSUs”). The number of shares that may ultimately be issued as settlement for each award may range from 0% up to 200% of the target award, subject to the achievement of the Company’s market-based total shareholder return (“TSR”) metric relative to the performance of a selected peer group, and separately the achievement of a performance-based return on invested capital (“ROIC”) measure. The service vesting period required for the PSUs is generally </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three years</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the measurement period of the market-based and performance objectives is generally from January 1 of the year of grant through December 31 of the year prior to issuance of the shares.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As mentioned above, a portion of the Company’s PSU valuation is subject to the achievement of the Company’s TSR relative to the performance of a selected peer group. For PSUs granted prior to 2024, the Company’s peer group was the S&amp;P Midcap 400 Materials group. For the 2024 annual LTIP grants, the Company made an election to change peer groups to the S&amp;P 1500 Chemical group to measure the Company’s relative TSR.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation expense for PSUs is measured based on the grant date fair value and is recognized on a straight-line vesting method basis over the applicable vesting period. In the first quarter of 2024, the Company granted 17,970 PSUs with a ROIC condition at a grant date fair value of $200.16 per unit, which was based on the closing trading price of the Company’s common stock on the date of grant. PSUs granted with a relative TSR condition are valued using a Monte Carlo simulation on the date of grant. The grant-date fair value of the PSUs valued using a Monte Carlo simulation was $234.19 per unit, which incorporated the assumptions set forth in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:86.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024<br/>Grants </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of PSUs granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,850</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.55%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.91%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, there was approximately $13.4 million of total unrecognized compensation cost related to PSUs, which the Company expects to recognize over a weighted-average period of 2.5 years.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized the following share-based compensation expense in its Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:74.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">431</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-vested stock awards and restricted stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,535</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,171</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director stock ownership plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance stock units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,144</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">915</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,884</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,527</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 175000 431000 2535000 2171000 30000 10000 1144000 915000 3884000 3527000 100000 P1Y 872 P3Y 4300000 P1Y3M18D 41093 P3Y 8800000 P1Y10M24D 0 2 P3Y 17970 200.16 The grant-date fair value of the PSUs valued using a Monte Carlo simulation was $234.19 per unit, which incorporated the assumptions set forth in the table below:<div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.166%"><tr><td style="width:1.0%"></td><td style="width:86.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024<br/>Grants </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of PSUs granted</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,850</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.55%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.91%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0</span></td></tr></table></div> 234.19 17850 0.0455 0.0091 P3Y 13400000 P2Y6M Pension and Other Postretirement Benefits<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) are as follows for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:49.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Postretirement Benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,375</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,455</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,997)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial loss (gain) amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service cost (income) amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">588 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">671</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employer Contributions</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, $0.9 million and less than $0.1 million of contributions have been made to the Company’s U.S. and foreign pension plans and its other postretirement benefit plans, respectively. Taking into consideration current minimum cash contribution requirements, the Company currently expects to make full year cash contributions of approximately $5.7 million to its U.S. and foreign pension plans and approximately $0.2 million to its other postretirement benefit plans in 2024.</span></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) are as follows for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:49.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.861%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pension Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Postretirement Benefits</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,375</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,455</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,997)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial loss (gain) amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior service cost (income) amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">588 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">671</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 109000 104000 0 0 2375000 2455000 15000 19000 2030000 1997000 0 0 -127000 -101000 29000 30000 7000 8000 0 -4000 588000 671000 -14000 -15000 900000 5700000 200000 Other income (expense), net<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other income (expense), net are as follows for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-income tax refunds and other related credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,155</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from third party license fees</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">325</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) on disposals of property, plant, equipment and other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">407</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit costs, non-service components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility remediation recoveries, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">827</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product liability claim</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-operating income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,080</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,239)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, two of the Company’s locations suffered property damages as a result of flooding and electrical fire, respectively. Facility remediation recoveries, net, during the three months ended March 31, 2023, reflect recoveries recorded on the payments received from insurers related to previously incurred costs from the remediation and restoration of property damage. See Note 18 of Notes to the Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product liability claim costs includes recorded expense related to the payment of a product liability dispute with one of the Company’s customers during the three months ended March 31, 2024.</span></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other income (expense), net are as follows for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-income tax refunds and other related credits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,155</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income from third party license fees</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">325</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) on disposals of property, plant, equipment and other assets, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">407</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange losses, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(448)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,326)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension and postretirement benefit costs, non-service components</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility remediation recoveries, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">827</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product liability claim</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-operating income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 3.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 3.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,080</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 3.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,239)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 2155000 360000 225000 325000 407000 -19000 -448000 -3326000 -465000 -552000 0 827000 896000 0 102000 146000 1080000 -2239000 Income Taxes<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s effective tax rates for the three months ended March 31, 2024 and 2023 were 27.3% and 27.7%, respectively. The Company’s effective tax rate for the three months ended March 31, 2024 was largely driven by a mix of earnings and withholding taxes, offset by changes in uncertain tax positions. Comparatively, the effective tax rate for the first three months of 2023 was largely impacted by foreign tax inclusions, withholding taxes, and foreign tax credits, partially offset with changes in uncertain tax positions and favorable return to provision adjustments.</span></div> 0.273 0.277 Earnings Per Share<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings per share calculations for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,068 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,389 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,866,670</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,069 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,389 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,814</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,866,670</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,048</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,076</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,938,862</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,898,746</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div>Certain stock options, restricted stock units, and PSUs are not included in the diluted earnings per share calculation when the effect would have been anti-dilutive. The calculated amount of anti-diluted shares not included were 39,066 and 15,327 for the three months ended March 31, 2024 and 2023, respectively <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes earnings per share calculations for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,227 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,534 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,068 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,389 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,814</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,866,670</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basic earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.96 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.64 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to Quaker Chemical Corporation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,534 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: income allocated to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income available to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35,069 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,389 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,908,814</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,866,670</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effect of dilutive securities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,048</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32,076</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,938,862</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17,898,746</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.95 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.64 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 35227000 29534000 159000 145000 35068000 29389000 17908814 17866670 1.96 1.64 35227000 29534000 158000 145000 35069000 29389000 17908814 17866670 30048 32076 17938862 17898746 1.95 1.64 39066 15327 Goodwill and Other Intangible Assets<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for the three months ended March 31, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:51.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">283,103</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,940</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,475</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">512,518</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,011 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,954)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of March 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">282,988</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,288</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,299</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">522,575</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:23.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Book Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.32pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer lists and rights to sell</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">843,295</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">841,562</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253,464</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,872</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">589,831</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597,690</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks, formulations and product technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161,613</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,411</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,879</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,980</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,734</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,864</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,892</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,753</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,776</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,012,550</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,009,067</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">316,628</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">305,527</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">695,922</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">703,540</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded amortization expense for the three months ended March 31, 2024 and 2023 as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:74.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,472 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,248</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,158</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,470</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,175</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,835</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,373</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, the Company had indefinite-lived intangible assets for trademarks and tradenames totaling $190.2 million and $193.2 million, respectively.</span></div> <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill for the three months ended March 31, 2024 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:51.055%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Americas</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMEA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Asia/Pacific</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">283,103</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65,940</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,475</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">512,518</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,011 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,011</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,176)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,954)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of March 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">282,988</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,288</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158,299</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">522,575</span></td></tr></table></div> 283103000 65940000 163475000 512518000 0 16011000 0 16011000 -115000 -663000 -5176000 -5954000 282988000 81288000 158299000 522575000 <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross carrying amounts and accumulated amortization for definite-lived intangible assets were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:23.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Book Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.32pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer lists and rights to sell</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">843,295</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">841,562</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253,464</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">243,872</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">589,831</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597,690</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks, formulations and product technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163,391</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161,613</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,411</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,879</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,980</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105,734</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,864</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,892</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,753</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,776</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.32pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total definite-lived intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,012,550</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,009,067</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">316,628</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">305,527</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">695,922</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.32pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">703,540</span></td></tr></table></div> 843295000 841562000 253464000 243872000 589831000 597690000 163391000 161613000 57411000 55879000 105980000 105734000 5864000 5892000 5753000 5776000 111000 116000 1012550000 1009067000 316628000 305527000 695922000 703540000 The Company recorded amortization expense for the three months ended March 31, 2024 and 2023 as follows:<div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:74.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.033%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,472 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 14472000 14513000 <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated annual aggregate amortization expense for the current year and subsequent five years is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:86.799%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 2.07pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 2.07pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43,248</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57,158</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2026</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,470</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2027</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,175</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2028</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,835</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2029</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 2.07pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,373</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 43248000 57158000 56470000 56175000 55835000 55373000 190200000 193200000 Debt<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the Company’s debt:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,806 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Term Loan</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.54%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">557,500 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.71%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">561,250 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Euro Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148,032 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Industrial development bonds</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.26%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.26%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bank lines of credit and other debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">769,632 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">755,612 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,434)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: short-term and current portion of long-term debts</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27,790)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,444)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">740,408 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730,623 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit facilities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During June 2022, the Company, and its wholly owned subsidiary, Quaker Houghton B.V., as borrowers, Bank of America, N.A., as administrative agent, U.S. dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility. The amended credit facility (the “Credit Facility”) established (A) a $150.0 million Euro equivalent senior secured term loan (the “Euro Term Loan”), (B) a $600.0 million senior secured term loan (the “U.S. Term Loan”), and (C) a $500.0 million senior secured revolving credit facility (the “Revolver”), each maturing in June 2027. The Company has the right to increase the amount of the Credit Facility by an aggregate amount not to exceed the greater of $300.0 million or 100% of Consolidated EBITDA, subject to certain conditions including the agreement to provide financing by any lender providing such increase.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, the Company was in compliance with all of the Credit Facility covenants. See Note 19 of Notes to Consolidated Financial Statements in the Company’s 2023 Form 10-K.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average variable interest rate incurred on the outstanding borrowings under the Credit Facility during the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> three months </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended March 31, 2024 was approximately 6.4%. As of March 31, 2024, the interest rate on the outstanding borrowings under the Credit Facility was approximately 6.1%. As part of the Credit Facility, in addition to paying interest on outstanding principal, the Company is also required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio. The Company had unused capacity under the Revolver of approximately $445 million, which is net of bank letters of credit of approximately $3 million, as of March 31, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings to an average fixed rate of 3.64% plus an applicable margin as provided in the Credit Facility based on the Company’s consolidated net leverage ratio. As of March 31, 2024, the aggregate interest rate on the swaps, including the fixed base rate plus the applicable margin, was 5.3%. See Note 17 of Notes to Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with executing the original credit facility in 2019 and the amended Credit Facility during the second quarter of 2022, the Company capitalized an aggregate of $2.2 million of certain third-party and creditor debt issuance costs. Approximately $0.7 million of the capitalized costs were attributed to the Euro Term Loan and U.S. Term Loan. These costs were recorded as a direct offset of Long-term debt on the Condensed Consolidated Balance Sheet. Approximately $1.5 million of the capitalized costs were attributed to the Revolver and recorded within Other assets on the Condensed Consolidated Balance Sheet. These capitalized costs will collectively be amortized into Interest expense over the five year term of the Credit Facility. As of March 31, 2024, the Company had $1.4 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.1 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheet. Comparatively, as of December 31, 2023, the Company had $1.5 million of debt issuance costs recorded as an offset of Long-term debt on the Condensed Consolidated Balance Sheets and $3.3 million of debt issuance costs recorded within Other assets on the Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Industrial development bonds</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024 and December 31, 2023, the Company had fixed rate, industrial development authority bonds totaling $10.0 million in principal amount due in 2028. These bonds have similar covenants to the Credit Facility noted above.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bank lines of credit and other debt obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has certain unsecured bank lines of credit and discounting facilities in certain foreign subsidiaries, which are not collateralized. The Company’s other debt obligations primarily consist of certain domestic and foreign low interest rate or interest-free municipality-related loans, local credit facilities of certain foreign subsidiaries, and capital lease obligations. Total unused capacity under these arrangements as of March 31, 2024 was approximately $34 million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the bank letters of credit described in the “Credit facilities” subsection above, the Company’s other off-balance sheet arrangements include certain financial and other guarantees. The Company’s total bank letters of credit and guarantees outstanding as of March 31, 2024 were approximately $5 million.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense, net</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,282 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,876 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,635 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,229 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the variable interest rates associated with the Credit Facility, as of March 31, 2024 and as of December 31, 2023, the amounts at which the Company’s total debt were recorded are not materially different from their fair market value.</span></div> <div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the components of the Company’s debt:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:48.830%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.002%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest<br/>Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding<br/>Balance</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit Facilities:</span></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolver</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51,806 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30,904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Term Loan</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.54%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">557,500 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.71%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">561,250 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Euro Term Loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.00%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148,032 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.13%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,366 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Industrial development bonds</span></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.26%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.26%</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,000 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bank lines of credit and other debt obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">769,632 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">755,612 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,434)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: short-term and current portion of long-term debts</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(27,790)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23,444)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">740,408 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">730,623 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 0.0500 51806000 0.0513 30904000 0.0654 557500000 0.0671 561250000 0.0500 148032000 0.0513 152366000 0.0526 10000000 0.0526 10000000 2294000 1092000 769632000 755612000 1434000 1545000 27790000 23444000 740408000 730623000 150000000 600000000 500000000 300000000 1 0.064 0.061 0.00150 0.00275 445000000 3000000 300000000 P3Y 0.0364 0.053 2200000 700000 700000 1500000 P5Y 1400000 3100000 1500000 3300000 10000000 10000000 34000000 5000000 <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred the following debt related expenses included within Interest expense, net, in the Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.001%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,282 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,876 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">353 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Total</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,635 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,229 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 11282000 13876000 353000 353000 11635000 14229000 Accumulated Other Comprehensive Income<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined<br/>Benefit<br/>Pension<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>(Loss) Gain in<br/>Available-for-<br/>Sale Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative<br/>Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115,417)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,738)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,407 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(124,415)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of March 31, 2024</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(140,733)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,384)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">378 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,752 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(146,987)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(132,161)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,595)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,484)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(138,240)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of March 31, 2023</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(117,696)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,721)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,150)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">390 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123,177)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the reclassifications from and resulting balances of accumulated other comprehensive income (“AOCI”):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency<br/>Translation<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined<br/>Benefit<br/>Pension<br/>Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrealized<br/>(Loss) Gain in<br/>Available-for-<br/>Sale Securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative<br/>Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2023</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(115,417)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,738)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,407 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(124,415)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive (loss) income before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,316)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,045 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21,888)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of March 31, 2024</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(140,733)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,384)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">378 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,752 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(146,987)</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 10pt;text-indent:-9pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(132,161)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,595)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,484)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(138,240)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss) before Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(243)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,190 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts reclassified from AOCI</span></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(40)</span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related tax amounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Balance as of March 31, 2023</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(117,696)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,721)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,150)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">390 </span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(123,177)</span></td><td style="background-color:#ccedff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -115417000 -10738000 333000 1407000 -124415000 -25316000 320000 63000 3045000 -21888000 0 150000 -7000 0 143000 0 -116000 -11000 -700000 -827000 -140733000 -10384000 378000 3752000 -146987000 -132161000 -4595000 -1484000 0 -138240000 14465000 -243000 462000 506000 15190000 0 76000 -40000 0 36000 0 41000 -88000 -116000 -163000 -117696000 -4721000 -1150000 390000 -123177000 Fair Value Measurements<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company values its company-owned life insurance policies at fair value. During June 2023, the Company surrendered and liquidated $1.9 million of these life insurance policies. As a result, the Company owns an immaterial amount of company-owned life insurance policies as of March 31, 2024 and December 31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, see Note 17 for a description of the Company’s derivative instruments.</span></div> 1900000 Hedging Activities<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s ongoing business operations expose it to various risks, including fluctuating foreign exchange rates and interest rate risk. To manage these risks, the Company periodically enters into derivative financial instruments, such as foreign exchange forward contracts and interest rate swap agreements. The Company does not hold or enter into financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Exchange Forward Contracts</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies. These forward contracts are marked-to-market at each reporting date. Changes in the fair value of the underlying instrument and settlements are recognized in earnings in Other income (expense), net. The fair value of the forward contract is determined from sources independent of the Company, including the financial institutions which are party to the derivative instruments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open foreign exchange forward contracts as of March 31, 2024 were entered into as hedges in Japanese yen and Mexican peso against the U.S. dollar and Chinese yuan against the Euro. As of March 31, 2024, the Company had open foreign exchange forward contracts with notional U.S. dollar values of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:85.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mexican Peso</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,000 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Chinese Yuan</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,800 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open foreign exchange forward contracts as of March 31, 2024 had maturities occurring over a period of one month.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Swaps</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to manage the Company’s exposure to variable interest rate risk associated with the Credit Facility, such as the Secured Overnight Financing Rate (“SOFR”), in the first quarter of 2023, the Company entered into $300.0 million notional amounts of three year interest rate swaps to convert a portion of the Company’s variable rate borrowings into a fixed rate obligation. See Note 14 of Notes to Condensed Consolidated Financial Statements. These interest rate swaps are designated as cash flow hedges and, as such, the contracts are marked-to-market at each reporting date and any unrealized gains or losses are included in AOCI to the extent effective and reclassified to interest expense in the period during which the transaction affects earnings or it becomes probable that the forecasted transaction will not occur.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.933%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.935%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps:</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,873 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,828 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the net unrealized loss deferred to AOCI:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AOCI</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,752 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,407 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and the amount of net gain recognized in the Company’s Condensed Consolidated Statements of Operations related to derivative instruments for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,229 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> As of March 31, 2024, the Company had open foreign exchange forward contracts with notional U.S. dollar values of the following:<div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:85.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.628%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mexican Peso</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41,000 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japanese Yen</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Chinese Yuan</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,800 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56,000 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 41000000 7200000 7800000 56000000 P1M 300000000 P3Y <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance sheet classification and fair values of the Company’s derivative instruments, which are Level 2 measurements, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.933%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.935%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps:</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,873 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,828 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ccedff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts:</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccedff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159 </span></td><td style="background-color:#ccedff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">687 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the net unrealized loss deferred to AOCI:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.866%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March 31,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td colspan="3" style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AOCI</span></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,752 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccedff;padding:0 1pt"></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,407 </span></td><td style="background-color:#ccedff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the location and the amount of net gain recognized in the Company’s Condensed Consolidated Statements of Operations related to derivative instruments for the three months ended March 31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.435%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.916%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.352%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.920%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate swaps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange forward contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,229 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 4873000 1828000 159000 687000 3752000 1407000 1286000 0 943000 293000 2229000 293000 Commitments and Contingencies<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in its 2023 Form 10-K, the Company is party to certain environmental matters and other litigation. See Note 25 of Notes to Consolidated Financial Statements in the Company’s 2023 Form 10-K. During the three months ended March 31, 2024, there have been no significant changes to the facts or circumstances of any of the previously disclosed matters. Although there can be no assurance regarding the outcome of any of the ongoing environmental matters or litigation, the Company believes that it has made adequate accruals for costs and liabilities associated with these matters. The Company has accrued approximately $5 million as of both March 31, 2024 and December 31, 2023, respectively, for these ongoing matters. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company previously disclosed in its 2023 Form 10-K that one of its locations suffered property damage as a result of an electrical fire. The Company and its insurance carrier continue to review the impact of the electrical fire on the production facility’s operations as it relates to a potential business interruption insurance claim; however, as of the date of this Report, the Company cannot reasonably estimate any probable amount of business interruption insurance claim recoverable. Therefore, the Company has not recorded a gain contingency for a possible business interruption insurance claim as of March 31, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company completed its acquisition of Coral Chemical Company (“Coral”), a privately held, U.S.-based provider of metal finishing fluid solutions. Subsequent to the acquisition, the Company and the sellers of Coral (the “Sellers”) have worked to finalize certain post-closing adjustments. During the second quarter of 2022, after failing to reach resolution, the Sellers filed suit asserting certain amounts owed related to tax attributes of the acquisition. Since the second quarter of 2022, there have been no material changes to the facts and circumstances of the claim asserted by the Sellers, and the Company continues to believe the potential range of exposure for this claim is $0 to $1.5 million.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, during the three months ended March 31, 2024, there are no new environmental matters or litigation that the Company believes will have a material adverse effect on the Company’s results of operations, cash flows, or financial condition.</span></div> 5000000 5000000 0 1500000 false false false false

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